Gene list
Applied filters:
Organism: Borrelia recurrentis A1, A1
Gene type: CDS
Number of genes found: 990
 | ||||||
| Show UniProt / TrEMBL protein name | |
View in Fasta format (DNA) | |
View as list | |
|
| ||||||
# Borrelia recurrentis A1, A1 >BRE_249 Phosphatidylserine synthase MIKINLILAWLVHILTASGLIVGFYSIIAIINTDYNLLIKLTILGLLIDG IDGTLARKLKIKEVIPTINGELLDNIVDYINYTFIPTIFFYYSNFIQEKY KIIICIGILLASAYQFSQLDAKTSDDYFRGFPSLWNFLIIFNVIFEINKN TNIIIILSCIAFSFVPIKFIYPSKTKELKYITLPITIITSLLIILIIFIK LPDIYLTIGKTLIIIYCLYLILASIYLTCKTKQK >BRE_772 DNA polymerase III gamma and tau subunit MKILPEIAKTIINEYKKENLANAMLFWGERFSFKKTTAITLAKEILNTKN LTNPNLIILSDLNVVEAKAYLSSTSNEVINRYLEYVKNIIFAKYNFSSDK NLKKIETNINFINDVYYNNQYNDTTKKELINKIEEIIKEINFNITIKDVR KIKYWVLSEKNKIKVIYINTIENLNFNVYNALLKILEEPPPNIYFILATR NKNKIPKTILSRLRIYKFKKENREFEISLFQETFKKNDKLTIEEYFKSFN SEEHTKLKEEVKKILNVIQEKQSIFNLSSTNFIKDDNIFSLFLEELTNQL RNEFLNQNLDINTYLQRLEHLKYIMKYNPYNQNKKLIIENLMLHYED >BRE_810 uncharacterized conserved protein MVKISDNSEIYDLIKDVTYLLGISIIEINTFRKRDEFKIQIVLYKSDNFS VDMLCDLHKMILLKLEAVLKYNVSLEISTPGINRKIKSDREFKIFEGKKI KLMLNNDFEEGFILRAERDGFIFKTEYKKVKILYSNVKKAKLS >BRE_32 uncharacterized conserved protein MNKKNFKKLIIIILTFLNLECSSESIFSQLSKLQKINSNNNILDSSSPSG ISLINNTLYIAAMHLFKKENGNITRVNFSNSYEFVIDLVNVSGTTYLLVQ NKNGQLELYSFENNNWKLLFQKNVTPIKFLKSISISEITAAYILAIENNG KQIILDTNGNNQTPNSATHNDKFYQISNSNKSITGRFAKIWKLNSSEVTK VNTTNEIMAIIDTNIRGSQETLVFTGRNTDSTDNKFEIYSNKDNYKFPIF NRDNIGEFIAYFAREFHDIILIGSSNGFVELIKDKDTFILQPPSQSVLSG SYNGSQLSKTRLNDIIPISKEIIYILTQGKGLWKIENKKLIKE >BRE_817 uncharacterized conserved protein MVFINHINIIFLSLFLFVSCLTNENIKIPLEKGGVEISFDLMVENKDSNI DDLKIEERDYLLGLRDNESFFLSNAFLQEENSYFKSARESYAKQDFGAAS YYLNKIVTDEKNYPKELVAKANLFFGYLNYSMGIYDLSEYNFDNFLKNYK YSHASLRVAELKYFVKDRLGAISALKEVDQTSLNSDYDLGIYNFLNNKFG INYLNLETLGFLDNSIFDMFVFENNVFVANIFGGLLRYDIKNNEYKVYIK DKKSIFLNGLKGFTEHRGSIYIGGNNVLYYIDDLEGSVKQVEKPLQINLG SIQVLLGAKDGIFVGTLDSGLWFYSDRGEWTYIKLNSNRISSLYLDEEKN LLFVGTMNKSIYSVDLTDFNNVKHLNFFSKLESEKNINFIKKYNNYYYIG TYGGGLFRLNLDNHTYIRYDINNDSSIGYFLDMEIRDNKLLFATFEHGLL IYDTMSDSWDYLGPGDGLISLNLIKILNFDDYVILGTLNNGLVFINESIK KQL >BRE_329 putative lipoprotein MNKLILPLTILLVSCYTIAHLDDQLTEKTSHRIYLKEAQKAKNINDYQTA LKIYEKMIQNYKENKEIVATGKYEIAFIYYVNNKKETAKKLFEELIQSNI ETPKWVIPLSQKILQKIKTQ >BRE_696 uncharacterized conserved protein MQKKIPIIILFLTSQCALMGTNKDLAFLYSDIHKLRDNLNLKKLEIDQTL EIVAKEYAINLDKNDVLTHTLFGTTPMQRVSKYDKNFCRIREILAAKMEV QDVTDAWLQSPKHKEALINKDTSKIGGYVLRTKDNKNIFVVLFGEKCKKI >BRE_1078 uncharacterized conserved protein MILNIILMLTTFVFSCSRLSASEKITIHHNVDDSTVKVEMVLGNDLGGVH VVYPYVSDKYKGNYILFNFDIKTKKALNLLRVSFNGIEVASKNLWRFYDA PLELTGKEYLLPFDDSIELTGFYIYFDPALGEHLQLGDMSRT >BRE_275 uncharacterized conserved protein MLFGKKSKYVLLFSSFAFILAMILGIFARVSFLTVLFRAFLQFLIFFAIG LLIEFIYNKYLYELFKDNDLSSNKDVINKNDNSQPEPNDIDSSLIKDFSS KNDKVDNSNYDFSEDLNKYADVRDRQNNVNFESKLSEQISYVKNSDPKVV ADTIKTLINKKE >BRE_190 uncharacterized conserved protein MLHKINILLITIILISYLSCTKDKITDKDFSYVIIFSNATEYFFKIKNTP FIQENILFINEKDIENIKEKLNNIEKILLTHKLNNEILNTEQIKNKTFYL SEIKFSLKKAINSIFNDPSIDLTTSLIIRDHTINQEDSKYLEKIAQDHNI NITTIDDKNISHIKNLITPKITKAIIFSMRNNHIFLKKLSESSLFKQIEF ILIGNIKQDIKEVNVKYIISINIPNLIEIIKNINKNFQYEFNIYKTTK >BRE_543 conserved hypothetical integral membrane protein MLELTQDKQEIKIKNKFLAHVFGLMSVGLLISAIFAYTTSENAIIRAIIF TNPMSYIAIILIQFGFVYAISGAINRISSGTATALFLMYSALTGVTLSSI FMIYTQGSIFYTFGITSLTFLAMSFYGHTTSTDLTKMGSYFMMGLWGIII ASILNMFFRSSGLNFLISILGVILFTGLTAYDVQNISKMDNMLEDGTEIK NRMAVVASLKLYLDFINLFLYLLRFLGQRRD >BRE_65 uncharacterized conserved protein MNLILINTNEFHNGIVLNDPRVKHITEILKLKNNDTFKFGIIGEEYIYSC IYHKDVRLFFKKNHKISKSNKLTKVKVVIGFIRPIAAKRIIQHLGSIGIS EIIFFNSLLSEKSYSHSKLFREKEYEKYLIKGAMQGGITYIPKIKIFNNL IEVLENIKDDNFNTTKILLERNSKNKLIDLNIKTENVVVIIGPERGFITK ETNLITKYNFNTYNISPNILKTETATIVASTIITSKMND >BRE_316 uncharacterized conserved protein MDLVHNENYQKILFIDSLILQTLDEIKNVKKSGKVGVDSNKTVNFINLNL NVLSYILSLNYFYTRPRLKVNYDFRTNLFSFISDFSLFVSPSLLISLSEL VSNGSVIKLNPEERFLIIRKLGYLIDLGMYFSKGDSKSIFLLEDIYLKFI ILAKNFIDFKNLAKNLVIDSPFYKSQLLHLTKSLELLEEGAFLLRSRYEA NGAYGLTEQILNYIQAGKILATVTSQKEMAEKFSKFYEVWSVKFKSDLSK NK >BRE_16 uncharacterized conserved protein MKKISYFTKEEIECPLCKQKFRKEELLTGSSRLISGKLKVDLKREYITNE KYGDIYPRIYSIIVCPNCYLSAFPNEFHTITLINNKTKQLLINHTNERKQ IKEIFEDDLNFNQPRRLQEGAASYILAIMCYEHLDKNHNPTLNQAKCAIR AAWTLEDLEKKYPNKNYNYLQKIFYHKAAYLYKLTIEKEQNNSEPINFAI IFGPDTDKNYGYDSVLYLSGLLEYFYGNIENKQYRYNQLIEIKTLLSKIA GMGKSSKEKPSILLDKIKEVYFKISREIKTFK >BRE_535 uncharacterized conserved protein MSRYFVMVLFLCIHNLIFGIKLINLESIDFYRSLEKQDLLFIIHLLEREK YLNQKDELFTYIDLANQALIEKGTQVLGGNDKLDDMQLINSLQRDNLDNY NSSKFVLQASKALNIFVFFDDIDGFLKTLDGRRVSFSDGNFVILDQVSFK GYNNVASEHSTIEIYEKSILNPDFNKLILDKLGFFVYIGELNKKIYFNDI VKLSKGELLFLFYELFPISRLKGIKDWYDFGFTSIIREIKKVYNTRINSR KLK >BRE_610 chemotaxis protein CheD MINFMLNHFNFKLKRDVTIIIPGEAFVSNDRVISTILGSCVSVVLYDEFR KLIGLNHYVLVKSDLVVDDLKKGRYGVYAIPMLIDAMIENGASKSNLKAK LFGGSNFMAKGTIKVGVENSSFALSELKKCGIPILAKDLGHSKSRKIFVY PEDFRVVVEYPDGAKVF >BRE_1107 hypothetical protein MKEVKEIKFPKRKNLKAEEMDIEDFIAQVDYTTMQLDREFREFQRQYGSD KSLDDWMVHMEQENQIQNKKIQETSETLSSRFAKKLNGVIGKD >BRE_649 conserved hypothetical GTP-binding protein MKLRYNLKMSNKINWFPGHMKRALELIQINIKKTNIVLEILDARAPFSSK NPLIETIIKNSNKDKIILLNKSDLVHEGEILKWKKYFETLGNNVLITNIY KKGIKKQIINNIKKIANIKKIKTYKEKIKVLVIGVPNVGKSSIINLLVGK KSTSVANKPGHTKNIQILKVNEDINLFDMPGILWHNLENQEIAKKLAILD MIKNEIIDNTELALYLLKEMHIKNKTKLIGKYNIISTDTLKILEEFATIR GFINKKYGTDIESASKILIKEYREGKFGKIILDLRPDNSNK >BRE_741 uncharacterized conserved protein MKTEVIKESEIEKAVKFINSGELVVFPTETVYGIGANAYDENAIRMLFIV KKRPITNPLIVHVESIEKIKELVEYIPDSAMILMKKFTPGPITFILKNAG KISKLINGGLESIAVRIPSDPIALKLIKMSKVPIAAPSANLSKRPSATNF EMAIKELNGLVKGIIQKNEVSQIGIESTVISFDAKSNVSILRPGSITKEM IERELNGKFNVEYSLGKKILQQSPGNLLEHYRPRIPVYLFRQKDNIRKYI SQQDTKILIMKNTIKSYWFNKLWNTNHICVFNTLEEYAKNIYKVFVESER THKQILAEFVDNNQLGYSINNRLKKASLDKFISE >BRE_231 HbbU protein MSCSKRSKVTKSDIVDQIFLNIKNNNEKLEKKYIRLVVDAFFEELKNSLC VNNVIEFRSFGTFELRKRKGRQNARNPQTGEYVNVDDHHVAYFRPGKDLK ERVWSIKG >BRE_1088 putative lipoprotein MNKKSIVNLIILLQFITFSCKSIASLTNEPEPPIEPTLKNLSIYETQLTS YVLYFETFLIRAKQKFPNYNFPPFTLFDPKNLKEEHTLQTIKENIKHLKH YINTTKPIAIDVYKKCSKLKK >BRE_69 uncharacterized conserved protein MKFVNLLAIFIFIVFNSVYLFSNLLNVVFHDSYEDAIDEAKKLYKNVLIL VGKDIKDNLIRDFLKSFEDDKIFKLIAKHNVFLVIDVNNEIFSEINLKKS PTLFFVDAKSEQVRAAYTESIKDTVQYNREFLNYALGVFKLDDIVYKNDN YEINIFDDKVFFYKTLDGHWRLRMNGKDKKLLPSKIELKEFLVFQDENGG RLYALPKSKKGGIYFSESEKEEWKFFGQIKS >BRE_350 fibronectin/fibrinogen-binding protein, putative MSLNYHEINILLEELPLINSFLKKIKQPNYKNLVIEFYNKSTDEKIFNVL ISLDPQKTRIHKTNKKFENIKPPLRFFEFLKSKVTNAKVCEAHQIKNERI ILIKINKNQNYYCIFIKLWTSSPNIIVTDTNFKILDAYYRRPKSKEITGE IFTKAKKIIENNDMTEKKEVKLKNEYDNKLPYSTFIENYYDNLKIKETKT HNTEMFNKTYEQEKINLERKIYSLNKQLISMDIIATHKEKGEMILSNINK IKKGMSEITLQNNNEEEIKITLEKKLSPQDNALKYFKTYKKNKIFLKIVQ EQLKNAKTQYNTLISNTTYTKEKNHITLTNEKTTKQKTIQKTSIGLHFIS HGFEIIVGRNAKENDELLRSWAKGNDYWLHTRDYPGAYVFIRNKKDKTPP LEVLIDAGNLCVFYTKPAKQAGKADLYYTNVKYLKKIKGEKKGLVIPHRE KNLNIKLDLKILNKLKNKN >BRE_667 uncharacterized conserved protein MRKVNFEVFCEKCGERVELDKAMCLNCHSKLGDLECPSCGYVGIISAFEN GCSKCNYSPFEKQLKKLSINRGFKRLWSGDSFLRRKFYFGFYVNVMLYLF ANFLIILLFVYILFF >BRE_14 uncharacterized conserved protein MMITKKFINIIKLLFEDWQNKAISILIAIIMFITFYFNSIESVNIEKNFN ILLENEVTLGKMPDFNKILLTVKINKKDSKYLDFERIILSVEANNIKEAG EYELPIKIKNFNPIPIVEYKLSKNKIKINLDKKISKLVKVEPKFKLIEKE GKGEYFIAKYNIVPERLTIHGPEKVIKSINTIKTKIKEFDTNTVFISDHL EVISPDQLITLEKNHVILNITLGKKYIQTTITKPNLIFNNLKNGLEIKNK EKILDSENEMFIKIRSGLSEKITKMHINNNNINLNLDLSKIENPGIYDIK TDIILKNNTYGIEVYEYEPKTIQVEITANE >BRE_669 uncharacterized conserved protein MNLKILFALIFFVSCVRHIYDKEIIINDTKFFVTLAIDKVTRAKGYMGTR HIGINNGMLFIFDKEKNLSFWMRDTSIPLEIAYINAAGIIKEIYSLIPFS EVSVNSKYKVKYALEVPGGTFSKFKIKVGDKVKFNFDVNSLNIE >BRE_656 uncharacterized conserved protein MSENEFVFCIGYDGIRAIIDKELLGQHKDKSVEELFNLGFYRSAFSKAFY RKDDALIDYLIKRYNNISNSTYSRKEELELLFGVIYPDDIANIKVTYV >BRE_440 uncharacterized conserved protein MEDLSFKKVADVLKNYLNTNICSNKKLSANLLLSQNWQVIFKELADKVKL LNLKDNKILFVAVKNSSILYNISCNKAKIIQSIKESAGLEILDIKVLIR >BRE_120 zinc protease, putative MYIFFSILAFTFIIFIHELGHLFFARLFKVKVEVFSIGIGPSLFKIKIKD TEYRFSPIFLGGYCKLKGSEHLEHELRLNKQLEANKDSIFGISHFKRILI YFAGPLFNLIFALIVFIVIEMIGIVYPDYSNKIIVINKNALSKFRDGDVI LNVDNTNIKYYSDLKKVLPLKNSKVTFTVLRDGENISFEDNTSLDKFLEE INPWIDLVVAKVKINSSAEVAGLQPNDRIVSINDVSISNNRDLDDLISKL DVNVVDIKYERDGEILTSKLVFQDINKNLGIYLLPGLKRLVRADNLVIAF TNSFNKVLDILGRILYSIIELFTNFRSNSKNITGPVGMINIFAGSFAFGV LYWLDTLAIFNLLIAGMNLFFVVIPMLDGGQILISFIELVRGKRFKAKII YYFYLFGILMMLILFILGLLNDLSNF >BRE_551 uncharacterized conserved protein MRDFNNNNNKGFLVALTSIVTVCAIIFLGIIIFFPNKNLASDIAGKNIIL QETKNEKSTENENNQDTLSITDKPNEIIIDLTKTNKEDTNFNNNMDKNNK EIIHKKEAQIVKPNIPKKTQTQAKTLKPKKINAKASQEIKKKQNYNKLES KYDPQKEYYIQFASLSDPITADNNIQELMKYKINAKIYSATINDKDTYRV RSGPYKTISEAKIDLQKISNSNEFKDAYILTINK >BRE_457 DNA polymerase III delta subunit MQEVYLLLGKEQGLKEAYLNDIFSKLNADDIHITKLFMSELSSIELSERF LSSSFFAKREVFIIYEIENLKNKKDLELIYNTLLKPLNKIIIFISDENSI SFEPKVSVNVIKKTFYELSDNDKFSFVKKSFFQLGIKITDKAINLMLFML DADTKILQSYVNSFALVIKDKTIDEDDVTAWLSFVRLENVFSLFESILKK DMERALVKVKAILEQGEELVGIIMSLGWKFKKFLKIKIDCENTNNISSIL KKHKIFFSLEKTYKIGLCNYSVLDIKFIFKILHKFDLYARVYGKNMHLNL SYFMVVILLNQDDTILENFSLKFKCDF >BRE_4024 MlpL-like protein MNKLNILFLIIILLLNNCKQSSSNTQNKEDKHKKDLTEEQLKEKQKNPEM LLKEKLSDDQKKALEFFKEALNNESTFNEFLKLDISKINPILDHIHNEVT PCTREKANSKDQFKTLIKGYFNNQIDDNKLNDFATNVKSMCNS >BRE_702 uncharacterized conserved protein MKEYGNEIELIEFVVKSLVDKKDEVKLNVVEGEKSTILELRVSANDVGKI IGRRGRIARAIRTLLSACAAKTNRRVQLEILD >BRE_586 conserved hypothetical integral membrane protein MITETLIVFLNIYRILILIRILLSWLVSSGISSNAFFKFIYNVTEPFLSV FRSIRFFRFGIYDFSPIAALITITITERMLSYGNYKLSTFIVLFIMEAWG ILRSIFFALIFFFVLRVVFLFLHLFNGTDFMKNVDSLLVLLSFKIKNIVT DKHMSYAVSLIVAASLLLAFIIIFEQAIMAINILSFYLPF >BRE_53 uncharacterized conserved protein MIQGDFLNNEMLWCIMLICTYSILIITYNFFGQKGLLAWLVSSVIIANIQ VLKQITIFGLHATLGNIIYASSYVATDILSEIHGHKNSKKAVYIGFISFI AFAFITNIQLYFSTNNSDIYLENLENIFSSIPILLIASIIAYIISQLNDI YLFRFIKEKFPKFLFIRSNGSTLVSEFIDTIIFVSIATYFNIFPKEAYLN IIISTYFIKGIAGIMGTPFIYIAKYIYQNKKIQINE >BRE_526 Response regulator receiver (CheY) modulated Serine phosphatase MRMNSNNVINVLNEFGLKIEEIFLLINTYSYALYKETPRYFYDDITNYLE LTLDIANKFQGEFADSKDLKLGKFMLRSMKCDLMSYLYLSLELIDNSMHY SGIGDAGIAFFKAISCKILSVVSYIEIEFENMVFSSALKNRKDANKGGNQ LLIFSCESAYSTKLVNYLILKDYIVISANTVDLFSQLLCDNFYDLIILDL NSDENIQMILDLLRNIKSNSLYEMVPVIVISQITRKDIIQTFIEEQVDDY FFKSLDLLVLDIRITSFLKKKKVIEQGQKYLDLVLHGRECVESELIEAGN YIENLLPKKIRNEFFHSNWIFVPSKRIGGDFFNYYFVNDDNLIIYLIDIS GHGVDSALLSLNVSSVINSYVMNNNDISPYKVLNYVNTYFVKFRSDMFIT LWYGVLNVKTKHLRFASAGAPPAVVLSEKGNVYLKTKGAILGIEEMYPCK ESECYLNKFSHLLLFSDGVYEIENNQDIIMSIDDFYKILKKNTLNLDSFV LERLYNKMLNLSKYNVFRDDFSILEFIIY >BRE_1027 putative lipoprotein MKFICMVMSITFGVLLFTGCDAKGPSGRMGLAGSDGVDGKPGKAGRGDLA ILYMNFFNLYRSYTANREKFDSEVNNFDAEAFFSHSVFKDEFSGSNVEQR NDFYASLKYNIEDIKVVEKVVEILVDNKDEIIRSNALHVLNVLVDSARHV KLVLSALEPSLDVLNEIDDVEGISDLNVMLMMMWMGREKIIDDIRLLFSM LKGYIDVGNPSMRNIMNSLNVIITSSGNIYKQVNLGVDSLFSLKEAILNK IKNLKRRV >BRE_349 uncharacterized conserved protein MSFIMNKIKKIILIISPYLLFAQISANQYFEEVHSKYQNVNDMQAKISLN IKGLKQTGTLLYKSPDKFIINLDSNNQVFVSDGEFLTIYVPSLGTSFRQQ LTMGKSGSGFMNILSTEYSVSYTNSPNLEPLDESGGRGGAENFMKLTFSR RLYKGAATIDSFMIAFTPSGAIRRVIAYPTDGGREIVIDLLSVKFNVGIS DSKFKYDLPKNANKVDNFLYDVKKT >BRE_800 trypsin-like serine protease, typically periplasmic, contain C-terminal PDZ domain MMHRKIFIVIMLIFSCNTIRDIDDKQIYYVPSESISKHIEDNNFEFALSS YYNLRNNGFEMEQDILDLRDKALSGIQNEYLNLCKSKDYEGALFKLETLN LFGIMLNESKKQLILKHLESLRHKDPMLASFFAKYYLFDNNFDFLQNFVI HEKSPSKNVLLDTAVLTVWVDMGTKIVNGNRVPNIALGSSFVIDNLKGYA LTNYHVISSQVNSDYNGVSNLYVKLPRGKGEKLPAEVISYSKEMDLALIK VSFKLEHQFNLDYSANINIGDRIYAMGSPLGFEKTITSGIISGKNRNLLS VGDSYQIDAAINQGNSGGPVINENGGFVGLTFAGFVYSQGLNFVIPSKWV LKVLPFMYRGGVLKNNWLGFTFSESLNNLEISYVVPNSPADIGGLRSGDS ILSVNSLKFDSLRELQYYILQRKSMVSVKYKRNNKEYESYLYPQNRPENI FESIINRDSFKNVVGAFLGLNLSFIAGKEYRVAKVFANGLGDELNFRTND EIFIYDLKYIRDKRVFILLLYVKRLFSGYLGAPLQLIIPFDSIIFV >BRE_635 putative lipoprotein MDKFYNLIFFTLIFIACTASSEIDLQDNASGTISVVFNVNKEFERIRREL VTTLVGGDAAKMSLFPVDEIKQYFRDDGEKIGLKLLDIKSNGDSLKLVVK FDSLIKVARYYLAKENLPLFKIENKNGKNIIDIDLNLKNVTKVINENKEY INDELAALLPSEEIPMSEKEYRDVLMYFLSDFTDNASALIDNSNFKIKIK TSRKIQEQLGFNQINSNTLELNLDMIKTVSLQKPIKLRLVY >BRE_819 hypothetical protein MCFLLGDVYGWKGVYSSTCSKPYSCYYLAKYSFNGCRFNTIFETSKEMKV DKIFVNNILLTFLFMNFLFVILIVLFDLLTNLLNYLEHNLSINDIIYIYY LYLPKCFSDGVALSFLFAVSNLLGNLSMRNEIIGLFSCGISIARILRSII MLSVFVSVILFFFDNYLVVDTVAERDAFLKNNIGNQGANDRNIIIKDFAR EIYNIKRFDVETHIITNLMIILKDQDDNFKKRYDISKAEWVDSKWMLYGV REFYKVELDVIEKFYEVLDGENIVNLEPGYIKIIMLSSKTLNFSKLVTWI GDLIKENLNYSDALFDLLNRIFFSFRLILLSFTVSFVSLFLKKNIFIWSL LNSIAFAVVYVISIMVFNFLADLGYLSIFIASSLPTILFIIINFVIYNLI CK >BRE_854 conserved hypothetical integral membrane protein MVQKNKMPSSFTIVFALIVFMTILTYIVPAGEFHKENREVNGNLQEVVVA GTYHAVDRAPRGFWDGIFIVLTAMAKGMEHAVEVIVFVLIVGGAYGVILG TGAVDAGIAAAIKKMGNKDRLLIPLMMFIFSIGGTTTGMYEETLPFYLIM IPLVIALGYDSVVAVAIIGLGAGVGTMASTINPFATGIASAIAGIEIKDG FYFRIVLYVVSVFVAIAYVLIYAIRVKNDPKRSIVYSQREENYNLFVKGR SDDKSDSMPEFTNRRKMVLVLYGLMVVFLIYSILELGWWMQEMTMLYLGT AILSAFICKMNESKMWDTFVEGAKDMITAALIIGMARGVMIVADEGMITG TILHAASEFLYGVPKGMFIILNELVQIFIGFIVPSSSGHASLTMSMMAPL ADFLDMPRSSVVLAMQTASGLVNLLTPTSGVIMAVLGMARLSYGSWFKFV MPIFVIEFVICILVIMANVYL >BRE_1081 hypothetical protein MYFLVKNDNMNYKITLPSKSVKGECLMKKIILSAFVALFTLISCGDKKVD PSKYGTGTGINYVKFIQDPDKVVALAKNFNDIKDALPKETTDKPYKEANL TAAFTAISAHEAKFLKALALEKARKSAKENENANSTEIDKEFETYLTENL KFAKGDANVDGSYASVMKKFTDELVK >BRE_631 uncharacterized conserved protein MEFRKLLFVIFFMIIPSIFFPRDYKGLDFKIKFFNQSIYRVNSNVSIEVL LSNSSDDLITLEVGDVNTFGFDFDVTDTTNIKVKRSLEYVKNRSKNIAIP VRTLILRPNERFSVVMSLNQFVQFDKDGVYFVKGVFFPNISDPQKRVESN VITLFLKPKVDNLAEEFDFSNLASNREVQNVLKRENLSPDKVIEYLFSAL RLGEREKFFLYIDIESLILNDQNKSYLYKQELKSGSNNMIEEYKEYLWNN GNSYISKVPSKFSIVETSYTDSTGRVVSDVYFEDGHFYVAKRYTFFLKKY DYYWIIYDYTVQNTGIKEKY >BRE_355 uncharacterized conserved protein MLDMKKELFTFLSNFIVFLFLFVALVFCYTYFFGVAYLEKHILVATFFDT VLSVYHNFNGFFIFFVLIYFIFLAKPETRLYFKGYKGYLFKKFYPFMFLF FVIGIVFVLIFNSIMSYILSQKNEYKYNYERYNLLAEQTTTIMNELKNID INLSSNKTLDVNELVEVFKQKKKYLEELLRIYEKMRLISDNDELSINYYL ARSEYDRMPLYGVDLEKVRKTLKMYLIKSLSKRDFQDIINGFIDKGDYAT ANYFAYIGFFATKDDEFSALLDLTFKAINEYKNVELEREASIFEEKQRNF LYLNTEKFKPAYYGFLKLHNLFPNDNEILSYKNKSLDKLKIHYFFFDEIE KYYEHYGINDVFLVQSNSGDGTYDYIYMQKVVNTVFSYTKMIKNFELIRF DSLGKVILHIKVPFATLKGNTVYQNVLDKKSENSDITATRVFVLLKDFDL SDIKIIDLNNNVDNLHLFANSVKGSIFLPIQVLISAFNQIKTFNLRLIGI FSSSLFLMISPILLVFFGVLFIAVASKVDFEFDLKFMVFLVSIVVAIFSG IVSLLINYLLLTLIALFMHLSGNIYISFILIFSFLFLIVLYVMLVNYKKD IPSL >BRE_63 uncharacterized conserved protein MIKEELNLWAEGVEFRHLDAYYNFILSVLNFLCIKEYELSVILCNNEYIQ KLNGEFRQKPEPTDVLSFNYFEGSEQINHKIQGDIVISLEYLEFSSLEFN VEMYEELQRNTIHGILHLIGYTHDTNDFQNETMLIIQERVLRETRRVF >BRE_54 uncharacterized conserved protein MINIILWTILITFVYSQLTLLYYLFGKSGLFCFNIIMNILSNLIILKKVT IFEQQISLSGITFLSTLCSLNLITEKYNEKSAIESITLNMLSHITFVIMM HFTLYFHQNEFDTSNIHLKVLFYNASYISIIFTGTYIIFLSNYVNIKVYS MLQKNNINSKWISHNVSRFCSSCIAYMLANISMYIIEQLYPGNNINMVKS SWIFTIAIMIIDTFIYCFLNKLKIRKTAISQ >BRE_361 hypothetical protein MLKINSLKTKRIIMTLIIAMQTIASTLILLALYKLTSNTIFINNSSIKFL IAFIIFSPELCIAILTIQYILYDQLKILSNLINITKSLQIIMNILLATLG LALELFKTYQPWLFTFLEIIIITYVIFNLVILILLKFKDKITE >BRE_529 pantothenate kinase MMSKIVDSTQLIVDIGNTSISFALYDVGGMQIFCKLKTKLDLSFRELCNF LKLKFNFKVSKVFVSSVVPVIDKVLIDAIIFLYNVTPLFIGYDLSYDLSF EFYNGRKFILGSDVFANLIGAIEYYNINDALIADIGTACTIFAVSRKDGI LGGLINGGPFTSLTALVENAYLLKDFNLVVPQNLLGLSTIDSVNSGVIYQ YKYLIEGVYHDLIRNYDREFKLIITGGNSNLILPLISVDFIFNLYLTLEG IRILGNAFKENHLS >BRE_447 heat shock protein, HSP20 family MIKKEIYMWLTNYNKNFLDFLNDDFDFVNSRGIQDVPVNIKDEGDSFVLE AYLPGIKKEDISISIKNDYLTISYENKDEREERDDNYLRVERRDISFSRS FRLSGNIEQNKIKSELKNGVLLIKLPKNSEVIEKSKEKKIVIE >BRE_762 ribonuclease Z MNFNINILGTGGTRPLHNRYLTSVLIEYHGESILFDCGEATQMSLRKQKI SWQKIKMICITHLHADHITGLLGIVMLMAQSGDTRKEPLTIIGPIGIKKY LETNIELLRVHKNYQIIYKEIIINKTEPVLYEDKRKRIEYIKLKHSIDCI GYLFIEKDKPGKFDTQKAESLNIPKGPIRKKLQEGYEVILNGRKIVPSEI LGEIKKGLKFAYITDTAYFEELSTYIQNFNLVIIESTFKDDLKEEAKKKL HLTAKLAAQITKKAKVYQTGLIHFSERYTLNKDLYELLNEAQQEYPNGNI FLAKDGMKLKANKDKFIIK >BRE_481 uncharacterized conserved protein MSQFKLKYKLLKNSIILIIFINISCIKNNDVKSKETGREITYIVNIKKNT EKIEIIRFKTNKKNKLIITLKNNKKIDIKQNSLAIFKKGNKTGHIIQEGI KAGEKNI >BRE_1051 uncharacterized conserved protein MRYLFQLEGDIKNMKVLGNLLLFFVLFFCCKDEKYSGNFDLVYDSDDVAF RDIIDSDFDIGVNFDNVSLEKLISDFDLSNEEKQAVRFLRSALTDSTILD DMSHIRTYSDDEFYEFLVILNADKVKEAVADIVLTLKVRDEILDAIYEFA DGKILKKIHLKYNLM >BRE_632 N-acetylmuramoyl-L-alanine amidase, putative MIIIGSFMIILFKILELRRNTRPFILKIKWFWSILYIITFIDLYANFKHE VVKGDTLYSISIKYKVSVKELKIANNLKSENIKIGRILFIPSSSKSKNKL NTKKVNTKKYNQKAKVVKYGTDSKIYIVKVGDTIEDISKKYGVKEKELIA WNNLSSKILKVGSRLNLDEPDFLKPYLVKRGDSLSKLSVDFDISISDIMR FNFLDSKNLVIGQKLYLKKASSNVHFHYVRWGETLGKIAYIYGVTAKHLV RLNGDNAINLKADSILDVSRLVESDLATPSVLKLEEKAKNNETFISHKVS VGETLYSIARQYGILLEDLKSWNNLNGNHIVYNQELKIYDKSKSSIIDDK VLDGIVGDDDNSKSKVKAIANVVSAKNKKLNLDFSNVLEHRNAFDISSLV VLEPKIPIFEFNGIFYYWYKPKKVSQPSEFYSEDWHSPLNAYKKASQLFK SFENLVQSRPIKNNSLKNKLIIIDPGHGGLDPGAIVKAKDGLNNEIFVVE DEYVYDIALRLYVYLKEHGANVELTILSPDHLIRDSVTANNTFVNVKNEV YNDYDLNKTDTVDSWINGTLEGLKKRLSVVNKFVNKYRNIKREDMLYISL HADNSVGAPRCMGFYYHSEDEGGFDTHSKSIIEKMTADFKRSPYIKGQNL YMLKNNIVKTKLLVEVRNLAFDEEAWAIRSSKLRNLDSKILADAILKIL >BRE_443 60 kDa inner-membrane protein MSPNKRILRAVYLSLFFIGIFMLLDDFLFSRKASSFMNEEIKFDLNKDFD IDNSLIDEDFTFNLSDNSEDINVDTDIYHATFATFGGNLISLKLKNHLNL DKKPTEIVKVHPQNQSLFYITLDKLSKSLFLYEQIDSHVHDFKTNVEVNG KYYEYIKRYTFSKSNEYLIKLEIFLNNIDVNDDIGIDFYKFVLNSGIEEL SAKGKLQYNNYLSHAIYYDTKLRYGKDGLNIANPKWVGAGTKYFEVLVSK ENMKVEFKHENKVLNAFILNKLDNKNVSDVFYIYAGPRDNKYLDIFNQRE LNSFGLSNVEFGMSVEKSLLYFLQVPMQLIMQIFYNVIPNWGLSIMFLTI VVRILIFPLTFKSFRATAELSKLQPKMKEIQVKFKSDPKRLNEEMGKLYR EEGVNPIGGCFPILLQLPVFFALYGLVNNFFVLRGASFIPGWIDDLSIGD SIYYFGYKVFAWTDIRILPFIMMITQLLSTIVSSNVSFKSLGSQQKFLYF GMPIMFFFILYDMPSGLLIYWITTNIFTILQQYYIKMNLSERRNK >BRE_3002 antigen P35-like protein MRKNFFTNIFILFLITLIMAGCRPLNKEGGYGGAGQRDGASKSQEIDLIP QLIDAYSQLIQSEEDDEVNGDVQKNLQSDKEKTELIALIKEKVKTEIEVL TKYSNKIEDNEQYGMKWGVFKFLIEDNNKRNIQSAENTLARKQLYASLEW NEDRLRKFGTIMNEVEKCDRVVAKTILETGMNFVQGKFENAIISIDDKSQ DLDNLILKELKDIKKNLDLIDSFRKQWISSVDSIISEYDSNTGDIQKDSQ ALVNRVNTEYKEIFENKIDEIKKAVDDIQTILK >BRE_757 uncharaterized conserved protein MISHKNSFFIKEGPKKVDFDMDSVFLQHSVNAQVVSIRSDDIKVLLDEKL LKLDSSLKQRHGELVDYLKKVEVRISRVENTILDRSLDFLENSDNSSLKS MSFMKSHDDIIVRDNEFSEVLKRENNLPNVSLAQEELDALLEGLNEISSD NKKNFDNDNNGNAVEDDSEPKEILMDDRKSLDIDNNLSLYNNDIYSVQDK LSETEKDESLKSNLAMSENIDLLEESSSLKMDNIVHDDGSDQASAASLDE YNKVLTSSFTDESPTNVELNSEDDYIDNSSVNEVTSDMKNIESDIASFEQ DNLGKYEQHSLNSNLNEAMSLDQNLQDANDVEVQEGNKELDGLVDITDHK VNSLDMINDGKLQESDHDSTLTVEHKNSNVVSSNLKKFDNFEDVLKADLN YVDLQNCIKDFEEKNLYDDAGDLEEKVGQDEKLNASFLKEQETTGDGYNS CNFSFTDVEAIINKFNDNDYLSQINLSDEERALLVKFIDNLENELSFKPK GNNFKIKKEYEILQKIKRLLERE >BRE_1076 hypothetical protein MKLQIYLEVRMGFINKIGVLNIFFIFLNVLPFSYQFCGAMVLGDFSPNNK ICNLIDSVFKSATTTGADRMVMSSVVNFGFKIKGAIYYLGSDDVAEVISD IDVNTNREVVGEVVGSGVVGMQDENGVFNFKDYGIDIDEVTSEKSNSDVI QNSNIIKPKLVKKTQNNKDLGDDANDTDESFGNISDNIVKFSSRVDKFLG WMRDDSVKWKELITLMQKFYNKKRQEIRKKMAGWHLREPFFVDQNKGTVH LCDTYVVDMKGDNIKIFLDDYSEENSSDWSWACIRFFAREFLFALTAFGN NYDKIYEHLKTFFEGSILESALKDSFKK >BRE_172 uncharacterized conserved protein MKNMIFLATFFLLFLYFNLFSYEIQNEMFIPTRYYVGDTVEFKFSLILDD DEKFIPIAFESIKNEFVEIDKILYRPESGEIIIYFVSFYIGSNTLPHIYV GDIIRSDKTFKLILNNIKINTSTLVADDDSLKIQDIEGVLFLPGTSTYFV IFILAFILIPYLFIKFLKLIKQLLVFLIIKHNLRRPYRVFQKQLSILDNY IKSEEKQNVFYNLLNSSLRVYLSKKTGFNFNAITTTEISEILQSLNVPHE IRSTFVNMLRLSDFSKFSGINLSGDNLSLVLNDLKKAAFNFEEFNRGDNV NI >BRE_515 uncharacterized conserved protein MRYIFLFLIVGNLGLFAFENFFYDFSVRSSYSNYFSSSDDAIKIETTKYH ILDNYYIEVSNSIVGDYVYYSFFNRKNGVSYIFPGSYVIKVGKHGIEQVK IFFLNRSDTFIRIKAGDVHSNADFYLINTLIHKDIKLPFKISDIATGSFI EVVRYIDNFIDFELFNPKYLEVYDNVSNMVDSLKSFLKISPLMFEVHDGA MNEFGEMVYIKTGEPQREPIGFNCSGFSKWVADSIYKVKTEKLLKIKDLK VRHIGVRGNAFTKYHEFSRDPFFGLDWTRNIAYKLHNVNVNLDLSKIKEF DVNNIGFLKYIENRGYEIDNLEFILYYLAVKDPGHIYLGSLNTTIDGFPG KIFHKHIVVLFPFIDQNSIFRVSLMEINDETSIKSLKDRYPNSYIHLVKV KVPKHISVVSIPRRIKN >BRE_247 rdgB/HAM1 protein MKTLFFATSNINKINEVKQILDIPKIKIEIPQNFDIKETGKTFKENSLLK AKALFKILNNKQPVFSEDSGLCIEALNMEPGIYSKRYDQYKLGKKLDNNE KNHLIIDLMREQNNRTAYFICVISYIDVDGTINNFEGMLKGTIALNIDYY QKNGFGYNPIFLTTNNKRLSELNLEEKNKISHRGIAFDKFKKFLMQFLD >BRE_315 uncharacterized conserved protein MGEDVINMHLYRESSTKFIKMRFFFLSIFLLIFIILVNSLLRVTIDVSTS YKFNHFAKYDNLVEMFSNNNVFMQDQILNLDLNKYYYHVINDRLVSFSEY YYVLGESQNNYSIYSKNTNKFLFSLSYKDLVFTKGDAIFALNNLYKTLEV YGEDGSQIFSFKFVASILSVDYNDGVLVLGASDGNVYVYKHGNFIYSGDL LDLGLPIICVKLSLDNKYLCLLRQNEFYSLEVINLDHGYNQVLSLKDLKI KDFNPFFKIDKFYNLFIKTFDSFLILNIKSGKTFRINDENSVLQACYDSL SNTYRIYFYDLNSSIINIRTYSVNSYRLFDNIFFKDKVRSYVEFDKGILY FNDKSDLKYLGL >BRE_159 uncharacterized conserved protein MEIFAILTPHCIRLLYNKSIKIRLIYQGMVMFLIMFFLAYTLFSEEIYYK FVDYDIDYKIIGKYEINKEDAEEEYGYRFTYNDGKLIVVDYIGKLSILMP SFFGTNQIKIEHFKDIERRLFLNRGFAAKNLKDVYVEQIEYLSNGKPKSI FNYNKSNEIIRDKYGVAYYHFVYNDDGSFYVYRFSEVGFQIKDLNDVYYT KIIYENSNRTKTVLYYDGNNYNIKAKNGIYGFKLTYDSAHNIVKEEYIDE DFSLSSNPFSVAVKTYRYDSSGNLIEVVNYDVKNNLTPDENNVAIYRYDY NLKEKDYCCREYNYDANNNLTVSQNGYAMRKTIFYIQNNEKRIINYSNKI NKNYDSAVPVSYEEKYEIMDNFKGIAVYSYKYDNKFYLIERLFFDKNFNL VSDSNGVMIYKYAYNEDGLLESQEHYGDFDNPISDIVGVFRYKFLYDING NVILKSNYSKNGALVADENAVFEYTYEYDKQNRLISQKNFGNLGQLQDDI YGVSMYKYEYNKFGKISKKTNHGPDLRLRDNIGGISIYKWIYDSKGDLID FQKFDSLGNLI >BRE_358 hypothetical protein MANLKDIYSKPDRIYFFGAPIDVFKNHEKLISRFEYLISHPYHSMVIFID CKSLLKFLIFKSFRNLVKSSSLVFSNSRLLRTLCKFLKRIDIGCYDSNSI LLVLMSVLENTYKTCYIIDKDKIISKKNFLRLKESHKEINFIGYYDLRAV KRNKEMFFANINKLTPSMIISFCNSNYLENLFYVNKFGIRTNLTVFL >BRE_343 uncharacterized conserved protein MCSKSLFSCFPIIKRARFFYLYDINGNRYLDLYLNEGLNFLGHRVQGLNL ILKQTFSRGLTASYPSIFKKQFENVFFSYFKEAGFVRVFRFERDARDFLL SLTGQNYFSNPWEVRQGIYEFKFGFNNVRYPMFIKLPMPGCMSINIVIVD NLSKKMEFRDSFDALTLAVAKHMLVKILSYEKSLKINFDIFSTPMFKLIN RYMFPCYKSEYHGEVFKEYLSNGYLISPVFDFPSLLPLKFSKGDLDGFRK ISAKLQNKFGC >BRE_805 outer membrane protein MVMVSGARCLFFGNLNIEGFEVQLFRTFIFIVCFLLVFNLSYSQDSYKGK IIKNIDFIGLKNVSENDLKSILNVYLGQHYSDELFDKLQVDLYALDYFDG LIRPEFKLDDDKLLIVFFVKEKSLIKSVNFVDDSGIFWNSELREKSNVKV KEALNLSKIKKSVIKFEEMYQDAGYLDVAVTYDIKEENNLVSIVFKINAG PKYIVKEVSFEGNLNFKSRVLRKYLVSKTASLFFDGKYLKSNIDKDKMRL ESYYKNNGYINAKVVNNIVDIRVPSDSKKLEREVYLKYFISEGDIFKFGK FEIIGNLVFKLDELLSLVTFKEGDIFDESKFEQDFAKIREKYYSDGYIFT EIIPSQTIRDDFVDYSIKILEKDKAYIESITVSGNNKTDSHVILREIPLI EGDVFSLERLRMGMLNLQRLGYFGNVVPDVVPSNIEGLMKINFIVEERET ASLRFGMNFGGITNSWFPFSLFGQWEQSNFLGKGYSLSARINLAFSEQSI RLMFEDNWFMQTRWTIGGFFDLSHSVNTAYQDINGPIFIGKKEVPDPFVS WEAYNNAKNFSDFNIMNYSLAKFSVSGFTGYAFSNYLGKQSFIGTIQTAL KYVYYDDNVNRPSNYYLRDNYNTIRFENSLGVSVAWDTRNSQSLSNNGFL LKQQFDFFGGFLFGQSHFTKSTTTFERYFSLLGYQDVFSPFIDLILTFRS IYSNILPPLGNGFEIEIQPHHLLVISENFMVARGWGTLSNIYSSFLNTIQ LSMPLIKNIMVWDILFLDMASYALEGQKNALFVPFSNFIFSWGSGIRFVL PQIPLSFMMAYPFYFDNGSINRYYNYLGGFRFFLAIDMRY >BRE_530 uncharacterized conserved protein MRMQKNKDKISEILEFIYSKYNKREFVHPDPLEFLYKYTEKEDIELVGLI SSSLALGRVERILSAIEYILKPLGKQPSKTLKTFTRKDLNEIYKDFTYRF FTTEDIVKLLMSIKTIKEKYLSIENLFHNIYKKNKNFIASLDELITQMEN VNKKPFGMILPKPSKGSACKRLFLFLRWMIRKDNVDLGIWNKINPSNLII PMDTHMRDISAKLFNLQNTKNVSLKRAIEVTKYFLEQNKDDPVKYDFSLT RFGINKSFNKKELFTNIFNFKTNDFL >BRE_205 N6-adenine-specific methylase, putative MVYIYLIFLQNDLKCILMRVSSGKYKGWKVACPRVGYVRPVMAIIREAFF SILFNQISGINFLDVFTGTGIMSLEALSRGASLVHLVDYNKFSKNVLIKN FDIVNEPYKFFFTKAEFFLAKRDLFYDLIYLDPPFNYPLKKNLLEIISKN KSLNKNAKIIIHYPARENLDNNILRLSKYDFRKYGGSRLDFFEVNLDI >BRE_6014 uncharacterized conserved protein MGVVYKFFLSFIFIFFSCNFDVSSKFFTPLEDAIKLEISRYESLGNNKFK TYLHSKNYFESVKDINGYSYYFILDKTTKSIVMEIILFSRIAVLLDYKFG FIFNFGFNFDFLNVISPNVFEFQVKKLFKKKVSLGLGNGLDIKNDRQIST YNFNLQHVEEINREFENRNHKDDLNSSTSELMYFVGSSEYSVLRETYIVL YYYVFKAIERFMQ >BRE_421 hydrolase MPRKFDVISFILKEDIAMNANYEKYKMLVFDLDGTLLNSKHEITPLTLKV LLRLRDDFHIIIATGRRLYEIRDILLQLQDLRINEGYIVTANGSEVFLNN DLLLRCSIDYGIVREIFKVDREGIDINLYDLHDWYSDREIRSPIMNHFIQ NLGIKPIITDLSELKINSCSKIVYYSHDLLRLEEFANTLREKNFKGISMF YSANDLFEITNVDASKYNAIKNISLCECIGVDSILAFGDNGNDYEMLKNV GKGILMKNAHDRVKNSLPNNELTKFCNDDDGVAKFLIEFFDLDIN >BRE_1015 hypothetical protein MTKVGLMLCFFAVLFLCCRQGNIMTEDLEDSNFEETKERKKNKRGRFGYY DLNSLEQAYDELSTSLNNLRSLYYYRDDGFNISLFSDIDDEFRIKDNIFI MDDNVYAVLHGSIDVVGNLKKIVIDLNEDQSSYMYKNFNGHSLVAKLDHI SQFTIFAIMKAYYDVKGNQLLEKLKYSKDIEGLKKIKLMIDDFCVEWAKL VAEVQKIINDVAVFADAYIKIKNDRFKDNEKISYMKSIEDGLRPIAVLDI NNFNQVCSDSLICKLKNELVRLANQILDKGDDLLNALQPQNSTP >BRE_133 uncharacterized conserved protein MMNLDNYLIVYNDFKGEIGVFFDYIRNKREILKTFNLNQIIEDFLAFSEN IEMDVRELIKFYSFTTSLLYLKTQVLYPVKLKDRKFVEKEIVNKLMKFSD KYVVSRKVVRKKDEVCLDISKFPFLKENVVFLKNVDDAKNYIANINEVKN KDRTMRVSKERNDILSDRFRFNIVLDTYDAKIADKKNKIMSLLAKEDKCR FEFLLRLDDKFYFFERFCYFLIVLEYKMSNVIDLVYVNNELIVIKGRGID EYKQQRA >BRE_1019 hypothetical protein MFKVYFLIFILNILLLCCKQVSNDLINTSTPLAIKTNSINKRNLNKNKLQ TSKLTKETEYTTLIKSLNKFKALYNCMPTKFHDPLFFDINKKFNVTYNNR DHKNPIYSLVKGDTNTLHNLKKIIIKFNTPAEYYTSMIGDKLIDRLSLLA FNIIFNTIDINNGVFKNTNMLKLQYSKDEKDLKELAVMLDNVCVKWDMFV EQVKNIINEASNLNIKSNVIHKLIQFYDLDLNNPNQQCKYDDKLCNLKNE FLNSYLKTTNKIKSLI >BRE_546 hypothetical protein MRKKLIFITLLLVSLFSTSYAKVIYFSAGFSTQISLESLSFFGKKTGTIL DKLMSSELFPILKNIRVNLFNQIKEFESSAHKLHNSFQKSLSLFVQLYKN RKSGTGQVENMNDSDLDGLGPLLNSTHDLRSFLIELRKLHLNGTFRKLGE SGSHLKELIVDLENTAKQALSLKDSLFAQLNEFGVYNQDDLMKIWNEIST PGTNLNDALRQKLSPLFSSGFQGYFQVGLPIFQSDFYYGFELGFGMNLGR LIVPHLRLLESSYPVKLGMGIMPRLFVKYDIYYLAATLFSGFGDRSLVVD PIYVGNLASKNKITNPFSLIETGLRLRLAFLNFESSVLFSINDFKYRDLR VGLGFEIPIII >BRE_431 uncharacterized conserved protein MISGLNPTLRLFKEHRILYSNMERGLKPLLEVDNFINKYIQNKEGLEIYD KIVGKAAAVIIYNIGLQNVQAGVISQPAKDFLESRGIRVSFKKLVEKIND KTENLIESLENPEEVYKYLIKRGIIVSNF >BRE_348 uncharacterized conserved protein MDRSDFIRFGDFLKKTRIDKGFTLEMIADDIRISIKYLRALEDSNIESFP NEVLAVGFLRTYSEYLGVDVWYVSSLFKEYKRRLNSNYIGIKSDDQNGSV TFVSESKLGNKYFDVTNIGFSKIIKILVGVVGIVFLVFVVTNISGFKQIL GRIFKANYVGKRVPEVHEVLFDKENFWNVVLGEGDFLSLIFGNSIAKYRV SFMNDDLVITNDLENEQYVFNLGKFREVDLNGNIRVKIVYDNYSQDKVRK AHVSLESFMLNVEYVFETNLSNRFNVVNWGFEVNGPKNRVISEYPTVYSS TNISDINLSINFLNDTFLRYVDENNLYGKSLLLLKGSDPLNLNFKKSLIL FFTRLSDVNIVLQGKDVTSVLKSYGSEMIAIQFFWLKTPGGFDLKVSEVY >BRE_407 uncharacterized conserved protein in borrelia MKKIIYCCLLLSCINLYSLNNEIKNKENKISNEKTQKKDEINKKNSPLKE KSEKNKNSIFSINRGFIYSTGIGLGTGFFLNANNNHIIFRPYYTFATNNL DFMAVCMILMIEDYNVSKKIQFSSTYIGIGINWNIINFFQKLKYLSTSMG IGGRFYLSTNLIGNFRFYNKIPYVVEPYIFFEFSTKESISYLNIYSKVEC LFLDTFNISFNFGIRYNLKNKKGENQ >BRE_207 uncharacterized conserved protein MTITTKYQKFYDNLKILKKYINTNVEEKILKYSILSKLYKLNEKEVINLI TISKNYELKKNILNITLEEYYYEKAQDNNLKNWILEIIKEKNLLQIKKET NLISKRPGITYKLNSSNFLKIIEIYNNKQYTEEKKELYKQLILNFSNNLK IENLEPTIDILIAVKYRNKEKIKQILKDNLSFQRLFKSSLSQKQNRVTKL KKLLILTYWPVGCLSKSLFNKILTKNYKYIIDEVLTLKYDEILKYLKTIK TFSLNEIFYKGSNKNSNFNYFFSEFTRYTPKDFQNTFKTYLFSLEKTAIK QYLKWFFKDKVPHEWKDFIFTIEYIDTHKLLNLNTNIEDMITAKFQAEEF FISFEKMNFNPYKSSKIFQNKNLRRIFLINVINYIKKHITKIDTYGWISF YIYADKNDRIQTEKDIKQFFKNKNFEIQNQIFVYFLSFYPNIDKKHFEFI SEIMLYLDSNKITIPQEIIQMQKTSPHKFNYCKSYIFVKSLTLRTRVFKI LNKNIKLELLFQPEEFHKKISLLPAIYYIVCYYKPDTLKEEQKISPKQKE EIINFITFLTQEQNKFGFKTL >BRE_804 uncharacterized conserved protein MNLFFIRNKDTLSFICSILVFIFVLIIFVLFVQFQVYSARFFIMNYLEAK LGFKIKYSKIDPYFLSSIKIDNLELSLNEQDKVLMHTVKVNLDLFNLFLG NENIILDIFVKGSTLNFDLNDFKILKSKSSIPMKLELNDEKASRVIIGKM FGSFESLHMHLEDININLKLGSGRFLRFQINNFILKTIDDDFLFNFVVNF GLPEVLYPDVNSENIVNSVFYFEGKFKKDLEDGYINFSFLEFYTDYFTFL EQGFQINYSKGNIEVFNIIRENLDFNLKYDFNKNFLRLDALFFDINLLDW IKLNDYLKNYNSYLNTSLNGQFAFSYDFTDKDLRYAFLLNSSLSDDIADK EIQGVTIQVKGNEEIADIQNAFIKLKRGFVGYKGYYSFKNLMPIGKLDFK SAKIFNLNDINGHLNFSKEKQYFCVKSKDFKIGRLKIKDLNLKTDFDSKN IHVDYLLNFVNNNSTLSLKGDFNRENFNLNLGVKEFPVLFFKDIFPEIFM SKIIPEYFLSGKYLNLNSDFNLNIVDYTKSKLNDLKFTLFSKLSNFSLMF DASGEGNSYKVKYFNYNSGDYDVNSSFLVHLFDDSLKIDTKFQYLNRNYP VSFEFNFKDRYANLKLSPKAQINLTYSDLIIAYFFDINDFRFYNGDSEIL LSINSYGDYQRVTDNLSIMFSRFRLDKISINPNFNFNFSFEGLYKDQKVS LSNIKFVNKNSNLQGQGYLNLNNKLNGNLNLFSRLNSERYFLGIDTNEDG SYFVGRFQEFNFDNLKFLSFLSGKINGNFILNFKDSDFFKYSLNAYLETD GLSLVGIPTYFSLNLGLVDNNLNIYNIKAIQNKREVLTGNFRYDIENSIG LSNLNVNSDLFSSKVNASFQMLEDSTEEEFGILRSEIDGEIALRELMYKD KNLSELTIEFENNSERLMISSIEYDLISYLYEYANGNFNLILNDYLPFSF IATGNIVKDKITSSIGNIKFNSKLITEDLLVSQSLFNIKEHFVLYDLDLV GELELDGDLYNPNLNGKFQVLNGSMSTEYLKSFRQYGQSRILELIDVPVS IKDNSVIIENKFHLDYYSAVDVVAHLNLNFLSDSIVDYYKIDINVSGNSG VPIKFDKVTINFVGHASGDFFIEGNSEEIMFKGDLNVSNAWVYLLENSIV DLLIDPYKKSKDVGVFNTDSKGLDIVTDLKINFDNNVAFHWPDNKISFLN AVIVKGNTLEVKSDTKTDDFILKGDLNIASGSFNYNGKQFVFRGVSYISF NENKNKFDPWVKAEATNIVKDGGENLFITMTIDSPLSLWNFKFSSYPART EQEIKYLLSNAIIGGGKHGLQSAGVNTLEMALGLVGDILIDLIIQPIEDY MRSVLKLDLLSIKTDILRNAIGTLRNSPTFVGVLDKTNVTVGKYILDGVF AKAGFGFLIEEITPFSQNLNFSINLGLELDSPFFFIDYTFDYNFMKHGYG FGSQVSIFWKFKY >BRE_456 lipopolysaccharide biosynthesis-related protein MKIAIFTDTYLPDKNGVATCIKQIKEGFEQKGHTVYIFCPQYYKSDLSKK NIYRCFSIKLNRTVDAKISFPNKAKIKKIIAEYQPDIIHTHSEFTMGNIG KNLALEYDIPIVHTNHTMWNYYLHYLGAIKYFINPDKMMKKFYNQIHHFI YPSIKAHDKYFHLAKDADYKLIPNGIDRKLFIKELTQKKKQEILSKYDIK KNDKIIIFVGRINKEKNIYELIQNLKKLLIENKHCKLILIGKGKEERNVK QFRKKYGLENQIILVGTIPWEEMYYYYKISDVFASLSKSEVYPMTIIEAL TAGIPAILSNDIIYKDVIHQGKNGFLIDNDEDMYKYMKEIIENDEKLQTA KKYTEKTSIIHSSTSFVERIEEYYVQIIQNHKNLSKVY >BRE_430 uncharacterized conserved protein MLKLIRKIFVIYFLCITLAGIAMVFIDSKFSEKETIQDGKSQIIKHTISP NLIMLTSAVGGFLGTYSGVWLFNYEKDNFYLSWGSLLILIYNIGLIISIY SKTKE >BRE_1058 uncharacterized conserved protein MRYKLKILTKHKAYEYVIRDIPMYDWDSILGFDSSQETLRRELNNLSTLK KISSLMISASFFDEFYDIINDNKEYSFLYKYPLPTILFAIEYSLVEKISG LQKPSLVYIESFQDSDGTFVKYSYIDERWNYDDLVLREVG >BRE_561 uncharacterized conserved protein MSSVKVYYPENFNALVSLFQESSKNYIIYNEIDFHKNSEIFMKNDSDSFF IINNFEKFNKIFLRSNFLEIGPCVTYDAILQFGEKNIPRLFYEFISMLND RIYLNSINIANGFYYKNTIFDLYPLLLSLDAQIEFKNILTKKNYTYNAYS INRDDYIQNRHVLFLSKLKFPITNLWNKSFCSRIFDYTFSFNFLDEMNII FICVLLNVKRNIISDFLMKIFYNDKVITLRDFQVLLLNKTLPLSLVEIED SLRMLDKSIRDVKNFSLEERSLKLIKNFYFDILFNF >BRE_744 histidine phosphokinase/phophatase, putative MSCYIIYFMTFLNNMKRPIMILAPMEDVTDTVFRNLINLIGNGKDGPDIY FTEFISVKGLLNKSKNSMQHILTKNDELSRPLIAQIWGDDPDKFVKAIEI LSNLGFWGIDLNMGCPKKKIVKKGVCSALINNKSLAHEIIIASKEACLKY GLPLSVKTRHGFFCSEVEDWLGFLLKLGIDMLTVHPRLVINQSEGPIDVN VFDELVKLRNKINPYVVIIGNGDVLSLNQAYQMINKYSIDGIMFGRGILK NLNLFRRDEPNFLDSDLNFRLNILKLHITDFHSTWGITKDFNKLKKYFKI YFNENEICSEYFYNIMSSNNYDELFENLSRINVIGDKLK >BRE_828 uncharacterized conserved protein MKSMTGFFHLEKAISNYMFSVNLKSYNGKFLEFKFKLPEVLYAYELDIRN FIATYVKRGNVFLYVGYKEIMPNVNFNLNPHYVEAITRLRDNLLKNSNLN IKDELSLGDFLSLRGALIVDDVSVEQSLIYDVFKEVLRETLLNYDKSRIF EGENIKQDIISMLVLIEKDLKLLKKSHDSINNKLFSSIKENLLKLMDDFS DINVAEEAAKMAIRLDINEEIVRLYSHINNFYRNIEHEVCGKVLEFIAQE MHREVTTMSNKAIDLDIRNLVLNMKLNLEKIKEHLRNIE >BRE_237 uncharacterized conserved protein MEVNMKKLVLLFFSCIFINLFASNDSLIDERQKELAIFYYEVGQRYIDVG KVTKGKIFQKKALEMYPKLKGEVDLKSAVEDIDSKMKLESEATFLSFDDV KLDDIPGIIHDKIEISEVTNAPRIEYVASRERENHKEQAVKFQFNKFVRA FLLQDLNLLDSVIADDVKVLGKIAPKSDFIANLEFASSDFNRDDLGYLSV DDFYDLKSLSITKTTDTSYTVKVKAKKNDITQNIPFWRDVQTLCFVNQDN KWLLFSVK >BRE_541 TPR domain protein MTNKHFDSKLRIILFLPLLCLTIKIQAQVKEDSLLLYRQGKFQEAIINTQ NEIKNNSNNLDARVILIWSLIATGEYKKAELESIKGLEIKKHDSRIIQAL GEAYFFQGQYKNALKHFQKYIGLDANGARIAKVYILTADSFYKLERYNEA DFAYENALRFFPNNQNILLKLAKSRINAKNKILAKETLTKLLTLNPNHLE AKNLLQKIEKNNHNS >BRE_542 uncharacterized conserved protein MSIDTLEFEENSTQNVIKSNFNFEGYIESSKPIIIDGILKGFINSTSSIY LREKAHVEAEIKCNNFLNHGTMKGNVEALETIKIYKTGKLIGNITTKELF IEAGASFNGNCEMEEK >BRE_75 uncharacterized conserved protein MFNSQTKIKRQYKINIDEIQIPEYILIPLETANSKSTIYVIENQRISEGQ ILSKNKNVELYTYAPISGIIEKIYTANLPNKNQIKSALIRFHGRINNEKE ISTEEESREKTLEKLIRLGIPWFNEDSLFQYMNKCKKIDKMILLINGKDS FTNISEILITTKLDKIVYGFENIDKIFKFKEILIITDNHNIKKELEKLNV TKDKRLTIKLISNSPHPYSNHELIMHFLYNEENTKNNINPNKNILLTNIE DLYNVYSTLKTNSPYKEKLITINGNKKIQSKITKVKIGTSIKQIIDKNID LKKYDIFLNNPTNKIKIDNLNVPITRDIYSITILRKKTILSKVNKIKLLN TPSFSPLCMEQIILEKIKNQDNNENTQQQYLQYTKTEIEEEINKVKKEIK ENILNISFNNELIYTENNLKDIYLITILALIPNLIFSFANNIKFLIDSII LIITSLCSYIPIMLKSKYRYFSFFIYTALITNIILPLNFPITLKIMAIFF TFLMFFYFSRLSKLLINPILISFIFLLLNFPLSFKQTYYKELVKQNDIIP TWNKIISKNTNIHNLEKLKEFKRHENKYIDIIDKFINEQVLSHLNIMIPR FHIENLLGFQNEKYLSPILIYIGFSFILKKFIINKLIPLSFYISLLFIAY ILQNLSLYNYISFDILSLIMSPIPMILVFTMGTELQTAPHFKFEQILYGF ALSLGYFITLSYIPLETFSAIISIFILQISATLIKKYSLTFHIRKILHYL RINKEKVRENKNENGEEIIKI >BRE_204 uncharacterized conserved protein MILKEIKKIEDLTEKDIIFLNIGNLTKLSTKINEKIITFLKKGNVSHIPV ISNYENISHETLVNTINKELLNNKLNFLKEELIEASKDIYKPFSEKDKIF TISGKKTTINLNTLMEREPDSIYSKEIIEGSFKILPRHKIISIQKILSTI YDYFGFQKIIDQDNLHHQTIKKLNLQSIRRDYEFFREQVQTEGDSILIHA IDTTIYFLFTIAQLNKERAAKNAPRSTSKFFIDKSHYTEFTEFFYDNDII IQAAFGVLLHPIGLMHTTILQKIRNKISIKQNDTEKQLFSKIEFLEKSIN ISKNLFRMRDDISAITKMIINGQKNYLNKKNHTETTKKFTHELIRIFCII DTYDEMINPIIIKEPVNPLEAIEFLTQNSAKYYWDKDKPDEYLRNKKFDI KMLKNFLKILAPFDYGTIINVHTKNCNEPIFKAVVFKYTMDILPILSIIK QKDKSYKIGDILLNLESREIIIKGQDGEIKKSPFKNTDKFELRHNIQELK SEQFPLLDSIQN >BRE_1001 hypothetical protein MHVASPRILIMLVLLLVVLVVFFLLRFLSVLLLLILLIYHMPYYMPLLLM LLLLELLIILILVLLFFLLLLLFPFLLFVPLTLIVFFFFVLLLVLLLPLF LLVFFLLILVLILVLMLIVVLLVLFLFVILFPLFLLVFFLLILVLILIVV LLVLFCLVSLLLVFSFLILMVFLLFFLSYFLFLFLVCLIYPVYFLNYRCC LLIFVYQTPSSKLNFLE >BRE_84 uncharacterized conserved protein MSKTSEERIKIYLSTLSKHKNKILKERRIKEIMGRADISDADMENIEKHF FKIYDRARQLERAGDFAHSLRELDAVYLYSLHNKSLFTLFFNLYKRLVTE INIKETNKKLIHVSLQAREFGIIDGVDLREYDEFSKLKQRILVLLLSFIL ISVIAFITYRTVYPFIVGHEYFGDLERDIKEPVVQGLPSVTRASDLIVES ANLIANPNVLYYVEVESAKVLVFEDSHTYQLKAGIISSKDSIKNISYSIT VYDDLGKPILNKVFEKKSDFPNKWNRGVYVPIDFIYNVSKGISSHPKKMV LDIRLIEFFKDVNDFSGINLETSSSILTFKYLGSYFHESFEIYEVNSLIE VYNSSSDDVKDLEIEIIYVTKDSQVIRSLKRKLISESNSFLKSRSRQVFS LKTIFPKEIYANIKEELSSIKIINVFVK >BRE_793 stage V sporulation protein G MNITNVRIRRVDNKDSSSKLLAYVTVTFDDCLVLHNIRVIRGQKGVFIVM PNRRTKVGEYKDIVHPINQSFREILQSAIFKEYVKENPANFELELV >BRE_5014 putative lipoprotein MQKKFSLFNIMIVFGLIIGCSTDVQPSSVLKDQKYFGDQTLVSSDQGYLY SDLSRVDETEKLYQDIVSRGRKYFKKFKVKRENFALKKAQFDESIIIKVK KRYPLVVKCEDCIYAGLNYSEEAISDLVSILNKLLSGPIGEIMPYRNDRV ACVFYLLKILQDIERFTREVVCSDDSYVSDSNLLNVHRLFISLDIINKDN MLKSKLATIKFALNIFIKKRNKFIRLIIENIKEINKQENVDEIVKLININ MRSWDNNGKIFKKMYSFNTSSKSLYSLHDFIKNQTIDLNNQFIIK >BRE_364 periplasmic protein MRNKNPNAIVISEKAVSDKDVIKIKSIFTISQIIESRKNVSSSYIKQSNI KFAVIYNHKRPIDFSINIANDLKSINNVHSIIINNEYIDESIYRPNYIEI LQSIQELSEKNKLIQQKKFYYDNKNANLDFFLNLSELIQEIVIITNTEND IIYINEKGSKELELPIKIKGKTNKISDIDIIDFEKETKIDLSYNIDDIPE FKNILITDCLLKGKNNKKLTVDLFISTIAQNNIDKLITIKDVSDLKSKHN IPHFEVIDQETDLYNIKELEKLLINQIDYSSKKTYLFDLDLHINTEYEYK GNRDHIDVKILKKITSRIMSFYSEYIFKLKDNNLIVIISTSGGEQRVISI AEEIKKTISRELKKEGLIILKFNIGIIEVNLKEDIETKISKLKIATKISD EYKDSMPILYKDELPETIIIKNQNKIFEYIIKAIKNDFFSLYYQKITPLK KDLTPKIEILTRLFDYTGTPIPNNHVFGLIDKYNLTVEVDKLVVTKALRE YTNFVTKNGVHIFSINISPYSLKSKNFRIFLKETLLQSHVSLQNICLEIT ETGIVENFELINTYFNELKTFGIKLALDDFGSGYTSLSYIKILPIDIIKI DGSFIQVINSSQIDLVIIKSIKEIADTKQIKIIAEFVSNEEIFKKISEIG IDYGQGFLWHKPEPI >BRE_750 antigen, p83/100 MKRIWVFSSLLFIFLNIVTFHAREVDKKKLKDFINMDLEFVNYRGPYDST DTYQQIVGIGEFLAKNLVDNKANYYNKYYVNRHIDGEDEKSSSDVFVIGL NSSLDSILNLRRILTGYLMEGFKYSKESAELLAKAITIYNAAYRGDLDYY NNAYINSSLTDLNKHNVGLSRVYSQWAGNTHIFIPLKRNILSGDIESDVD LDKIVTERVVASLLGENEEVGTNFARDLTDVQDEIRDVDQKKIDIESNTL KTIDDELNETIDNLREQLEKATGDTEKKEIEKQIDDNILQRDALKSKTEE LKKSQKKLDSSQEKLDKQRDIVKDKIQENIDRSNKDKNLPKPGDITSPKV DEKLQLTETIEDLEEQLNKVTDDTEKKEIEKQIDNNILQRDALKDKKRDK FKEVDNGDLNKQKEPAENILQRNVESKNQNNNLPRPKTTSQNDGKSQLSK DLAQQLKKAIDDAEKKEIEKQIDDNIVQRNVLEDKRDSLKELDNGGLDKQ KDPVRNRLQGNVGRKNQNNNLPKPKATSQNDEKLKSASELKRRLEKATSD IAKNSPNIANKKSLQKLSDKSLNAKDNLVKSEGVKKLSTEDKDKKPVFLE ILNPNTNLGVLRLIDSDKEKLDKNYQYGIRRYGVYERKDDFVAIKLCSGI AKLQLLSKSENLKVKSQAGFELSRDSSLYVDSEMILVVVKDNDVWKLAKF SSNDLSKFVLSEDEVLPFTSFTVNAGRVYLQDASKSIITLDINTLKKTN >BRE_2027 MlpL-like protein; lipoprotein MKITNFTLILLLLMSSCKQDNNTNKGIKSRNKRDLEQQVEAQKTPEEALR EKLNDNQRKGLDFLKDALSNSESEFNKFLNADESKIKDALDHIQSELAKC TRDNAAEQKETFKQVVKGALQAGLDNFKSSADSTCGNNQ >BRE_398 uncharacterized conserved protein MYFVMHDLYYIIKTMKLLIQVFGLVLIFSCYKSKQSDIKSLTSLLEASNK KGLNRFLIIDRIVDIHMHNKDYEDALSFVNKGIADDEDKEYYPLYFYLIG NIYSYIKEDEIAFTYYRYIVDNFDDYIYENSSIKLDIAKRVINLNIDAID KINYYKLLLNDNFESMTNADRGNYYYNLALSLEDVQSYDEAYLYYKKLLS IPRSDLKIDSRDYSAVMTKINYYDNPDFVVYRNLNDLISDVKRYIFSGNT AKLLSIRDKHNFFIQSWDQRSGKSNSINTNSFLTTMIKLSSRRKNGIQFA KTFEADSSNDISYLGSSGWEHIWEWYFVFKKISYPKDPEINDGWAWIGVY LGKK >BRE_652 uncharacterized conserved protein MNIKNAIFIFIFIFLLIIVGPKIKFRNEFDKTQIPNKLEEIDQYLLIEES KFNLVENTKKEIIWNKEKEKTQYAVVYIHGFGASKNEIYPIPNNIARALK ANIFFTRLKGHGIDNKNAFKGVNTKDWLRDIDEAIQIGQSIGEKLILIGT SNGGACVIWALKNYQDKIHSAVLISPNIYPKDKRTNLVYYPWGRQIAYLI TGGYNEPEIRQNKRIEYSKVNIFHSPIRQIDSIIAMMGLVKLININGFNE IKTPLTIAYSPNDPTVDSQEINNFINNYGGYKQSIPIILVESPHSHVPVG NHSYRSAQNTSYLTKYAVDFIQNIKKSK >BRE_194 HemK family methylase MTIQEVIKNAKKYNLSTIEILLLLEKILNINKELIFANTNKNLTQQEEYK LFSQIKNIKSGIPIHYILGTKEFMGIKFYINKHVLIPRDDTECLVEEALI QIKKNNLSKILDLCCGSGCIGLTIAYYLKQKVTLADISAQALKVSLKNTQ RLNLTNHIEIKRSNLLKYIGKKFELIITNPPYLTKDELRIKEKLAKEPRI ALLGFGQDGLKIAKKIIKQAKYKLTKNGLLILEMAPWQKKSLEKFAIQEG FTYLKTIYDIENRERALLLRIKHDTSL >BRE_353 uncharacterized conserved protein MITLNFVFKRRAINVSLVDFLVAIFNRERTPEQVKQRRLKEVKKSLSKSS NFFSVSKIQALPQFAKFIYNLYKVFYPLKLFVQRYRNSNEIIHFVVEKYL NSTQKQALEHIYSFSANEIVNFTSDMLKNLDTNLNYLLKSITQEQVRLID ETCGALDIFFDLASYQYYILIKHFDSLFPEDDFIYKPRFSAVSCGVILDD IKDYLECIYSIKDISIWRNLYDILLKIYGDEDNFPMKPNVWLKMITSIIE INKNKEILYLVRYVSGDPNYLPISGLKKTKAKAFFNYLSKHVSNEMLKSE ILQKNSKSKILAKKLFPGVTLLTLDNYNEHMNMKITSKITNTTGYVYADI LGYLKTHAVNLVKKDLNDIVNILIIKGQWKDMEISRDVSNDIHDLVNIYS NLIDFDNSLGEQGNYGNRINALLHRVYVGGDKSSEKLLLNIIVDVNKKAL ILLNDYYSKIYSLKQLLSGCLEDYFKPSSEKELIYNWKELDLELVKSYGN NVNFSSIIKNIIEGLTLFLKLMDLYLTKKNGI >BRE_673 uncharacterized conserved protein MNFMKNSGFNMLMKNICVCYDFLRRHCSKYLLEILIVFLLLSFLFSSYMI FCNYDNLFFRKVFYFHSEHELISDLRYLKKRKTLKENLDLLVKDFLLGNS KGFYLQFGTTNVKLLYSFMSNDVYFINLSKEFYDSFGNGAYKDSEELRVS LFVKSLKETINFNYPRDVKEIFIFIEGYILNV >BRE_626 beta-glucosidase, putative MKKIIYIIVFLINNNCFCYDFWSTENKEKLIEQIVSQMNDKELLGQMFMI SYPKEKITNFTLNFIKEKNLGGIKIFGWNAKNLYNLIESINKAQTISQKN RFKIPLFIATDQEGGWTQHIKLKTSKTIGNLGITATLSPNDAYFTGYHIA NELKQLGININFAPITDIYSNEENFIIGPRTYSNNPQIVSLFALAFYKGQ KQAGIISTAKHFPGHGNTVIDSHIKMPIINSDFKEIKRNELLPYKILIQE NIPMIMSGHLAYPMLTNGKEIPASSSTKIIKEILRQDLKYDNLIITDDLL MNAVRYQNESIYDTIERIIRTETDILLISLNEDIQNNAYNQLLNLMQKDN TIKENIIKSNKRILRIKLEYLKEKRNKEELFPKYDNAKEIPTKEAEFFFE QNTLRSITKIKLSKKISKHKKTLLISPYNTMIKEGKKIFQNSYGYYYNYY PLNSINITQLKEIKNLIAQYEQVIFNVSTPASLEYIKNLKEYKNKISIIV SLTPQHIKQLNWIENIVVVYGTTTLSFKSGFLTLTEDFNPKGQIPLMNLK N >BRE_1048 thymidylate synthase protein MHDHVDAAEEVLDREYKVLDKGFLRLIDYMGSDERIVNSARVSYRDSKAK RDSAALIDYLIRNEHTSPFEQVVFTFHVKAPIFVARQWMRHRTSRINEVS GRYSLMREEFYVPLREDIKTQSLINKQGRSDEEIDIDVAISFLDGLDESY KNAYKIYDDMIKKDVSRELARITLPLSLYTEWYWQIDLNNLFRFIKLRSS GHAQKEIREYANVLLDIVNLVVPLATSSFKKHVLEGVMLSSEEVCEIRKA LDLTKLNLSQKSLDRLKEKLNL >BRE_1004 hypothetical protein MENLKISLLIILYMTSLIHLFAQDKVKIKLPIVTEWENKLNELKGDPEFI KEVEYVKSLPEGIYTPSRDIYAEADFRVYCEVIFDTTKCYPPDGYFGKEY EPLFAKTYNFLKVLKRKDPAKVIYLIRTMKDVAGSFGDIQEYDNWYIYNT KGVQVLDKRMKDIGEVLKIYRKTKKQYFSSMDMLDINDMDNSIAELIIQL EEIRKSIEYVTKKMS >BRE_73 uncharacterized conserved protein MIKDLFTNDLFLSCLISGIIAQMIKYIIQAIKTKKIKLTPKYFLKSIFLE TGGMPSSHSSTVTALATSILIKEGINTHFIIALAFALITIRDSFGVRYMA GVQAEYLNDLSEQLKMKIKIEPLKIKVVKGHKKKEVFTGILIGIISAWAI CNKYYIE >BRE_622 conserved hypothetical integral membrane protein MIKIINSKNINKCTQFNLENLQKNEIYIIYIENNVNAISYLKAKIQDKEI QINNFYMDPNFHSEGIEKILIRNLIHYGKKNKIHKILCKINDIKEELKNL GFVNNNNEYEKDLTHEIKKDTIIMRIGLISVLAEVASITSKLTVGILFNS FALIADALHVTSDFILSTITYFSLKITNKPETIHYPYGYKKMENLIALII GIAIIISGFTIFINSTGLNQIIDFHKEPELHMNHEHHSKKNILEIFSNNS FKKSIWIPLIPFIFFLVKIIEHVVKFQIGKRYNNYLLLALSSSDKNCIFS HGGTTLSLLLATYVWTGFDKIISICIGFIMIKEGLHVIIDNANNLLSKQN INLKREIKNTLKNININFRELNFYHQGNEINLYIKLDLKYEDNLEKLIQK VDKIKHTIKECHQEIYETHILI >BRE_410 conserved hypothetical integral membrane protein MFNLIFFDEDIKYEFYRKFFHISSLVFLLLYKVNLWIGFVVSLFFMVIYL ILELLRVMQKKLFFLGNISEILVKTREVPFCKIYLSPIFLVVSMFCTYFF IAKPFSYIGIFSACIGDGLASLFGKLIPSFKLVNNKTFAGSISVFVVAFI VFYYFVPNFVMALIVGMGAMLVELFDFAKYDNLFLPVGVATLSFLLVT >BRE_802 uncharacterized conserved protein MFHNNFFVLYLIILSILLIINVNASSKFFYAEQWYVIFNENMQKKPDNYK RNIFFLQNALKYPFGNPNYSLAQIKTKEEWNKYKLFFKMHVNLLLVKQHL YLGNLFDTKHVYFYNTPKKDGILKNLNQAIIFYKMATSYYKKALTYHKQL DKYKFIKIQGNGITNWEDEYYRIEIKELNYYDIIERELIRIEKTKEFFQK RPNFY >BRE_1039 transposase IS200-like protein MYMSHKLTFNNHCVYSINYHLVLVTKYRHKCINAELSSSFYQIILNICSL WKITLNEFNHDKDHIHLLLEFIPNIQPSTFINNLKTVSSRLIRKKYSTHL DKYYWKPYFWSRSYCLISTGGASIDIIKKYIQNQNKSIY >BRE_1011 hypothetical protein MIVCAIIFALNILSFSCAQSVTNLANVREGIVTGVSKSLTEFELKKQAYS ELEHSFNKLKSLYHDSFKILNIPFLNDFKSKFNITNRQFHIDLIYAILRK NYFLFNAWNGPDVIFVDGDSKNHILSDSVLLLLGIYTLVINTLSAILEQN DVFGNYKLNKLKYSRDITGINEIKNMLYDMHLKWTEFSILLKNFINNLSK FFYNDIQNYNDFFREEILLQLRKIRDINFIDKNQFYKDNYKICELKNDLI NLRYQIEVKSNELIRVIY >BRE_3003 putative lipoprotein MREVKINLYLFVIITISCKSGDYVDGQENKKIDLSSKKIVTPAKKVIIPP PVVILSSALPVIKTEIPKPNPPVQNYNALDSKDKAYIRLKKSINQYKEQC KINPNQTIKNTEEIETLIKSLSDYEKTEEYNYIYTSLENDDHIIDSLKKV LEKLSSIYWYPPRYNNEANITYYEDDEEIPKATYKHYHEQMMVKSTTKIK QPKTKKYTGLLLSLLNKLFDMTFFTNNLLYKCLHDKNLAHFKSAEEINKI YDQLNDIMNKRKDVILKFKDQILLAEKHFDEVKMVDEIKKIVEPGKEVYS AYKAMYEAADGIWELKYNLGFMPFDKNIII >BRE_1062 uncharacterized conserved protein MMDAINLAIVRNMKRYTQPMFLFKKNLIKNRTNFSYEIKIDKTTPIKFDG VFLPSGESNIELFDSNIFVKEIHAKTYTLDILDFNSGEQLLVGNDIMEIL SVSRHLNFSLNQRFRYIVLMLRKL >BRE_480 conserved hypothetical integral membrane protein MSTSKTKIRKLILEGNLYLVFLFISFPIMVTNLLQSCYELVDMFYVGKLG AMPLAALSLTGPINFLIMVFAMGMATGSVSLMSRSIGEKTFSKFSKYAGQ LIFLNFIFSLFVAILIFIFIDSILELVGVRGELKELTRSYFYVIVYGIPV MFLSISVVYILNSQGETVVAMFLILVANIINFFLNPILMFTLGLGIAGAA WSTLLSKLITVLSYLFFTYRLNCGLKVHFKDIIPDINVIRKIISLGLPAA FGQVMASLSFLIFNHIVIQISSKFLAAYGMVNNIISFLLLPGMSIGTGII SIVGQNLGAKNIMRVRDILKKGFFVTLVIMLTVASFIMSFKDVIIALFTF DLEVIKYANGYLSLAVIGTVGFGLQQVFLGVLVGSGLTKLVMIVVCIRLW IIRLPTVFILQYFGIVEDSLGYAFIISNYLALIILLFVTLTRYGQICNKS NM >BRE_246 uncharacterized conserved protein MKDKRGFRILSFLKKLDRIFFTIFSSFFKFLSHVCSFFKQNISFMIIPHV RGNVKNIKISFFTLFLFCVFFFVIFIGFIFLAVNYVTLKSIVNSTEKNYA LAESEIEDFRNTVVEINSVSNNFSKVLDELSSSLRIKENNVGLNRSKLDG DLADFIDLQMLEANSFKELNDLKNVKNTIEGSISPLKNIVRLLHSQNKLL NDIPSLWPIIKGNGIVSLHFGPAIEPFTRQWYIHKGIDIAGVRIGTAIVA AADGEVVRASYQVTGYGNFVQIKHKYGLSTLYAHMSRLNISKGSYVRKGQ VIGFLGQTGYSTGPHLHYEVRIGSQVVNPDMYLNLATGASK >BRE_1005 hypothetical protein MLVKWKYFICVVILVLSIVILKCPLGKIINNNDFLLNGDLDSFDNLNEKN RLNTLDAYSALQVSFVKLRDSYIYIPVGFDEAQFDSIFQWNSTIKRVKYG IYSVLKRDIGTLNNLNTIVTNLSSSFDKNLKSVVSDLFIGLWDIASSIDS VLARRGYILSDANLIMIKSSSNTEIINDIRVSLEHMLELREELVRLLQNI INSAAIFGINALDRIEENLRPIITLALGSTGLACSTNRICVINNELKSLS NQIEDNVSKLKKEK >BRE_5003 uncharacterized conserved protein MLLLRGFCFIMKDIKFPKKKKGFRDEEIDMEAFIEQVDANIEKMDREFKE FQRRYGSDKSFEDWIEYEEKEQKLKDEKIQLRVKNLSSRFAKKLNSKIIA K >BRE_474 uncharacterized conserved protein MKVLERELYYEFEVDSSVKLIYTKKPFDLEIKNISNDNLSFIPKNKEIKY LKQLHTNIVYEVADDFVNFQRGDGLVSSSFNVALLAYYADCLPIYIFDKS KKYIGLAHSGYKGSFQLILLKMLFKFQDMGSNFEDLRIIFGPYNRGCCYE VSSEFVSKINLQFSKKLLDMSFCKKDDKIYFDNANFNLGLISNFNLKVED SGLCTYCNCNLYSHRKFKGKRSYAVIWRT >BRE_1097 hypothetical protein MVKGRGFILLLFLILIIGCNFKSIKNSEMYKQGLSKKISFEDRIGFVNFI FDDLNEFKISSENQEFVMCLERVVGDPDIMVSKTDRTYTKDEFYHLLKNM NRDDIDKIMEFNVIYKDLKKVEKMIFDLKWYKLRYNLNFNFQNYKNIYFL SLKRIFGMFSAGKNIIHPNDMLEHHSLILNKFVKDVENIKVFDSCFIELC DNEKRVIYYMCNLMSNMSLAFDKPVLHCGYEFYSMLGNFGSNGIKNIIKI HLDIIGKIFEIEKLYSDYLYDNIMDQKETFAFRNAKYSLRRTFNTMKTTY DLSLKIIFNNKDINAIYNSLVNFNIVAFSHLDQLKADIFVFIDNFKLQFD IK >BRE_274 uncharacterized conserved protein MTDIGDFADLREKIRRYLERENKVRLIEIEADTLEEALNDASLELSVPYK DLDYEILVRGNNGIFGYGEKKWRIVAYKNSYSKFGVLDVLSSQSESDESI SLDGKFFIRRSAKGVFLKVTPAQGGGSVVTFKDVMDKFASYSNIKNLDKN FVRTVVENASGEYERVSDFDAELAESVTMMVHISEDSMSVTIEFTTPGPN GAEVLEKDIFNILKKYGVVDKALLRNKIKEFVDYPFYGESIEMAKGVNSV KGRDAYVNFVVKSKYSAEYGAMGNEFRNVNKGDELAEIVPLSRGIDGYTV FGKVLKAESGRELNLVLGENTLREGNKILAGCDGYIFIENGIIAVHNVYV VDGDVGPATGNIVNNGMVLIKGSILDGYNVMAKSGIEVNGLVGRCNLSTD GSIVLRSGANGKGGSGIYAKKSIKSKFLENVDVRCEGNIEVVRGIVNSVV SCTKKVLCIGKKSKIVGSDIHAREEVRAYSIGSEGNAETAVCVGCDPEIK SLLSRFNEYLVKIEKRLEVLTKDISALKKNIQITVDKAEKSLKIDSCNEL INERDILILEIKMVKDKQESLQRALESSKTDGKIFVEYIAYSGVKLYIKD AYYELSRDYHNITFVEDDGIIKMVAYVPFESK >BRE_1092 uncharacterized conserved protein MRIVFDKETGIITKSIEEIQNIKKEILKREYNILIKDNSIFDIINYPSSA IDMEIIQALNELFETLKEGGKYFKKLQHSLSIYKSSTYKAVKQTLLAIPQ IEYANIISSAGTIQIYIIFTKEYRTLSAITQDIKIQIWKAIYNTAPCGTA FRGKIKLEFFNKNGQQKTYKFSLGIIKYAYLKVLYKTETESIHKEIDENI REIYKKIFQNKYKDMGISFCYQDLLGPVSLLQGIRKMKIGIHTKENLNTK ITEIKESEFQFNNDIEIKANELISFDENSRLIIERE >BRE_1026 putative lipoprotein MGVFMKRMNVLICVVNFLVILGCVGPTGIQGLRGPDGRDGEKGQDHHGDV ELLMSAFLVLKSSYNYNLGDVKKIKDSIEKSSIFSHVAFEDKFQSDKNKD YICIAVKSNELVFEDVLHILRLLVGGRSSTSQDHNVAKNFLNSLLDSASY IDEVINLNLFTPDFDLDRLRSFDRSVVFELNFLLMGMLGLRESIVNDIKV LLKNPNLAILGSSSPSNLKVELAPIIDVGGNIYEKIYGDNDSLKSLRDLI IKKINTNV >BRE_322 uncharacterized conserved protein MKKYTIILIWFNIITTIHATISTKDVSINKIEELYTKSILLKEFKKYNQS KALLMQIINQDPKQVDAYLLLSELEYLMNNWLKAIKQTNNYLHIIDFQDT KNYLDISWAYFLIGELGNSMDYIMQFIQDNKELLNSNIYVLIDTILKKGF YHLMQDEDLMFNIIMNTIFQIETHDDTIFTIFLNNLDVIKQIPFYEFNKT KIEDLELQIKTLKNLKNENNNL >BRE_1021 putative lipoprotein MNVIYKIIFILGVLFVCSCKQDGEQDISGDFTEAYIVLLNSYNRFKSLIN GPKGFSNSFFDDIKRLFNAYVEEYAQNDFYASLGFDAVAIDNLKRIITTF NLNRYYYNTEVGNSFVHRLRQFSLKLIVPINNLLQKNDNIGVLKDSNNME GLKELALMLDDVCVKWGMFVGQVKNAINEASNLTVKNAVINKLEILDNLE IENPNQQCVDVQGINNKLCDLKHELLQLFISIKDKVLELVKNVGKE >BRE_833 uncharacterized conserved protein MKKYVFLLFLFFPLGDLIFAYPLSFGGGFSYQFTNYTSKSNKDILLENDT RIDNGINFNLYFDANYVIFDISYKDAFLVSHHSRYFSFGFYGIYPIVFKE YVRTLFPLIGIKYTIDLSSIRQNLVFVSLGFATDLFIPEVKGLYIRPLFI LSISPTSFSSRSVSCLTTEITFGVNVGWKFLN >BRE_829 cytidylate kinase MRIAISSKSGCGNTTVSSMLAKYYGLKLINYTFHDIAREKNIPFDTFYEK EIMGRNDYYWDEYLDSKLLKLSKEDNTILASRLAIWLSKDADLKIYLYAK IEIRAERIINREGGMYSDILVSTFNRDFNDSKRYLSVYNINIDNYLDVAD FIVDTTDQSANKVFELIKNEIEKRNLYVK >BRE_192 uncharacterized conserved protein MLDNKLLDDFEDISQNSDKELLDVTEKSKRGYQLIKEERLFEAESLFNDI LQKDDDNNYALVGLGDIERKKRNFDKAIIYYQKCLAKHSNNNYALFGLGD CYRSLGDYKKATDVWEEYLKYDSKNITVLTRVASSYRKLKNFQKSRQSYL RVLELVPDNDYALVGIGHLYYDFKEYKEALKYWLKMYEINQVKIDVRLLT SIGNCYRKLKEFSKGIYFFKRALEISPNNFYAIFGLADCYRGSKEYAEAL KYWLTIIDRDPKNNLVLTRVGDTYRYLKDYENAQIYYKKALDVDFDMFAI LGLALLQKEQGQYEEALIAIKNLIKTNPKNSILYVNVAECYEALGQIEDA IGILSSFLQLGMKNVTIIDYITNLKKKMDA >BRE_144 uncharacterized conserved protein MYIIILCYYIGIIMNILIINKNILFYFIKTSYNINHLILIFLLSVPSYAE EVIKISSMDAVNMALKYSLESKNAKYQEEIKKLYKDRSWNIFVPNVGFSS NISRQNPFMSNVRGEHWHLGLGVSAELSISPSVVNKMRLASFNYDEVVID RERVNRDIKLNVLKIYNELLAFKSIVDVLKEQLDKGKLKFEQVSIAYDNG LISEIDYLDSKLKYNKLQPNLDEQIIKFEEIKSKFRLLIGLNVLQDFEVV GELSDDILDFSFFNEIVDVYEDLEIRKLNNFVKIMQTTLDSLWLDAFLPS LSLSMSYNPGNISFGSGFSGLGQQGFHFVFGLTYSLSEILPFSKSFTEIW KQDYQLKMLRDQIDNKMREFKSKVVQKRKNMRLYKSILDNSKMTLEISKK NYQIAFDAFNAGTIDLIKLNDIELSYKQSDLQLIKDKLNYANLVLEYKDL INKLD >BRE_257 putative membrane protein MHNIKKLLFIFTLAFIFIIGLFKVNAKNNDITKIYYKKETFQGGNIYFIS NKNFKKLSLLSTNQKPILSASPFKCNISNKDYYIALIGITPMIKEGKRKI QIEFENKQYIKEIEIKKFTFKKTTVKLNKSKSKLIKSQQSPKAKKQALTL WNIIGSIGDTTIYHYDTFLHPIKDKYQITSPYGDQRIYMQDNQKISSQKI HNGKDYAPFKKEKTPIFAAGRGKVVFARDREITGKTIIIQHLPGVFTIYL HLSKFGVKENTIVNTGEYIGNVGNTGISTGPHLHFEIRINGIAVNPDFFL EEMLIDKNQIINNTKKIE >BRE_66 uncharacterized conserved protein MMDNKTPHNQLFLDSQNLSDGNLHEFRENHDNKIHDLPEHVSRGLVLTIV GSLIISCAIFFIFLKSSDIVVVPNLSGLYIEEAITELQHKELIPYVELKF SSTSLDKGKVIDQKPKAGTVLRLDSKVKIFISKGSVINKIDNFIGKNIDD VLINLKANAINNNRMLYHLLRPVEIESTLPKGTIIRQEPSPGTKIASLVD LQFLVSKGQEDSSVKYIKNYVGLYYKDVIISLLNDEIDFDVNVSKGNDFG SVIYQSLSPGNRIENLDKLIITINEPRVNSTSVFGIMTYKLDVYSSSVDI MLKVKDSSGNSSLFYSFRSKGGLIKLPYEAVKGSTVELYIHDKLINQTLV N >BRE_401 glutamate transporter, putative MNEKIKFFLTIPIGILFGLFLPSETYNALSHIFIRLTYFSLIPFLIFAIP LGIENIIENKKFKRLFGKIIYYGILINISGVIIAIAVSTIYLPQRIPILD KNIQNQYLFDKKIFLETFFPKNIFTIFTNSNPNLLNIYLISIIIGASFYY AKQKGRIAKELLLSMSNLFYNTNDIIVKISQFGIIFITAAYAVNLKNFKN YQYYINSIIFLSLWTGIIILIIIPMISYRLTKNFKLSYKNILTSLHNIIF AGLTMDTYAPYSLLIENIKNEKINIKKSIIINIPIINFMSKFGTIFISTI SFFIILKSYSSLPITIYEISYMSILAFISIFAFPHIPNSLIYIITMLCST YTKGIELSYSNIIPILPILTSLAIMIDFTSSIAIMQIIDFNDSQYT >BRE_366 uncharacterized conserved protein MTYILLIWLIKHSLKDDKMHKETIETSEHILECFGGITNIKQVVKDLTRI KILVDSNSLVKRENLTKNKNIIGAIKSNEVTEIVMNFAIIDDVYTNIIYM INKKK >BRE_101 uncharacterized conserved protein MNSSTFEVLWGVNNIYSVVEVNTNTVYEGVIKGKFLNTREKEYSPLVPGD FVCGDIYDEHKVYIKERMERRNVFWRYNKKVALRQVIVSNIDNILIVSSA TLPEFKNSFIDRTLIVAEEQGITPIILVNKVDEGINLRVDSFIKIYEYLG YRVIKTSVVTLQGIDEVKKIIKNSRTSFIGQSGVGKSSLINVIDLNASQA INEISYKYARGRHTTVYAVAFHSDNKILIDTPGIKEFGIEGLGYLELKYY FKEFKYFNDLCRFNSCLHINEPNCFVISQIGFKIAEARYNSYLKIFSELK RYKSYAREIFGKN >BRE_112 uncharacterized conserved protein MYLAKVSFKTIIIMLIINSHAYNYLMKYQNDGIDKYHFDKLNDGFGFALS DFFDDLRSGSLIFIHESKHNFIINAEAHMLTFRGDKESPEQLRKRIDLLE LGFMYYFPILFKTKTQYFGNFNIDIGIKNLLYGNWGGSLIQRAVHFALRQ LRPIPKNYEHYHYRGFISTAINYSYMGFFYLENYIDLSYFLDYFFKTSIS MDFKNQFIGIETQLFYQIQSKIKDIETYLKIQEAETGIGIQYKLYSKNFF SINNLNLNNFSNKEKFFSVGGFGIIITEEYDNPIENNLYLLNHNFSIEYD IMLPFQTRNIIYYKIIPQLNYYFAISANYDINAHEINSRTNRFSSGITYE FFTKNRLILYIASGLFLAYNKDKKDIKSIYRPLKIKDTLQTGLEIEPGVN INAFTYNKTKYNIKIFTKMNYSPLVYNTNNHTLEKHKFICNYLGIGIKIN I >BRE_372 uncharacterized conserved protein MMVDRILFIFNILFFCFFLYFIYFLQIFNFSSFLNFIILHRYFILYFIVF VFVFNIVYSKFLYSRLYFILNGIENTYTFLRLKMIRKTLKSVFDISTLLK ITLIKQDKKAFDDIYLYLKDTKMSNKTIIELYAICVSFREQEKACSLIMN HVENRNKWVRYCVSLHAIFDEDYEKLNNEINFLKKSFLKGDLIFTIYFYY LLKKSKLERHLVEEKRLEIRNKYLKRKDRLNIKHTKLLGSNLFFVVFYYI YDISKKDIFY >BRE_185 uncharacterized conserved protein MLASWDLFKRAGIVKFISLANIKKECSHIYYRSVYFADAFYEYNGLKEVK HVKFIIEVTPLNEKHVTIEFLEPLNYPVLSLMVAIKRHVIELNTKGELP >BRE_454 Chromate transport protein, putative MNEKKETSYELLKLFYLVFKITTITIGGGLLIISELKKAIVNKRKLISEQ EFKEILTTSSIIPGVTAINFAFLIGKKIKGFKGAFVLTIAGILPSIFVIT IIALYINLNSNNIYFQKFIEGAKISSTIVMSMIIIEFSKKMLNRSIIKWG TCVLITYVLYKFHIDLSYILLIFLLICSITYTMKKKFLKARYKFDFTKFI HHIF >BRE_729 adenylyl cyclase, CyaB-type, putative MFEVELKAFIPKNRVKKIVKLANQKFQFIKEEIKNDIYYFNSKKIIRIRE SNISKKIITFKIKSLEKDIEINKEIEFKVDKIDNFISFIKELDFKILYKK IKKSLIYKKDNLNIEVNEIQNLGFFLEIEKIIDNKNELNLAKQEIYKTIQ DFKLQNNIEKKSYFELLSNQLKK >BRE_536 zinc protease, putative; lipoprotein MRCKRINNITILKVVFFVLSFIILSCSSSKLSLDKNLVNGQLKNGLKYYI YKNQIPSKFVHMGILFNVGSLNEEENERGLAHYLEHMAFKGTEDYPGSED ILEILKKFGMKFGADLNAYTTFDKTYYYLDLSDGGQESEVDEALNVLKNW AFQIKFDDLEIDKERNVIIEEKKYRDNYSSRMSKKMFEVVGGNSRYFIRS PIGIEERILSFKSEDFKKFYNKWYRPDLTSLIIVGDIDPKDIEEKIKKLF ASFKKPLDEPEKVVINLDTVIDKKFVSIDDDETLFPSIEFICKEETKGGI VTVEDLKRYIEKNLLNSLFINRFYELKVIGTNYFSSFNKFGSNYKSDNNY ILIKNISLTIDPEHFKEAFEGFFYEIERIRKFGFTKGEIDKIKSEMITSY TVDKENLKKQKSSIIADHLVGVASSNFHLLDGNEVFDVAIKCLNNISPDT ISALASSEAFIDNMTVIYKYSKKLHSNLTFEELQKFRDIALNKEIKPYDD VSIQGEFFKKSLQSKNIVDEKEFINEISSFTLENGVEVYFKHNENKKNIV DFTAISWGGLLSEDPELIPVLSLAPSIVSKSGYGDYSKLQIEKYLSNKLV TLMPSVSERTSRINGGAEAKDLETLFKLIYFTFNEAKIDDVVLQTTIDDM SATIKARKNSSNYLFSNAIKKFYNNDDYRLRDIQESDLQNISKDILLDFY KKRFTYADNFKFIFVGDIDLDTIKKFSSKYLGNLNSKKLNEFRDLDYSYK KNTKRIVVGKKEDAASSTVYVVYPFTFNYTPEEVLNYSALASLLSEGLVK AIRREQSSVYGIDASFDHYFRKHSDSDGFIVVSFTVEPKALDSVLKSVNE YILERQKIDFVDTDFDYIKKNIIKNNNIASESNGYWSSVILNSVLWHDSI IDTFSNKFVDDNLNKDTINMLFKKIDFKQGTEIVLIPSNDN >BRE_737 uncharacterized conserved protein MLIDLEQIKIKKRIRKNIGDTTTLKESIKKHGLIYPIIIDKNKNLVAGFR RYQVLKELGYKEVDVKVIPIEDKKRLLEIELDENNVRKSFTKSEAEEGEE ELKNYSEKNKIIRFIKKIIIKIKKIIIIKIKKQN >BRE_453 chromate transport protein, putative MILLNLFITFFKIGILNFGGGNGITATIHKEIIERKEWITQEEFINIITI SRITPGPIATNIATYVGAKIAGITGAIIATMALISAPILIIIFIISTIHK INFLKYYLEQLKPVIIALWIITIIILFENIFFKIDYNNIKLSKSFALAGL NLLILLFYKNVSPAILIISSGVLYIFM >BRE_4002 BBK32-like protein MKSKNKYLALGLLLSFINCDLFMNDEIKEKSLGLFDKVHSVLDASAKSIS NNKNGKFSQDVVSGDITSGLQNDVQKDIQVALSSTTFETGEAKIQKQQDV ESENSITKVSKVYSNVINGLTGGKPLRGTEKEVNYPNVDDGEATSVEIHH NSYLNGFGSTSSSSI >BRE_475 uncharacterized conserved protein MTVKELSLHLDEIFKVNDHKDIDKSLNGLQVGNLELEVKKVALAVDASMA TLREVKGYDFLITHHGIFWSKSDKIIAGMYDKVKWLINNDLSLYCVHLPM DAHTIYSHSRVLSDFLGFHNPIPFANYKGINLGIISIAEFGFSEILKRIE AHNKHILFYKKFKEYVSRVAIVSGSGYSFFEEALEYDIDLFITGDTSHQI YSLAEERGVNLIFAGHYFTETFGLLKLMEYLKNQRGLEVDFILQDTNL >BRE_596 uncharacterized conserved protein MTLLNKYPVKYAFLEILLSYFIVTRISPFQNVNVDLWNFNKNHYSYWLYS FFKIFFIVHFARLTSSYDFREEFCIPKFKFVFVWQAFAIFVKLLVCIFFV LIILCLCFLFFTSESVIPWMEMGSSGFIWEIKSTQSLLLMVVTSLFTGGV EELFFRSFFITKLKQMGISLFISSLISSVVFAYGHSYYGFVGFFMSLIFG IIFAGMYLRYKNVYYSIFVHSFYNVFVSFLLFLSNYSKELL >BRE_22 uncharacterized conserved protein MKKKKNKWTRIKQKFKFIILKILRKQLKNVFKDPKLILISTLQIIMGSLL MAISTNILYIPHGLLSGGIAGISLMLHYLLDFNLGLTIFMLNIPLFLIGI KFLNITFVIQSWIAMALYSLIVNYSQFLQYKIQLNDMILVSILAGLISGL GLGLIFKAKGSSGGTDIISMIIKEKYSISIGTTNFLFNLAVLLIAATFFN IEIALYTLIASFVTAIMTDKTSTGFGNQKAILIISDKGKEISYLLTNKLK VAATLLEGKGAWAGNDKTIVFIVVPTMRMSRIKYISQKIDPNCFIIVINT NEITGGKKIIETNTNKNDIAS >BRE_46 uncharacterized conserved protein MNKGNFIYCNFLFFIINIVSSFAFEKNKQNIYELDFNSERQEFLVNINSK FNLCFKDEAWIYIKNNKNNPFIKFLSESYQDGAMFSFQTSKNVGIVMLTF KYQNVKDSREFTKNVILRIVNQEKSLNLDQMDSEGNLNLDKDIKNGEDFG LNNQSGHNVDLKDIMRRALNLYHINDYKGAIELLNKYDFNSDEYILLKAE LYYKNGDYLNSYLNYLSLRDDFFYQIFVNLISLGIKLNKVENVLRDVRFL VENDIDFDEDTYLDILEFLLTNGEHEFYSSLSSLYYPKYVSSKFEDRYNY LLGKFYETESKYKDFVKSLSYYKRVIDSYPFSSYYELSKLRFLFLKRFF >BRE_3006 hypothetical protein MLICTLSVLMMLYCKNGRNNSEATDSILARDQSNKAETKPITPEEAYFEL EIGVELLKDSLNFKPEVFDEYSFKDIFEIALGERNTEEFRHSVYYNLKYD TQTLNNLKTIADILMSKSNSDVKNFVLLIESLSHLPSYEFEVIDEQGKIL NNNTLTALASSKDLEGLNELADMLYNMILQREQRFLTIQEIIKDASKSDT KEILLKKIEPLIKLDVMLNDKNCNNVKLCLDSKTLSDFPNKISDKVNNLM QQMK >BRE_588 carboxypeptidase, putative MLNWIMQYNYILMISFNIFSLIFLVSNLINNPSLEANTISKQDFQTLLNI IKTLDQVHQKQIKEQPISFIQELKPLLEAEENNLLILVNKKIPIPKGYNP TDLVYLKNFKELKNIGKENLKLRKILINDLIDLINAGKKNGLQIKIISAY RTKEYQNFLFKYNVKTYGIKSAQIQSAISNHSQHQLGTTIDFINTDDNLL NTKEGKWLYENSSKYGFSLSYPKKHEKETGYKAEPWHYMYIGKQACALQK KYFNNLQYKFLEFWNNNKKELLKLIQKYKININYP >BRE_851 putative lipoprotein MKHFICIFNLISLYLICSCALFTTDNQANNSPNTIYLTHNAPSAHNLITN NTHTIYHIPSNLIDKLLQHANDPNLLKILAIDLKISPQKIEEIQNYLLAY QKHLNNSQEWNKFLQQSNINGYLIIKTNTSFKKKSDIEQIHLINKNFTEL TETQMYLEKEILTELEQIFYENNMGYIPINNIASFFPQENIRNYTINKDI INGTEYISPHIIANQLLKIKDKKYFQNFMIHLKINNNTIKNMLLKQTIVD EHNNLYDSTKSQQKIDSMKNIIDPETGMEITPQKLRSILSHGDILLIKPK IDWTDFFYFWQHTGVFDADKYDNTKKIAFAGKDSFDIKSVITSNQIKFDT ASVQGSGYEKLSTYIQSRILKIFSPITNKRTIQKAMNFARNRYIDNNFGY MVPLLSSNMWTDSINLEDIYHKTYCSLVVDRIYRIAGLNVSRNYEISGII TPGDINAAAYDFYMSYTIAGIFPSTLPNRIIKPTLREKFIGYSKAIKESI ETQNANEKKFGKSCNITNLWCLGS >BRE_43 uncharacterized conserved protein MRKRISQTKSVISGGENDKRVGMWGIFALILIVFGFIIAPLMPGLFDTTD SSNLKFGFYKGQPIYYAKDNKFAQYVNFYSNFYSKLKRDNNYDIDYFIWR LAFMKYVEDIAFLDLAKSSNFYISKSVLSQNVMNSPVYLDSNGNFSPKRY NKVSDYQKFKIYSDAVENLLSSNIQIFLNSSFVFSDFLLSAVKNMSKIRK NIAYITLSYEDFPKDKVISYAEDNQKLFKSLDLVSISFKNLSNANDAYDK LSKGMPFEEVAKFYSEDVANFKGIASSRQYYFDLDLMLKEKEGLSSIFSL KINEFTNPIKSKSSGEYKIYKALSDIYNFDQNSNNDISAVKNYIETYEPN VIETYLENKLNAILSEINSDVGEERSLQKYNLKVKEDVVNLAYNMNIYSS TLKELSIFSNSQGFYDLIFDLKEGQWSKPFLADHKVYSFYLRSSSNDSYE SDVLVQEDRIIDNFSKANSKLLLDNVLKKNNFKENFNEAFFSLKDFSLNA GN >BRE_478 uncharacterized conserved protein MSLRILVSGEIVGKPGVFVVKNFLHSFKEKNKIDFVISGNNFTTGFRGLC KRHAFLLKKYGVDVLTLGENAFVRAGLSDELDRYNFILKPLNCPARLKGY SYFIYSINGIKLAVLRLVGQTGITKYNFNNPFLTFDYFYERIKSITNNII VLFDSNTTAEVNAMFFYLKSRVSACLGIGKRILTADLRIFDNTAVITDLG RVGSLDSVVGYSTVFEIDKFLKGFLNNKFTESWDGLGFNGIIVDIDDGKA VFVEAIREYIDFDSSIANSTDI >BRE_1069 putative Viral A-type inclusion protein repeat MLVFKIRLNKWRMFMQKLSQIFIILCLLTNCDLKTKQRVDDRGVDEQNPK STQQQTEPTDPEITFNQEAQKIIQKLNPEENEALMFVINALYNKKTDKDN KAYTIKQINDFIIHLDAEQIREMIANTIKVLKETNIKVLKDKKETNEGFE SIRHYPHGKELNKRLKKIINKYMEDIQQAANQVSFDIAKINIQNTLIDND EIKKIYDEENRAIEVQKMHDRAKKEDKDSWYPYYAFLHFVIIPEKSCTHD QFNQFILNRGPNKIKTIFKKLTPALKAEKSAKKTIFQIADKCQQDKLYST LCSYAINSRKAMIQAIANGNLDFDQIEANLMQLPSYLDQIKALQKQAKDI LKDQKEETK >BRE_379 uncharacterized conserved protein MNKNVFPKIYYYDQDFIDIYNKSLSWIRDKIIFSQSLEKGKKDKNYYSEN VEFIDQLQACLSSFFLVYSNGEYSPTSTIDKFYELQESSGAIRSRYDHNN NIIQLEGNDDGIGLPIFAWVEYNLYHKTGNKKRICDVLPVLDKYYKWIEK KFLKSNGLYSIDMNKIFYKNSPRKNVHYPIDFNSFQVHSAYCIAKLADIL NDKNLSLEYKKRFFSLKAKINSLMWDEVDGFYYDLDVNEKIIKLKTIVGF LPLLSEIPSEDRIERMVLYLKSHEHFGTPNPFPTLSANDPNFNLDGNGYY GSVYTYMNFFVIKGLEYCRRANIAREFTIRHLYYILDTLLPDGKIKGHIW EAYKPMKEGPAYLDVTKKTLPEKDVICYLALFSISLMIENIIGLTISLPD KTVYWNIPALEIMGIESLSLKKNQTTIICNKGKRGWEIKMESEKLYYFTI NILNKKEKTLPIPSGRCSMLLDKL >BRE_672 N-acetylmuramoyl-L-alanine amidase MQLNFGKIILLINLVFVFLFVHADEFEYVNILDSFDSNFFKFNFNIERDI LTIEHEKGHLKLKVGFEYGLSSIGYYIYVDPILLRDGEILITKKALMQIE NYFRSLQSYSKPRITSIVIDPGHGGHDRGAIVTHKLREHNITFFEKDFTL TYSIHLYKILSNYFLDRNILLTRVDDIFVSLQDRSEFANAIKPDFPNNVI FLSIHANNAPNPDARGVEFWYLPQNSKREVIRNLKGYDIRGNRYLRELND ILDIKYKYESKKLAEILYETFSDVLCETKIRTIREEQWFVIKNSSMPAVL IEIGFLSNIDDAILILDYNYMSKINILVLESLIKFIEFYEK >BRE_670 uncharacterized conserved protein MVSNNMLKKSILNIEQLKYSIVIAVLTLITFISCKDKNVTYDKRIKKILD NNKLEYRIDKENDFIISKTINNANIEIIVRSKLNSYQNSKIREIFGIVET FDVNSDKIQEISESLMSDSYNNRVLGSWEIIHDPERGNNSLVYIVKAEEN AKEIFLLDAFEEIAATISIFKKVIRDDKTDINIKDKSNETFNKIPNDTLQ NEDKINDHEEEELQKIKAK >BRE_668 uncharacterized conserved protein MGITVFYLFSIFLSFNLGDNVKTVEDNMKRNSIFYYDIEEVEIASVNTQI LNFRGKICVKNAYFSFDKYKLYSYTFVFDKKLVSQYSIVLSVKEKFGDAS VVTPFNYVWDIGDSIIVLNDNILRMTLKSYINGKN >BRE_720 uncharacterized conserved protein MGINYLKFIFYFVISLSLVFFLFFILSYLKAFSNSYLKAGPTEVNLLVLW ENKEYKEIIDYAENGIKENKFDFNLNLLLGFSYFYYSLMLNDSYLKNQFL DNAIERLRFLMSINDDVPMSSLYYILGKAYSHKGEYYSDLSVKYLNKSLY ASSFDFVNVKKDIFEYLGYSYQLLRDYNSSLKFFEKAYRENKSDLILWSL AYVNYKAGDIDKSIEYINKFLEEEHGSLKGDKRDDNLVQKVYLLYGNIYF ERSAYEDAFNCYDKVLKINSLNPNVYVKIGDIYRKRDKDYPKARKYWREA LSINPYLEEARERLKISPEDF >BRE_1043 hypothetical protein MRNYMRKSNFIFYVLLFGVMSCNLDSKVDLSQLQASLKTLMPQDASFVED GKNLSDFKVLLQEYKDKVKDSKDKFEKSGHKFDFCNKVVEGLEIENEFNE DYVYEAVSYNVDVLKHIDAIVKKFDAKVVPKEDVVQNNDKDADKDDKGDD KKYLLSVYLLLYNLNSDARFLSDFVKQNFSDENLDKLAKIEDVEKFTSSL REFLDSKEKLMSVNNKVILEIDLNGNNDEILDQLNKINEKNFVDKNEVER SLNNGTYINDVVKNL >BRE_1060 uncharacterized conserved protein MPQDTINVNLIEDKVKLNNIGYYNPLLIYKSDVLEKGHFVLTSGSFRDFL TSMSVRDDVKTDVGKVKLAADQIEFLIKSSNDFFNEEGLRSFDFYIYENI EDVVKFLKKNIHVVVIFVANLEENFGAEWNMIKGLVKFVVFSTNLNRLPE FLEALAVSQRDGVILVYDNGADNLHLKFVAKYLYEASMFHSVNPYGITLR ASPIYDATLINNLRRNNINFYSLLNETGRDGVLAFKEAVDCSSMPIDEAF TYCLLKNESTHELIRIWNRNHRQNSKLSELKFADGKPNAYTAGLECLFKE FKERGLIVSFGDIKFGLKRDNILGLDLSIRVKYNDSFKSVVLNISSDDIN DYLRREVD >BRE_1029 putative lipoprotein MRVIRIYFLFCFIMVSCGKDLLDTLRKNPGVEGQLNVGGRSVYVLGKVDN NGSVARSGSTTVNGSTNGGNPGPVEVTINGSEQSVIDELYNVLVNKTDRY KATLVDEASLSNLAGNPYNIPFRKIDLQYDNLKRQSNFYAGLGYDVQAIK DVGLIFNNLNLEKAMPSHDRSAEGKNDEWMLANNLLILVWQVGHYSEKFM NHLDNASLSKIYRDKNKEKLLSISKCFDEFVKVRSRAVETMKKELTLLKS LVKTEKFLNKLRATLGLVDGYDNNIKSLSYEIVSLEEQLLRLKNS >BRE_244 uncharacterized conserved protein MKIDNLVSGAFNLDLKDYKASKKKINSSKTNIFSAIFKSELVKEDKHLIV FENGEFNLELIKDMLAEINDIGEKLLSEPSRQNVIFYKKTIGEFLSVVLS NSISLKEQKGGRNGEFKRPKYRIIKIINEKLDKFAYSVLQNQISQFKLLS SLEEIQGLLVNLFR >BRE_272 uncharacterized conserved protein MFVVFCFILIIFTFIYFHVYISLKIKSNSILKKFKSEVDKTIIEINQATD RNISIIEIKIESLNRIIKEVDERIEILDQRLLGFNSHSISMVNNNFGIKS DSGSYKGNLDYSIPTIEKNIIKEGYNIRRQVISLYEQGMSLEVIAKKLKL DLGEIELIISIHRGI >BRE_1030 uncharacterized conserved protein MKLFGLLTGTLVYSVGSIVKNRPVRKVFDLKRNTSSGNVRVQGSFNISDK EQVFYTLKTRVIAYREEINGLYSQFNSGKFLLNIPFKKISSDFADSDKQY KIYSSLGYDMEVIKQLGNVLNKLDFNSPHFINIDADVAYKLLKFLNNITD YAKTLVNYYLSDETLLHIKSSKDKLRITEIYNHLEDFITLRENCMSKIKL QITYLESKITRESVLTGMKEMVAYEGEIGQDINLMSTIAITIWSLS >BRE_418 sensory transduction histidine kinase MCNLKIFLFVLFFSYISLPAKQTLKFKLVDQYYPLYYKNKEGKMTGMIFY LLNKWAQDHHYEISVEAIDYLDQNKIEDDVVYLGLTYNSDLSEHLYFKNE IGKCVTALVYNSKEEQKITNPFLSKEFRVGVVKNSIYKDILKLHGHIDNV FSFSDTQQLFSALRDNKIDLIYGSYKSLYFLWHIYFDPSFLKVFNSDYFY SFGIRVAISKKAVNELKNLDIDLLSYMKALSKSEYASFKELDYLFNLDVG IYNDYPPLSFINSKGQLSGILVDLWNDLSREYAFSLKFVGFPKESIKLSL DDKDISVWGGIIEDNNILTSKIYKVTDPICMLDFNFYLTNSRNSDKILNS QIVDFHLSGIRLDKNTDIVNNFADIINNSYGFIENLITTNYLLRLHGYNN ILKFKDLSFNVQKPLILASNIRKLQLFSYMLDALTSNILFDTLLEIDKNW FTQNEIKDYQSSCYSHVNSSNFNIEEKIWLEHNKKLNLAVKNWYPVDYVN SGRYKGINEWLIKKIKRLTNVDFNIINVRERELKDLIKNGQIDILSSNLD SANLDYFFNIKSVSGIPLYIFSQKTNLFIPKSSDRIAVLNFLYSNKLETQ IGAQLVQVESFKEALDLIYKRKVDGILSDEYTATVNFEDLNVRDLEKIVN VSDLSFNLNIAVYNQDYILRRIIQKILFRTNVNNKLYFDDWVFNVHESSK DMKLKKSGILVLTIVFFVLTILMFFLFRLLKEIGFRKKMYSSVISEKKVI EDAIVAKTIFLASMSHDIRTPINGIIAATELLDNTDLLGVQKEYVQMINY SSTSLLSLIDEILYISKIDMNGIYIENNEINLEYEIEEVVKSFQSQSAKH NLDLIFYSESDLNNYLIGDRSRLKKVLINLISNAFKFTKEGIIIINYEII CTREGDNGDRIFTIEFKVIDTGKGIKKGNIPVIFELFKQGDDFDAKEYEG TGLGLAISRKLVSLMGGPGITVESEVGKGTTFSFMLPFVLGNEINDKEKS KFKLIRNKKILTLFSSNKAVVLLNEISEILDYKDNVRNFYSYEDAYEECS KYPYYDFIFINVDNADLQKCLKFAERLEKLNLDAKIVFVFYYLKNEEIID FKYEYIQKPFKRWGFYSDWIINGSLVDAPLIDNSGIFKLKDNICILIAED NEINQKILKNILIVIGVREDSIDIVDDGFKAIDYLKTNRYDIAFVDIRMP KCDGFTVSEEIRRYEKQNNLNSCVLIAVTAHALREYKDRCLESGMNDYLA KPIHIKSIKYILKKYLYIDEVKNNNIIEYKNLDKLDDLDINRALQDLDIS YDMYIDLCRGFVVMSDNIIRDLDEAFNLNNVVLIKELAHSIAGALGNMRS NLFDNFKQIENGTDSIEELRVLYSKARQNLIMLVKNIRDRILNVVDIDDY EKLEFQSNNDFLIIMQKLLNEIENRNPKEYKKILETLKKYHWDDDNIVLF DSLVECLRVYNFKESVDIIKRMMSHNRIGKS >BRE_6012 uncharacterized conserved protein MIYIIVIYFNCMDTGFLYFFKKALSVDDNRMVYISYLYDNLVSIQPMQDW LKIDFRDSKRGKKYFFLFQRNKLNGEFISCNFLRTETNHALDIKFSDGNL NIFCKDRKSLEFLKFRVEHFFKSSTKSLKVVSKSNNKPKVGKIKVIKANI RKNININNKNKNF >BRE_12 uncharacterized conserved protein MSKKEKIIAFIFDFDDTLIYGNMQQVLFDEYNVDANLFWSEVENLSVTYN ENSCNIITNEMIYLSHFLTYVREGIFRGLNNKILFELGSKLKFFEGVIDL FKEISDINESLKKSDAIVNIYIVSSGFRQMILGSSIASYVTKVWACEFVD SYLMPFYQSLDNKFSENSVLSSVCYFVDHTIKTRVIFELNKGSYDKINKR IPKSRREIPFENMFYIADGFNDIPAFEILNNNLNHYKNTLTVYYGNNENA KKLVKEKRVGDLAEANYGKGTKLYNWIMEKIFSNI >BRE_1110 uncharacterized conserved protein MILKRRRKMTRYNDVFILLMLISIVSCKNAVDGTKTVKDVNGNARNGSRA KGDFVVANGFDIRNGPTLENNSGIDNANIRNDVDRLSKDDIVQLKTFITK SVKYARSLCLLIQEYHTIYSFLKNYVYCVNGSGNCDNAKLTKESIDVIVK MKVDNIVDKLENILNYFKIHNPKMSIDSIEQLKKIFKYHVNFVFDSNEIK MDQVVDVVKLIINSYENVIDTAVNMYADMFSFIVSQCSSKKLAEISKNFV RSIRLCMKENDSNNILLVQIMISVFESIFLNQGDIRDVKENARKLFFYRR GKELSNSIDELYVVYHIARLN >BRE_1006 hypothetical protein MQRIYMLAFLFALLILCCKQGGGKIDNTGSKRDVSKDRSVRTINSDRIGK TDDSLVGSTLDNQGGGATLGKDLPGGGVQDNVVDQGIVVVGDKGDGQDKK RKTLEEESYDAFKTSFDRVKALYYYRPEGFNDYMLSDIESEFNFEYSLPF KNNVYAILKGDIKTLHNLQKIVVNSHPEKVLEEYLSKNESHALISKLKDI SDHIIHKLINGHWGDFSNYNLSKLAISKDIAGFNFLKNGLDEFCAKWGEM TKLVQDVINDMAKSKDKNDILQRVGTITSLIPLNSNQQCNTRICAVKNDL NVLRVKLGRKVEQLIREIYLWL >BRE_1083 uncharacterized conserved protein MVFKNKELKYSILFKSNLSISDIAKVLGVRESTVLKAKINILGEVASDLN NFDTNACVNFDLDALARDATCQAYMLEKERDSFYKSFYKVANSYINSHFK YKQIIINSDLKRLITLNEEILKLTKDINNNDKDLCKKLKLDLRYKIYKKN RLSKKIILNEMKEDYGCLLKLKKIFNSKGLKLE >BRE_777 uncharacterized conserved protein MNIQNIYVFIKRHKLQIKVLFIIITSFASISILFSSFVYLKSNNNKINLK LKDKLAKLKRHNSTKTKQKLKLNNSKPEFYLIIDDVGYDEFMLDEFIKIN LNINFSIIPFLPKSMEFYNKLQNKNKIIMIHFPMQSKHKNSIEKFHININ DDEITIRTKIETTFNTYPNAKIMNNHMGSLITSNENIMKIMLIKLKEKNK YFFDSLTTKDSISIQTGKSIGILVEQRDIFLDNRDNEKSVIKALERAKQI ARTKGIVKVIGHIWSKNTLKILQQESENLKKEFVFKNLINLYQREENNEG TWNRKLM >BRE_1052 uncharacterized conserved protein MQSNYEISRRLGNLSEGLAFEDAKRYLQDNVFICRIGIVKKFDFEKQEGI VVIEEYEDLNIISRNISNLKLELVEGDRVVLLQSSINIFNESDNNYFDKH YFYILNALTLRNVGISVEKFKIDTKELDVTSEDSSLNLKNIICDGEHSKI SLKSLVIEAGNIELKGNVYINGKLFESHTHSSGTITYINASGAPTLASGS TAGVS >BRE_1089 uncharacterized conserved protein MLNKTNTELGLIVLKNLIEFFVYSDTQDDELFQTGIKKVIDIYKYMNNIY TRSLQKMEMKESKQIVLELETILSKIAKLIDAINTDADTTLIEDLRFERN NLIEIKTKLLQEELDKINSKNKKGGQK >BRE_688 tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase MKIAILLSGGVDSSVALYTMIQKGYKNIKCYYLKIWLEDELSYIGECPWK EDITYVDSVCKKFNVPYKIINLQEEYYNRVVTYAIEELKMGNTPSPDIFC NQRIKFGAFFEKINEKYDLIVTGHYAKIENKNNSYTLKQAKDKIKDQSYF LSHLSKKQISKLHFPLGDLLKSEIRQIAHEIDLPNKNRKDSQGICFLGKI KYNEFIKYHLGELKGNIIEQETGKILGTHNGYWFFTIGQRKGIKLSHGPW FVTEKDIQNNIIYISNSTNYLKQGKEQFLVHKTNWINKPLKNNNLSAKIR HGEKKIKCKIETLKDEIIRVNLEEKDYGISPGQFCIFYKEDECLGGAKIL KTLI >BRE_1035 hypothetical protein MDLREQNFDELKEILIGFREELENERYAFISKQSQLDINFKGVLDDIIYY QSDRDKIYTMLGYDVEIIGRLGLIFSKLNFKHVYDRDTRLVMNLLNGLMR VAHSIQTLFKDIFNQTKLDLLQLRDNEDIKKIVIYLEQFIEIIKDLMLQV KAIIVSVASKINEDSILKELSRVVAKLDSKFNKGVRNIHYLLFDIIELVD FL >BRE_784 uncharacterized conserved protein MFKVFFVMLVLGVCMSKNILKIVFLFWFAFFLFAESESKKEDGSEVLGYW VGYDDKTNAKNSVIYVYKYNDKVYGRILNVIKDGKIHDINNPSGYKVVGF EHLSTEGLDFMWGLKYFKSSSKWDKGKIIDPNNGKIYTSEMRVDPKTGNL VTKGKVWVFGRSKVWTRAKEDEIPNLDVDGIVPNPPVVEE >BRE_756 uncharacterized conserved protein MFLIQKIMFSVYVGVISYFIIAPIFGETGIINYKKLNNNLIMMKKHIENL KMIQKNLKTKYINLQISKPAILREASKLGYYPQNSIIIKNSDEDENYYQG NILNIKQTSNNTNIDKNFYLISIVLSLIFYFLLSYFEKIKILHQGR >BRE_155 putative lipoprotein MKKFYKIHLNIFFIIISCNTKTLNELGEQQFKIPFGTLPGEITPLTNKFT NSGFDIKTYNGLVYIVETKANKLMIFTSYGKLIQTYQNGIFKTNDNLKIK KVNFENIQAIYPSKDFIIVSDKINNTKSKFDEKENIAYSTQIFILNKDSS VAILGQEGHNGTPFPEVCDINIDDGNNIAIITIYHEGYIIYSYDQDLSPL YKIYINTNILQIPEEEKKKYNISIDKIFFEVNKKIIYVKTTYYENIRTNE NINDLGVKIKNQHFYTMSLNKNKEFEIKNKITLPQNLLDDQQESFINIIG IQKNKIIASTNMKNLSNILIWKLDNRGKIKEQMILIEPPNLKFLAESLSK DGILSILYAEKSGVSVYWWNLNTLLKL >BRE_761 putative ABC-2 type transport system ATP-binding protein MINVNNITKTYGSFTALLNVSFKVNEGEVLGILGPNGAGKSTLIKILTSF HYPTKGNVKIFGKDITKNPKEILQNIGYIPEKLALYPELSVKEYLNFISE IKGVTNHNKEIDRVISIFKLESVKNKLISTLSKGFKQRVGIAGALINNPK LVILDEPTNGLDPNQIIEFKDFLKELAKTSTILFSSHILSEVESICKRIV IINNGQIIADDTKANIAKNRLQESEIELIIYKDSETIKEHFNNNDIFTSI KIEEFEKETNVSLKLKPNKTERELFNYITSKGIILKAMIPKHESLEKIFS KLTKERKE >BRE_1100 putative lipoprotein MNEKKSCDVLFLLLLLFGGCGVDTQKKQGLATDSGVYIPSKVVAKQPDTN FTSLTRFEQSVASPTTENREHKPVNYEGREEDLKPDDSEASGITCDDSSI STLKDKVVEVEESPEKEEARFFSLINRFGLSDDEKMFIGIIKKFVTDVNV GLNMGYKTYSNSEFYNLLEKLGATFVKRIVKSLKPTFIVLNNAQIAFDKL KERNKNHFQMTFNMAYNGFARDLKSMFNKPCFADIYNSSLQYNNPYSVQF ISLKRHFDYMNGDEK >BRE_689 3-hydroxy-3-methylglutaryl-CoA synthase MMKVGISDIRVFLPLNCLDFCVLLDNSLYNSDENFFAKFNRAIDGTLQKA FRFTGTNEDSVTMASAAVKMIFDNNDLDLNNMRIFLGGTETGVDHSKSIS SYVYGALKLAGINLENNFLTFQAQHACAGTALSLHSASSILSHLNGSEYG IVFSSDIAHYNNLTTAEITQGAGAAAVLIEKNPKVLSINLSEFGVYTDDV DDFFRPFGSLEAKVKGRYSIDCYNKANEEALADFAHKKNMSIKDLFSKYR FILHVPFAKMPIDSMHYVLKKYYSEDESERNAYLESIDFYDSIEASKEVG NLYTGSIFLSLMSYLKKVFQKKDISGESILFCSYGSGNIMVIYELTVEEN AHCVIKTWDIDKLLSVRHNANFDEYRNFFENKIIPHESQGFYLKEIREDG YRIYGYRA >BRE_625 uncharacterized conserved protein MIDVIEFIKKYDNFIIVGHKDPDFDCIGSSLALASFLRRIGKGIILLNEG PFVRKEIIPFKEKFLSKWPNVNLLDYAVIILDCSVFDRIGDEFVFYVKDM PILVIDHHSSGDKLDTLGYIDSGAPSTTFLIEKLIRAFGYEVTKEEAWYI LVGFCTDTGFFRFISRDDPAPFEMVSRLVSKGLILKDIYNYIESVKSLAS IDVLSMMLNNLRTYFDGKVLLTVLPFNAKRDNNVSGVNELFYSLLANVEN NEILIILKEIEDGSILAGLRSKEYFDVGELAKYFGGGGHKHASGFKIKNT ALNLLENQIIAYIKDAINS >BRE_87 uncharacterized conserved protein MFSEEIKKELIRLSKIKKYCFQVEKNQSPIYHKSKCGDQIIFQTDKDNKK IKLKYNAYGCIVFLASTYLLTKICDNQPKKTTLEIITKIINNNFENLEEI NKNLKIFENFLYTNRKNCFILPYKALKEILK >BRE_136 uncharacterized conserved protein MSSEKIAELIKDIYLSFKKGDFKTALMKSEEAHSLDFDNVEILTALKSSV YWNGQIESLDRIDKDYEKAEFLTREWNNFARRYLKKMNFDFIQGRNSIKY FVFQLCLNIYQNIYRLQPENLDILIKIAKSYKGMGNYERAIAVFLQILGD AKDNADVVAELADSYALIDEIKEAKVLFREAFFINPQKIDIDALESEMIL KLVEAIKSDRNISDTLIKEWIPVYGALNGVFNIKRELRPIELGHLKQSVY SLRNELKEKSYRSINESILLPRLINKYFWLIDHYVRIKEDRVRIDEILSY IKEIDIGIYQQYVN >BRE_47 uncharacterized conserved protein MREKKFHFQQYFLILIFLLIIVSFLTYLYSSKIIDESKNNTEENVNLKLK LLNIEDFYFDLNSSFNMDDFFFPKPSLPDGKLGDSVMHYRTINEDILQDL WVKSDNLFNIDLEKENELLVDKILENYK >BRE_514 GTP-binding protein MTLIGSKIQNYSSVLIVGRPNVGKSTLFNKLLSSNRSITNEVYGVTRDLV REICKINSYKFYLIDAGGFTLLKDELSQVVVNKVIGLLDSVDLILLVLDV NEILLEDYELIDRLRKYSDKVVLILNKVDSSHKEVLAYEFQKLGFRKSFL VSATHGKGINDLRIFLRDSVGKLSDDEHIDVKIGIIGKPNSGKSTLVNFL SGDEVSIVSSMAGTTRDFIKAKFQRNSKTFELIDTAGIRRRARINEIIEH YSVSRALRVIDMVDVVFLLVDVNEDLTSQDKKIAHYAAKRGKGIIIVFTK WDLVKYRSGYFEAVKNRVKFFFPVLNFSPILKISVHNRMGLDNLFKETIK LKEQLDLKINTSDLNKMLNLWVKDYHLNSSYKVKYITQISVNPIKFILFA NKITNFPNSYYNYLVNNIRKIGYYNVPILIELREKTRELK >BRE_200 hemolysin MLELIIILILIILSAIFSASETAYTSLSLIQLQDIKKKGKLGTVVYNLSQ NPSKLVTTILIGNNIANITASTLTTKFVLDKYGNNSLAFSTGIITIIVLI CSEIFPKQIAILNNESIVLYTSIFIKTLTIIFTPAIYIINGIVKILLNLC KITTNQKITKDSIKNMLSLAEKLGILENDDRIFMQKMLNIGEVRASEIMT HRTEVFSLSSTSKLKDKIKLIKKEGYSRIPIYKGQNREQIIGILITKDLI EISKKKLEKNIIKFIKPAVFVQQNKRIKDILDIMRQKQKIMAIVIDEYGG FSGILTVEDIMEKIFGAIFDEYDFEEKKQLITKKDDNIYLISGETTFDEI EETVGIKIQHKDYINTMGGYIMDLLDKIPTKGEQVNTEHGEYLIEEIQNH KIKKITFKKIQKE >BRE_642 nicotinate phosphoribosyltransferase MNNLSLFTDFYELSMMNAYFTKNINPKAKFEMFFRKTPFNNGYIILSGIH TLINILKELHFNKEEIEYLENLNYFDKKFLEYLKTFKLNIKINSIAEGKI VFPHEPILIIEGNLIELLLIEGLVLNTINFESLIATKTARIKEAGAQNLA ELGLRRAQGINGALSASKAAYIGGANFTSNVLAGYKYNIPIIGTMAHSWV MSFPNEEEAFWEYAKTYPNNVNLLIDTYDTLKSGLKNAIKIFKQLQNQGK KNFSVRIDSGDLEYLSKEVRRKLNENELFDVKIIISNELDEEIIMYLNSI HAPIDCWGVGTNLVTAKGESNLSGVYKMISIQQNGKFIPKMKISNNIDKA TLPSQKGVVRIYSNNQMIFDLIFLKEEEEEIKKILNLKKQFTIFHPTQDN TFKEIKTYDSFEFLIHTIFENGNILQPDELKLENIRVNVQNDLKKIDHTY KRLINPHIYKVSITEKLKNLKNTLAKANNII >BRE_161 uncharacterized conserved protein MKKFPEIFYLNDKEVDILISQIGISSDTQKMILRVILECKNNVIGYSKFV EDYSVKIRSLKGELDFLFRKLYEVKRGIIVNQITSNGELLPDKIIITDEN SSDFYYYAIEDLFLKHYVGIEFFSTLLTIKNIDRNLLAFEREFVVLKNED INFKYFQESASLKKILILDSLIIPSRQTLYFVEFMKRILFRTASNRVVKD VFIRARNLKISEYDRILYEGVNGVGVAYNLLLGILENKEEILNKKGVNIS KHYFTFLEVLNIYITNEKKLEEIKNLENIKIDETLKSIEKAIEFKPGFIN IEEFKSILQEHADELSDAEHFFNIANGYFFESNIKGSLPRIFSIRSDIYL YKPCAYSIFLKEFDQIVIDVKDKLRNEFTKMLNNGKNSSVIFTEEGLEKM LSEFVANYDLNDYCLKNKVAFLDFIVSHYRRVSKIQNIQTQIKDIIKNEA AKYFKNSNTFLPLYKIYKIDLSSILDFAYKDLSLLRKIVLFLTGKYQSYK ESLSRLNSKVIVNNHVGGLFDPNERVKRQLDKRRKQREEIKEQIRNSYSK KGKGTSNKGQTAGRVYSKSEQDEAWLKFEDKLNKK >BRE_2015 family 115-like protein MNKVKRAYEDYAMYFEEGRLNDAEIAKELCVTRANVSKMRQKWESSKDNP TEFYSDNKVTICKTTLNSILDRVLETNAKARELKSKFSITKSQLGLKFMK AFNNYLELELEDCIEEINLLEREIKMIQNKGNSRELQDKKIKLKDLKREK EDKTMKLCYETMKKLKIADLDESRFKFGG >BRE_799 uncharacterized conserved protein MVVLKIVLLFLIFVNLNANLNKRDEDISKILLLESKSFNGTQRGLDMLYG SLEFNLKNSDSLYELSLRNDISLLDRIYLLKSAIEINNFVLVKPLDLYFQ YFSLILDQNEDVYKNKEIIDIYDKLDSDLKNDKDLIYMRLEASSRLGDFS GTFDKVLKSAFSVYSDDIRFFKWFLKEDKFFASLFNKLKLKGDSFFKSEN IDFIFKNTTLNEPNAVALFTFLKNKSKQINGVQSMYLLKYRLLTPDEAYV FFKEKPPSTLRDYKMFYDLLGDPNIREEFLNYYKNLSGVYFVDDKNDVVV FKNGVLVNFFSKIANYTSNLNLDEKYLNKVYFENKIPIRYENVLFGYNVY YSIYPYVSMIEVKYPNKKAVYIFALDSFRYEIFDNFSYSFDYVGINNFLI ADVPEIFVPNMLNLSPKQVSSFDIRQALISKKIFNEHDVVEIRNYSFGDL TSVYKKINDSKKFNYIEIYDKGVFKAKRVILDDSLDVYRNIK >BRE_835 uncharacterized conserved protein MPLTLSKILLTLLITNPLAQTNNTDKNNFEKLYKLYMLYDLNNNLPKELE TINAIKSLNSEYYYLLMAKYLLKIKKYEEANNFLQKLQPPKDQNTKNAIL LLKLKLNEDNISEEEINDLLQKDKEIDIKIIYLLYKITKIKNDKISLKLK NIILKNYPKSIYSYKIKRNE >BRE_1025 putative lipoprotein MKKIYVVIFILMLLVFGCKIGERGLAGFVGHNGKDGLSGYDGRSDVELLK VNYLKFKRMFHSNYESFKLKKEDFDKEIPFDNIIFDNEFKTESQRNSVYA SLDYNVEDIEILKNLIARLFGFIDEDRKQNIKALLFSLRDIDQYVSAVIT ASDVVISDFNLVNIKKGNNMHIVSSLNAMFGELLYRRASVIKDIRNIFSS IKKFMEVASADRISSINGNIRIIGSNTGIIYKKIHVGDESLLGLKNDIIK KLEELKETLWLQ >BRE_399 putative lipoprotein MHNKIHLKFNKKYWNFNMNKKLIYILLYLLFLSCSNKNDKYGIILDSNNR EKLPNGSLVTIENINQDKKATINYNGIKFIVYKFTIEKFQTKKEAEEFQN SIQPYINKYAISKKDLLPLRTSPDNYRENIIHRIPKETILKIIHIGETTE AGSLKGKWLYALTKDGHKGYVFDYALEVFDNIPGKILTHSLDQTSQDNVI HTFKNIKYLRPLYYEKMIANNTYNKNLLKNEYGLFFTQQNKIKINIPELN LIFKFDIIEEVKPNGFLFKSKNSKEDFILIVKSNQNYYKAIIQVKENQLE SNFVIIEQNIEKIILESERQNQNLINKLTSYENLTNTQYGNIKFNKDKTF VWEIDNKIYNLPSSGTFEIIGFSPNLQISYKNALKLINEEGKEYFCLIDY TNNALQLIFISSKNVENKLIITNDKDKIAVIIFNNNSSNQDIITKQFQKT I >BRE_4008 ORFk-like protein MNKNKSILILCIILLYGCNANKTPSQRMPDSAQITKSQDDLLKPQDLESK SQKHAHITLTTEEKMKFEIFIYALNIFQKDRFAFYNRMKQDISQEVKNLF NKYYKFRSWISDDQHIQEQKELSKAFNYAYNRILYNKLKSSDNDQITMQY IEGAFYYYLYDQYKDNHHYDGKLYGSTNSGFPTNYVSLFFEHFIYTIIAK YDTNEKIFQAIKNELEEKNSEIYAKTLNMLS >BRE_763 uncharacterized conserved protein MEYEFAIIGGGIAGSTLTYEILQRKKSVILFDDGIQKATTIAGGVINPIM GRKMNIAWRESEIFFFAIQYYKEMEKNIHCNILKEIPIFRPFTTKTQKEE LLFKINNYSNIEKFIIEIKNDKINDFCNDNDGGILIKGATINTELYINNL KKYFIKYQAYTEQEINNKNLKIDENFFTINKLKFKKLIFTKGYKEKIEGL FSYLPFKLAKGEMLIVEIKGLNLKEIYNRHVSLIPLENSKYYLGGTYEWN TLDTNTNEWAKKELLKKLEKITNLNYKVIKHKAHIRPATIDREPFLGEHP QYKNIFILNGFGTRGISMAPYLSKKILDYIENKSNLPTYYDIKRYENLYN HSNKKGTIK >BRE_23 ribosomal large subunit pseudouridine synthase D MEKLKKEFIVKHNSQRLDIYLSEHLCLFNRSQIKKRELKAFKFNDGYFSA IKLSKPVFINDRILIEFNESIDLGEYLVPLNLPINILYEDINVIVIEKPQ GILSHLGISNLENTVVNFLLHHISNLRYKFQENKIRPGIVHRLDKETSGV MICAKNLETLNFLFEQFKNRSVKKVYIAIVKGNFKVDSGIIDTFIDRDRY DRKKFTVHKNSGKRALTEYKVLISMKNYSLVVLQPKTGRTHQLRVHMKYL NHPILGDDIYSRLDQEFKEISLMLHSFKLEISIKEGFLKKFISVLPKRFI DFLSNFYDDATLDLLVKDLNVVLDKF >BRE_567 uncharacterized conserved protein MQKIMIIILTSSMWINSFGKSSYLDRKIGFGGSIGNPIFNYIMSFPFIDI EIGYGGTNGIKLPQSILKSKKYDFNVFVLSAIDLIFTISLIEKLSIGTGI GGNIHISSNKSNFKSMEAGFGFRIPIAIFYDITENIEIGFKMAPSIEFVS NPQSIAYHYLYSGFKINIIGGMFIKYYI >BRE_740 TPR domain protein MIILIRGFMLSNIVYVSLPENFTSHIKGFLFDPKVLLPVEVSDIEHFSQD ELSFESIMSAILKISAYDQNNVNFPYYKKLLLALNPNIINILINVGLSKI DEGDYNLALEIFLSLKGVEGENEVILFNLALLYEKMAENFLRLEQHMDAI SSNQNALNIYERLLTLDSPNENVFANAGFFFVKQYKLDRAQELLRHYLRI SNNLGLKNKVNEILNVIEVHKDLALNLERIYDLIILSKEDEAICELIKLL EYHKDSWNIWFLLGWGYRRKGFYLQAKDAFLKVLFFDSNNVDAMNEISIC LMELFKFDESLKYLLRALELEPDNIKIISNLGILYLKMERKKEAREYFQI ILEYDPNDPIALKYLELLEK >BRE_712 uncharacterized conserved protein MNSSNYLDSDSAVQVDDFLSKKFMEESFWIRIWIYILSFFQRDRTKEDVY KIYLLKNLERRVNNMYKNSVIDFRKGYLRVGFVEMFFEFYCHLVKLKGYF RMLESDNIVEQAMFEIIQGKIPNSKSKMEDFLESEEYEQFVKKDKSQKEL DEIIKVKISNYISSIPSQIYVVVEEMFEFFYILNSVAFFPYKSFFSFFDI ELLDDKDNFDIADLDGTISTSFESVDKYFKCFCEIVHTLRDVVINEEVLK IIIKNYFLIVKSNENGILNEENLLDVDSIFKNMLGIIIKLINLSKTLPYL DVFKIYYENPVLTPKKYVPCFDVRSFYENILFLNVSEQLVENYSKSVTSM ATKELKSLIKNYNVIMNLDKIIFKGLDLDYSVFKKLYFMNEFFKCIYDVR MMEVLKTVNNVVLAHNTDLRSLYIKLERDINILRKEIYDLYFELNYRNGE YENYNSEDYSSDDSYRDKTLEWCLKEVETIKRLVFKFISCFVDLREKYIA LLDNNNAFIQSALNMFNKLSTEDNVKISLSYVINNMLLIVKQALFVLENL >BRE_473 ABC transporter, ATP-binding protein MRVMLKVNLLKWRKMFLNKKNRIESIKEKLSLNAVTDIVLKADSIVKKYG EKVVVNGVTIDVHRGEVVGLLGPNGAGKTTTFYTIVGFIKANSGRVLINN HDVSKLNMYERARLGIVYLPQEPSIFRELTVEDNILVALERREDLSQAER KIELVNLLKDFEIKRIQYQKAYTLSGGERRRTEIARALAVSPYFLLLDEP FAGIDPIAIGDIKDIIRILKSKNIGVLITDHNVRDAFDIIDRAYIIYQGQ VLDSGNVDYIINSEKAKKLYLGEEFRL >BRE_314 uncharacterized conserved protein MIIIFLFLFSISNLYSFLEFGKDEKFYLIDDFGEIKNDTLNIGIKLRALD THFSIFSNNYKVLYSKNKINEYDKSVLIIFDKDLNFNLEFFGDFIYKDDK VFLMDNKNFDIVVVDQYNRQIINPLFVIKNRNNLNIISSFFVSELFLKSK DNIVFLLKENVDLDLELGNYTLVLNFLKRDVAKESRILTGIYYFEVLLNN NSVFRIDFQSIYLNGNSYVVSGNKNYNLNVFDLKKNNGSIKIDNLEFTNG SNEIKIKYGDVYNVENSLTYRFTLNG >BRE_748 ABC transporter, ATP-binding protein MIRVNNLEVTFGERILFQDVNIKFSSGNCYGIIGANGAGKSTFLKVLGGT IEPSKGEVLVAKNQRMAVLEQNQFAYDDFRVIDTVIMGHKKLYSIQKEKD EIYAKLDFNDEDGIRAGELEAEFADLGGYEAESNAAVLLRGLGIDESLHF SLMRDVEAALKVRILLAQALFGDPDILLLDEPTNNLDIQSIKWLEEFLIN FENTVIVVSHDRHFLNQVCTHIVDIDYGKIQVYLGNYDFWYETSRILNKQ LKDAKKRSEEKIAELKTFIQRFSSNASKSRQATSRKKLIEKIKVEDLKPS SRKFPYVNFKIERDLGKNVITIKNLTKEFEGQLILNKFSIVIELGQKIVF LGSPISASYFFDIITNEDRDYKGHYEWGSTVNFEYFKKDNEEYFNVDLSL IDWLRQYSKEGDETYIRGFLGRMLFSQDEALKGVNVLSGGEKVRCMLAKI MLSGANVLLLDQPTNHLDLEAITSLNTGLKDFKGVVLFTSHDHQFIDTIA NRIIEFTPNGIIDRFMTFSEYIEDVKVKELRDKLYEGHSILKL >BRE_1024 putative lipoprotein MIRIYILIFMFYILNLFLACKVHNDSADDIVVMNFDDLSQSGNTLAPSQL PPIRYKYPQANVVYDQLMKSLYALKSSYSENRDAFLSVKLQFDNGIFGIY DMDFSDDEAKDDVYGSLKYNSLIIANLKRLIETLISANHKDIALILLYRL SASAIYVREVIDEDYGIFSQDNLSMMRCSNNITGINLIKSYLDEMLKLQN TIVDEVKNMLSGAIDVINDNDKFLLKLNLITGSQGYIREMINGLKSLRYL RVALEEEFDNLKLCL >BRE_760 putative ABC-2 type transport system permease protein MKIDLRQSLILSKKELKILFGTPTAYVVILFFLIFVNFSFIFLSGFFIKD NASLMSYFSSMPIILMLVLPALSMGVFSEEYKTGSIELLYALPINPQEIV LGKFITLKIFTLILFALTLPLTLMTIFMGEFDLGIIFLQYLGIILYSYSV LSIGVFISSITKSQIVSYILSVFVLVIIVFSGKLVMIFGKDNIFGQILNF ISISNHFGYFNMGILNLSDLIYFSTFTITFLILSAYSIKLKKWR >BRE_99 uncharacterized conserved protein MGILKFQEFESVLFNICLYVDSILEDEFGNAYELHPSRLSRGKAANGCLD GLFRVTTSFTFGYGSKFGRGYLIIIEMITLDVVDVEFNKKIVEKGIEVFG AKLKEKFPEKDLSIVYDINVYKIIGNFFHDI >BRE_269 uncharacterized conserved protein MIIPKKDQNVFKRKKNFLFNRAVKGDFELRDFGNIRNFNKKKRKNCFCFF NVFTKFFYVFKLLFITLFGQIMDINNYKCRYSSKKVTFKMVNTYDVNLSY SVIYNFIFKINVLVFVLILIFYLNIFAYYGSYVFLNKLSFPKDYFIDTFL YYSDQDLSQINNYFFGLDASNYNATTIRKPFVLKVVEHKIKPGETLSHIA SRYNITSETLISYNDIKDVRNIKPNVIINVPNMKGILYTVGKNDSLSSIA KKYKIPKVDILDANNLDNEVLSLGQKLFVPGGKMSKDLLRNALGETFLFP TRGIITSGYGYRPDPFTKTISFHNGIDIANVANTPVVATKEGIVVTAGFS VGGYGKYIVIAHNNGFQTLYAHLGSFAVKVGDRVSRGQMIGRMGSTGYST GNHLHFTIFKDGKTSNPMKYLR >BRE_511 uncharacterized conserved protein MRPGLLNMQDSDVIRTLIVGDIVGNGGLKKIFFHLKSLKDKYNIDLTIVN GENSSGGFGITPEIAENLFKTGVNVITTGNHIYADPSIREYLNKQEYILR PNNFSDLLEGHGHCILNVKGEKVAVINIQGFLGMTFIVKNPFENVKKVIN MIKNKVKTIFVDFHAESNYEKESFGYFLNGLVTGVVGTHTHIMTCDERIL DKGTAYITDLGMTGSLNSVIGFNPEISLKGLLEYISLRTETVEEDVIIQG VVITSHLYTGRALKIERIQK >BRE_731 uncharacterized conserved protein MKTFVIIGLSNLGIHILENLSKLDCQIIIVDTSKELVEEYDVIATESFIL DQFTKNALKKIIPVDTDAVIIDFDNDLGKSALVTHYCNLLGVKEICVKTE DGDDAEILKTLGATRIIFPSKDAARRLTPLLVSPNLSTYSIVGHDIIVAE TIIPKEYVGKTLLEADLRSEKGITVIAVRNLSNSRYELVDGDYFFLKDDK IVICGKPDKIENFTNNKDLIKDLISVSKTKDTSYKESSKKLGFLKFFDFM KKFNKDKKNN >BRE_477 hypothetical protein MNFLYFVLCSLINLSLMFFIFFLEFLFVSRLNIIVSPIFQYVLIIVMIFI SIAISYFLSSVIFRNIISKFFDLD >BRE_170 uncharacterized conserved protein MSIGNYYAFYLFIVLFIVLFVYVYDFRKALPFFKALSLMHVNSAYVKNYY IKKILMIFFFVLSFGFLILSILDVSWGQKATEDERVNLRISFVVDISRSM LTFDEGKSINRLESAKNLISLILNSFENVEYSLTIFKGKSLLVLPFSKDK SSLYKMLNYIEPNLISSPGSFLGDGVLSAIQGIKDSSYYNFLVVLTDGDE WGENNYYTFSKLIDVRNIVSFVIGIGSNRPLPLVDNHVNVKDKNDSVMTF MLNEDNLYLLTFSIKGSYYNLYLKGTNYVINEIRNDIIKKSSSNILLIGI LRYKLFLAVSFLFMMLYIFVKVIKWDDTF >BRE_266 uncharacterized conserved protein MKKVMFKKIIYLFLLNLLSCSFVKESLSSNILKKSINSFDLNHLNWLWNF DYVGQNFDKYFGIDSDSYVYVAYLFKKIGYDEKFREYMHKAINSNNNIAS QFAGVKLLEYYNSRREYYEAELVGRKLYNKYNDNKFIILGYFKSLYWQKK NNEALLVLNKLEKMDFMQAQENENLLFKAVLYFNISDINTSLIYFKKLFE NLPAEYLHVRAHDYLVLEGKDNLLNSTFLSLVKFKSLVANGDFKGAVNIL DDSFKKYYNNFVFLNDVYKTFVGLGYINKALSFFSNLDSVYKDYYLGLIN LKLKKDIGFVTILKYLENSSIINEPYRLEMLNEIFRNFIFMKNTRNYFSK NIANFYTSKDKGNFAFINVLDEYILEAVQLGDYDNLYLLYYNGQNVIDSA VLARLAFLNARLIYHKFIKSQSVGEYRELLHSAIKYDQISYASFMSRYLL DQNINDLFENALDINYDQSDYERFLEGFLKFNLHSYVSVFVANDFKNGYR FSPNFYRNLYDEFVKHEYYYESILAINYLVRQDFSALNKDDYKRLYPCLY TALIKSWSGKRELESSLVFSLIKAESSFKRDAVSKPGAIGLMQIMPATSA DVSREIKYYKYYPYDLKQPKDNVIIGTHYLRKRIDMLEDVYKALASYNGG IGNVRKWEKDYGHLPKEIFIEAIPFGQTRNYIKKILVYSVLYDALYERKG MDFIIEYIMGKFSKRF >BRE_104 uncharacterized conserved protein MQIKILYKIVLMSPVLILFANEKLKDDFKIFSNIEKEITNKTNKSKPKIN KSNKINYPHKKINYHHEIRRKKNTDFKSYNKEHINNHTNGTVKIKKSKKI YYPQDKINIQEPNLEKNVWYNIKVYPTNIKDRFKKIKLLNNINTKIKKDF ALIGPILEDNLGEITKALNIRGYNELEYIKLE >BRE_445 nucleotide sugar epimerase MRVLLTGIAGFIGFHVAKKLADDGHEVLGIDILNNYYDPSLKYERLEILG FNSENIDSKKVVNSHKYNNLSFVNLDILNKEQVLSLFNNYKFTHICHLAA QAGIRDSIENPDSYIAINIVGFFNILDACRIYKDSIEHFVYASTSAVYGL NEKMPSSEDSITDHPLNLYAASKKSNEVIAHAYSSSFNIPTTGLRFFTVY GPYGRPDMALYLFADGVMRQSTINVFNNGDMARDFTYVDDVVNGVCNVLK KPARSDSNFDKQNPNSSSSFAPYRIYNVGTGQAVKLMEFINELEINLENK ACKNFLPMQKADVVESCCDISKLKNDFAYEALTSIKDGIRKFAIWYKSKI SK >BRE_83 ABC transporter, permease protein MMHSNIKELLKIAYVIFIHSKNKKALIGSGISLSLVMIPLIIVYYMSNNI MNATIERYIENEGFSVQIEYNEIQKDEYLKSKLEKFKNEYKHDKLRYFFE KRTYGLIGNKKKQGALIRAVENKFINNNKHIKLVDGKKNFNKNEILISRQ ITEKLNLNINDSIYLIVPNNKYQKILPRAQKFTIAGIIETGLREIDKNLV FISLQDANIMTKELSKSIIGLSIKTNTKEKTNNLKEKLTKEFKEYKIKTF SELYLNKYTNLNISKKLLIFIMAFIVIFASINISSSLCMLILENKKKIAI LKSIGMNNATLKLIFILIALVLSSTSCIIGIIIGNYLTINIEQIINIVDI ITNIILKIFGADNTELLNSDYYISEFNIKISTKFSLIILLAYTLISIATT LIPLNIISKFKEKEIL >BRE_1050 p23-like cell envelope protein MIRIIIALLAIVSCSVQQNHNLEKQHKRFIQPTYNKFKHKRTPGNIDPDN DITKYQSEQLQIEEGSLDVCLQVTPHSWWPFSSNNCKITWIKNNFQKIIE TDTQKESKLLQGKLHYTYIVAPIKSHNEYTKYVMPLILFASLVDYIEIIS FKLKCRPNLNLDFEKGSMQNLRNRVADQVNKAVKAQGYKKAYLYGTINML YPEGGKDLINAFKSQYKNGNWSFMEAEITIKDTLDHKTTTQSILLDSIMF NEFLKLVIKKHPDIKEANNQFRAPVD >BRE_604 uncharacterized conserved protein MAVFIRGQYFILSLIFLIFFGLFVFSGFLFYLKPVIYEISPMPASHENVI VIKGRNLGDKIGEVNINDHYLVKSSIISWSNERVVFKITNEINSGLVFIK NRQGISNELFLVISRQVPIKLEKDNSPFLFLEENLVVMTNTPVVLRGKNL TSDSGVVEIFIQTKHELYKVLSRDILSLSEMEIRFIPPKTLNINGEIFVV VDELKSNKLPFKFNENFFAWNLQKGKNFKISHEISFLKNKNDSSNEILDN INFNIFYLSPVENERQKIQFVDNNGTLLNLDNLFFKNLKSDKYHFNFEVK TFQLNLDIFDVKALEGIRVSTDANIREFKTYVLDKRDHYLSYDSFDLTSI NLNVNNKDSAYELAKSIIDALVSYFTLVNNDLALDKSIEMKEISVDNLIL LTNLLFFRHNIPLRNAVGFYFDNKSSKLQKHIWCEFFLEHIGFIYFDIIN AVLFKDSSNYFLNMSENYIHYGYREDYDNDLLLDEYVDLVLFKYKSLTSH DHSLNYKITLEENSNDR >BRE_42 putative lipoprotein MFFKQYFIFLFFVLFSCVKGNKDFIIFNKDFNKKMSNSKLNYSDANVSED SGENVFGSLIDLKGYKILSVHQENLNLDVYFEQVVLAQNFADLKTHLFII GFDPKSHEAVVLFKTQVNIDSKNSYNMYLEDITGDYDFDIVVQGFLDEYA VLYVFKRAVANDVSSYRPIFFDKVNGNIIINKYSRSSAYDDKKSRESYSI SLERYEKQGEDMIVSKIEKYVYSQAQGKYYPLSTSEKVRRIDNDVYQTLK NLPKDEVYKFLYGIWYDNDSHQRSGKLDLKNILLLSFNRHFNEISIFKNN SQEIAHIEYISRPAYNILNISTKSVFSDLIVYNFWIKIVDIDNIEIKIDT GTDAYDKYGFSGIFKRFNNSVLENDDQKFLFIPNGNYVYKDVIYDFSYPS LTYIVKDNIYYGIFNVLNLNNNLVLEYEISMDENKVSESFIVEYSERIVN NQKFSTIILHPIKILKDEVSLLKRQKLKLERIEKLG >BRE_1037 putative lipoprotein MKRVIMVFLRVNIVFLLLMIFISCVSEYSGFLDPDARKVYKAFKNKVENY KIIFLSRSDSLLNFIDSKISFFTGDKEAYSDKLLYFNEDTTKRVIFATLG DDLGVVKRLIDILHQIYVLIRMLVI >BRE_1072 Viral A-type inclusion protein repeat MLYIVGYCAQNKMRLKTGGYLFMQKLLLILIISHLITSCNQQTKTPTLAQ DKDDQDLIQTTRTKRKLKTILNTEAQKITKHLTIEENETLDFMIDILQDD TIAKNIEIHTDQKINDMIIYLGTQKIKDMVGNINQVLKAIKNAKIKIQEI NDNNPHKTELNNRLEKEINKHKVIIKNAVNYKSFDITKDDTQNATIDIIE IIDIQNEATQAIDAQTKENALKDDHKNALRYLRSALTENNAYTHKQFNYL ISNLVLDEIKDMLTNIAMELEHKINAINYITQINDTTQKTNLNNEIENAD KNFKDLLKIAFNYCIPSPHVTKQNIKKIPPNNFIAIKNKAKQAIDNQGSL SAITKLLDTQQKKALEFIIDILQNEKIYPYQKTYTSEETDNLIIYLGEQQ IKEMVVNTVKALEEIEKAELNIQKINDNNPQKIQLNKQLNEEIKNYQQDI KEAANYMSYDLAKINIQNIPITYIIEIRRAAEIQNTIVDHITPYDEYAQN TFNYLKNAVAEQNNSRHDEFNQFILQIGPEKTKELIIPFAKKMKAIGYTK IYINHIRDRNTKDRLKSELENAHQILKKSIKNIFQDNKPYFNNINQKLQA ISFDIFKKIDEQALQIYRSQTG >BRE_318 probable inorganic polyphosphate/ATP-NAD kinase MILNEYLIRVSLKRFHIRRIMSSKVLIYVNYSNLDAEVLACEIQRYLEFK YGVLSLFAGMNKSLCDISNKDNLIFAITLGGDGTVLLASSLLLKNDIDIP IISINLGKVGFLADIKPRDFKDVIDKFFNNSLVIHKKYLLCISAYEDGNN LFTKYALNDVIIRSSILNKLIYVNLKVNSEDFLSYKSDGIIFATPTGSTG YSFSAGGAILESDLKAFILTPISPHSVYNRSFIFSSKSKLSLAFQKGYTL NSASIFVDGVNIGTFGVNIVFELKLDNKSLRFASFCTDTFVRRLKNKLL >BRE_245 uncharacterized conserved protein MLNLLVIKRDRKVGSSLLSDEVKTIVGKGDFFKGELVSSNFIRVDGDFLG TINSTKRVVIGDTGRVKSNINANEVVVSGIVFGNVHANNKIKVFQSGCII GNISCKSIEVEEGAIIDGYMNVGIGSLNFSERDVLIYTGSYKVDENILIE VNKGMKWENRNKETCVRENDKYLFNDVRKMDED >BRE_5020 ORFk-like protein, lipoprotein MNKNKSILILYITLFLYGCDTDKFDNKLQTQSATRFTTEQKLTTQRPNVI MQKSTIHASQKPMLSSEEKDKFKLLKYALDMDLKAYQQNYTNPKAEEVAN IYKNIINWISNNLNIEEQKDLINSFSHVYTFIKNKLNNNPNMDIIQYVED AYYNFQDDEYKKEHTYDSKLYGKPHGANHNSITMFFYLIKVNAIERQPNL QDNEEFYKNAIQKIKNELQDKTSDSYKYSLALWKD >BRE_1042 putative lipoprotein MRIVFILCVLFSILSCYSGDFGQVETLTKFEVVLREPLYSQLSEKVAKYK MSLSDKEIKFQKAAYQFNIPFFKVSAAFDSENGDVQDSIYASLGYDFDTI KILEMLFGKLLLEDPPAENEDTAVAIYLLALLRDTTDSVKVILNEYLNEA FFARLGRSKKGINIVFKIELLLDNVMRMRKDVILKIMKAMKKIQSEINND PDILSRLSDIFDENRDIKRSVNLISNISKQIEILSSQFA >BRE_24 uncharacterized conserved protein MMIIFLLFICNIFILYSNSLGYTKLDFEYLNLSQKFSLENEIYFSENNTN FGNEIFDKFQFNDDFFYKDIQENKDLNIEKTINSNWGKKVFRFSAISIGA FPIALFLGLYCFDLSYYFNSTGAKSFPYPFAINFKLSKDENFKKFVVSTS VGLAISLIIALIDSLIYS >BRE_1009 hypothetical protein MKLHYILLCRLNHKRRILMQRMRVIILLFSVCVLSCGQDRVITPDKYGMR KIRSFPTITPDVKVKSGNSGLTSDAQVEVIERFNNRTKRVPKTPKKAYAK FKRSYDKLKRFYNRRPKNFNVSLFDSIRKKFGVDEKQGFKDSVYESLNGD IISLNNLEKILMLTKGSGDAYSVELNSRPLLIKLCGIVGSSIFSIMNETG AILSKDHLALMQDSQDVDGINNLGNKMDDIREKWREMVKLLQNIINNAAR FATQEDVIQNLQPIIDLDTLRGDQKSTSQLCSLKNELLDLCYQIEEQVRK LRLGLVKSN >BRE_227 Zn-dependent peptidase, insulinase-like protein MKKKKLFNLISKTYLEEYDAEGSYFKHESGLEIFELKNSTFKENAFGIAF KTIPFNNTGVAHILEHAIFCGSNKYKIKDPFLYLMKGSLNTFLNAMTFPD KTLYPAASTIQKDYFNLFKIYSDAIFNPLLKKEAFMQEGYNINPNNFKPS GIVLNEMKGNYSSKNSLINEISTNSLFSKGPYQYDSGGNPINIIDLTYEE FIEFYKKYYTLENCKIFLFGNIDTNKNLNFIEKYIIRPCTNKKSNVNYNI DKATRWNQHKTLSFNIPKETENTLGVYVINWLCSDIENIKENIGLEILSE ILLDSSCQFTINMLKSEIGDVIADVSGINTDIKECIFSFGLQNVLPGKIE EFKDKVFQELKNLVKVKIPQELIQGILFGYEFSLKEEKGQGWPINLMIKS FKGWIHGLHPTETLKINYQLNEIKNKLERGEPYFENLIEKYLLNNNHYTL IHFNPSDKMLKEMEEQIEKKLMDREINIKKNPEKFSKFTKDYNKFKKYQN KKDLKSDIAKIPILKIEDLPKEVDKSLILNYVPELKAHTFELKKNNNIFN VYLFFTLDFLQKEDFLYLSLLKRAIQDLSTKNYSYITLNNKIQNTLGQLN IYESYKEDIHRNMINLFNINFKSFNNKIQESFTLIKEILINIDFHDYNRL KEIVLSLKNDFKSILIPQGHILATTRSESKLSQSKYLQELQFGITGRQYW HKIKTDIESLKEIAHNLENLRNKIILKNNLSSLLIGNTKDVIKKLETELF ILKENLNEKIYSNNLITIQPSSNVLKEIMIIPSKISFNAMSFASYRITDK EYPTINFLTHILKSGILWEKIRVAGGAYGAFASITNGIFSFASYRDPNFI TTYQAFEASLEELANNEIKCDEIYTYLIGVIGLNTNVKTKSTEILQSYKR KMLNISDHLRQNIRNNYFKITNTDIKNISEKVLYQLKEKNSITSLVSNTI YENDKTKIEKFIGKKYRVKKIY >BRE_5016 uncharacterized conserved protein MDFMCNRVVLVFCIVCFISCGFLETKNKTRLLQNLENIDLKSDWKDNLKL SNDELGILTFFVNALKDELSKAHISADHFNIHLKGDLSKVEGYVKRFFLK LNDKDKVRELLGYIKYGIDNPPNVEGRDVYVGMDAKEHYRLERRLASVFD NYFMLLNPPSSEPFADSSAKVPFIGGDPEDKMFNDIKSVCYEYRGSH >BRE_467 uncharacterized conserved protein MAVNPLDFLKNMSNFKDNIDNIKKEISQIVVCGRAGSDVVVVEMNGEFVV KKILIKEDFFNDLDNEALEHMIKSAFNDAVFKVKEEIKSKTMGSIPFGI >BRE_559 uncharacterized conserved protein MKLENMDEVWALPVCCNIKNSIIEDFKVSDEYKNQVFNISYKDNIILKFI DIIDSHEFNLKLFDNHIDFEGQVPLVLYSDNLDTLLEAESNVIFELRPIE QNDICCSLNLQESDEFKIYTSHYEFSDHLNYCSDFILVKVFFSDDNLIID ADLDNIALVKQIISDNFCISKDKIIINSINNNCINILFPIVFNAVVQGIV ISKKLGLKVNVIYYKRHFLIAESLNLKFSVVNYLSIENRLNKIMLELKIN RPLNFLYKFYFNYLNKIFSNLFFDVLVHINLISINSNSIFFCDNYFLFGI SAYSFIYSNFYNLAVSLSLEPLNYLLGYVKSEYNIFFKLFKEMDLKNSIM RKSSSISLNNEYNVLDVKRKGVGFAFLNLDSNIDFALLDIGNLTISMNLY KDKLDVFIPYKIIDINLVNYLKNVLAKAFNLSYNCVNFLVADSFKDDIEF SCSLLKESYFIESAVLTMKEELSVVIDDEGRKEYPIIVSRNFVVDIDAKF YVACSLEVDVIIHSFHIIFSNVNFFIENGKFDKLRVNSKRVFSIFGLAVD YVFGNITYDVIDSVGLEFIEDGEFIFSFRVLFIASVSAIRSSLIQAFDFD ICKTPIDLKSILDDWSVRIDTN >BRE_223 uncharacterized conserved protein MFLEKMLISLSFILLLLASFIISSGIKGIGVKNANYITVKGLSEREVLST FSSWSLNYELGGNSVEEINKLNNANLLRIKDFFVSYGFHEDEIDMLNMSL NIANYRDTLYKYNAYVSLGVRTSDVDKMEKASKNITELYNKGVLLNSNLG PRYYFDKINDVKPDMLADSIKNAYSAALEFAHHSGVALGKVKTANQGYFE FIPIDRSDEDHARYSKKILRVVTTVSYYLD >BRE_330 uncharacterized conserved protein MRKACFIIFLFIVFNLFSESHDHLSINIDDVYVEAHDDGFHLFIRKKPNI KSVILTESFEIPDKNKDASTYSFRTLEYNNINGDEIRILNGRVIQNRSLL SLTSSTPVQNKRFGEAFHILIPKKLRYGFPNFSTRSGDIDLEILKRNKEP FWFSIRTFEKKYNDYLGQYKDNAYELFFGDTQRENIVENSVLEEGFSRFA DDVVTANKGLDIVDKIKDILEKSEDPLVDLDLVFVIDVTDSMKNHIEILR EHLLDMVEPQLNQFKSYRIGFVFYKDYLEDFLTRSFDFNSKKYLHNILES INVGGGGDYPEAVFEGVNAAVTQFDWKSDNRFIIVLGNAPPHEYPRGPIV YEDVIRAAKEKDITIYGILLK >BRE_70 peptidase, putative MEVNTRILSLRKLMIKNKIDAYLIASHDPHMSEYSHARFNIREFVTGFTG SAGTVIITETESVLFTDGRYFLQATNELEGTEFKLIKLGVKGHPDIFSYV NMKLKGLRIGVYAEDISIKFYDDLVKNCKFTDIEILHEDLISKIWQDRPY FTGNKIFELKEAQKNDKRINKINKVNAKLEENTIDFYVISSLDEIAWLLN LRGFDIESSALFYAFLFIARSERYKNVLFVNVDKLDFDLIERLEVEGIEV EDYGNFYSFLEEINHEGKFLIPVNSNVKILESIGRSNAVLGLSIVNELKA IKSDYEISKIRDAHIIDAVSLVKFLYKFKNLTKDELADLDEVDVSNMLLS FRTLRDEFFSSSFDSIIGFKENSALPHYRPKKGFKKLNQDGLLLIDSGGS YLELGTTDVTRTVLIGTASHKEREDYTLVLKSFIALASLKFPFGMLGASL DGIARFPLLKHGLNFAHGTGHGVGFFLNVHEFPVSISPLSTYSFKGSEII SIEPGIYRTSEYGIRIENLVFVKQSYLNEFGIFLEFENLTLVPFEKELIV VEMLSKDELDYVNSYHEFVYFALKKYLSGDELKFLEMLTSKI >BRE_843 putative lipoprotein MLKLIINICIAMLLIGCVTLTYHPPKKNISSIMLLDSSSDIYAYVNLSKN RFIYSEFEMKYKIGLHTVGNLYLSYTKNPETFSLIITGNFPKSIFWKINN HPNFQSCGNIFMNPKWKIKNSNIYITPTKDKKGILINQKEITHQNTNILI TKYIDIIDQHEIFILINDITKLIPNNINKTNLIPFNKGIFIANSANDNEY NFKAYLNTNNPKILSIASKKLIPSILKHTTKIIISGPITSKIQDKNTIEL QFNVNKMSIKEFITNLIYTKHNKH >BRE_719 uncharacterized conserved protein MNKEVFVESNIDILRNLEGIYKSKFELEERQRNIPKYLQTKKVQIDGLVE TFAELQLRFKEYQKEDASLKLDIQDINVRKSKAEEKIDSIKTQREYEALE KELQTIIDDEVAIRKKMTHITGLKTKVDREIADVKSKLEIEQNIYAVESN DLENELLEIVKKLDSIKSEEEKYSSRMDEDFLFKFQRIIRNKSNGVVPLI DSVCKGCHMILPVEFANKVRREPDDIKFCPYCSRILYYQDKFEVGLGMVP GGLADLIE >BRE_1044 uncharacterized conserved protein MKRIALMFSMCVMSLIFIILACDPMVFIKEMESRDRAYAILRDTVLTYKK RVISLFDDFQKLSYEFNIPFEKFIPVFSLPDSRNNVYAAFEYDVASLERL VKICEKFDITSDMMDADTKLIYDLLYLLKEIAEPIDEIINVHLRDEHLSR ISTTRSASSISVITVALRDSITKERELVFKIKERILAIDPAGIKQVIVIQ IRDILDDGNINANIRFIKEMARRISRAVR >BRE_1031 hypothetical protein MKILGLIFYLLCVMNMISCRYWSLEERMDKDFNQKDEVGGTRNLKKLDKL NQSEVTNLSFISSDLWDEIFNHPEDSVKSSDYGEQIVFPENEFDFQLDIE KQQRIDDFQTNDAREGVNGGDEIDKDNLEKTDRVDGNKILEEREVEFRDN FENDDSDLGGEGKVYDFLLEKVQTYKAKFLNERDQFYLTKLFFNIPFDKI SSDFSFEEEQDKVYSGLRYNVGLIARLGNLFDKLLLTNISNGILEVFDDV LSVLSELSQYPKDSLELLNEEILANIRERDIDIKRISDALDNIVQLKEEL VEDIRDNIESLGSIDDESEIISLLQKDFGEGKYKMKISVLREFAMLISNL VIN >BRE_7 beta-N-acetylhexosaminidase, putative MVLIMYYRINIIWILRKVNGMFRLILFVLLFFHFVLLGSIPDIDYDYFES DKFDLIDVDKFLGKVNSKDILNGSCIFIGIRNVSNPSSVQSLSKSELMKI QEINPVGVILFRENFKDAEQTKKLIEKLKKYLGSKLLIAVDEEGGLVSRA SENEKLGVYNFPSMESVGKTKDVQLAYKIGEILGKQLRRLGINMNMAPVA DSKFAPDSPLGNRTFGYSFYDIGLMVEAFVDGMQREGVFAVVKHFPGLGG TKIDTHKDLALLSYSKNFLMLNNFVPFVFGKEAKFLMLAHILVPNISKDV SSMSRDIVEIIRDNLNIFSIIMTDAYDMGAIVNNFNLEYAIKQSLNSGID IVLIPEGFKGINIEK >BRE_236 apolipoprotein N-acyltransferase, putative MKTKYFSLAAFSGLLTSLAIPNEINNMGYSHIGLIAYIPLFIALTKTKNK KFLITLTTFYFLIANSLQSFWLAFFYSFGIITFLGAILGYIPYALVLGYL LYYSLKTFNNKTLTLAILFTLYDYSKSIGFPAYPWGFSAFMVHNFNDLIQ VADTFGVFFVCFVVYFFNAGIANFLINQNKTNILSMLFSILLISTSFAYG NIKKIELNPILNKEIDTLNIAAIQINIDSWLPGNRKEGIKKSITITKQAL REHPNTELVLWSEGVLTYPFNTYKDYAYYDQELLELYNSVNELIINNKAY FAIGSPSKTDKRLLTHQNSVYAINPNLEITNIYSKIFLVPFSEKIPFYEY KFIRQFFYKNFGLFGQTNGNRLEILKLKKFNLGFLICYDDAFPDLARSYK KQNANLLLNFSNDSWSHTNSSEWQHFVVAKFRSIENGIKTIRATNSGITA IINEYGENVKSLETFKEGYLVSKIKLPPRFTTIYEYIGDLFIYALAIAIV IMTLRYHLTEKSNHLLS >BRE_681 hypothetical protein MNLKIYFPHLYHYLFNHESIKGLSVFEKEVEIIKYIEDNKKTISTFINEN FKFDTDSLIQYVKEKTNIIISPIILSNIESIDLNIVKDLFNKKFNKNNLE LIFNSIKTNPYLRKEFLYNFNIISSGYITFYINKLFEDKNSYTIYLIKKE SNIFDSSKIIKNYIKILLLLRILIIKFYLEKEIKLVPQNIENISQLVSKE IEFLDNNTVKIITQSLFKYEHLSNMSPIATLISIFSNRTKIPNIKNNRTK GFIGYDESWFSIKQSNSKDYDPRIIKELLEIARKNKW >BRE_525 NH(3)-dependent NAD synthetase MLIIYFVKICVAQIKCRIFRFNEILNEFKVNCEYAIQNKVDILVFPFIFI EGIEYENLFYRPEYVKKILYCIDFIKGQVDAGLCVVFGHYNFYDGKLFDC ISVVSDHQYILTTREVNVPVLFSYKGQSIAVLNLDDELLFHKSQYKFHDS FSKIDYLVIPSKSYFTCEKNNLRLEFFKDVAIKNNLEIAYANLYGIYDSI VFDGLSFFINKYGKIKQAKEFEYDILFNEEFYDLEFDCESKIFDKLLGAL VISLREYVALAGFEKVHLGVSGGIDSALVAYIACTALGANRVIGIFMPSR FSSKGSVLDAERLANELGFELIHMPIESMFQFSLDYLDGYLNTKGVTEEN LQARLRGLFLMSYSNANRSLLLNTGNKSEIAVGYCTLYGDSCGGISLIGD LFKLDVYNLARYVNKKEGREVIFSNILLKEPSAELRADQKDSDSLPTYEV LDGILNRYLLENEPLELLYKSFGKEVVVRVLDLYSGSEYKRRKGPMIVKV SKKAFGSDIFLPISRVALIEDE >BRE_723 conserved hypothetical integral membrane protein MICFILYYIISVLLGQIFQYYCDIGFSFSVDIFLIILIFNSLNFAFNVGL ISSILHGFIMEYFNGLPLGFFVFCYVLVFYLLYKIKIVVPKSMFSVTMFF IFSKFIIWFVAMIFADFVDLKGFNYSIFDLNLIINIVFLNFLYPILNYFT RSFYTIREEY >BRE_1036 hypothetical protein MENVTKYGIILLNRHLNNENLAKIKDYFKFEEGLVTFIDNIMFHLDYFMK AREELISDIKHFVNEAAARRGDKLMMINYLESLIDDGILLNRILIGIVDN VFKIEDKLNEIFKS >BRE_354 putative lipoprotein MYIKKLILMTILALIFSCSKETAITILTDNKIIPIYINQFNVQNKTNFII KYKKNINVQTINKENAQIIIAKNLDNINITKNFKNIQKYYYSDYPILNNI SKKFAYKIVPLSFDIPILIYKNEYDIQKYIDIQSIKEIYTNFKKDKKIFI SPYISENIFYTISEINDINIYFGNNKPEYDEKKILNIINYFKSFIDVNEL TLHKNFTEKYKYLNLETILLQQKTILIAGLTNLAYYNKLNQNIKDKINFS YLTNKEKKSSICNINFMGVKETSQPIAKFIRWILNQKIQQSLITLKDKAK FNEHFGLINGFTPYKGLNLKLKHVIKEIPQFIINENYMNKDSYILNKEQI EKENNIINELMLYNIKNANSS >BRE_716 uncharacterized conserved protein MVIKKIFISLFVFLLLLFIFLSFLYFLNSSPLKSDLVYEFEIQKGWGVKK IAWELKRKDLIRSAKLLIAISYFLGSDKNFREGKYLINGYCSTFDVYKEF LKGRPILPINITIPEGYTGRRIALKLNESGIISNVQSFIDLINDVNFVNE LGLEYDSVEGFLFPDTYKFYKGMDMKEIIRVFVSNFFNKLYSIGIDYKSY SSKDLYDKVIIASIVEREYRVKNEAPIMASVFYNRIKSNMALQSCATIEY IITEELNKPHPTRIYFSDLEINSQYNTYINKGYPPGPIANAGIVSLTAAF FPDNTNYLFFVIKDPKVGTHKFSSVYSDHLLAANSYIRSFITKD >BRE_255 hypothetical protein MLFNKINAIITNLYHKKNYSLLNLFHSKGIIHTIIHDYTIEKFKLNINNL VKANFEIVKKNNLCKIIEVNDEEFIVQDLTYEKLTIIKLWIKLINLSFDE GECFKLFNEATEMLNNSSLGKTQLIDLQYKIRFLIIKGLLYLSNLCFQCN KQIKENYYYDTHIYGFNCIKCSNNKNQYINTESFKYLENTTQTNINTTLN AKLTNRTKELLTFMIKNKLNREFEQILL >BRE_581 conserved hypothetical integral membrane protein MFSLKRFFLLFNIDFVYHKQFYFYFFMSIFLIFPLIHVLFKSYLDLNLVE LLVVDDSLSNTVFFLILFCMMYCVSIYNMFSDFKSIHDPLKNVFYLSLPV STLEKYLFVLSKFLFLFPLFVVICCYMGVNITVLLDKKLFLGNQAKSLSF NVFFMFVGNTYFIYFVGFSMLLLFRIVFKRFSFFKSVVIISLCYAALIVL FDFMMFFVNNYLFELKNNFDKWGEYYFIKYISMSFALCSCFYSYFLLRNV GNLSTKKINSNILVGLMSFFVIFVFCFVTFLLLYVIYAHILHA >BRE_623 uncharacterized conserved protein MEGCLMLQSQLFVKKCKRCISKDEVLMNNVKNVENVFYDFLKVFDKKALE NMFNYYYENFDFDKGIYDFIDKFIPMIDFLSLEILEHEFNFDEKRIILDI FDASACTMKSNQLSEFAKAIVSLGILS >BRE_128 uncharacterized conserved protein MVDSRASRDILAFKLPYGYFDKSSNAKVRGFDIYYKFYPEGTNHNFSGFA RSVQRDFDALKSVFNNVSAFNLRGFYKINLDRDHFSGSPTLKLDKSWIQG KFPLYIELNFENLRKSIPGSAFITIRKGNNSSSPILKEIKNMYRSYVVDG FYTEFFDVLKKSKVSDSKDRPFDLKHISDSFFTRDVSPKYNLVIFVMAAG NAIEGDLYSVIVNLGTLNSFELSN >BRE_1032 hypothetical protein MLKFVYIYLYMKKGIFMRRINIILCILFILSCSEKNVDKSSENVNDADDK DVCSNLSFIRLVGIDPRYVTFYKIHRLVKEYRNKLNGRTFKLKEGESKPE FKFPLSKIFPVYSDANFIFESLNYNVKAIYGLEYMFHTLILPTYSSILGD ASRFSIFLSYLDENSKVLKRLVNDDFNDETLERLKTTKTDKELALIYYYL VDFIKKKASLDQDLEAILIKLVAEGADRETMLNVFNNSIVNIFLKFPNGE LTIGLSNTRLIRDFEDLKSGPLTIIKCLIK >BRE_1094 putative lipoprotein MQRNNILLAVILMLFIGCDLDSGIGLLRGVLDKLDGKSISSDGMIDFKND DINVINGKDKGNLVKREELVPNVEGLVPNVAEEKYLEPGDIDINDIDNID VDKINDYTYPWDSSPKSFRILFKKLDKAQQRVQYAYDIWDKACSARNVAY EFYSKALVALGEFVNAKDENGKNGISDTDNKHFELTKEVDRKWDDYQKAV AEEERTREDCKESR >BRE_1079 p23-like cell envelope protein MHTKTLLPIITTMFFIQCNNATDEQIQYKIKIPKESNTIHDKFLSNINNL TSNTSNKQINSKSILTQLIQKPYETLERNKLITIPLLFLSTKLTVTWIKN KAISIKGEDGKPLNELINKIRYSYSISPIKENEKLSSNIMPIVLFETTQN GQDLEVTSFTLTDEPNLDFNTRQYSSLTSLFYTPPKTETSQESGYVNAHP FWIANKNNEVIKALTKNQSIKAKIKVQNKNSKVTTKYNIMLESHYLSQLI KDTLQKYPEINTIAPKFKLL >BRE_1054 outer membrane protein MFMVKVRYIVFLFILFSNLNSVVSPSSPLVRPFDFSSWNFERDIEEAYEA SYKVVDGILVNVDDPNKNVKSKHILSRISELEGYYKCLVNVIRDNIFLQV EDEFLREYGQYFDDDVFTETDNRFKQLIEIPMEDTFGMYRHRVLTFSNKT WIKNPDYTKLFIKLQLKEIEFVEDYIKQRLGIKLGANGQKVNHQLNDQRY GNNSMENEYDDASQERRGAVVPGYDRGSRPVSRVQRPNYDRESRVQQSVP RQEMPRSVVSRQSSGRPNVSGSKVVKPSSIKRGNLRPSSIRPSLRRPGSD IRPNFVRPIVRPLGEKPVTYKRGSKDSGDE >BRE_680 hypothetical protein MVKIFSNFFKAILIASIFTFLMEELSIILFLPYKIRFALIFIGFLFDIIL ILIFLYKILKAFFLKKSQIYIRNNLFFDLIHCLVPLIFYSSHQMQNILNP QEIILTPIILSLFKLRFLRLLRFNDLMIEIYYNPKEKNLILIAFARTFSI SSLVPFIFFIIFSSSGFANTIPEKQEFNIIKNISITTEKNYIKEKYPFIL IIKDKEQTIYSKSDDIFFYYSPSEYKIIEIDKTKFYIDKYLQRKNDSVIG IFLFTLFISFAIFLTNFYKFFKASFLNPIILMHKVLQDPFEYRKIQIPFH FSEEKVYEMAKTFNNVLLKNKLNTKRKSKLPLEIEQLKKIINSNNKENI >BRE_36 uncharacterized conserved protein MLKENDSLNVTKEQPLTVELKPILGITPKVYVFFTMIILPIILLLGFIIN AKLNNPGVYLKIKTNIKNSYVYIDEKYIGKTPLNKYVNFNKGTLKIKRFG FETYETKIDIKNKFFANYKLNVNLKLIAPEKIIAKRQKELSVMTKIKNAD DNIKLIPVFSLIMNDLQNNSEYIKKFFQTSIPHIHSNIMFQDFISAYKTI YSINDNNNKEIWTSLKQNFNLEDRAIIWFFENLDPEQQKQVFHEEWFKTF IEKLKNENKILSFENQNINLSLNNFKKIISQNIDSIKNYKLHSQDLILKT TYKLKEFLIQNKNITKAEYQNFLDKNPKWALNNKNNLIKEELVDESYLKT FNQMPSNEDITHISYYAAIEYAKWYSSTLPKGFKARLPISQEWELYQKEV PQSIDNLNINEVSKKIGFWNLMQNSSFNEVILFQNKNDIYSENHNFNSLI TELRTYTYTNNSTLKPLTQASFLKYWCSPNIGFRLVIEKE >BRE_767 uncharacterized conserved protein MGIYIKGLLIGIANIIPGISGGTIALITGIYYNIIYSSTNLVKLKRVKES ITFLGKLSLGMLTSTTIFAKILKKYILDNATKEMYLNIFFIGLILGSIFT LKKEINTNSTFNINTKINKYLLFISGLLTILFLLILKHHNVSLNLTTNQD KTSIQYYLLLACSGIIGGSAMILPGISGSLILLSLGTYKEIINIIAQIKI IPCIIFSTFTIIGIGITIIIIKKTIEKYLIDFLYLSIGLISGTIIQMIFL TTKLQIKLSLQIYVFSIILFIGGIYINKLLNNKNNPKI >BRE_3007 BBK01-like protein MNNFIVKEENMKKNVLLSAFMLTLLFLLSCDLDVLNSLLIEAREKFLDEN KNNKGLHLKDENQKDQEDVIIGFEGHKSMQQVVPGVGGQPVVSMKPVNSE ISVLRWYPYNQEEKIEIKEEDLIPSTEDEKRAQAEIEKVKSVFKDFNFDQ LIEEARKLKDEYVQLESSFYDTLLKLQSKIGSYRPLNRNSRIKKQELIRI KKQELMQVYNQLNNERNDIDMLMIKVDSGFNDRSSARYFFEKSQKTLKEA ITERLKNERRNRWAKKGNIDVIARRARSEAESSLNQLESASSKIGEVMER KEEIEELIEGAKSVLGGF >BRE_71 uncharacterized conserved protein MKNIKAVVSDLDGTLLLSNSQIGAFSELVIKKLTKENKKFIIATGRSKNE IIPLLIQNLNSHVSFFITLNGARVYNNQWQLISSYDLAPDIVKEILNIRE NKYKDIPHFLQRSDDTDENLYADNITKNAINDIFKKHRLLNKHQYIKHEL QDINIRYNEVNNFQEIKNFNKIAKILLLHDEEAQLIKYEATILEKYREKV NAYLSTPHSLEIVNSKVSKGNALKDVLTSININLNETIAFGDGFNDVDML ENVKKGLLMGNANYRLKKMLSYLEIINTNHNEAVAHYINDNILEDPA >BRE_554 uncharacterized conserved protein MSVNTNVILKKYLQDLILELKKLKAILEFENTKITQGIIDILEITNPKKD LIVNSINNYYTTINSWLKTQEQIQEEINKLIKYALSLKKMIYTQYENTYK MLKKIFAQKKAIPKIQFFKSSFNHKEPILLDVII >BRE_31 uncharacterized conserved protein MKKIFLTGFILVLLLHINTKKLEAYSIDRNGNSIIEVDLSLGIPLFYNDL SNIFSSNLYPGGLGAAKYKYHILNNLSIGAELRYIFNFDINHSFNLLNPD SVIGKTLTIVPITFLTTYVFDIGELFQIPIFSNIGLTLNYYGDKSDSISN LRTFDTMPVISIGSGIFWNFNYKWALGVTTSWWAMFEFGNSAKTAHFLLI SLSIIVNMNKL >BRE_743 ATP-dependent helicase, DinG family MNLSEYIIQQAELNIKGFVRRDTQLRMIDKIKQTFRDENFLVIEAPTGTG KSFAYLIAAIDFIHQTKEKVIISTSSINLQEQLIKKDIKSLKRIIPFKIK FGIIKGMKNYICLRRLEELKKSLLAHTLNKKNLETLIYWAQNTKTGDKDE LNFIDEQIWEEVSANPETCSEITCPNENKCLFKKARNKILKCDIIITNHH LLLNDLYIRNEILMEKENHENNFEEENININLILPSIKNIIVDEAHYLEE AARSLFNKNFSKTGIKQIFIKIDKIIKRQNINNIYKKDFEIFTIQNFENI EYIINTQEKLPSIYRITSDTHKTNFYIRIKTYLQNIIYNLENYQITIRSI IQNIENKTAKIELNRLIKNLDQKKLLIQNFISENQDDNLCFWIDNKKNIP LFQTSEIYLGPELNKIMYQRTKRIIFTSATIIINQSFSYFLNQTGLNLSN KHIEMENLPYSFPYQEKSILTITSDIENPNNEEEFLNQSTKYIKELVILN KGGTLILLTSLKSLEYISKNIKDFLFENDINIFIQGQLPKNELINSFKKS PKKSVLIGIKNFWEGIDIKGDQLTMIIIPKLPFQTPSDPILIAKNELAKK TNENFFIKETLPQAIMKFKQGFGRLIRDSKDYGIIVCFDKRICNKTYGKS FLKSLPKIKTYYSNFTTIKHTINTFFKIDQNINP >BRE_1064 uncharacterized conserved protein MSESLFNNEEFVNTLRDSLFVDRPIPEYYHFFDNEQIETNDASLTSERVI KWNSSIVDLPTLKVNDFSTVATIKFKRQVVLVNYLPFQYAFTYYAPDGRL DIQAVNNINMREGLRYSLSQIHKLLSSHYLRGGLCFSGSKERTLLVDDSN RETMYGLLNIPGQIDKNIKITKASDLIKACNDEIGNINVEDERGVPFRVL TTPKIKAILLERLSNNNYSYKDVLFDSLRAINNDADIEFETTNLLDDEML IYPKSSKLLLLKDGHPPILNAYTQMSSSNFRTSFLDFSIGSILASEKSIL RFKISWT >BRE_1017 hypothetical protein MMRLIYKTILILSTFFICCCKQDKGEQNASTIKTDSNKSRHTDAWKEKMK LKKAKQIPKTPEEAYDALIENYNELQVLLNTPKEFNSSFITEIGNFFGVD YELFVKNNFYPSVGFDITTINNLKKMITTFNPTKKPDIPGLDVASIHQLS LFTKELIRPIDNAFKENNQINILKNSNDVKTLNELINMLDNLYEKWDTIV SLIQTTINEAAKLNKKDDVTKKFKLLNDLHLGNFNQICNENGVNNEVCEL KNEMGKLSKNIKNKIESLIESLVDN >BRE_211 uncharacterized conserved protein MRKDLKYKIQKLIQQKDKALIELGKELKNSNIIELKKLESYTSLKLIEKE ISQLKANLNKSEEVTHKLNELYKKNKDYTAREKHILKAYEIKLKKIIEII INKYPNNLSMILEHNLDFIKSTLAKDKYKTTEIINCKEKINFFKKLIINI KQMLKDKRNKTNIKKMSKEFENKILKQYLESENLEETVNEFIENKDLSTE IIEEYKLITEMKTEILKINNEIKHANTTNNMHNKNKIKRTINIVQFKKES ILKKIAEEFVELSQTEKGLNKTGTINSSLETIKNLSKQISKLNKELIKEI KKSEIIKIQTKMQELIKHKESIEIKLNELNSKIETIQDEIHELDNQ >BRE_97 uncharacterized conserved motif-containing protein MLSSYYYIISSLPYLDLKVEKVWSISDFFDNVEIVLSREDFLFIKDLSEL RFNKESSEVAKKFFEFEEIIRYTLAVIRAEKLGFEKDIYLESPYFSSYYL GILKPLCLKENPFEVELGIDILKWQFLTELEVGNEFNFEKLIIYFLKLML ISRRSLFREEIGEKNFDDVCQKLSIKISKNF >BRE_654 serine/threonine kinase, putative MIFRKTRNSKIYIVIVSITSFAESKLYSILSNAKYLIESQKLTYKIHWTF PTYFFEILKLNSELNEWFFKRLKNNEDIYIPSTYSGSPHEYMLHDEIHVD LYWALKNPFKSGYKDLFQDNPNTFYIYNMEKLRKRVLELYRKLNFNYIEG IRIAKNNKKYLVFYKNNCQFLSEIQEPDIRKQNTDSLIYFHEIKDIYDNQ VLKNFLLSLKELDTNFYSIKIQNLEGKKINTELLEIPEFNSLKEQALVLQ FQNKRLKEYQINEASLKEFLTNKNFENQSQNPEPITSKNLEYNMEGNFTL SHEKYYVKFKEGKLNRIKYKEKNSEFLDSCRTYIKTLSKKEIIIEPIIES SFSFSNEKIIGIRQYLNFNAKEKSIIDFFLDENLASFFISLKLVWPTTVI NCNNKKLNINNINYLTEYSSLEIPIFEVERGTNLKITARYNDLDTYEKII ETKKDTQGYINGTEFLISKGSDQNSNFFISFLNIEKCIIYTINYKIAKKG FKRWFILNIGGSYNKVKIEDLKNYSLSLNLLLLPNNNNFDNKIKINSKIK TLLFYPNIKKNENK >BRE_4016 uncharacterized conserved protein MNSNENSLPYTKPSKKYHNRYYKIVSIVKFFQKNSIKYNQTSILNTLNRF LAKDELKIITLRTLRKDLALLCNQGIIKKTLLRLGEGNGSYIRYSANKYS LRNLKRFLENKQAIVEHDANATYKFTKETQQKYYLKNKELNIYKSKNATK NVSHNITNNKKINNKKKKREKTKEIEKKTIDTNYMIKNVSKWKTMRYLDK VKENENKKRYEDSIKRTKEWLKNLKIENNTYKNC >BRE_273 uncharacterized conserved protein MDINISSEVTKIITQGAFKASEVSNETLRKKKVRETQHLSLNEREDYHYD SEINVIFPIDELKDDNFNSVTISKVKHDDKNSSDLYDINLHDPKLGKNID IER >BRE_713 uncharacterized conserved protein MKNYKSNDLIKLSSLLIRVLVIVLFLNSILSFFMFLAGAYNIFMHSFQKF SLEFTIVLSSVSFGLEITRAIFFYVFRGRKFKHCVILILSFVICFCSFFI KVFLD >BRE_773 colicin V production protein, putative MRTSMLNNPFKITGVVDILIIIIFTSLGLRGFLRGFIKEITGFVEIFTLI FLLYNKTNDFKILISPILDLSYIQALLVFFLVIHIGFLILQALIESIISH LKLLFFNRILGLVLGLLEAFGIIAIVVYIIHAQQIFNPNYFLEGSNFLEY LNPGINYLFKISKT >BRE_460 uncharacterized conserved protein MKSLFQKKFLLDLWSFLSNMNSINFEKALELYKKGDFKNALLNLDVFDDS FDSLSLKSLLYFRLKDYKALLYVLDTYPVLSEYSFLIKLLYDGEFKSDEG NLSYFQNYNLGVFYFGLKNYEKSLNCFLTSIKQYPNLIQAFNNAAVLFEM LGNRDDALEMLVKATGIDKDNALIKLNTWFLNNTCAFKSVRPFKLDGSFL NVNLSLIINYLMYYLYFMGEIDGAIKLSEKFLTDSNYSKYIWHNRATILH KIGNMTQATKSYVKSILSFPNVYTIYNMHIATIKLLNFDSKKAIDRMLLD YPDMELVYFYAFLFFLRNRELEDAYFYIKKLCVMNIDTYSRFLNLLESSE DIFIEELLDECALILKGEWILEYLFFVDNSLDLREPVFVFDYYTRICPYI WKVKDEHIELRASNSEFEITKEILSDEFTQVQLSVTIKEIKDLIEAYKDF KINY >BRE_191 Tatd, Mg-dependent DNase MKVDFNRAIFLEKLIDTHVHFNEMKKHSVDIHYVISECFKSGFSYFIDIG LHPSDFYERKQFLDTYSNIALTVGIHPLNKASNSDFELIEKILMTENVIA IGEVGLDYLKANNKNEQIEVLGIQLDLASKYQKPVILHVREAYDDIYNIV KSSNFMHRGILHCYSGTYDYAKKFIDLGFKVSFAGNLTFKNSDLLRMVLK KLNIEDILIETDSPFLAPVPLRGKINTPLFLGYTCIEIAKIKNCDIEKIV STFYNNFKDLFKDLI >BRE_832 uncharacterized conserved protein MKIKLLPLIIFFLTCKIKQEVSLIKEFKLPKSSILGFPQKVGIITKNYTI LNNTIQIQKINYDYLTIIRKDEIVRIEKIMQDTEQHGIKGKWVLATYKGN KGYIFSKDINIIDNIIIE >BRE_157 uncharacterized conserved protein MLQIYFISVLLNILGGIILAFPTLRDKLKCLIIFDEFVNAINNNKAARSI FGTIFITVSILEIIIPYDLPIIGNLFPAISLFLIGFILFLNQKMPITLQN NKEYGKFQSLVENNKKLIGILALIIGIIHFFAPRIPFL >BRE_105 uncharacterized conserved protein MKKFVSYEDVRINGLKLAYKIYKDGFIPDIMYVSLRGGAYLGNIISEFFK FIKPEKPLLYAAVVARSYDVSNKQKKIMIDGWTYDPKYLRVGDNVLFVDD IFDTGRTIIHLREEVLKRGIDSQNVRIAVYDYKERGHIDYEPDYYVNKYS DEDELTTWIHYSNHELIGLSEDEYKLNFVNLDDELLDILKFLSKKL >BRE_80 uncharacterized conserved protein MTTNIIKLILISILIQNIYGKSYFISDVFFNKYQEIYDIPQTGFYIEYTK VNEIEKFSLFKDLKLIKYKTQKKIENNKKQLTFYNEKDIKIKEEIYDELN NKIKEIKYSPKGIILESVDYFYKNNDVIYKEIKILNQKPKTIHYMKDTNG KLLKITGSDLQIWNYGINGEIKSTYLDIKKSKTKVIQYDDQKRHLKNIIL DNNKIVSKENNQYLDDNEIINVKEEDNTKIISKYKDHNLIKQEVYKDNKI TKICDFEYNESGHVTMENVIIKDEDKEYTTKTTYEYDSDDKLISKTIYEN DLISLKTDYFSDNEYEQKIYHNGNPIFTIRYKNDEIIEQINTDTRDKNET K >BRE_171 hypothetical protein MKNLIEVIMLTFNEPLYLFLLLGLPLIIYFSHFFNRRGGKVRFPISIYGN FGSIKLRDYVLNLLYFVTYTFFYLAIIVMILTLAGPSISRKKMTYLSSGA DIVIVLDISPSMGAIEFSSKNRLDFAKELIEYFVYQRENDNIGLVAFAKE ASLIVPLTIDRDFFSKKLDDIYIMDLGNGSALGLGISIALSHLKHSEAPK KSVIVLTDGVVNSDEVYKDQVINLAQGLNVKIYSVGIGSDEELNVGFKLR SGKFYQGVLKEVYDPSMLFEISNKTGGLFYSVGDDFSFKLAIQDFSKKEN VERKVKISVDNNDVYNEFLLVIFFLLILYFVFSRIILKEVL >BRE_357 transcription factor, putative MSFVLDQAVVYPMQGVGKIKNIQNKEFNGEFIDYYEIYFPFNEMTFMVPV ARAADLGIRALVSKEKVEEVFDIIKDFEGQIDQKKIKDGSHDFYKQSDIL STAKLYKFLYVKSMQKELPFYEKRILNDFELILQHEISLALQISFEEAKE KIREVLSGGQAVLD >BRE_82 ABC transporter, ATP-binding protein MHNTQNIICIKEIYKTYTKNKTKIQVLENLNLNVKNGDFISIQGKSGCGK STLFNIISGIDKMDSGDIISCGISLKNANEKTLSLYKNTKIGLVFQNHNL IDEFNVFENIILPKIIEGKDNFAEIKKKALRLMKILDIETRKEHYPSELS GGEAQRAAIARALINEPNIILCDEPTGNLDINTAKTVESLLIETSKTFNK TLLLVSHNPEFSNKADIKYELRDKTLKRI >BRE_671 uncharacterized conserved protein MYFRSNDYSYTVIQSKNSYVQKSTFGISFVILNRGTKIFREDLFEFLSNF DFIREIISIEKQSNRTSLQFISENYDKLKFILLSGDLNSGEKVNLAMKES ICSFVFVLQSDMYLLNPFWIPNIFDEIVKKNVLLVGGEFFDKDEEVVPSI FLPTIDKYQRLKVILINSERDYEKTLITMDYCGLYSKEKFIQLGGFDKRI KNEYFQRLDFGLRAIYFGESIYIYRKLRIQYTALNIPEDLTKNKSFLIFL LKNYVPIFIGNGVKFSFLRFIRLCLRYGVNPFRFGREFKEIKYETIKNSL RFKGDLKSAIELWENNIID >BRE_1109 inosine-5'-monophosphate dehydrogenase MMDKIVKEALTFDDVSLIPRKSSILPSDVNLKTRLTKNIYLNIPFLSSAM DTVTESRMAIAVAKEGGIGVIHKNITIEKQRKEVEIVKSYHRNGIIRNLI TINEDTSIKEARRLIVKHNISALPVTDHAGKILGLVTSRDIKYIADDNIP VINAMTKKLITAKEDITLSEAKEILFKHKIEKLLIVDESNSLRGLITCKD IDHVEHQEYFPNACKDMNDRLRVGAAVSTDVDTLERVEELVKADVDVVVV DSAHGHSTKVIEIVRKIKSKYPNLDVIAGNIVTKEAAFDLIDAGADCLKV GIGPGSICTTRIVAGVGVPQLTAINDVFEACKDTNICIIADGGIRFSGDI VKAIAAGADSVMIGNLFAGAHESPSEEVMYNGKKFKIYVGMGSLAAMARG SKSRYFQFESKDSSGKLVPEGIEGMVPYVGKVKDIIFQLKGGLMSGMGYL GVETILELKRDSKFVKISSASLRESHTHDVLEN >BRE_1077 uncharacterized conserved protein MFIRSKMLNEVLKKKSGRYYHSGSDRDMVRKITYYENLNLNRVQKFSFAA YYINEDSDEFKSLQNEEREKILAPYPYFEFHFAVADNGYLMDFKDVFFSW LDGDRVFMYDNKLDVDFKSSDVPYFKFNKSNDLDSKIVGEYPVNVINYFS ISINEALFKLLLKQKTLTITLISADDAKYNISVTNFLSSDDFSVFNKDED KVEDIGIDEF >BRE_4009 MlpL-like protein; lipoprotein MKIINFTLILLLLMSSCEQDNNTNKGIKSSNKRDLEQQVEAQKTPEEDLR EKLDDNQRKGLDFLKEALSNSESEFNKFLNEEESKIKEALDHIQSELAKC TGNEAVQQKETFKEVVKGALEGGLDNLKILLIALAIKTTNKTINLQNKFH KQNLKCRFKKENTKISSYK >BRE_1106 hypothetical protein MSVMINIMSIIICSVITFTSCSVDEKNNLSIQFPEDDLDEVLHDDDSEQN QIQQDGDIWKHLNDSQEQVEKGSVAQRNDYEIIKEKVLEGSANGQQFVIE NVLEVEKLDDYLLNNSFYSVQGIVDHIAERIVVEKMSEHSDILSTMSQKD LLKVYKIIFKTNLNDGQKEALEFLEKALDSKIDKLDKIFVLDEDEIKNML DIISNNLNIIREFESSNEFIFDSDVLDVVEVVEFKSDDVRVEYAEVKSDL KGEIEPSLDDYLFVINAYFNDYDDIKVIVDNVNSIKILSP >BRE_324 conserved hypothetical integral membrane protein MNTFRKEYILFMFSFSALCISYFFDGFFSFSYIKVILWNFMLLLLVATGI STCAKSNSLTLGDEGQVYFGAFLSYVFCDFCGLTYFNFILIMFLSSLLVG LLGIIPFLLTFFCGVNGMLTGLLMSYGNQRLVDGFISKLLSSNELLSQTK SINKIFARDVALPYLLVFSLLIWGCYVFIHKRTILGLKLEILSDRKTLSK FFSINEFKYKFCTVFTSAFLNGLVGAIFVIFFKNYLFLSLTSGLGWNGFV VAVVSGFNYIYVLCFSLFFAMLNEFNNYLKINYSFKYEFIGLYQAISVFI ALFFINTGKK >BRE_233 uncharacterized conserved protein MQELFFYKIRLLFIFCLNISFSIYYMLLYRSSFSIFILFLMFINFFVMVS YLRYFYEIDFKGNKIFYKKFCFKVNFDFHDIIWIEKRLLDNMLILGLNNG TKIKMCFLRKEYLSSFFKKLKLIRSDLFITKMQELPIRYYVSGTYILMYL FRVLINIFVYYISFGSIIVFSLVLILGIKVLIRDILGLKNLVIFYEFRQN SVYERKLFSGKEYYYEFFNKIFVYNSELTGDGYLSFVYPYKSIFKKVYIN DEGMSYSMKKVFAYIDKYCNKCS >BRE_38 uncharacterized conserved protein MNNSFNMYIMQTLGCLFWGYFMKRVLILVLFLFCIFESFAQSYDEMKTDI GSNSINGSGNLEKLLLYESYKQNALIPFLLNLFVGFGIGSLVQGDITGGL LILGFDALSLGLLGYGVYSTLNSKSVEVPVIGLSLMTLGGITMFVTRIVE VVLPFTHAASYNKKLRQNLGIALGSFHPEVDLSFDENSRVIFELSFTKKY >BRE_226 putative lipoprotein MEKNIFMIKSPTTQKVLIFISLLISLLGCTKKSKKISFNDIDTLYNEKNE IIIQSISAEKESELLKYKIRIPKIITQTTESNKAKSLNDEIESYANEIVS NLESATQNTSQNPQKPSLNIDYEIYYGYGIHTIIINTSQEINNTYITNHR SYYINSNGDYIYNIDEIINIEEAFPYFTHKIKEKITTTYQNKLLFDLQQA VIYFKDKKIIIKFPLYVFNLEATDHTENIFEFSEEESKKYIKQG >BRE_599 uncharacterized conserved protein MNKTTFYITDKYLKTSLMLFPIFAYTKNFLEGTIISTWISLCILLPAVII KKIEFKNHILKIYLLIIGLVISITYPFMQYVTPILYENLRFSIPILTVII ISFHKNEPFKSPSIWQYSKSPIIIFISLSTIISFFREILNTGNLKLFNIT FQIIKNYNITKIPAYSSNIFLITSLIFLLINILKNIQGQKND >BRE_2042 uncharacterized conserved protein MKNTSHEVKIHTQPLKKYHNRYYKILSILKYFQKNLLRYNQTIILNALNR FLAKDELKIITLRTLRKDLALLCNKGIIKKTLLRLGEGNGSYIRYAVNKY STNNLKRLLDDKQTIIEHDANEIYEFTKKTQQKYYLKNKRLNIHKHKNAT KNVSHNITNNKEIKNKKNKKEKMKKIEKQTIDTNYMIKNVAKWKTMRYLD KIEENANKKRYEDSMIKTKEWLKNLKN >BRE_376 autoinducer-2 production protein MYIRTFWEKRIRMGKIRFRRHNQKGVSNMNKISSFTIDHTKLQPGIYISR KDTFDNLTLTTVDIRMKTPNKEPVINNAEIHTIEHIGATLLRNNKVWGDK IIYFGPMGCRTGFYLILFGNYESKDLIDLISWLFNEITNFQGNVIGATEK ECGNYQDHNLNMAKYESSKYLETLENIKKENLIYP >BRE_768 uncharacterized conserved protein MELNEYQTKAKQTAKYKNKKEELILSTLGLAGETGEVVEKIKKLGRDKEY VLDEEYLLAIKKELGDVLWYISNLSNNLGITLEDVAITNLEKLKKRHKNG TISGEGDER >BRE_826 uncharacterized conserved protein MVFMTLKNLFKKLTFKNALGAIKDISIVIKHKFVKIKVYSLVGVAGTGKS FRSHLIADKYSIPLIIDDGVLIKNMKIIAGTSAKFENNVFDAIRRSIFED DVHRNEIVEALRKENFNKILILGTSVRMIDKITSRLFLPNSSKIIYITDI STQKEIEKARISRQMGEHVVPAAAFEITSIKPNLLLDSIRVFFKRKGFLS KKRNYIRSIVKPNFHDEGGILSVSKNAVRQVIEHCVSEYNKDYIVYNLKI KKSHGSYYFKLFLDIPLGSNLLDDAEMLREYIINNVLKYTIINISGIDVI IHKFYEQKGNLDK >BRE_574 uncharacterized conserved protein MYFKEILMENNDKFLDIDSYIGNVLTELETFDNRSRQVYASLSKSIPRLI EKLSKDIKDLSFNIGFISNLDVDNDYSLNNFISKVIRVLNDFVSYFNSST EILESQFSIIRDKVKDIEILEDVIEKMKKSSIDMEIMSINTLTVAMRAGR AGGAFSYITNEIKTLTQSMIKQADQLTSKGRDIKVGLDRAKEQVLENNTA ENKILEEFKEDLIKNIDEFAGSIGEVIAFYDNVLKILNEFKFKFVNAVSY LQFQDRLTQSLHHLNVMYSSIDVFKFRDISEIQKLKVLSVFTDSSKMIIR DVISKLDENCMAFEEFIDTSISSIQVINDLKSDNSSYVDISKSVEACSII LLNLLRRIDDVEKNNSNFLNLYYEQIKLVKSLELMFSNISAISSRFQNIN IASKIEVVKRIELEDMEGNISEMSKIINNIDLNITKGREFLSQIIFFFEK VVKDCDNRFYIEKNYFNKFKKLFIEIKSNIFEIKRLAIDHVLSYEMFPVN FLEIFEEVKLDIHSIKALREDLINIEKILIDIENDINSNLNSELLKHDLK CIEVEDKEFIRRIANRFTLFVHKKYLLSLIEDEKDVHSFDEGSVILF >BRE_739 uncharacterized conserved protein MFFSKKIKDYEAKYRGKEIKMSTEINSFLNIKNSVEIKVGTYVVVGVIYS ISMNFIKIILQQDEILPILAQNGNLGNLNIKNYDNNVVDNAFCIPSLIVK LVSTSSYSIQNKEYNLLTLEFVSSMPEEILVKIGKLLDLKLGQNQRIHER IIIDKESLKKLNLASDKAFIEVNGIKHKCLIKDMSYGGALLISYFDYEKL EESNTDLILSFDVADKKVSIVGQARNLSVIQTPNGKVLAIGIAFCEEKIP LDYIMLIHDYFN >BRE_397 uncharacterized conserved protein MNLLNGLLNFLFLFYSNVSIINDVSSKSSIKRTIDWDAKIVYFDIIKPVD EDRFGRVGIDSTSRLVFSVNDFKDTLIRESLFEIIIDSDSTFKDYFDSDP HLILYFSGLDSILKRGYMKYSEDLKNITVRYELCIFPDFINLFLGHSKPY KAFFPLMNTTVEQFVYTGIIIYAGDDYKSSSGSIVKLADAFFVKIYDENI KLYFDKRMVDPDALKKWGMFEYTNDISYKNKDRIGDYPLRLIAKGVYGKN HSDIILDDYSINKIFSNENNINLLREGKFVIIK >BRE_184 uncharacterized conserved protein MILSFKREDEMITFSKSFFNPLPIGKILALYGEIGVGKTTFLKGLALNLG ISSFVSPTYNIINVYEFANFRFYHIDLYRLHLLDEFELIGGMELLLDMSS IIAIEWPDMVVDILPKDRLRFLKFKIKDDSRILEFDNEYSCN >BRE_660 uncharacterized conserved protein MKFFDFGSLGFYRFFDFQKHLNFSIFRYSLINYYSYKEQSTLINDANLFK NKIVFLDKIRKDITNITYISSKENDNLSVNKTIFCDTLNNIKSLIKKYYP ESEFLDFECDVLLDDEDTFDKFLDRLRYLNFKVDLKKKIEEFDRRNKTPY SCIKIATYFIKEEFLERLGHSIDFFVNEANNSSLDLINKEIDEYCEKVEQ VKVSEYIKDTHKKFVMEYAKERISKIMKEHSLDISKLLVKISLLDIVIHC FESYYLNLLEVLNILLSISNIIEIGLDELPDAIFNEWNELIYLRRKEFQK LVLISDYVFQKRIISTINSGAWKFTFFSLSPRQGDVIQFTVDINKSLSSL EEGIKEYKLKIDKLNSLKRDWEQSLKNFEQLFV >BRE_470 putative adenine-specific DNA methyltransferase MIMSVVIRPILKWAGGKKNLLNSILNNIPLSFNNYIEPFIGGGALFFALN LKNSIINDINFHLINFYMEVAHNLNNFLLRIEKYNNVPLTKEYYIDIRNS FNNANLTNLEKACIFLYLNKTCYNGLYRENGSGQFNTPFGKYKKINLFEI ENLRLASKLLREVRVLSLDFFCLLNVIKKDDFVYLDPPYIPYSKTSNFTS YNKYGFDFSMHERLLRFCDKIDKKGAKFLLSNSNTTSSLELYKNYNIIFV DSKRLINANPIGRGNIREILVKNF >BRE_1073 putative lipoprotein MQKWLKSIIILCSLLSCNTQGNKPDNKTNFNLIMPNTKAKATTKKLNLDV NEALIFLINILTNNTIANNIKIYTDEKINAFIMYFTPQQIDEMVTNIIKV IEIKKNIKDNIKILNDDDNHMPTHLKMSLINQLNEKLEKEINNYKIAIKI AANHESFDVAKINIQNIPITNITKIKDEAKRAVDVQNTIIIKANAKAIEA KLNPSEKDALKFITETLQDTTINKNNTIYTDTQINKFINYLREQQIKEMV ENTLKALEEIENAKANIKILHDYKQQKAELSKQLTEEINNYKIAIKIAAD HESFDITKINIQNIPITNITKIKDEAKRAVDVQNTIIIKANAKAIEAKLN PSEKDALKFIIETLQDTTINKNNTIYTDTQINKFINYLREQQIKEMVENT LKALEEIENAKANIKILHDYKQQKAELSKQLTEEINNYKIAIKIAADHES FDITKINIQNIPITNITKIKDEAKRAVDVQNTITAHLPNNNEKYAYALIY LTKTLPEGNSYTYDKFNIFILNIGLDKTKDMLTHLAKEFPKVSTTENAVM SYIKDISQKSKLNADLQEAHKDLQKSIRTAFSNGTLPLDAIKQNFKKINF HKFEEIKAQADLILKNQFP >BRE_1007 hypothetical protein MQRVYRLIFLLSILIFSVLILCCKHWGDETHGTNHVLHSSLVRARPESIS SSTVKNVQSKFAVDDFENKKLNLDLEVGLTPSGHFVINQVRTTDSNKPNL KTNVVDSLGSDVLDKDVENPSQDKEVNKEEELVQVEEETEILKKNYAMLQ AKIEELKTLYYSRPRMFDENILNNIERKLDASYSELYKNNIYAVIKGDME ILSKLDLMLIYLFLVWDGSYTYFRDLLNVLQHISMSLIFRIINENGSIFD KSNLVALQSSKDVLGLKELVSNLDSICLKWNRLVGLIKDQIVQASIFYHK DELIKHLSPIINLFVRSDNYKNDPIRLLKDEILDLIKQVETQVYKLKAEE >BRE_595 competence locus E, putative MINYRYINTRLSNFIILNTKMISHINDLIYLKHTFKKRFLVIFLFIISAL SLSIRYYLKLNLIYLNIILILIFIIKKNAHLSLTFIINTSLLIIFEISLI FNILENNYYQITNITIYISKYKNVKIEAIDGFGQNYKFIFKNIENEYNIG DIVKIQNNKIQCIKKPLLVKLRKKYNKLINKFLNSISIKYSHFLKAILTN NKSEITTYEKHLFQKAGLSHILVISGLHFYLIYIILNYLLSIIINYKLKY TIIIIILLNYLILTGLSPSALRAFIILKTFIIYKLIYGKINLFSTLSISF IINAIIFPYTLSSISFQLSYLSVIGICISIALNKRYNLNKIIYPMLTTFL IQILTAPILYINDLNIQPISILSNIIVTPLILIFFIITIFSLLTYATSTN LFLFFDLINSYIFKTIKNTITIFSKVEVINNSNIGIFLILSTMILSYLIY KLEQEKYYRENIKNS >BRE_1041 uncharacterized conserved protein MQKMGFNIFNIVVAVGLISCNHSGKTGLAEGGGRYSSDCKSGFPLNELFR SVHGAGAKKGFSGISDILLILENYKMDDRNRKLNLKRLVKNIDVFKFPFH KMSLLKDSIATRDNVIASLQYKRKLLYSLIDILKMLNLDDSSSNEAMLAN NFVLLLEKVSDLTLQLIYEDFNGACLDRLKNSTDRELVFVIYKRLMSRKL LLNSFEFIINDLVENMDSLKAKSVDKEYVLNTFNKLVGNDNVLLSVFEGM QDRV >BRE_463 putative lipoprotein MTSKFSISIIIIFLITIACTKHDKKTESAEINIETKIIKEDTTNEDNIMF HIDAQIPTIEGIEFGFEELIKKWKNDTIELFKTIKEKKEPHESFYYSDFE IFKNLNLNITSILYNQFQIDKYAANGLTTYHSINLRGKEKIELADIISKD QLDSLIQVLREEVKTKFEKIATHYDNKSTFEIEFEKIFKQYQYYFKNNEV VIFYNPLIIGPHSDEKIEFTFPINNNSEGDITKKKKTDCPICS >BRE_1093 uncharacterized conserved protein MDIKIDNEFKIIFNNDLKIVDGLDERKQRLLLYLKTPIGSLYDKNYGLDF NFFIKLLKNQKEEEIKIFFANALKTLDIDILNIKIKKKNNITIFFSWRYC KYGI >BRE_76 uncharacterized conserved protein MTSNLITYLLANNLLLIHFIGIEDIKIKDNKTLSKKYLTIIITSLLIYSC LFYIYKLFVEYNLLFIIPIIYMTLIYILTLMLKTLNNILVVMYNSKTKYS NDFLLSNSSLIAIIFFSLDKSHNFLEGITILILSSLSILITIILTKIIKK NLEKKSTFKLITNETMYFFIIFILSLIPNIIILINNSESL >BRE_3017 uncharacterized conserved protein MKNTSHEVKIHTQPLKKYHNRYYKILSILKYFQKNLLRYNQTIILNALNR FLAKDELKIITLRTLRKDLALLCNKGIIKKTLLRLGEGNGSYIRYAVNKY STNNLKRLLDDKQTIIEHDANEIYEFTKKTQQKYYLKNKRLNIHKHKNAT KNVSHNITNNKEIKNKKNKKEKMKKIEKQTIDTNYMIKNVAKWKTMRYLD KIEENANKKRYEDSMIKTKEWLKNLKN >BRE_213 putative lipoprotein MLRELKFNIVLFFLIIFCSCEMNYPEIREVDYVINYYFNKDKFDYFMTFD FAVKVLNAGTLNKFIIENMDSREFIEVVKDKYSSSFVNSILGQDVLYCKD LRFNFADKTFDSFVAKVHLIDSGMRVYSKDVIISLNLSNEELASIYDHVY KSKDVEKLNEISSNNLFLIKTSKDEINFLYSIIKINDLMNIQMDNNLDTY IGFYHMGKYSNLFFKLN >BRE_262 uncharacterized conserved protein MHNIKKLLFIFTLAFIFIIGLFKVNAKNNDITKIYYKKETFQGGNIYFIS NKNFKKLSLLSTNQKPILSASPFKCNISNKDYYIALIGITPMIKEGKRKI QIEFENKQYIKEIEIKKFTFKKTTVKLNKSKSKLIKSQQSPKAKKQALTL WNIIGSIGDTTIYHYDTFVHPIKDKYQITSPYGDQRIYMQDNQKISSQKI HNGKDYAPFKKEKTPIFAAGRGKVVFARDREITGKTIIIQHLPGVFTIYL HLSKFGVKENTIVNTGEYIGNVGNTGISTGPHLHFEIRINGIAVNPDFFL EEMLIDKNQIINNTKKIE >BRE_162 Na+/Ca+ exchange protein MVYIYFFCLMLGIFLLYLGGNYLLKSSVNIATYFKVPNLLIGVIIVSLST SAPELFTSLIASFKQKNEIIVSNIIGSNIINILLALSLTGCFLKIKTDFK RLKFSFMMLFLLMFLLLLLSFDFSSLSFFKVPYHKTSSLIILFVFVSYLF LFYREEKKYNVVERDLDNLNCDYGFKFLFLNIMFLFLSVYFLYLGSKLLI DNSIYIAHNIFHISEKVIGIIFVAFGTSIPELVVSLFAIIKKESDIALGN IIGSNIFNIGFILSSSSFISPVLMSDIYFVDFGIMFVISLILLLVVKVKG VFDRGPSIIFLFLYILYNVYLFGVY >BRE_679 hypothetical protein MIKKILLFLIINTSIHSRLITPSIEKRSSESIKKYSAFNLLIEEEYYIQY PKSTHEIQIYELTENFIKSILKNKIDDSKITPTYRETNKYLLQSEIIDKD FTKYKIFKIKTIDSIFKSSALIYTTKGFYKLELYISDNKDKLEIFNLNPS YFTKNPNEITNEMIFYNNNNK >BRE_451 uncharacterized conserved protein MKEKFMEPKIQAINYHLNDDMKDFILKKLDKIGTHIKQHAKSLKITIKKE NDIFDIDAHLHFNWGKIIHITEEGKELHALTERLIERLQNTANKEKSKKD TIK >BRE_5002 uncharacterized conserved protein MTTKPTFMPGEGLMTNEFGQNELVRVTPAPINENFSNLEARIIAEEINRI QKIEGSNKGHVIINNYLMVMFWMLINLLEC >BRE_409 uncharacterized conserved protein MKTLFSKLNFFLLTTISLGIIVISIFIYYLNTTINFYNYLSKIYNTNTLA LVNKFFIFNIGIIGSIWTYINYKRTNNIQFVFFYCFICFYIIEPIAIFKY YLLSNTLSLELYSLMKFYHLIVIFSLLNLFFLSLYICDFQIKSITYTIYL IFTFSMIYSYLIPINAYQHTNDFFSPIKNNKLYIYLFLLLILINFLVACL RKKNLSYLLLFVSTSLIVLGTYLNLIEIPYAFIPISIGVPIYLQESGKLF FYWL >BRE_6021 family 88-like protein MLSSGIPLSQFTKKNFTITNYTHDTITYTSSSNLQIKNHTLVNSTLIINA IYFLKKHKFNIIYIKLNRILKKLFRTNITTKHLEYIYSIILQSLNKKDNS YFYESILHFFIKKISNLYDDVMTLIYSVNFNIGKNILKLKKI >BRE_78 uncharacterized conserved protein MEKFKLIIIMLLSISTTKLAYTQSNIEYRFSYIINTKEENKELQKGIEQT LNKIYNAINEHIINDNDKDFIRRIYIYQNIISKEQEFSKLKEDMDKKKLQ NAISLKEENKIEVKIKNLKEDIKNIKIQQQELEKYLITLKKIKANYKKNQ DKVHLSNLNIEFLTSQELFFVNYIHLKKVDKHYLVEISNITPQGIKVYKE IFKLSSSVDDIAYKIAKLSLEEILGREFIKLKINVINNLDAKIYINEEFV SKGLYNNDIWDISKLPDKEIIIDITSTTYKPYRIKQKVKSGDTIDLNITL QKANSNKILITSNITSKVFKKGVFIGETPIEIEEPENVESILLQAEEHKN KFIIINNKDKEVYIEMVRNNKSELITKRDLFYINLSIFTLNLIGTAFAIT KYNESSELYNIALNNILKNRIRPQDLYNAKVEEMIATFLLGTGITFSVGS FIPLIIHLVQYIKEATRGE >BRE_806 uncharacterized conserved protein MAFIVFLFACFFPLNLLSLNVTKIGIVDFEKVIIGFLSPQLKSNLEQLKN HYQERIDTLNSEIKDLRKMYDDSMEIHDLDNAKLYGNQYNLKIDELKKLK NLAKSNFEQQKQININSLNSDGVLWSKILKSIQYVAETSGISLVMKKDNP YILYYNSTVDITDDVVKYLNEQ >BRE_571 uncharacterized conserved protein MSFMIYKPEGELIVNNIFKVKEDLLNILKNMKEKETLVINLANVEKIDIT FIQILYASNKYAKDRNLFIKIEYPSDEVLSLLIYGGFLIDIEDIDNLDLG LSLIEF >BRE_5015 putative lipoprotein MNKFLGVSFILLFLGCDGKEFTASKRNKVFSGDNVQNHNKVNDLSIELSL NVDEKKTLNFFIETLKDEYAKTTSSTNMHFKRTVNDINKIEEYLEQFFLE LKDNAKAKELLRIVKDTKENPGVGGLETVKSSIAGAFDNFFGATPEPISH KSKSISTFESIKTACDAYKAKTAKQA >BRE_690 isopentenyl-diphosphate delta-isomerase MDIEFMGIEPNILNNKRQQIEICLQRENVNKSDNLLNFVNVKHDALSELD FCEIDTHESLFGYDISMPIFISSMTGGVREGNKLNKSLVKIANDIGIPMG LGSFKLIFKYPEYIKDFSLKKYADNIPLFSNIGVVQLREFGVYEIIEMNK RLEVDAVILHLNSGQELMNSKGGRNFKGIKDTIAKFCSVSNLPVIVKETG FGISPDSVISLLELGVSYVDLAGSGGTNWVLVEGIKEKNLDIASCFANWG ISSVLTLLSIDESFKDKIFASGGYETGMDIAKGIALGAQLVGVAAAVLRV FYSGGEEALYKLFKDYEYVLKMSMLLSNSQNLAQFRTNKYFLSYPLMLNI KSFKDCYET >BRE_547 uncharacterized conserved protein MLGFALMYKGLFFCLLYFVLSCKTFDKDYQTIADEYYKLAKLNEELGNNQ TSVELYEQAIKFDSNINAAFGYNFILAYVNLKRYEEAELKLGSLLENDKD NILLINLKAYLFFKKDNLEEALKLYLKTLEIAPANQEALFNVFYIYHLNK DMENAKKYILKYQEFKYSVPSNASDIVSSILKD >BRE_163 uncharacterized conserved protein MDVVYMRLNTCLMFFYVIFLLFSYFFLCFRLHSLNGNRYFKNGNFFFVHK GALYKKRNNGIFKIETKGIETRWIYPFENPVSKRITSIYEDFYSLNSLLT TSDAVYVSHNYFKNFIKLVDTEKFNKNSYITSSALSRGEYKHVAVGTSNS GLYISINNNLDFKSLNSLISKTYLGAGYYDIISSLEFSKNSESELYCSYG IYGDIILINIVSGVIKKLDFPFKKQIVRIIDLSDEKLEKLLVGTYDNHFY LYVDGKWIFDSQFSIYESNYFQKSKRLNLASNRGSIYLTAYTLRNKTAVD ERFEFIKKLGMNSVIIDFKNDSGILTYASQLELPNKMNAVKKLIDVPYIL KKAKELGIYVIARVVVFKDSKFYLYNNCEYALWNKKTNRPWSNVVKVMNG NSFKLIQKEHWVDLFSKNTWDYNLDIAKEIQLLGVDEIQFDYIRFPTDGP VSLIASRFNKYEMRAIDALESFLILAREKISIPISIDIYGNNGWFVTNSI GQNISMISDYVDVISPMFYPSHYTNDFLKNDLYYTTRAYKIYKEGSNRAF VFSSGKVIIRPYVQAFLLGSERIVSEEVYLQYFFNQLQGVKESLGNGFSL WNASNIYYMVKTNLNKFLGFS >BRE_583 uncharacterized conserved protein MVRRYKMNESDVKRAISMKRLVKYFFDELKYRMKIPCLRHNNQYMSKKYI LLNLLRKIANLPFYDQYEIEEQFFLDILGKGVLADAVLIKRLDYEKCVIV GIIEAKADHVDLEYELSRFLIQGDKVNVLFWQPKRMLLKQNEELIILDAD DIFKLDNDFYLPLVKEKLEDFINVFVKFFSYEDILFEYNKIIGKYSFIRS K >BRE_1068 putative lipoprotein MKIYKIFITLLIILSFGCDLTGLLGKDDEGKDRLQTIIEGAERFLGDLVE EHVEYEYYYVDDQGNYFDEHGNVVVLNEDGTFVYKDKDVVIGAEGKGSIS VNVDRDGKIDVSAVGEAMVVALDGAKKLVADVKAEVFGKPGEVQGDLVAK VSDVVAKGSDFKSLVAKLEGDVNGEIKQVVASPVVKTRKPVSVSTKQNTY KKPTNYSGHKMSNESRSKVYCQTYKVRPGERATKVYISDDEKKMFNFLEK HLKDVISLIDKNSYSSRLKNRHDYKEKIKTKYEKLMGMSKEDTVAGDIRR LELGRSVKKFYDFMKENAANSAEVKSLIENGVRDKSDILEKAGIKSSSDI KNYYHVAALIDLALCYKDYSSSIRVFFENVADTLWYYADSSDKSADTQDL IWMMEAKFHASNSSDLAQLKQGILGQ >BRE_416 uncharacterized conserved protein MLKKLLIILIFLQTVSTYSEEETKQKLETKENSTTKENSETKQNQTRYFY IDFQTAYYPPHALRISNSKFSPSFITPKFTSTDPSKQIEPSSWESAKLIS HFGGHKFIPLQNNFDSIFFKNNGIDLDVNIGLSPILALSHAKIGITPIAF LNIYTESEFGIGWEAFGFKGIGVHLGNGKYSSKPEFYYEFTTGGRLQFDL NSILDGEWTHVITVVGNNMKLRYNPHAKNNQLWKYKADEGKNINGTIINP YALLAYQMPMPLNLVGFLYEGQTYIGNARHVSTMQDKGWGSDFFYHNFSL IAKIQVIENLTLDVLFKFSTAPSYTEDTVGLADITKKVSTNNSYVYYDSI GLSLTYKI >BRE_545 uncharacterized conserved protein MEDISLNTLTISHELSKISQVDYDSALSELSVFFKDGRAYKYFKIEPRHF NIISKLVQEKKSVGKYLTEHIFYKYDQERL >BRE_650 N-acylglucosamine-6-phosphate 2-epimerase MSCQALEGEPLHSSFIMSKMALAAKMGGAIGIRANGVLDIRQIKSEVDLP IIGIIKRVYHNSSVFITPTLKEVDELCDEGVEVIALDATFRNRPDGLLLS EFVNKIKEKYPSQLLMADIGSLDEALNADQLGFDFIGTTLHGYTEDTEGF NIADNDFAFLKSLLKCNLKAQLIVEGKIDTPLKAKRSFELGVSLVVVGGA ITRPMEITKSFVDKINEVITI >BRE_1057 uncharacterized conserved protein MNRSEILNEYLNYLKYLRSETCKYYFPVLMEVCTFNDVKKFKYDELMEIN KIANFKLKKKVYEKFLVSKLLG >BRE_2006 uncharacterized conserved protein MTKQKLELNTQPLKQYHTRYYKILSILKYFQRNAINYNQTKILNTLNFFL KKDDIKITTLRTLRQDLCFLCKNGIIEKTLIRLGKSNGSYIRYTVNKYSN NNLNRLLESKESIVEHDANAIYKFTKKTQKKYLQNKKVKIYKPKNATKNV SHIINNKKEIKDKEKNDIIFKISKVTKGKTMKYLDKIEENKNKKRYEESI FRVKNWLKQLKLAEFANRGYYNQSNKEE >BRE_356 uncharacterized conserved protein MLNIVRFISLISCRFIFMFFLFSFVFVCTSYLKYTFLHVDLSVLSFELYY DAYLYAFPLSLVVTFMRIAYPFSMTTFRVSGILYIVVFIFILFLSYFGFL ASVNFNTIFFDLHNRDEKIIKDDTVHFFDDQIVFYSNDIKSFGFKGVLKI TDNEFDDEDFKSFSYNSGFSESDVANFNENAFFTQKLYSNLVGYTFNDLD IFNNFLLSLESFGLILNIFGFVLLLFSFSYIFNFIFLNSLSLFLYPIFVI LFFKVYNIYAIEFPESLDLIMGENVISNYLTFIFCVLTFCSTYLIGFLFK YIKVNEGFDNNTLH >BRE_129 uncharacterized conserved protein MFKNKFFIGILAVIIFVGIIIYFYDFTDINYVKEGGEIVENLEQDLNLYL KSKNTEERQNLESKIEKALNSKDDITYEFLPRFYLAKSTYSQSKGLYEEA LKDLDVVIALKWIERELAYINKAVIYEKIGQVENALLMYDNVINQTKLDF MKIRALLGKAILVELQDKKLAIDIYEKIANFSYEDNLYINIAKNKLFQLK >BRE_1040 uncharacterized conserved protein MKNFSMTLVCVLCLLLILFIMFGWDSGVKYHSEFQRELERSGIRPLNPGE IKDSSIEDKISKYERSTVQDNSDETLDDENLLSEVPDSHETREQAYDELE NKVREFKNEFLDRSLRFASGKHQFSMPFFERFAKFDGDDKKDIVYSSLGY DVDVIRKLETLINKVDPNVPSYLSRLDKGIASGLLDVLYNVTYYVREVVI NNHLNLFNLGNIKTSSLITADDIASINVLIDTLMHLRRNLTLKLGRYIVL AESKTDKLEMEAVLRKIIEQNGDIRRLIAKIMFISQSIGNLVNVQTNP >BRE_792 uncharacterized conserved protein MILMEDMLRVDDIKKLCKIISDFGGIDVLGINVSSVCNWADFFIIVSFSS FKQMEVLYTEKLIAFFNERNLNCCLQGKGFLFDWTVISCGGLVIHLMSKN SREYYELEKIWDKGEVIYS >BRE_6005 putative lipoprotein MIKFIKYFILLHFVFLMFSCETIDLKDIDKDLEGLSKNSKYIRLIFGNNK ISLRHYFTIAGKFHLRYKEPLFLKCDNDIVALFLFRRYKRIGSGYIQTFF SVGKDVSLKVYLELVRRKKFFIINSAGQVLKTIIFSNNSNSEDVLLQNNK II >BRE_765 putative lipoprotein MGLSFRLLLLDLNLRNLFLSLLVLSCSFPKRDFSILELSVINFQKNLILI NALVDIAYNLSFFDFDLVIVKNLKNKEELDLINNKVAFGDFQNAYFIGQN DILSISILSKEKIKIQILDLIEGFYACRLGVVVDFVFKDRHYGIVIFNFD EKIANNLDIDLVNEQIKYLSYRYENLLFILDKSELILLDMIIKNGFFNLI YNSINPFYIINAISSKVYSNFIAQISIHSLRYVVLSYLYNNFYMSGLPKS ILIK >BRE_830 uncharacterized conserved protein MLNKLRRFLKVMKIPLKKIQDFDENYYELVMAVIVRTDQIIEQISLAEHS IADERVVSQAFNDIFAKRFLYSIEDK >BRE_230 uncharacterized conserved protein MPVNVKNSYKWDCKLDSSLIFRGKLKFEGALYLDSSFEGEIFSEKGILFI GKNSKVITDVVICDTLIIEGILKGNVNASNKVYLNSGCKIYGDVKTKKIF INDDIVFDGKCEMIKSNESIDLFSFTVSQLKDTLQ >BRE_234 conserved hypothetical GTP-binding protein MALNVGIVGLPNVGKSTLFSSLTASKSEIANYPFCTIDPNVGIVEVPDER LLKIANLVSSKKIIPAVIEFVDIAGLVREAFKGEGLGNKFLANIREVSII VHVVRCFNDREVIHIDGDIDPQRDISTINTELCLADLETVQKSILKNEKN AKSIDKNISENSKIIVSLLRDLEKHLIDVRPASEFKFDEFGYNFVKSLNL LTMKNVIYVCNVDEDSLSGNKYTDVVKNIALSEGNNYLILCAKIEAELAE IQDLSERREMLESMGIKESGLSNLIRTSYYTLGLRTYFTAGEQEVRAWTF IDGMKAPEAAGIIHSDFQRGFIKAEVYSFDDLIEFQGVHGLKEKGRLRLE GKDYLVRDGDIILFKFNV >BRE_1075 expressed protein MLCKFHLLLYIFISMSINLLRRLDMRYFGIIVLFLSISILCCKFYDIGDQ KSLWNDNTGRAQDVKDFFSSDVGKMSSDIVGMKFDNKRANKGDMGKVQDS LNGVVGKSKGDDKKEKVDGDAAGREAGKQDAVADGQQKDEQKKDDQKGDK EQVASVDEQQKVNVEKIQDDSQGVEAREEGKQVLNSEGLSSEGQNLDGAE QVKDGKQVEDSKEELQPNNSNDSSVDSSGSGSSNGGSGGDVGSGTLLGSA AEGSVDVQGLDVVSSEQQQNQVQEQIQPQTQSQNDLTADLVTTDLVTDSL EKLSLSGVEDGSRKVLSVSMPEVTSNLGLKDNSISTESIDKDEHRDVKGV NLGSSLIDNRVTEGIVSGESLHFNLVSQSNMLDSNVVEEERKINVPTSNP TSNIPVAKENKPVVSLKETSASKVQDIEVKGGQVSTSKSSTSKSSTSKAS TSQTQNVKTQNVKTQNVKTRSGKARSNVESNSNFKSADKSLGKSVSVSGN KIVDNVVDGIVHGIGDGVEAVINKADTLVTAAVQGAEAAIGVIHDAGTFV IDTLQNMGSSILVGIDPTSYFSNSGNGMYLGLTSSESQAFARLEGYLKSA IKVNGRAEDESKLEAGHKKLFDWLKKNDSDFVKRKELVRAIEGIYQFIRE KISYSFELRNWVENIIWDMKARNIIFDINIKDQLNNDEIDVLISNTLRSD KYRGTIVSLLFQALTDTLYDSVGDNYKSELQMFEDLKDAFSDSSPKGKNV RELKSVIESRTQIVN >BRE_1061 uncharacterized conserved protein MLLSLYESQTFLVKILFEFKDYLKKHSLKVKIINSYNPLYLNDLEINGSY LLVIRPEGFDSLDVRNFRSGSFYENVNEFGFKFILFFLGFVGEVGELKIY VGLHTIYEYFLEFLHENAFKFKFLKQNPLEKEYDLSLNYYLKSTSDLRNG GFVKTSCNGLKGVLGLSQNYRANIQIVENKID >BRE_781 uncharacterized conserved protein MTTLKSRFIFYLLTINLSYIKAYDTCFKMSPNKVYFFSKEYSKICNGNNL SQIYISPHFKKKQIIYSMISHITKTLENKNIYILQFSFDESEINIQNQSA INIKFKITNQTSYKNIPIQKIIIYYAKQFEDYKKHNKINIYIDIIEPIVF AKTTLKTGQNLNEHNVYFKYQINTTSNNENLNLNALHQNKYIVLQNIMKN EKIKLNKIQKQQ >BRE_4034 antigenic protein P35 MKSKNKYLALGLLLSFINCDLFMNDEIKEKSLGLFDKVHSVLDASAKSIS SNKNGKFSQDVVSGDITSGLQNDVQKDIQVALSSTTFETGEAKIQKQQDV ESENSITKVSKVYSNVINGLTGGKPLRGTEKEVNYPNVDDGEATSVEIHH NSYLNGFGSTSSSSIQGEIWDSSNFFEVTYNSAYNSEPELSGQNSLSEDY YEEDDDDYDNEHENSYEEDDEDYEGYYDNYDKKESEEKYDKDEYDEEEER LDREYKLRSKNTKDSVKKAFKLAIQIKKDWGTVEFHKTKLNPIYGIRATS DEKQKSQRKLSKFNKNKLIESLTKFLNAIEESLNNADALTNIPEYPGSFA KDLQAKAKLDRLKTEIKTLISKVQKSNKTNYQSYEEIGSSIASSPKIKSE LKQVLALLYSLTGAR >BRE_560 hypothetical protein MILISFNLNGENLSKSIGLSLSTKELLISVFYSGERNLIERMNKRFSLVL LDLRPVYSFLVPAFMLNGRSIITVEGLENTTFYNTLTKVLLESDFGFCDS CFSSNVLLFYYLLKCKVIIRTDILGYYSTLKCHCLDVNTFLDLYLRLEEL EKK >BRE_822 uncharacterized conserved protein MMYLRFILLFYIIINAFSVNKSPALSNRSLLPLRPETKINEDKVKDALES DSSKKSTSRDIDLNIKQVNDVISYGLDVQVIEIIDSLRKSGDGEYNALLE KRLQKTFNIDLKRAILDLFLSLQYEGGIDASNDILNNYESNRYPNDLINL AILYLKKLGDKNDLKKTLIDILENKEGNIVAIAAYYLGELSSPEYSREMM NVYDKYSNNDGVKSAILIALGKSNVIDYVDRFYEISIDSYENPSIKASAI KALSYLAPEKITENAHLYLQNNNNNHNIKLAIIEALSRDVSLKSKDILHD FLRDSDANIRIRAVEAIKEHNDIDSKEVLIYKIKSDPSSKVREASGKALV DMGSGYEAIQKIVFDFSVESNFKFIVFSYLLDKDIHSARSIALDLLNKEN INKPSKFLVNIAMLFASKKGNFDDFYSKIIESQNMNLMNLAIKGAVYNKS ALLLDRLKEIKKTTNSEYLKRLLVNY >BRE_156 uncharacterized conserved protein MKNNNCKYKVEETNKKLLKKKLMLGIIFVIILITNKVIIIPKLQKIENKH NPTITIEHKIKNKNLYLKINIQNNDIKYFGKANIELYLDSKLVENNMIYI DKINYTLYTNVAYKNESLLNIMLITQKGYKAYFNKRLDLGG >BRE_1103 uncharacterized conserved protein MIRQVFYALLLLLVLIMNCNLTSKDVSDFDGTSLVVNSLIDQTLDKGSRL LEKYEEGGIDSIDLELYELLDLFGVSKNGKMLIFYIKEALCDSDIVDAQG QCEIYDYIQFYELLNNLGADKIIEIVNHLLGTFNALREAELAISKVSDGD LKREMQIRFDLKNKAYKLDLKKVFSASVLDELYNQIISYDSSYIDDFINM KIDALSKYSRN >BRE_1059 uncharacterized conserved protein MMKDYYSLDLVFFSFSGVLIDRGKLQYSTSPNVMATASTEERNVPIPSFR DPRTIIHIFNLEITKGSFDYKVLTKLSNEQFYGSSYKRDKLKSLVFNDQM GLKIISNSAFFSEIPSRTYASGSDTVNFVIHAINCEVERS >BRE_373 uncharacterized conserved protein MQSFDNLAKEIKNFSYVIEKDFLIWPKDSLLQPINTELIEKWGLKNAIQI ERNFFNESLIRETKKYININEEYDEESIANYHILISNLEEIYETCKKNKK IYYQDVIPIVKKVMEFYKKNQQTFIKYIKIPKLLSDYHVVHSINTSILTV ALGNEMNLNNHKTVELCTTALLHKIGFLFIPLSISKKKEKLTDKEFEIIK KYPVLGHKIISTTNFSRSICLAILTHKENLDGSGYPNKLKSEQINIEANI IGAASAYSAILLDKIYKGASSSGASLIELIQDADKKFDKRVLKLIIKVLS QCPLDFIVELNDNSIAKIIKINEININVPYIKYIIKDGKVIHPNDNQGYI KSIPKTETGIKKILRQDEINLILKKYSLKEI >BRE_400 uncharacterized conserved protein MKIIFIILLTQFITSLNANETIKTIKELSKTVYNFNNQEYTTNKEKLDKL IELIDINNKNILQELQKIKNEFLITSIYFQNIKGTLIAINLAAQINFRYK VSPLSIAIINNDFKTTKILIDYGIKINNIDETKHSPIFWAIYLNNEKIFN LLKEQGADLSLTLKNGKTPIQAAIEIENINLIELLLKKNVYISDEYKKEI KNLKNQNIINIFKKYKTT >BRE_224 tRNA-dihydrouridine synthase A MLINRKISIAPMVEITDEHFRYIIRLLSKKITLYTPMISAKSIIIGELNT IVKQNPNDSPIAIQIATNCENDAAKAIEILEKNFNFDEYNLNVGCPSSRI QKANYGACLMQNPIQVGKILKAMQKNTNKPISIKHRIGIRHNKKEYQEET YTELKQFVDKIIEYGIKNFIVHARIAILNGYSPKDNHNIPKLKYDFVYQL KKEYKNTFIEINGGIINSNHIETHLSYVDSVMIGRAAAQNPYFVAKISRE FLGEKEQIPTRKEILFQMVEYIKEYNEHPTINTILRHIMRVIHSQKNACK FRQALTAPFNQNLKNHEILLNAIEHLKEDTLSSNS >BRE_1095 hypothetical protein MEKDFYNSVLFLLLLTDMSCGLSTSTSSSKFPDEKLPLKKFTSENVDAAK PGFNSQDLESKFDLKERRVEAGGRQGGIREEKPEEIESIKNFYSALMYND KVVFHSVQKMASGFEGYSDSEEYKDDQPRFYRVWGNLGINKLSHIMSEYS RLNKKRSDIQWMMMNFDIRKIKEHFNNKLNDCDRNYALEFRGAFQKDDFN TIYDGIVSVMKAYEENLDVFESDYERLRIFKRIHSGFSVKLRSSFDYISN ELTDFNVEDESQSKMYFYYDFCVLFGDETGNNRYLQFVEKFEPIFELMSS LREEIKFEIEDDAVVSQFTEVFNELEDRFKLYLKEVFPRIVSDDMSFEGL DSYETDFENLKARVMDY >BRE_1056 hypothetical protein MGLGIDATKKDLTYLSNFNIELDEYLKSKFKSKFMGSNDFFKKQIASLFS ISNSNDFKSKDFGKVFAKDFSDDFISYLPKLSKSKLPNIDFDLIESPKSM KNLNFKDLSMKPFRSREKNDNQENNFNLIKPLVSNSFLIPLVPMESNNLY DNLPRLNSNLDLVSNANIKSNMLYSDIFKYLNVNAASKTRLNMLPGDFDF KTKGGSVLGINDVTYNKSETQKIKSMLASTGKFDTQVDINDFIRKTAGFK SLLFNDQQKSVTDIPKMFFEMVNLASNFKGKQKPNDNDDAVSVVYKLFND NILSPFKNQLTKSFATIKEKRTDYIKGSLGNSLGAPLGGLASDLFSNLMS QFGTKLDVMLKDFNLKKIIGWNSDEEKSEDAEQDVVDKTSLKIEPEANLG TNLDLDSLKFNDVCNDLNVILIEIRDSIKQVCGMDFERNVLDPLSVYFNN VENAINALSDAITRNSQGGSFGSNINDSKIGNAISRIP >BRE_531 uncharacterized conserved protein MHKKFILLLISQILLTVKSYCIEEIIEINTSTQKEKYIPFLLSKGKSQVE DIVKYTLKMNPYLEAEYVKTIAQIYIEEAIIEGINYDIAYAQMLLETGIL KFNGIVSKEQHNFSGLGATDNFTKGNSFSNMQEGIRAHIQHLKAYASSQD INSNMVDPRFYFVKRGSAPTIYDLTGKWATDKLYDKKLKKILLGLLEFEN AKK >BRE_580 ABC transporter, ATP-binding protein MKIEFRDIAFSYYKTNVYFNVNLSVEKPQNYLVLGKNGVGKTTLLRLISG LLNPSEGEILFNSLKTFPRNPLNLVNLFFVPEEFSLPDISLNDYYKSLCK FYPNFKEEDFKEYLLRFELDINLKLSSASYGQKKKSIIAFSIATGVPVLI FDEPTNGLDIASKNVFRYILSNLRNTMVFITGHNVRDLSDIVEHLIIIGN NNVLFSDSVSHIKNNYKVKIVDKLDGEELYYEKVKDRFKSLYYESGTFDN NNFDIEFFFLYVVNDGLKDFSNV >BRE_61 uncharacterized conserved protein MNFKRFFIMLLFFYLNFGSLMGATITAIEYYQKAQTYYLMQKYYDAIDEL LEAVKINPNYYEAYKFLAEIYYKLKIYNQAQFFIEKAYKMSNRDTEYKIL YANILLKNNGASQAKKFYSEVLSKQKNNIDALVGLASIFEEEGLLIAAAN YYLSVLEYSRTNYSAFDHLMSIYEKLNMNDKAQHLINKVRGTFTSLPDFH RRVAEFSIKTGNLGSAEKYAQNYLMLLKTTYKDFGLVDAYRLLALVYLYQ VKYDDAVDVLQKAIVIEQDSDELYYLLGYSYLKLGEVDKAVFNLERAKNM KKDLEFYDMALEESFFVSNFRSAFQKNNSTNIEISKRYHNEGLKAFQDLS LDAAIFNVRNAIDIYPDNDGARFLLAKIYKFMKLDVMAYEELYYLVEQRK VTDSAILDFYDMVAFDIRSSLFFKYGYKTIGDLNKLYDNQTVYRIGIFTQ NENKVFGANDLILKYAERILDRNLNIEVVNYRFDYNKDKDYLVSSFSEEF SYARNNNLDLFLMFDLDVDVFRNLASLKVDVFSGKTGVKVKTFSYNSGGV LYLSNILSSFSRDFNDYLPKKGKILQIKKDDVLINLGYVNDVKLGDVFLV LKEGALKYNSDSASFMSYSKSDILGEISIEEIGDYISRGTLKSSALLRDY IQEGYTVFIKK >BRE_548 uncharacterized conserved protein MNSFRYFGGFNVMKIKFLFLSLWIFVTVNVLSSVDFELNLGFGFDFPVST ISNFYKTALDVGRELESTMSILKKAKIIRNFADMVNISKSGLTYGGYVQM GAKFDDFCSLGFELGLDFNVFRSINSKGRLHNLLSFVSAIEPKFYTRLDF FIGAVTFFTGPRVNIATAIQDSILAEFGIFGWDLGARATCAFLTIEGYYC WNIQNNKFSDFKFGVGLEFGVV >BRE_312 uncharacterized conserved protein MSKIKRFEIGFYCLLILLLTIIVCLNIYFNFRYVVKLREFDELNNEQNDI IDENLRLLTIIYELQSIDRIEDLSQNYLDLEKKDNKDINIIKR >BRE_6015 uncharacterized conserved protein MRRKKINKIPFNKVVDRRLKVFWVIKKLQHNYFTNKKRYSLRNVVIMVNS ILEKNGFKTVTRRTIQSDITSIEKIGLLKTDFNPLGKNNGSFTYYIINKN LEKMANKAISTAYFIQKKKNTEQAIDKAINKDKLKEQKQQFKISHQIFSC LLSYKKDKYYRYKNSYFKKKKNGTEHLEKIILQKFNITKKDLSEIRNIVK TQLSYKNTLWNLKDFMEALREYKENDVVVFFKTFLKKKRDKIWFMSKRGV KTDFNFMIGSFKDKNKTKAQQMYQNQRKIVAPKMNYIDDPNKIVKVSDLV SDIIKAKNLISS >BRE_797 cell cycle protein MMVWDNIITRIEDFYKRNLLTKEKVIVAFSGGPDSTVLLLNLKKYLNNNI VAFYFAHYIRSKSEQDLEIEHVKKFCNLYDIVCQIKKCDVDIKIKAKQLG ISIEELARKYRYNALLEALNENHASYVALAHNKNDQFETLIMRFFQGSFL DGFVGIPVINNFIIRPLLEVSREEIEKFLSVNNIVYSIDSTNHEDLYLRN KVRNNLVPVIKKIFKGYEKGLRRISDFSRELTNYFDREDFLPFIKGNYYY SFDAMVFFNLPKYLVFRSVFKILNLEKIVTNLSYGSLSEIFRVSLNNKRS NILLKNNDFFLEKRRDKVNLIFRRSEEMRRPFDFFLRVNEYHSLSLGKIL LECLECEDDSILTLRCCSYEFRHKFFKKKLQSKKFFSKFVRYNPLYLMLL VLNDKIIGIIDLNTLNLMWSDKNILKKISISLFGGFLKE >BRE_1055 uncharacterized conserved protein MLDKKNVTSMILDIVNHILSLSASSNFIVLFPRPDFKGFVYVPQLFFIFP KSKPTEESFSNASSEQGTVNVNLKEGEILSYNVVSNPEIINVSNGILSSI HDKFLIEHFKKTSYANSVLEFNVNFVKVHFRERFKMGSYYSVYGPMIGFH ELAIINSLKFRDAAFIEEINVSLQIKILKTFNISTYKG >BRE_327 uncharacterized conserved protein MVLKLYIIILLFLSSQVILFSQVASIKEMEGQINVIRNAVYVKLNLGDEI FEYDFIDVGSNSKLKISLYGINGIESDLTLHSNTYSLICYSSLKDMQDAK IYLFKGSLDVTIYKIVQGSSFSVDINNYFFKTDAPAKFYVNCEYFNNYFV SVFDGILNHYNKDTYWISTNTSILLWNNNSFLYKTDDAVPQNVIQNLKEM SRKNFISLNNKHSAYVFSKYVEDSFRFDFVYDYLVRDPKFNVIYSKWSLE DKNYTLGNRVDMINDVNYLRGRVGILFKNFVYLANVFFFIEDIVNHTSDM FDKVIIYGSVLKFFENYKQNRSSLAKKFFKTIHSFKMYLVRTNGDLPSNL SVNEFYLLTPREF >BRE_1063 uncharacterized conserved protein MDIIMDSNEDLDKIYSKILNLLMIKSLDFNFEEFNLYIGLLEDVLLSRGL GLKDLNSSNVFLLIYYFIGCELKKRGKLLYFDLGKIKSERLGEVSVEYFD DALHGEVLVNDFCSAFNNLVEDIKTNRKVLIGVV >BRE_771 sensory transduction histidine kinase, putative MSKFLKKTLTKLNKLSSDQKLKFIQDIYKKIEIYDGIFASINEGIMVLDK INNIIYLNKMLFQILSISPKYKLETLKDISIPTLTNLIEELATNEDKIIG FEVQISTNIYIKISFMPYVRDQKLEGNIILIEDIKDKKHKEELFRRAEAL AAFTRHARNIAHEIKNPLGAIDINLQLLKKEIDKQNIKSTKTNHYFKIIK EEINRMDKTVTDFLLTVRPIKIMPQKKDISDIIKSVYNLLNPELKNKNIK FILSLKKVSFVLIDEKLIRQVIINIVKNAEEALLESNKKIKKIEISIHEN ENNIYVSIKDNANGITNETKDDIFKPQFSTKENGSGIGLTISYKIVKEHG GEIFVESKEMKGTSFTITLPKLNKDKILIEGCLENE >BRE_403 uncharacterized conserved protein MKTQLTILMIFLTISSSIATTIDPEALNRVLNKQHSQKSSYPSNIFGIGF GIGNPITNIIINFPYVDVDFGYGGFNGLHPNNFIPYIVLGTDIVFKEEVY HNTTLSGGLGIGIDLSQVKPNEQDASNVTQQNNNGQNKQEEFSLTSSNNR LGFTIRLPIILEYGFLKNVFIGFKAITTIGATMIFNPTLMEGIRFGFFGF GFIKIYI >BRE_1080 p23-like cell envelope protein MNTKILLSIPTVVICTQCNNTTNEKLQYEENLSREIISRRKEYIEKFEDL QSRTTNPTEELNKTLKEPYETIEGNKSITIPILFMHKTINITWIKNKALT INGLDSKPISELQNKIRYSYSISPIKEDGALSNKIMPIVLFETTQNGQDF EVTSFTLIDAPNLDFNTRKYSAVSSLFYTPPKTEKSQESGYVNAYPFWIA NKNNEVIKALTQSRLIRAKIKVKNPKTRFAEEYNIELDTQYLILLITDVL QKNPGLSKVAPNFNLK >BRE_178 putative flagellar protein MEIKLETELKNTLEEETFLIEKIYSMYLNIKKYLDEKNAMMLKESIDKTN IYLQEFKDVEQKRDKIWKEFTQNEQFESTYMAIEKLCSTYKKEIHNYFHR LKIGTLNIQNLNHLISSYVETSLDMLDSIFQDAQETVDNITYKNPYGPKN GTPNEASVLINKKL >BRE_15 holo-acyl-carrier protein synthase MNNKMTKSIGCDIIKVMRLSSFLKNKKKLERFFTQREIENLKMKGKGVLE SLAGKFSAKESLLKALSPLVNSKIKYSLKDIEIISLPKGNVTFQLHNDIK KLIAKMNLKLYLTISHEREYAVTFVIVEN >BRE_48 P115 protein MGVVLFLEKIGLLGFKSFVKMQELKLNSSLNFIVGPNGCGKSNLLDAIRF CIGEDNLSILRIKHITDLISVSKSKESNFAEVTLFFNNEDLSIGDFRDKF YIRRRLYKDGTSEYFLNNDNLNLKNYMDLVNKLRFKNSPYMFINQGKIER ISSSGNINLKSLIEEASGIDMLRVEEEQAYKSLEKSRENLTSLLMLRDEL NEKYEKIKNDFLIKDKYQKLKNDLEVLDKNLSLKKLFNLNFELTKLKNGL NIKDIDNILHLSSFSIESIKEKLEFYSLREKNVIKNIELIKKEIEMLKSK LLTMEIKIQKLEHDKRGKLNLANIFMGNKSQIESVKVSINEELMNLNNSL QSKKKDFFILTDEINRYTRSFFELVDLVLSIVKESNIEEFEQLKKNILNS LKLFEDTLSIKYLKNIRENLLKYIVKEDKLLNLLREKIEPIFEQNVDLRK FLLTRNNSKTSLAKEITTIESLVSEKTLKLNEILGEIEYTELSRLKNEDE IKLIDSNLKFLFETRDELKERLNNLNLKLDELNLERSDINVNLDKFLSDA KGSELVGNKEVNTLSVLDAFKNSSYYEYMKKQAEYDILLHSNLDIKDEIK DFNFVNKDMEKFDLEDDLVQIASLRKEMSMIEHDNYIFFNVEREYNEIKD KVEKINLQINDLNATKESLDKLRKRIKREINKKFNDAFDKISDHFIYFFS RIFKGSGSLFYDKDLDEIEIKINFKDKLVKGNKMLSGGEHSLISIAFLFA LYYYSPASFCVLDEIDASLDFENSNKLSTLLNELGQKVQLLIITHNMYVA KGSKNLIGVTSDNGESVIFNI >BRE_1102 putative lipoprotein MFGEKICVLLVSLVLIISCNLKSSDLAKDGKGLENSFGKSVVVGPLYEVN RFVDEPFSPRVEYDTPAVRKGVEEMGMGIDIGDMDVELDNLLTRLNIQKE DRDVFVYLKKVLCDPTITDDQGVYKTYTVSEFHDLLDSWGAGQVSVIRSK LIRVFTSLKALRVLIGDCRNNILKQGLLNRLMFVKKEYERYLKKVFDSSD FSIIKVSLEYHNPYYGKFGLIEIDASNFKDLTDVRDRYSAFVDDDQKRIQ EIRNILTSANIARGQNLKTYSDDEFDILFSSWSNYQLKRVVRMHLGYMRR ARDVKVQIGYFDDMKNIDIRTELKYRLVTSLTTWKLKLEDTLSQKDSGYP EYLKQIFNKSTAVEIYDNIPFSSKYDINDYNFYFPFNDAYFLDIDRYYSI RNEFISKYNKLSYAEKVAVEFIRNIVFNANIAADKGYKTYTDDYKFYLIF ASSDYYFSELVQRQLNFATCQSYIEEYINEIKENPVRKNKLLQKRDELVK KYHVSLKKFFHGVNEATFEFDDSSRKNYSEVWDIQLDFESFFDNIAVEGL >BRE_849 uncharacterized conserved protein MQEFLYRNVFEKSFVILILLNIFSCFILFSQNDNDKDKIKNKLTLMQKAN LRELELSSDEDLKKWALKEGIKEKDISKIKSLLLEKFGISPDLFLKDGKD AGRYKVVIESTDNLENFTYELTEDENIVFKGRVKLIIEDVKENKKHNIQG DKIVFNKKTKKLFSSGNVDYKLDLSSDEKLYFYGNELFVDFDSKNLLLKD GIIQKKIQRNLVDHIVSFGGKSLKRLDNDASILEQAFITTSKIPEPYYSI KASKIWILPSGDFGILNAVFYIGRVPMFYIPFFFKPGDSLFFNPSLGYFP KRGLTLFNTVYLFGKKSVDSDKFSFLDFDFHSMYDSSKEPYIRNGYLTYF FAEDVVSKLNKDYVKLIFDIYSNLGFYTGIDLNLSNTLDLFKTFEVSFGI GFTRTVHRHILSGVYRPFDSNSINYSLFSFDNINKGNIFGFEVPFRYLLK SKSEFLISDALFSVIFEHYSDPYVMIDFKDRLESGTFLSLLSSPKSSSEI EKMISTFDWNLSSFYNRTFDDNSLIDYRLNNLGFTFKLASYDNIFNAKSK KNIKDPTRKWFYLERIHLPYIDLNFQKDLYNNNWTVSSDSKTKEVIMGSK VKDIGDSFEDDKDKSDSEKLKEKKDLIKDFHLVPNPIVSNDFNKQDSFYI RFGINPYLKNNIFFDDSKFKSPQEFKYDVKTYLFDIKNKIDLKLYADFNN RQITFEDILYLNTVEYNPLDKNYNLIEKDKKGEHSIIHKITLNLLPFMMY PNFSRSSIKFENKITLYSFDKKYDVNSKILAGKSNTVFLKSPETFYQDFN FDLIYDYKFFTTSFLSVLKNTFESIYTSSEFKFSLEFPYLLQEVGIGVKY DRKFKEDTKKTFFSKKTLINSSPLKPIYPYKHLKMNPALYYKLEPRYLDY LKFSFLIAYDPLINGLSELSLKVNAYDFKFAFKMKNDFEYKYDKLLGDFA KVGSMAKLVPYSLSAQYKKDLYEFKFFNEKFSIGFGTDVGWKMNLQKFVD NEFWAEFTLKFKYTKFFELDVATRSINTKTFRYFGGYMNQIDLATVNFLE DVFKSFNFFNIQDRKDSLFKIKKISTSFKFNFYDWKFVGEYSLSPDILKH DNNRYSSIWRNTFSIYISWNFFEPVKSSFESNSSTNYELLINRKSNRQDR IF >BRE_11 conserved hypothetical integral membrane protein MALEIKTTDRFKFVRLQSIFYVVALIIMLITILKVAQTIFKPLSIAVLLG FLVYPIYTFLKKLKIPRVLIIFIIFFVLFLFSYLVFSFVYYSVTVLIDQL PYYQKQLIFIIVDILEKYKLDSAIISNIDFSKYIYPFLTRISNEIIGFAS SLVVLFLLLYFLLSEIHIFDIKVKNAFKRSVSSMFIEVLSTINNQISKYL GIKVFVSFLTGLLVFIGLKLFGQDFPRVWAVLTFVFNFIPSIGSILAVFF IMIAALVQFYPDLNLVLYIFIYNTFVQMLIGNILEPKMQGHRLDLSPFLL LCFLFFWGWLWGIVGLLIAYPFTVIIKVIVDNIVYLRPFSVFLSGSKILT LDNIDNNFNNKKN >BRE_18 uncharacterized conserved protein MNKNKLIKKIILFRILKNNISGNIYYNYKEEIEKIKNTIIKVKNVDTLEQ THIKENQPIKSVEHNTKQTNTKNLLIIYIDKKHLNKNTNAIIKKWCESIS ILNYKIINNSNTLIAEIDNQQPKAILACEEVELFLNQNLRIQIVRGFELK FKKIPIVFTHLPTSQISNPELKKEIWQDLKMIKGIVKYG >BRE_8 uncharacterized conserved protein MYLFTLCLNEVFSMCEVIDKVFSQKVLNMLNMHDLKGLDISFKNFPSESH SNILSLTDNFVKLKFRKELIENNLKKYFDDYRKFLFSSEGDFYVFTADNL IKIGLSLYPYFSFGILNGGSATSYFDLLKNSDFNNDLYFLYANKILEAKE FFGHLPKGITPAYVNADGSYGFSFLELKIRHLLLLSRQYYELYGENIKPS IFQMTSVKTYKLISDFLDGIFDNNLIKSLNYCDFCKSDILTAIQPLVYCY KELSDGHYEYFDYVNNGKKVFLALPAGHGQNFKVLRDIYMQLYNSGKKFV YIGNIDNVGFTVNLKTLAIMAITNDSAGFEFSVKTPLDTKGGILILDDDN NLNCVDIGSVISRETVLQFEYKGGKIFFNCATGLFNLEYLIKNIDRIISD MPMRVVKQTKEFGKYTSIEQITWEVIKMVDNPLIFEVNREDRFLPAKLFI NTLIMSNYMSDKFSDAFFDIAKYLNIGLNNVLQNKYNLDFKKGKWNV >BRE_459 uncharacterized conserved protein MRLIFIFSLFCLYVFSAFSQELKLILDYKDGFKFIQEAHNVNFARDNRGI LGIYLDRYKGILDYNNIDFRLEIEKDNLLKDAALNYFVDSNNAKISNSFH NISGNSLIFYSSRNTVKLKPLTRKAFFYSGNVIADFTIQFWVYRSTSVTG EVIVSWNGYKNIKGVWVDQAIRLESEGGTFVWNFNNVFLNDNGDPVKIKL KSDDDFVPKEWHLHTVRYRQKDGLLEYLIDSKPQAIEYVTFDKREGSGYL LNIGNFIDFALGQYFTGAIENFEIYKSFEEVRSAFFSRDKGYIITKPIEL SKDYSQILSIEFDSLKPKDTDIFYYYRLDNKVFYEIDKNGEIKRNLTGDW IHFDSKNGLPKFDISKYIQFKVEFYPSGNPIESPSLYSMVVTYIPESAPF PPLITKAVPGSSEILIEWFPVISSNIGGYYIYIGVSPGNYHGNAGNILKS PIDVGNQTSFKITGLENGRLYYISVASYNLDKSVNEESFSKEISVRPMEF FKQYE >BRE_516 putative hydrolase MIKAVVFDLDGTLYPERSINLIMFPEFLKNIRFFLAFKKVRKEIRILQRG KSVPSSRDELISRQVNMLANRLGFNENKCEFLLNKIYYGTSFSDKFRKIK PYSGVHDLIYSLKSNGIKLGVMSDFPIATRVSNLLNIDDSFWDILYSSED TGYLKPNKVAFLRILDELGLDNKHVLYVGNSYEYDILGANSLYMQTAYLS KKKLLKDMNCDFIFSDYKDLQRYILLNI >BRE_1090 uncharacterized conserved protein MENEQDNTEESIQIKDFNRKIRVNENDLIPIDDIVEETYAIIYKNLLIQI QEDTFYRGIEYFKQVIREIISKELLEYESHVDEMYIKTISKLIGLKNETN KITLDDVLKKIKEILIQNINQAGDNINSSKISIYNPQRQDFELIGFQTFI DKLKQIFAEITNLNNLKNQTDKILEQIKQITSITNNINTSYLKNHELESK LKSIIPEMPEYKYPNMELEFLAFHPTNKQLYRLGIEYRYLKGIPNDFQYW NIQPTHDAYYTLKEFYDKLLKIEITGEKVELRFPRNYKEQNIYLQIMLAL TRDKYPNNTMTKIIYLRFSENSNASQYNIIYSYTGKQHNTTITLLDGWYK LKSYIYNNDENQDVPHLLKS >BRE_471 uncharacterized conserved protein MIGYALFYLLPLFLLFNCTFDYEEYSNRTGAAKEAPTIQILKISYHNIVG GKKQTILEALSFNYFNYYKLYKVENGRFLYHALENRISGKFSNLEGSHVT KDLDMKDSVELKIEDMNNYYLINTNRLLWRDNEKKLFSPPNELVFIRFDE SNITGKGFSYFFKSNNFYFYSGIEGLVK >BRE_323 conserved hypothetical integral membrane protein MFSIFLHSIIFAYLALGILYTERVGLLNISIEGISFLSVFLTSLFIYWGY GIFISVIMTICISLLFGCFLSFIAINGYNIFITGIGINILCNFLVRILMR ANFNFIPGFSLNISNNIAIIFFVIFFFTFLSFSIYVINYSKVRVVFEFIR SNDYENVLGEQTSNYFKSFAIFVSVISASVAGSLLAINFNVYSYDLGLNN GWLAICILYIAFANPWLILPSSFFMVFIEYKFFNLQDYVNSYFALSLPFY MAILINVFAAFFRKTKLF >BRE_359 uncharacterized protein conserved MKQIVLDYSCLFDDDIIIDDIKIYHYLVNVRRLRVGDRLNILLGKREIRF SEILSIENHRIRFATLRVEELKMRDFEIDIFISNLKGRKLDLSLRQVVEI GVNSINIVNADNSIAKLDMDNLEPKKLRFLKIIDEALKQSGNAQIPSINF YNDFFSIPYSSSVNYYVAYSKGDFLHLGENISVFGKIGILIGPEGCFSKL EIDFFKKLNFKFVRFNTPILRADTAIVYALAHFKLLLEGNNG >BRE_662 HemN-related protein MNFLSLKELSIYIDFSKCFSHIFYEKVFRELSYYLEVLGFPKVKTLYIKY NDLRLVDVFELKSFLTSLSAKFNFFDLDEFTFELHPGNITTSVLTVLDNF FVSRISLDIKSFSSKFLEKIGIFGVSIDKVNAAIENIHQFHFDLNIDFDI NILYHNKTNLKSDLVKVISYAPEHISLSEVLIDKNNCIVDSSSDAYSDYN DIRGEDLWFYAFDFLESHGYLNYEISNFALRGYECKHNVRYWELSPYLGL GLQAVSLLFVSENNGLRAVIRKDDNFLYSVESSATFENLSDLDFFIYHFI TNLGTKRGLDISILRRRFIYHQNDFYKFIDYLLSLNKSVVLSNDILYLEQ CERFKLNFYLRLIEEYFIVNSFKVSFKFL >BRE_558 uncharacterized conserved protein MMFMGKYKKIVSMIHKIFMLISCTLLFGEQKQYITKDYMFNYSTIYIPKE DLNEDFNNQNNEEKTIYFKQNKVSKENDIHTFKKQLNKLSFKDSSQIQIA NNRQIRNNIFTKDSDFEQNNMDDDWFIQNIDNLKFRIKNYEKKITNIENL LNDTNIESIKRKNEEYAMLIKSLKEKIERIKYLINTKENLLNDPYQDSYQ AKNNDYNDYNEQRYEDNQKEYIPNESYNYPPTENTYDTYIQEKEYSNSEN TILNKLDSKINNNKDSLNNHTQILGNLDNKINNNKDSLNNHTQILGNLDS KINNNKDSLNNHTQILGNLDSKINNNKDSLNNHTQILGNLDSKINNNKDS LNNHTQILGNLDSKINNNKDSLNNHIQLLGDLDSKINNNKDSLNNHTQIL GDLDSKINNNKDSLNNHTQILGDLDSKINNNKDSLNNHTQLLGDLDSKIN NNKDSLNNPTQILGDLDSKINNNKDSLNNHTQILGDLDNKINNNKDSLNN HTQILGDLDSKINNNKDSINNNIHKLGELDSKINNNGEILLAFHQELTKF KNDHDNSFKNIENNLLSIEKIINSLKNKIEKNEELYKENKNIIQQKQDQI NILDKRLTNNENDILKLKEGLTKYVKKDSTKHKNRKSQQITQGSYPQDIQ TTNKNAIIKNAEFKIYPDTHLNNYNFKVQSNEFDFKKSNGYYIEIEPTKN LHRAKEIYKLIPKYNVKTHFINPSLKHKEKFFRNLIKVEYTNDINTLYKN LASEFRNVRIIK >BRE_850 uncharacterized conserved protein MKKYYACILNDKNEKFIFTSWEECKNKIIGQKNKIKSFKTKEEANKWLLE NGKINTCHPKGIYFDSGTGRGQGVEVRVVNEKGISIIDKVVKQNFINDYN NYYVKNFNGISNNYGELLGLYIALKIALQENTKNIFGDSKLVIDYWSKGF YNKNLNKNTIKLIQNVIKLRNIFENSGGQIVLISGNNNIADLGFHKR >BRE_305 putative lipoprotein MKRCVSVFLLLWVSCGDGAKEKSNLGLRIREVELSGGGSLEKVEVYKEFI DREEKNVLKIINSIAKKARFFILIGLELIKLGQYLPAIEYLNKNLEYGPD NHLSHFYIGVSSYNLAKGMQTQDKIEEYFTLAENSFLKSISLKDDFKEAI FALSTMYVYDLDKQLEAKGYLSKLEFMGENYFEFLMLRGANYYSLGDFNN ALLFYNKAKSKASTQEQIEGVSKIINDFK >BRE_166 DnaK suppressor MQKSNFEHEFVEKMQTLLLELKKEILNSIRSVEDSKREIINNDMHLKDIV DIAFDNMDGNNLEALSSVEKKKLNLINQALYRISHNIYGHCLACDKDIAQ ERLEAIPYAFLCISCQTKKEKKSRRSI >BRE_1034 hypothetical protein MKSSFGILSNLLMKFKQELESKRVAFFSKEERISINFKGILNDIYYPSDL DEVYEALRYDIEIILSLGRVFQMLNFKNMGDRDTRIVTNLLNGLMYVAHS IQIFFEDVLNKAKLEMLKFRDEDDLEKITKYLVQFIDAVKDLMSKFRDVI VVVASKTNEDDILNELQKVIASSDSNFNKEMRNIHYILFDIIELVDLL >BRE_569 uncharacterized conserved protein MKQKNIFILILLLLSTSAFANSTARSNFGIGILLPFPIALELNIENFDID LGIYNGANNLFQNWQTLFLAIDYIFYMHTFKELNQMLNFSIGGGGYGTIW FARWNHTHTNSGPISIGARLPLILNLAIFIKKFDVFLKVAPGLGINIWNG GAGFRWEIFAALGIRYWFT >BRE_1038 transposase IS605 OrfB MSANKAYKYRIYPDANQKKYFSKVFGCVRFLYNKMLSDKKDYYEKNKQSL ITYPSKYKEEFLFLKEVDSLALCNAQLDLNSAYSNFFREIKKGNRTQGFP KYKSKKNRQTFRTNNQKNSIRIENDYIKLPKIGFVKLALHRKIKSNELIK NVVVEKDTDDKYYISVAVECLDVKNNDKTKCNKKEIVGIDMSMRHFLVSS EDEKINYPKYLLKNERKLKKCQRKLSKKQKGSRNRAKSRLRVTKLHRKIS NQRKDFLHKLSYYFVANYKNIAIENLSIKGMQKGMFGKSVNDLGWHEFVR QLSYKSEWSKSYLHKVDRYFPSSKLCNNCGIKNTTLKLSNTRWTCSGCNI LHDRDINAALNLKAYYYKEIKTKAGTA >BRE_834 uncharacterized conserved protein MNKIIPFIITLILPFNTLLSQQLPYPNNLQPKYEIIKGSFQESNYVIVKI KNKDLKFIISKPIYDTKMNNYYFKGQTTSQFLISNKVDIAINTSPYTIKG TMFYPNGIYIYNKKLISHAKKDQGIIIIKNNQIILNPKHNEIKNSDYGFG GFFSLIKNGKYTKNFKENKHPRTIIGTDKENKHLYLITVEGRGTNNSKGI SLNEAIDLSLSYGVTNSINLDGGGSSTLVTKVDNLPYKLNTTSNLFGQER IIPCHLGIKLPNLKTSNQH >BRE_807 hypothetical protein MEKDTSQSNVFYMCKGDSIFIKLINRFTALYSVNFKTFIKNTFINNNDKI NNLYIDLSETQYLDSTFMGVFLYIDNKSNEHKKNFKIINSSKEALQNLRS LGLEKILKIENRKKKLNKSDMQEYFCFNTHKNTIFKSMLKSHILLSSLNR DNKKEFCTLIRRLKKENSN >BRE_33 uncharacterized conserved protein MLNKIFVDADSCNLEIIKFLQNFVLSRNVELILVANRKLKLKICKNTFVK VVSDVDSFILELVDKNSMVITRDILFVKSLLDCQIKVMNDEGQIFDRNNI SYLHFRAKLNVNLDIKIRKSFYKETNKIKYSNFTMNFHRLFFN >BRE_1018 hypothetical protein MKIIYKTIFVLSTFFICCCKQDKGEKPKIQDETKNFASGHTATNEETESF EETDNIPNKSHKQLLEKYNKIQALFKKPEGFQSSCIEEIEGFFNTDYKHS VNDNLYYTLNFDTTTIDNLKKIITTFGSKNDYPNPAIGESLVRNLSYLII NIMRKIDNSFNRDNRMNKLKNTKNLESLNEIAKMLDDAYIKWNMFVSLIQ KTINNAASLTNKQDVIHIFKMLNELKSYKTETCSTNNAEICKLKNKLIVL STNIENKITELITEKVQH >BRE_527 uncharacterized conserved protein MKIPKNYIPGTNPYKSLPKKPIIESTKKISKKQEQINAEIMNSQEKILKL YMRRLQKKEQMMLQTFIVEGHKVGSKIFNNLPKTLKEIITIMNIESFKIL LKNTKNPIKKLYIKFSSWTLNKLLKSIDNSSIKQDKKTSIKNTQKQKTKN K >BRE_235 uncharacterized conserved protein MFRVKILNLYSTCFSIKKIALMFNISIFLINAFVLNAQGIVTNKDAQEEF KWALNSYNNGLYDDALLSFKRVLSFDPSNLDYHFWIGNVYYRLGHVEEAL MEWRNLQSQGYKSAYLRQLISIIEQRRGISLNNEFKNIEKFVQVALLDNS IYKRPNGYQITSLKADQYGGYYAANFVGNEILHFDANNNIHVLVKDGITS IKSPYDVIELDKLLYVTLYSNDEIGIYDKTFGIKKGSIGKKGTEDGELLA PQYITVDERDYIYVSEWGNKRISKFDAKGSFVLNFGMKTVGYAGLLGPTG VTYLNGNIYVADAPRNSIEVFDTSGNHLYSISTSFEGIEGLSSDFASNSI IISSKYGVYKYSVSSKTFVKLLKADKIDSKILSSIIDVNNQMVVSDFDNA HIAIYKSDVSVYDSLNVDVRRVIRAGGSKIYVELNISNRNGLPIVGLKSE NFAVANERYYIVNPKIAYDINTSNDMNIAIVFDKSFSMKNYESEQIMSVN TLIKSRKNKKFSFINATNLPLVDNIDSLLSMIHKTNSLGVYDLNDVKTDV SLKLAGSELMSKSARRAVIYFSDGSLSHSAFSRYSVDTILSYYKNNDIRF YLILFGNSPIESKLQYLVNETGGAIIPFSSYEGVSKVYDLMMKQKTGTYL LEYDYPGPQEPNGYYNLSVEVNFNQQIGRGEFAYLIN >BRE_6008 putative lipoprotein MRIFLNFYIFFIFLFFLSCYTVLLDKFDSNDDFNFLTLRELMAYPELRIS GIDLKKYAVLNDLYNNNFEFIKGDQEGFVSISDSSYNSNIEYIKKLYLYN KKLYKIIVAYSIVQGSSFKSEILKYFDRHNIKEKFPLRINVPFYRTNIGD KSWVVIKKNFLDLLIQDKRSLFVAKRKLENMLEIFSVQ >BRE_528 uncharacterized conserved protein MNDMKRYLSLSFFYLLIGILFLFIIILIQFRNLSLNIFLLNDLKFFVNNK VEDSHYVLDNLVLNIRGIKINLSKTYPIIIPENSLKLYPISYKVQDNSIY VYFENNIFLLFVFDLNNNFQISSNLSKKFLISYEIESDYKILFDKNIIVN DSTNNYFDVSLGKHSKLKEREILISPQEVFQIGNLVAKPQIANEVVSRDI PLNMNFSAVYSLIKKISKKNFDSVLMKFRDKVYDAWSSSSNFSIKKGGWR KGNVYSFDEDIFIYYLAESLTRHNYEDIFPKLKPLISLNEDSLTYLSSSY YVDAEKIDMFFHYLSVNKTFINSLEPDKILKYLKEDAYLLEKIFLSENVS ILNESLNILRTPEVILSSGFDLTQAYNILSNYIIFLQFDNDSFILDKLRE ELIKFISTLFFVTNNGEAYVSENKKDLSWDIEYTLKIAGLLKRLASKLNS NLILEFACNAIYYSLMNSDGNSIPYENYYADIVDNDYIPKFNLFPNLGIG HWIYSSSKIVNFNFSQSFYSIEFDRDLNSPGYFFFKGVERPTLVRFRNIN WFTDIQFYIYSDGWRYYAGDKTLVLKITPKKLDDTKIFLRFDNIMGFRDI DE >BRE_769 uncharacterized conserved protein MSKCIFLFATLFFVVQFNYIYSYPEIKSFSNKDPVFYDLRKKIVKYNKRE NVPLFIYLYRVKEGDTFFRIANKLNGWQASIATINMLDSPVLKVGQEILF PSKKGLFVFNSREYRFNNLLLATRDLKKAEKVKIKRNNKIYEFYFFDSIE QPKLSFFSTTEMLFFLNSDFIFPLKKFIISSDFGFRPDPFTGVKNFHTGI DLAAPINTLVFCSAYGVVGLVGFNNVYGNFVVVEHKNNVKSLYGHLNSYV VKRGDILRTGDIIGKVGQTGRSTGPHLHFEILKRDAPINPVTILK >BRE_6004 guanine-hypoxanthine permease MSDNNETLISQIKNNSIDYKTEIIAGITTFLSMAYIIVVNPYILSHAGMP IGALVTATCLTAGFAAIFMGFYTNTPLALASGMGINAFFAFSVVKGMNIP WEIALGAVFIEGIIFIVLSLSGMREEIVNAIPGNLRCAITVGIGLFIAFI GFVNSEIIVRNESTLVGLGHIMNFKVLLTLLGIIAIFVFELKMMKGSILL SICMTTLIAWCYALFDRNAALNMGIRLPDGFLRYESIAPIFNKLSFEYVL GKNFWSFSFIVFILLFNDLFDTIGTLVGVASKGNLVDSRGKIRNANKILL VDAVATTFGALLGVSPVTTYIESSTGIAEGGKTGFTSVVTGILFILSVFF APLFVAVPTGATSAALIYVGFFMCKDIKNIDFANIREAIPSFLILFLIPL TYSIAVGIGVGIIFYVIISVLYGLITREGIKVSPVIFLLFFIFVLKLIFS H >BRE_568 uncharacterized conserved protein MKKTIFIFILINYFNSTAKDEYTKNKGYFGIGILGPFPNAIQLNLAKNIE IEFGIYNGLKNLFQNFNTLFASIEFNIFSSNSFNKPKPINTSLGIGIYGL WWISKWQKTHEIYNSTNIGIKISLSLILPILKRHFDLFLKVGPGIKIWGI GHDYPKHKWEVFAGLGIKLWVA >BRE_510 uncharacterized conserved protein MSYITFSSILAGVLGVILGFIIRIILGRFSLLNLDKKLKKVQEEAILEIE NERKRVISHAKSQMLKDKNQQDREIRERKNEVFNLEKRLLQREETLDKRI AALDKQQSRIDFKLKEFEQKEKIIREKELSLVKKIENIAGLTKDEARKIV IEKVENESKRDAQIIINKSEQEAQLLADKVAKDILVSTMQRIVTEVSSEF TVTSVELPNDEMKGRIIGKEGRNIRVLETLIGADIIIDDTPEAVVISCFD PVRKEVAKRTLERLISDGRIHPARIEEIVYSVTNEINNIILEEGERAVFD LNIHGFDKRLIRGLGRLYFRSSYGQNVLSHSKETAIIGEILAKEMKLDPV VVKRACLLHDIGKGMESISENSEGHAITGAELAQSCGESDIVVNAIAAHH NEIKPESFEAIVVQIADAISASRPGARRESLNNYITRLKRLEEIAYGFAG VQKCYAIQAGREVRIIVDNLLVNDEKATMLARDIAKKIEVEMRYPGKIKV TIIRETRVIEYAR >BRE_4025 family 115-like protein MNKVKKSFDDYIVYFNEGKLSDAQISKEMGVNRANVCKIRRRWESRESNN LEEHPKVTISEETLNNVLICASEHNAQSGSIRSQLHMSRNRLGLEFIASF NSYLDLEFKSYNNEIKVLESKIERLREGIDNEDEQDLNNNLCELDEVKRA KEFKKMELYYQAMLKLKATDFESQVKFKI >BRE_517 p-512 protein MIDFVTILVNLLTVFLILFIYRQYDRRSRALDKIKKFVDLAKDNLEDFID EKTKEINNLAVDMEAYQRSSIEIIKKIDEVQQKIKNKSDDFAEVEKKIAY HDSMLKDLDDMALKVQDNIQRLQVDGKVVDKLAKTLKNFNTQIDSVDSKL NTIFEKFAKTNKENLESIKIESWEKFDNTIRDFSVRMDNLDKNLMSYQES LLMVEEKKRDLLDKGNEKLENEFKDFLLKIESNIDNYNRGMEKSFDIYES KSKSIENSLDLIVEQAKIKINDKEDFILTKLNEELQRKFNEVFIYVDDRS NRIKNELEGKLVLVDNEVLSLSSVFKDNTYSRLNSLEETIRQEMRQYEEQ FADILEQFRVQIESNVGDIYREYDSKINQFDKEIRERIDYSLEDANSKIE SVQSGVKSLLDDLEDGSNNIYLEFKKKVKGDIDSFNEDVFSRMNNIGNDL DLKLLNINTNIQDEVSKLDNVLYLKLKELNEKFVNEYSDLYENVNSKYVM LLESLNLKSNELEIQLGSKYKGIADKFERSINDFTVECDERFSNIAEKSD YDYQNFETISKRVNEGINSLNVLLEQNFETLKRNFESKLHGINSDIDNEV LNLKNHYGEEIGNFVRAMEANKLQYENWQKEVELNLKEVKSNLNSANEEF LNLIETQRIKGTELSENIFNELSEHIHKKAMDMHTNWKDELIILNKSLLD IKISSEELLSSTSSKIDSFEKDVNERLEYVVSKTETFEGSVLDRYRELKD MSSKNSEEVLLGIKEFIDNQAEIIHDKVIMMLNGFNDDFSNREEVIKNKI EELNYSLKDFKIECEDVLNNLRSDLDAFIETRVQKISAIKMDNQKQIDDF LTQISEDILSKKDMLDNEIDSKLNTWQDKLGEISVNIENVLSSGKMDINS IDSEMALKINDLKTTFKGLESYYLEKIDEFRNQGNVYADELLQNIMSHFD TNTKELEESLSKKFAIVLDKSEEFVKEVDSLLKDKRTDIASFQANIDITI DSLNSRFNDLNREINEKYSKVISDSREYSETLANKLENEIGYEIENVNRR LTDKIDVLSKNMDENIEKFKESFDISRYQVENFEIRIKDIVEKEEVRIGE LLREIEYQYKMRREEAIDYRKVMDNDVIQLKERFIGVINELKNNIEDKSE FLNELYKERFKIVENNFDERYSTFFVESEGAISRIRDEIYKILTDNDDRL RAKIAEMDRNFEIVDARSKEILEFEEGLRKKIEENNNSIYEQFDIVKFDI EKEMKIQFNAYMMKVTSAINDEIEKYEYGINKKIDVLKSIENNCEIIEQN LKEKMEKYNNDCDKVFDLKYAELEDKYNEKHSLIERKIDDKTNVVEELIS NKYAELEGKYNEKHSLIERKIDDKTNVVEELISNKYAELEDKYNEKYSLI ERKIDDKTNVVEELISNKYVELEDKYNKKHSLIERKIDDKTDVVEELMSN KYAELEDKYNEKYSLIERKIDDKTNVVEELISNKYTELEDKYNEKHSLIE RKIDDKTNVVEELISNKYVEIDNKYSSMHFDVENKLNTFISELNLKLANS SEKMDRDIKEQLDNLTKLKLNLSNIEGDVLKLKEDSYHNVSSHLKLLEED FFRDLKERGDNLRSSLENFVTSSDQRIENLEREIIKNLEDKENLIKDFRR EIEQKFILNKENFYLEFSKEFDVKKRDIESKIVLMETNFTNRVDEFIGFI DNRQSNVDSWFVKVKDDMLNWQKNAYKEFEERSGITKESLNQIKNDIDII ENDLAIVKSNVTQQTKETFENLHTDIKDFEDRTYFNLKNISNEVQGKVLN IENNMNFKISSINEKINLSTEELATQIEIKFLSQQKDLEDKIFEINEKLK YEYDLVTSKIEREKQSVVDNFLNGKDSFESQIKLIQNDVSKLSEQVNTYR SDIEGTIKESYDSFSSIMKEEYSVFENEIKDNLNYSEEEIRTLKNNLQIQ VSNIETEFKDRYNLITKSVDENISELKLKALNYDNEFNNFVSEIKNNLIA YKTNLMKELDDRYNVINTKIENFERLEAELEKNYELIKEVYHFKNKLEDL RKTLIDEIDLVKKYKGDFESVTREIEDVKIRTSDIIEVFNDLKTHQMDIK GIKKDFVEFLDFYSSFKERYKKFTESYDEIQIYKTKLKEIKDDQNTILDN YDRIGNKDTILKSTLESVDRNFDLISEIESKMNVLFKESSGLTHNIGELK DIVSELLANKDLSQEALNNVQNLKEMLLEIEDKLGYIQNVREKVAKSETR LENLNVAAEERIKTLGILVKTESKYKDNIGLNNATVRDSVIKLMRQGWSA LEISRATKLSVGEVELILELGIVSKSDD >BRE_1074 putative lipoprotein MQKWLKSIIILCSLISCNTQGNKPTNITNFNSMKLNIKDKIKTENFHIDA SEALIFLINILTENTVANNIKIYTDEKINAFIMYFTPQQIDEMVTNIIKV IEIKKNIKDNIKILNNDDNHMPTHLKMSLINQLNEKLEKEINNYKLAIKI AANHESFDVAKINIQNISITKIIEIQDESKRAVDLKNEITMITNAQIIEN NLDPSERNALQFIKKTLQDTTINTNNTIYTNNKIYKFINYLREQQIKEMV ANTLKALEEIENAKANIKMIVYMSQQNHSYELFHKLEKEINNYKIAIKIA ADHKSFDVTKINIQNIPITNITKIKDEAKRAVDVQNTIIAHLPGPDLQYE DTIFYLKEIFPEGNSYTYDTFNKFILNIHLDKAKYLLTHFTKEFTMINNT VKIVNRIKNTSHKSKLNFVIQQALKDLQQSMRTAFGNGTPPLDTIKQNFQ NVNFHKFEEIKTKVLQIYREENSQIKK >BRE_404 uncharacterized conserved protein MGKNTKKILTLLLIFNLYNLAFSQYDSMYFIECKQKKDGTICTTNDKPIV PEQPKIEPEQPEIEPEQPEIEPEQPEIKPEQPEIKPEQPEIKPEQPEIKP EQPEIKPEQPKPNNTANNNKKYKNAYSFAAGTGTGSPLINLLISVPYVDI DFGYGSFLYFNTINFKPYNLIAIDLIFRQLIGKSLIIGGGFGIGVDWSQA NLTSPSSQKPSPYDRIAIVTRLPLSIEYKIIKNLSLGFKIYPTLGPTIFL TEPKIVFEGMRFKFFAIGFIKMFI >BRE_709 acyl carrier protein MNEECLFMDQNEIFKKVRSIISEQLDKKEDEITMESRFVEDLGADSLDIY ELLYLLEEAFDDKIPENEASEFETIGDVVAFIEKKKG >BRE_267 uncharacterized conserved protein MELLKGFLGIRLSSNEYFSVLSLDDTSVKKMVLGKLADETNIKLDFYVSK YENFSNPIIIGSFFLDNLDKDSLNVNIYFKIDSMMLYVYGECDGITNKTK FDLSLMSLSVNTNEVNGDSLNSDKMDDLPIDFQDTNRKESFDSIVEEKQD DSLDFDLSNVNDLSNSKDLLLNKENDLDLVVDSLNLTNDMDEHALLSEGS KELDSESNVDLENLDFAPTKDKLEDNPIEETEVAHVLDDIDQYSVNQGIS TLDKVSIDVNERNDVFDNSENDVKSVKDKDDNSSSFNVYVIQNSYSDDLS VEDIIADVSKNLDDVEFDDVSLDLGKDNFTVDVEEPKFDPDLKEDRIQTS MLYLSLVSLFLLIFFSLFLIFSKILNPKNFTISYCSFYKEEKITRCEKSN V >BRE_6 uncharacterized conserved protein MLHFLIHTMTKLKLISYLILITYSHAWCYTRTNNQFTNIKPLQIGIIQHN YINLTPYNQKHKYRSFLGITIIYNDWIDFNIIPIHFYPHSANLLSNSYFN FSISLYILKYKIQIYPFIINILIGPQLPITLRTDIITGNNISAFLFPALP FLSIKLNIPINNVFSITSTFSSSLSEYFLVDAAIIFAI >BRE_189 hypothetical protein MNVFLIVSLPLVLKIYMQIKHPQLKLIKQTYTYAMSILLAATIFSSLYLI EEFILYKNLLINYQTKFDLIYSIFIKEQIYYYIFPLFIFTFFFTLNPNSL LRNNPIFLIYFAFGLVFSKNISLLITNSKVFGTYEYIKIPLIHMLELIFT AIICEKGIRLHLTQNINGYQAIFIPILTLEIIITLLKVFILINQQIYSLA ISLILLGITILNKKAIGSIK >BRE_183 uncharacterized conserved protein MIVGFWNLIMNTLAIEYSYKNLLIYFQINEEILFFIMKKNEVNNVFNVPK LFNDFILDKNIDLGNLDLLINSSGPGSFTGLRISLSFIKGLSLGLSIPFV NIPTFDVCVRLFHTESDILVLSFTAGRYFLGHYRDFKLCGNIVCFSEIDL LKYLNELDCKFVIVGNDIDFIYEKFKSRFRVIDDMCAFGAVLTDLGKAKY LNSRQGDDILSGPCYVRPSDAEINFYLLK >BRE_537 hypothetical protein MKRILMMLIFLTRLYAINETNNQKKCIIINNNKKIVYCHNEKIDHLILNL KNNKNANIKINTQYKSHSYNIPTIINQDQTMILEIKINNIKSINFNNIEI QKSSIQTTKTDLQKFKIFIDKDGYSINFNLNKNMFPIIGFKSKETILNPI ITNLYSKKESQKIVLSNLIKYTSLENHNDEIKSTKNDNMIQINEIGYINM NDYYEINKPINADLKLIFNYTKKNYRRDSFEFFNFIANPNVYIIKFKTLH DQALMLKRMAFFLEKKEFRGRLLSNTELENKVGWGGHDYRLQDIITFFNE AQKSNIKLNKEEITLKNLIIANKLAYIENNIIKIKNKSKNITFATYSEDE IMSKTDQMRIFMHEMLHMYFFIDNNFNKEIVNFWNKNISPNNKKSWINFL DNIGYDVTFNYLVMNEFYAYTTALPKENIANYLINTNYFSKTEFKEYEQW AIKLEKLLWQTKGLIPGELLILFKDNNN >BRE_749 uncharacterized conserved protein MFVILKVNFCILFFFSAYFSLFADINLYFQKALTGQVLGNPILDERRDTI TVLTKDRWLVTYTMSFGKKYSYRLDRTPYPFLLKDFGNGYYVITGRNEVQ KIRRGKLIWKYNLGVSPIKAPSIGNGYILVPTADGRVIALRLGDGHKVFE VDIEGKALTSSVVLENGNFYIVNENDEMFAFNVDGGQIWNISLMSSPSTL MISTDNKIIVGLQSGEIVIYDSDFGDVLNSVSLNYPINFLFEKFNGEYVA VSDIGVFFNLSKNLEIMFFNNLSLNLKEAVLYNNKNLCLVMKSNGVLVLD EYFRPVDRYDDMKEISGLVANVGFIVTGGFNWILTTYYYEYKDMLDIIVW NHTLGNRYHQNRIDFREKYLIEHEDVYLTLDEMLNSAYDKVTYRKFLSML DSILKKYGSFPKRYLNLYKKAIDNWLAPKDGIDRIFQRGQLYKYFMYVDD MSAIKGFVNVAIHEKDISNVIQLIKNIAKFEYYHDQDELVYNYIQYIILN YQGNLEIAYAVLLSLRKIIVNSSEENLQKYRSKYLTLLKFIKRQNFSEKI NGFANEIIAIL >BRE_3009 immunogenic protein P35 MKFKTRYLSLGLLFSFISCDLIFDDKIKEKSLILFDKVNAVLDTSGQSVE NVRSPKQKRKIVKKRLSTSGKKSANSNLAQDVLSDDITSGLQYDVKRDNA HMQKGLVLKDSLEKNDVFLNEKDLNVILSNTTSEFSKEDIQKQKYQDIES KNSITEISTGYNLDSHSRVVNGVLTSLNGESGELKETIESNAIEVNFTID SDLGPKHISGSNTIAYTDIVEEEDYDQYYWEDDEDSWEDKELLKEEVRLD NRYKSYLESVRYNVDSAIDTIDKIYNNYILFSTKQTQMYSTRLNSVTKAK AKEEAKYFIKEKLERDLKTLLNYIQVSAKTATNFVYIKEIHAKQKLDKLE IEMKSLISKVQGQSNSYEAYKAIVSSILQMKDSLKIVQSSTDKNGPWY >BRE_253 conserved hypothetical integral membrane protein MDLATLGIKHKVFILTTFTLITIILGFFLKDIKFDSNILKLIPKNAQIEQ TLDIDKSSSLLSTIVMFKDKKNIFNKETFRKINEVANDIVNILKVTPNSV TSIFTYFPQLKKDVYTDEDIINIKNKINATPFIKKLFLNDDETLIYFIII STTDTKTNFSQSLKNELEAMEDTIKRHETDTLKLYLTGDLVVREKILNYM ADDFKLLGPFAAIVVIVSLYLIVKNILGAIIPVLIAICALIWTFGIKSLF MSPITVPETTMIVLLISIGCANAVHIINGVLKQINKNKPLTEIAIITTIK TLKTPIILTSLTTAFGFLSLITSSIQAYRTMGIFMSLGVIIAMFMSLLVL PGILVKTPFKHNNKKNTHTFLEKLSLINQIITKWILNNKYISFIITVIIL LSSIIGLFKIEINFDEKDYFKENTSVKQTLNLMQKEIGGTSVIKIEINGT PGEFKNEQKMKNLDLITDNIDKFSYKTQSNSINGIIRLMNFKFKKENPKE YRLPENQAVLNKLILLISRSNSIKNMTNMYINNDWSQISIIIRTDQNSTE EIKQFADYASNVIDKYMPGHEYHFSGAYDKIPISQTMVREQITNIITTLS AIAILLIIFFKSIKTGIIIAIPVAWSVFLNFAVMKLFGITLNPATATIAS VSMGIGVDYSIHFFNAFILNYQVTKDYKNALLESIPNVFNGIFANSISVG IGFLTLIFSTYKIIATLGAIIAFTMLTTSIASLTLLPLLIYIFKPTVKTI STIKV >BRE_706 uncharacterized conserved protein MKELILRMDRSKSSGNDLERGSKFPYWKIRKARSELKKQSSSVLSNGANN NKSVGVNSNGHKNYKGNRQKGLGKYQRSCIKFKKICPICEKQIKDILSCM SMKFDGEDKPIHFDCAIDRLKSESQFLKNESLVYKGVGKFFVVDRSVRGN NLSFKIVKEINFENLESRPDWRQKILNDMNKVFKLY >BRE_455 uncharacterized conserved protein MLIFYFLIVIRVLFFCYFCTILHLLMDKQLKISNVLKRVFILPDYVHEIF QMIIDYGLRIVVALFAWCILRFIVKRLGTIFLKAYERSKLETKLDSTVLN FFKSFFKVVINLVLILMILPYLGVSTASIFAVFGSLGLAVGFAAQGMLSN FVSGFVILNSNFFKIGDYVNCDDAEGEVTDIQIFFTTLKTVDGKIIKIPN SKFTSTLVVNFSANFERRIAFTFQVPYGINFALLKTEMENLAFSFNRETY NVRQPSLILKEYTPYYIIVEIRCFIRTEFFWDFQYFMGEKIKDVLIDMGV EFPIHVVNLSKLC >BRE_181 uncharacterized conserved protein MKNKFSIKVKFPEGILGFEDIKEFIIKDSAHKPFSIMQSINGEINFLVTS PFNFLEKYLPNIENKDWLDIQAENENEKVILCIINMHVKNYKEITANLKA PIILNKKKLIGKQAISTNEEHYLRYRVFKE >BRE_160 uncharacterized conserved protein MAKISKNAQRSGSKELLSRWGGKIIMKSKFENGKIKHYAECQNSKNTARR PKDLF >BRE_85 uncharacterized conserved protein MKEIIYRFEKAEDYKLVPINNIYGSVTNTGEIFCDLVFESTEIPEEIVYT KTKEGVLEEISGDLRGSKEKVILINSFVGISITKDTAKNIAYWLLKKVDE LEDNE >BRE_1003 hypothetical protein MKNMMIKILVLLLMGLFGSCHLKGLVDISTEEDGEDIKFKIRFKESNEFD QNSNNNNEELTNLLVNKFGLSAQQIKAIQHLRRIVVDFDKEDKYTNNEFY QFIDCLKGLELKDLADNILYIMNEIKEVIKFIGAVKNDKKKQELFLEFKQ IEDDYMSIIRDSYSRPVINRAEIIKIYNLIQKNKFETFKYQRIRAVDFAS TRENKELIRYIKEIIDNTQPSEETAQINKDRHYTRLIFKIIESVYLNEDF LTSFSKKISELRKIIDSVMLVIDNEQDTNKKQEIETQFNNAKEQYESDVV NIYMNFDHMKDRPEWSQFLGLQERILLHKNAFNNIITSS >BRE_6019 uncharacterized conserved protein MLYSFKNLKQTTMLLISLFLACSSIDIEHDTINKKVRIYQYLNKNLELKG VIDYQNNTTQIFLHTKLKNHSIIKQTPLILPDTTKIEGKTSYEYDNKSSS GKWVNASSFILNKPILEKLLNEDEYVYNKEDVKIQVGLETLKMNKAKIKN FLIKLNITEKQYIKNKHTEKQNIKKYKEL >BRE_313 S-adenosyl-methyltransferase MGDIFHIPVLLEDVINLVETIYLDDGFVFVDCTLGEGGHSKAVLSKYQNI NVIGIERDDVVLNRAKESLVEFSKRISYSNTWFDDFFCKYSLHRRFNFIL ADLGISMFHYKVAGRGFSFLEDEKLDMRLFPSDGGISAYDIVNTFDKEML ENLIYELGGEYYSRRIVKAILEYRKINKIQTSRELQRIICKAYPNVKFKI NPATKTFQALRIYVNDELDRLKRSLPLWIANLSKNGILAIITFHSLEDKI VKEFFKGLTKDKYCILTKKPITSSFKEKQYNNASRSAKLRAVKKLYE >BRE_728 uncharacterized conserved protein MASMRSNLLLIFICLFSNFYSYADVKQMLTEVKPLSISSKNGKGSIYLKV DKSSDYILTFDVALGTDFVYMVYDVFNKKNITDKIRKNDVKLTLQKDVLY AVIYVTSENVNINFTLNDLDLSIIGGSSLKAKTSNIKKQNKTFLLRDLPS FKLSSRLKKYILKTYKRNIYVAYQMENNDTIKVASFIENIGWFDISTAVN DNITDISCFDFAINSKGELYIVFTTKSTSDFPSELIVRKFNSRKWIDVSP KLRDNVGFLVNISVDHKDNLYVAYLKKIGYEYKVNFIVNRGYGTTWNSII DSNVFKGTADVDVLSIGVISEPFLGIFYNYKLNDYMNSEFIIDKGKTWSN VNIQSVNMANSVKILSDVKSDQIILSYVTKDRPIVSISTLQCDKWQNVSP NIKIKGVVSDILKYSNDLLLTFEDDNNVRLIYLNSNNWYFLNEYEIFQKS ACKPQFAQYQKKGFVLSCLSLDFKVLFLKLIR >BRE_74 uncharacterized conserved protein MNLLKFFYILLIPLLSCNIAQFGDYKPIYLQGEKDLKIANDYINSLGYKT ISEYTTKVHILDFPNFKEITIDKLIHLNDHDLRKDLFLKKLPNLFNTGSK KILYVESSFTNNDLKKLKKDQNIKAEMHSSNYKTKIKYFSITTFIIIIIL LLSLNIKYAPFIILFLISSCIIFIFSNEISYFYPLTILAYLLFILIDNFS KNYNKIYLKDIGFTVLIKKIKTPIFLFLFIVLYFTLSINFLSTNLEALLI ICVSISTLCIFLIFTWIKTENNFKHTFLSLIKIKEQKRETKILKYKILIH VMLFIVSIMPFFYAQSILNSYNNCNYLYSKKLNYFDYLNPNNIYLMVGHN EEIPNIVGYMYHIFYQNELKYKITSQYGKVNTNVKEDYFQIENNKITINS KIIYKVDKEFISKNLNNELSRLFLENGNPILIYKETPVNITINKKNEQTL FTLSLPFFLLLFLFKAIRFTILLNMSEKNYRKYIRGSS >BRE_3008 uncharacterized conserved protein MNFVYSRVVLIFCIICFASCGLLKTKNKSRLLQDLKNIDLKSDWKDNLKL NNDELGILTFFIDALKDELPKTRASAAHFNIYLKGDLSKVEEYVKRFFLK LHDKGKVKELLGYIKYGRDNSPNVEGRDEDLGMDAKEHYRIEVRLASVFD KYFMFLNPPSSGPSAAPSAKVPFVGRDPENEVFNEIKRVCYEYRGSH >BRE_169 uncharacterized conserved protein MGRYFLIYLLISFICAFCLSCSNVKAMSLMAIGNYRYIRGDYQSAISTYY NLVDDNKSAAWGYYNLGIVYYSLGEYESSLRMFSYARRDDDFFLNFNISY NEGIIYYNQGLYRKAEVAFKEALKINPASYNAKYNLELAIIKKRTMPGNL NNLSISKSQNFIENNENFLRYIENLERVLWVMRADEQIVSLQEDW >BRE_72 aminopeptidase II MKKDLIKYAELIILKGINLQKNQCVLITGSIENYEFLRILAQKAYEYGAK YVELSIEDTEILKSRLQSTPENLIEFIPDFKHKFFEEMINEKWAKIRIDN TENLDALKEYDNKKISKYFQALKLASKNISSAMMNNELAWCTICAPGPKW ASKVLNKPESQKTLEEFFKIQKKIMLLDTEDPIKAWEIHGNKLHQRCKTL NNLQLEKLIFKNKKTNLEIYLLEHSIWTGGSEKISGTEIEFNANMPTQEV FTTPNYKKTNGIMYATRPVKILGNLITGIWMEFQEGKIINFGCDNDTLND ILKRHIETDVQAQYIGEVALVDNSSPIYKSGLTFYNTLYDENASCHIALG SAYPSCLSNGSELKTDIAKLDYGCNVSLIHTDFMIGSNDINVIGIAKSGK EHIIIQNGQFLI >BRE_50 uncharacterized conserved protein MEDLMGERGEVYSDKLFTNSDRTYFFNVKENRKGDYFLNIVESKRNVNGD FERHSVFVYEENIDEFESNLLKAISVIKKKVTGNLVKKGEYHNDRRS >BRE_339 P26 MCSLFVKELFGEFYNSIMGKTLRWLFCSIFFFCNVINVLATSYIIENFDL SLNEFLEVSTRENNLSPIVDSKRVIMFYPPNKGIRKIFAAFEFDDYAKKY LFKKNKYGLFFVKINLPHGIGKIKYRLIVDGIWTNDEYNKNVVFNKDLIP FSIIDIGVDYGYVSLRNPIDSSDGREVELFYIGQPGHIVTIAGNFNNFNP FLNRLVEQESRKGVYTIKLKDLPKGRIYYYFVDSGNKVIDKNNVNRVNLY SVENVENKVDFEVSYFDN >BRE_168 uncharacterized conserved protein MGNAGRRANCFFARRLVIFLILFLVHLKIYSLSGTDYLISSKIVKGSKII HIIRLNLSQDIDKKLLKFDINKDINENAKIALISRVIDGNNFIIEIKIEY VFDKLGFVKIPPLKVIYNDDVYLTSEFEVVILREDEFRSLGLPVGLYWDF NKKEIYEYQSVGFVLRSNWLLNNNVKSVASFFNAVKDAMIDRTPIFENIN YRTFHSKEILDVPLYNFILTPLRGSKVVVIPSVSFNISEDIMRMSPEISL KIKSIPEEVKSLAVGVFKIDYDFPNATSITQDAFTILIKITGQGNLPHIR FPEIETYNSRIIYNKKNYNFEPSKDGYKGSISNVYTIKPDNKGNLFVNIG DFVYLDPDDDKVYRLNGKRLKYEYYGEFKKNNSNQELLLDFNLLSYYDIL KYKNKTFLFFVPIYYLILIPGILFSLAMFIKHKKFFIASGCGLIVLILTL AVSLNAINDGFLSEDNINDLINDYRSSNYSDALNKIDNIIKRNSSYSGLW LNRALILSKMDRSFDAIYSAYKAFFTSPNNDIFYKIIDFIETKNGINENI RNNSFVFSNIFFIISLILITILIVVVSYRFYAKNLKRIILFLLLSMTCFT LFQTYYFYLEQQSEIGIIRGDLVSLYKVPDNFSRSWKFLKGNISVYLLDK KDDFVLIQTSHGLKGWIHKNFIVSVKDDLI >BRE_137 uncharacterized conserved protein METAPKKLINKSINYYNSHKYADVIKLIEKEIFFYKDYYIYHYILGMSYL RMGNLGNAQIYLKKAYTLNPTEPDVKQSIAILLAAQGKEDKAIQIWLKMI EDNQDIKRSELSLEIIRKHPIQGTLFLTKNKIYDKLFPKIKIEKGENFYK LTKIILSIVSISFLLIAIFSFTNFKENIKLIINNSQTNIKKTINNVATYI DDIKINDKEKIKNYEGQFVFILTETEIKNSFQKIKSHLKNGKDNFARIEI NKILNSNASESIKLKAKNLASFISNPDFITFDDFLILKEIKKNPLIYSDV YVKWEGIINNIEKKNNITYFDFYVGYNKDILEGIITTKINFDIEINFKDC VEILGQIKYEYNTNTLLLNAITIRKIKKEKE >BRE_589 conserved hypothetical integral membrane protein MHSLIKSKKSSVYRDVFNIAIPTVIEFFLFNIVAFTDNIMVFYLGDYPVV GVSLANKLFELFSTIAFAIMGAYNILATRQYSQGDIDSFKNTFFISIAIL LFFPFLFILVSLFYSYFLLGLLSDDLIAVSYGVSYLNIAVYSFIFAVVKG IIANSLKVVKVTKIQIVTSIISVIVNIVFNYMFIFVLNMGVIGAAIATTL VRLLELIFYLFYTVFNVNSHFYLKFENLKINPVIFSELIKVFVPIFLNDF IWYIGYFVLSAIFSRIDTAKYAAYSITFSTYFIGFNIVHAFCFAVNIVMG HEMNNDKDEIMSVAIYLGKIGLALAALTSIIMFTLSFIAPYVFYKLEYAS LTGVMLRYYSISVFFTSLAFQYLFGFFRAGASPNFGAVMEGAVTLIYTIP IAYFLANYTQTPFELVVFIPTLEDVIKFGISLPYFYSTKWIKSIRTG >BRE_6006 putative lipoprotein MRYSFFLFVLFFFSCKTLSVHEILDKKFDKIERASYFLYFYPNSQIYIKR DKLTNNFSVFLNIVLNLDLKSDFNSDYLKLIQDGNYIGNVSISKVVSIGR FRFLYVNIDRGNSDLILRALNPHKSLSFVLDEYSYQVWTRETLEYDAKFI DVDFESSRNTLKYVLDNNIL >BRE_5009 uncharacterized conserved protein MEDNLFQRRLAMHTSQKIQNYTQLSKKYQIRYYKIVSIIRYFQKNTIKYN QTIILNTLNRFLTKDELKIITLRTLRKDLALLCNKGIIQKTLLRLGEGNG SYIRYTVNKYSQNNLKRFIENKQDIIEHDANAIYKFTKETQKKYFKNIGY KTYKSKNVTKNVSHNIINNKDINIKDTKDINLLISNTSKWKTMRYLDKIE ENKNKKRYEEAIIKTKKWLESERNK >BRE_13 uncharacterized conserved protein MLMIDINNINQIKDIISRILDISLISILVYYIYKNVINSYSVNLLKGMII ITSIGIISYYFNLYTINWLLTYIANILPIAMLILFHQEIKKIIMQIGNFN LSFKLVNNKEETIKTITEIIKAIKHLSENKSGSLICIEKKIQLEQIINKG IKLDSIVSNEILISIFDYETPLHDGAVIISNNKIVYAGSFLPLSNVESIS KTFGTRHRAGLGISENSDAITIITSEETGSISLTRNGKLEYNLSLNEVKK KLNIALIE >BRE_856 putative permease MKKDKIDYKREIIAGITTFLSMGYIIIVNPLILSNAGMPIGALVTSTCIT AGLATIMMGVVTNTPLALASGMGTNAFFAFSLVKGMNIPWEVALAAVFIE GIIFIILSLSKIRENIINAISMNLKYSISVGIGFFIAFIGLVNSNIIVKN EATLIGIGNFMDLQVLITLLGFVLICVFVKEAIPSFLILLLIPLTYNISS GIGIGITFYVIMSLLYNFFRKEYVSVSPIIIVLSCVFVLKLLLSI >BRE_759 uncharacterized conserved protein MKNKHQEILNLTLNLIIILLIFCNISIFTFKIDLTKNKAFTISQVTKDLF SNANEKIYITYYNSASLGNYFAFPEQIKNFLTSFSDASRGKVIYKDIDAD KIATPLEQIGIPSQQIDLREINQLSILKIYSGIEITYEGKREVLPIVTEI SNLEYDLASSLDKLINNTQKILGLVFGDANLKATHKNFIEIMQKVFKTEV KEINIENEQLQDINGLFIIGSKDINENTLKKIDEFIVNNGRILITTSKID YNPQNPYTTTSTQSPIFNLIESYGIKYNENIILDKRSPSLFLGGNFQTYY PWILINKNNIIDSNNPLLKNFYDAIIPWSNSLNLIETKENNDDIKYLPLF TSSKESWQVNNEEVANIAMYSFNIPKTFDKENQQILGYSVEGKIKSLYKD IKSANSKIVLLGSNMIFSDYMYNGSPSNFEFAGRISDYLMQKEAFFNIKS REVRSKLKFINSSKEMLNAKFSLIVITLVILPIAIIIFGLIRFTKKRKIN >BRE_331 uncharacterized conserved protein MPDIEKINKFKKEIIDNIADEKARKDSFGIKMDIDPPKDGESILPWEEQE EVVDFDEEHDEGPDLDAILGVLDNEEGQKSEASENDINLLKNSENVEIDS EFDNLNEDFDVLGSHFEETLDKVLDDNSVSLDDAINLNLDNSGNNVDDDD NVQNSNVENSLNSNSSDFENPFENDDSSTQESQDYNNDDFDLEYMISKIK EADDEISSNKFDSSDDSLDPNTKEEKDWSNLTGDFQSLKDQENKIFEDSD FKVNYSLFFKHLDSYPRNLRIAIAEALMLENVSKYKIEALVDLVEQNKKG LNFIAKFVGDIIGRSVKLPIMYYKAEEFSKLEKQFSYRLSKALTPILKIA SFFIVLTFLSFYFLVDIMFFYIASDKKYKEGISYIYENKRELAKATFKDA YYMRPNRKWFLTYAKAFESIKDFDSAEEKYEELFTVDPFSEGASKRRRKI FDKDGYISYAFMKMRLGEYSDANSILDEVISYDIYDYEALMAKGENYFQW AQVDPMYYRNSINDYTILLSKYGYHKKEVLFKLFDAYIEAGAEREADNVN AFIKTNQELDIDEVVYTKYVKKLIDKYVEFTVYNKRINALSRNLKYLNAQ MNLLNKEFSNFKINSGKSVSDILNDVNLNSEIEYILRRILLKNPDYNKAL FESGRYFYYMGDLKKSEGYLLTAINGFRQEDSINNASEKIIAYRILSDIY EKGNDTLKASNIVSLALNEYDFYKRNGLIKGSRELALIYEKQGDIFKTLN GFQSAISSYKMAINEGVNSPDVYYKLALLSYKENNYKDALTSLFKVENMS GFANSNKVLNSIASVLYKMGDFEASRSYYLRVLQNLESEKSSIVSLRPKG NDHHKALLLREIEVYNNLGVVEIIASLGNKIKSGVIIDHDLFDSGIANLT ESSRIFDLLNRDEDMMKNVKRDLASLNLRSVFKNDFTGLKILFYDNLADN L >BRE_1023 hypothetical protein MMKIICLIFFILSCLMIIGCSFDGQLSSGESYPYLRYAKSKSNKGGTAAL SSFGIDIILQKQGQGNKGSLAYSELLQSINNIKKTLKFDCMEFDEAQFDD MFQICSSYGYKIGYDVKVKREIYASLNYDVDSLGNLKTIIKSLVNSGEKK GCDLVVNLLRYLSISTQYISDIVDEKGVILNVANLNILKRRDNVASLRDL KSKLDSVLLQHNVLVSKLSAILERSMGIYSDLADPQSKARAISVYLSSMI SRDSDIYNRIFNPFDAPVGANKLSLQSLNFAIIKKVEELTK >BRE_787 uncharacterized conserved protein MINVLIRTHNDIIIYILANGHAKSNGYISVVCSSFSFILRTFFSILDYER EGFIVDNSLKGYLEFRASFGTLNKESLFYHSKFLIHGIKDLCFEYPYDIK LILEETNGNK >BRE_758 uncharacterized conserved protein MDLLDLQKNEKSTNEGELMNNKYTLLGIKENIKIVIIIILISTFLLGIIF SKQNQVTRLLEEKLFTIDFKKTAKIETALEGTIIKAGTGWELKYNDIKLP IDEQRVNSMIQNLEKLQKNKLVSRNPKKHKELGINENPAFKFYDEQNNLL TEIFIGNPGEGDSRLSYIKGSDENVYLTNNIFLSYKGNSYNTFADTKLFN ENNSKIESLSFKIANKSKKSEENSIQNDYQVYIKDGLYFINQKVLKQEKL LQIIQEFTTDGLEIDQSKINNYNLQYNIEIQWDNKSISNIDVYINKDEKN KDILMKRDNDIYYYITNRWSFFDVFNLEKKIEQKDKESTEDHLEHNDHN >BRE_597 long-chain-fatty-acid CoA ligase MLDTVPKRFNEIIGLYGDLDIFIYKENDSRDFKRQIYSDFWKEVKSVGSG LLHYGMRKGDKVALISDSRREWIIIDIAVMSLGCIDVPRGNDSSEDELTY IINHSESSFIFVENAKQLQKIISKKHDLKFVKYVVVIDDDKLYEDKLGNI TIISYRQLLSLGHDYLKDYPKMFDLELEKVSGKDVATIIYTSGTTGFPKG VVLRHESFIFQLDRINDYLPSLEPGQIMISILPLWHSFERTCEYIVALNG LSIAYSKPVGPILLKDFAALNPHAIISVPRIWEGIRAGIIKKVSESFLKK ILFNFFLNVGIFYVKFMEKFLGLVPIYRKSNFLISFFMKIIYLIGLILIF PFKFLGHILVFKKIKKALGKRFIFGISGGGALVDYVDYFFKAVGIVVLEG YGLTETGPVLSVRRLKSPVANTVGPLFPDIEYKVVDHNGNVLPPGEKGEL WVKSPQVMSGYFKDETMTREVLTRDGWFKTGDLVCATINDEISIVGRSKD TIVLRGGENIEPEPIERALSKSVFIENVVVVGQDQKFLGAIIVPNFEVLE KWAISSGIAFSSHDDLLSNELVNKFYSKCILDIVNPKSGFKSFERIVGFV LLKDAFVIGDELTNTLKLKRYYILEKYNKKIMSIFNKDDCELL >BRE_6009 uncharacterized conserved protein MSYHTLSNISIYVGYIIIGITSFTIFNTNLRIKIKNKMKKLSFLYYMTLF IFFIIATNLSHYFSEKQLLEDFQKFKKDFFEIHQINETFLKKYILPLKEP IKMELMSKLNPINTIFNASIEKYSQKINKTPTDIKKNYDAYIKATNTEIK SKISQLEREILPMYNKYKLPCSNNQISNISVDKDGNIIPILRNSEGKITN LLFYDQTYNLTLFKVYNNHKVKFEITKNDNNYFKELINVYYIDSHNTKRN IDYYKNNIDTIPYYIDLTENQDNFLKSIKIKNEYKEYIKEKNKLKILINN DKLNDFKTFLKQNPNTFSLNTIFSDGNPVLIYAIKSKAKNIINHIMSKDF NINLTDQENKTALHHAIINEYDITFIKSLITKGANPHIKDLTKKLPSDYT PKDGEIYQYLHIYNNKNN >BRE_607 membrane-associated protein P66 MTKTIICLLVIILSHIMAFAEDNETDTNGNNSSNTNTSNNTPELNQNLKL PITLTFDNSSQFRFDMDELVPGLENKTNVGIKITPYINTKEVGNNDPLSA YVKVESLCLNASGKSNTPIKFSVENITAQINMYDFYLKMESMTDFNFNQE SLFSFAPISKIQSQYYGFPNKENATTRTILSRSTAKKIGTLQFGYKLPSQ LELILSIGATGTGNRNNKKNDKDSEEDKKNKEAIPYNDTYKGILYGAQVK WKPIQNNLTQYNSNISVKNPLELNFGISGAIGNSTFNNSSITYGLKDTSV TDSDLVNPTLSNASIITSIGVSYKLGLTKINNKNTYLLLNAGSDLGIDPF ASDFSILGHISRKANTDEKKQFDPVSNKLQFDIKRTPNFEFSVGTGIGLA WNTDEGEEESWEISGSKSYNKRIFGAQDKKSGIGFGINYGKSLYRPTSSN TLIQNIAKKSFQTLNAELSTYEDNKKGIIPGLGWIASIGTYDLLRDKPKS DDIIAALTPNTNTTNKTNIEFASATQLGGALYLDYAIPLKSMSPNTYIIP YVGAHMLGTLNFQKNTLYLKAGLELENLIKLTNIVIGWDSNNILASKDQN GSVFILFKISIS >BRE_268 uncharacterized conserved protein MILGEVKVLPLFIILSSAAISVLVFILFRIAVLNTKTRTKGKHHKTFHKT KKLISKAINILKTNPNEVGALQTLNDYYYTNKDFENGLKYVRKLCQLIEE NPTNKNIDSFKVFLSYGFYNLERNFNLEALGLLKKAYSLKKDDVDVNYYL GIAFLKNAHYKEALHYLTKIYQFDKSNNDVLKYIGMTLFYTGNYTKAVGI FNNIKKYIQNDVNALLAYAQSLSQLNQDQLALDIANKIKSKDGMIYEALL IESEINAKNHNLVELEDNIKEMIKIKPDLPTKISLKLFYKLGELYIEHEN YKKATEAFTQVERIDPNYQKIAEKLEFSKKLNENLALRIYLKSPKEKFDN LASAIILKLYKNKFQVRDKKINEITSQFIDINFQLSNNQWEENILVRFVR TDQKNFGELFLKDLISKTKENKIKGLCIAPATFSEKAKQIIEGRLIDLIE GKKLTQILRTLDISKYI >BRE_1014 putative lipoprotein MKRIFMVVFASSILLLSCKEKEDNVINDQAGDYMDMKSLTSEQQQIYSAL IASFNDLKALYDYKPEGFNISLFDDIKNKFGNTYYENFKETIYAAFKGDV ATIDNLKKIVADSIETKDEYMSALNGRPLLYRLNELGNILFLFLNNDSVF GNDGLIKIRDRQDIALFNEVKYMLDDMGVKWDELVSLLQNTINNVSVFAS KYIETRNVADKEAMIAQLEPIVELKSLDANQSCKGVICKLKNEFMDLYSQ IKEKSVE >BRE_576 uncharacterized conserved protein MSFKLDKQFYFHLGELIKFNSVNAPALKSKPFGEQIDLCRDKVLEIARDI GFKVYKDPDGYYGFAEMGQGDELIGILTHIDVVDAGSISKWHSNPFELGF RDGRVYARGILDDKGPLMAVLYAFKMLLLEKICFKKRFRVIFGTDEETKW RCIEQYKIKEEIPDFSFTPDGDFPIVNAEKGLLQFDVISDEKFFMNLELG IGYNVIPDECSFELGDANKDDFRILLDNFDGKIRYKFFENNVLIHGISAH ASLPELGVNVAPYALDIIKSLGIRSNFIAFFEDRIGFTINGEKLFGKVLE DLQSGKLTLCLTKIKLSKTSNQILSFDMRYPISYKREDLVSLIKKTLDLY SLNYSEVSFLDPLYVDSNLKFISSLMEVYQNFTGESDVNPISIGGATYSR ALKNCVAFGPLFKGSDNTAHQVNEYINENELMDLILIYKNAVEKLNT >BRE_693 phosphomevalonate kinase, putative MDTINFSVPGNLLLMGEYSILEENGFGLAIAIDERAYFSFKQSDKWRFFS KRTKIDNFTLIDSNDDFIFKMFSYLKYCYFNNLEAFPFDVYVDTSNFFLD SGVKKGFGSSAVVAVGIIYGIYLILNGNKNFIKDKIFMYCLEAYRYAQGG MGSGYDIATSLFGGVVMFKGGNSPKYELLDKICFDNFYLMKGPGPIKTTN AIIRYNGYRDSLLSFMRDVNIVMENIILNVSNSANCLLSSLKLARNIGLE IGKRIGISAELPLNLSYLKDECTLIKALGAGNETFLVYNPNFEVFKQFDI EPINLDLIGVKFH >BRE_411 peptidyl-prolyl cis-trans isomerase MNKYLLFFILILMLVACASKRKNLMEEHGIFALIDTNKGTIKIKLYYKIA PLTVMNFIGLSEGLIENSVTNQPYFDNLIFHRVVDGFVIQTGDPTGTGTG GPGYVFPDEFTKGVRHDEAGVVSMANAGPDTNGSQFFITLADNLTYLDFK HSIFGKVVEGMETVRSINLGDKIERVKIIRVGDHANSFKVNNEEFLKLKS SYETKKLKEYEKHMAWQFEIIDRDCKDFEKDESGILYKVIKQGNGKCAKN GDIVRVDYEGFLLNGFKFDSSLERGNIMEFELGLGRVIKGWEIMLSNMCE GEERVIIIPPNLAYGDRDFTSMIKANSFLKFNIILRKVN >BRE_332 glycerol-3-phosphate O-acyltransferase MFIRNKSFNKYFKGIENEFFSRFKDIENINCLNSSYHEADSVSRKLIDTM IERLLKSNSTIVGIQNILKLYEKSKSGKSSIILMEHYSNFDFPCFQFLLE KMNCKEISEYVVPIAGVKLFKDNLLIKSLSLGYNVIFIYPPHAFVDVDSK TMRERRVFNANSMRYVADKKNSGYIILIFPTATRYRKGKPETKKIISEIS NYFKIFDYFIMVGINGNILEVSSNDDMSCDIFREDVLVYNITEVLDIVEY KTLILEKLKKEGLEPTKEILGSKIADDLEKRFEILHKDGAKIYNDLI >BRE_108 uncharacterized conserved protein MKTNRLFFILFLVFFVSIFVYLSLNPYVLYILKGERDFNEVIIEIDDYIS SGNLDSAEKAIKFYSYYADTEYKWLSLVKRAKLYSDKINHYVLMRNILDL SVKSLPGNLKLRALEVYSKLKVGAVLEAYDVAKQYLLGYKEYKYLCDEAF IKSLILNYDVKDIKSFLIKMEQERDALAFETIGFNLQNNAFLINAMLLYI DKKDFDAARRILLKIKEDKDFAKELAYISYGLDNLDFTIANLKLLSDNSE PSLMFLLADAYLKKGDINNAKSEYLKLYTDFPDYSMMIYLGLAFIAKKEN DLKRAITYLNKANEKFKGNEMMNYYLASMYFEINDYFNANEIVKRYKDNP LFFKLYFILNYSNLKYEAKKSFLWRLFYRSNYSSDIAQFLAWNLLLYSDL KDLDLFFNVYNPVDEIQDWYYFYKFYYLFLKKDLVVAEKILLREQTNKYL YGIYYNFGVLKFYQKNYKESEEYFSNAVSTLPFAIDDKSSINLKEREDIA KIYLKRGINYLYLGEFEKGREAISIANSFYETNEGKLYMNMIKIFKERN >BRE_132 pseudouridylate synthase MTNINSKGLRVHVFLAEKGIGSRRFCEELIRKNLIKVNGIFAKLGDKVFL GDRVEYGKQVFVFQDSKVVNKIYIALNKPINYLCSNFDPMGRKLAISLVQ PLFRERLFSIGRLDFKSSGLLLFTNDGRFANSIVHPKNEIEKEYIIESKR VVSEDLLVNFKNGIKVDNELFKLKSYVMLGNNTARLILTEGKNREIRKVF LSRNIFLKKVHRVRIGNITLSNLKEGQIKVLSLAKINKLKTQFLGALM >BRE_1008 hypothetical protein MHQMYRVIFVFSVFILCCRQDRGDISNGQLMNRDRKIYGSMPATVLNNTH LEETKTSGTGDLRHNKLGVDLSINIKPVGDLSASRRTENAEDANTLTPPP NVLSNGLPDMPSNREKTPDVVDEEKGSDYTEQKQRTFEKSYDALMTSIDN LKTLYYYRSDKFSEYTLDKIMSDVKLHYSRTSNNNVYAVLKGDMHILSRL EIIMRYSVGSWSSEYNYPHYFFRILNNLGGLIFKIIDEKGEIFSDENLSK LKNSQDFGCIDVMTDTLSVVHKKWSELVKIVQDRIVEASNLDSVFFIVEY LSLIVDVYDTPKNFEEVKIRILKDELTNLRSSLRDKVYELTRRQH >BRE_532 uncharacterized conserved protein MYEQSYETIFLLSFGIFLIINLFNFKKEFSYEDYFIIFPGTFFIITLYLI EARPLMLYTGSIFLFFLIITTIKTLKTIILRRQKQRKQNNKLKRIIFTIP FKIMIVIPSIIIVFIATIFSYLSFFINYPKDINANYKIGFTKIKDHKNNL NLSVWYPINLTLGLKRQNPFFYYDFNPFFINEMNYLPTYENVYKDAPIST NQKLYDSILIILPSYSHDSMFKSLVNRLVKKGNIVYLYSPIYKHINIHNF IKNNNTTLLTHISNSMIKYLVEPIKIFSQRKDKTSDITEIQNVIELVKSS QKLKFLDSRMNINQLVLITMGNQINIANEIINQNQQIKKYINIGGKPQKF KIKTLQLLIKQDENEWQQTESDISSIKIINMNHIGEISDFIFSRSYLSSF NLFKNQELTLPRFDFMINEIDQFIEDKGH >BRE_140 long-chain-fatty-acid CoA ligase MSIVKTFFEIASKHGCGIAQIYKNNKDYFKVTYADLKENVLKFASFLRKI NLRYQDKVFICSENRIEWSVIDFAILSLGAVDVPKGIDITLFEAEIIINN IVPNVIIVENVDLLDLIIKLKFQIKPTVIVIDDLYEKDKLRFSEFEVYTY KECILIGENARQDEEIIETVNNISLNDMATIIYTSGTTGNPKGVMLSHAN FLYQVSSFSRMISVTEGQIFMCILPIWHSFQRSFSYNIFLKGMTCLFSNI VPRNMLDDIRNINPHYIAAVPRLWIAIKQNIVKEISKKNFFVRLLFRIFV KFACISDICRRIILGLYPDNGLDLLIPFKKILSILGVIVLFPLNVLGNLI VFKKIKKVLGNNFVVGISGGGSIPLYVVRFFNAIGINLANAYGLTEASPG VASNEYGKIIVGTSGKILPGTIAEIRDENGVKLKKPGKGVLFIKGPQVMI GYYQDIEATRQVIGDDGFLDTGDIVKLSKDNVVQIIGREKDTIVLNNGEN IEPAPIEIKLEESLLIEKAVVVGQDQKFLGALILPNFEEINKYLESIGHK IRDTNKQQIIANNIVLKAIGDEIKKLINRANGFKPFEQILKFVLLEKPFE VGKEMSIKMDIKRNYISNFYRNEIKNLFS >BRE_791 uncharacterized conserved protein MRRELFFLVLIILIILGIVIFFVDISKREQIYFELNTKSNISFLFLVEDD NENLLSMQEVFINIKTGNVGFLDIPIYTGYEDFKGNISWFEALYKKNNFT EFLVKVSKQLNHEPDYYIRFKKDNFVRFVDYLGGVRFLVKNPVKVYNLVH SILIPSGNSIFDGDKVYDYLSYFRDIASYDERFEFYKEFFKKILAQFANF QEEYDYFSKMYVMLDTNLSETVFKYILSNYKINDEKLIFLNIKGQEETFK DDDDNLIKVIFPYYGGAILKESIENLNRILIDGTKTEDVIKIIILNGTQT AGLARNVADIFKSLKFKVIRFGNADKHNYSHTLIINNSDNLEIAIKAGDV IRARNIKPISEFHMDILGLDISDMGPDVVIILGDDFDGRYVKSR >BRE_429 uncharacterized conserved protein MLYIVGTPIGNLGDITYRAIDILKLVDVIFAEDTRIAKRLLSHYGIVKKL ISCNAITEYKRIDLLLSYLSSGSNVAFVSDAGTPCLSDPGSLLVDAAFKN GYKICPIPGISSFNTVISVNPFRDKVIVFEGFLPNKGVKRVKRIEELYHR GDAFILLESSHRILKLLSEISLVDLNANVLVGREMTKLYEEYKIGKPLEL KKYFEEHNKDKGEFTILVSRKSKN >BRE_818 conserved hypothetical integral membrane protein MRVLKNNYESYIITEFCKYFFITFLFFLFVFFINQILFFMRILLQNYVSF FKAFIFVIYSLPMVVALSPPFAALLSVILTIYRFKLNNEILAFRSIGISI SNLLTPFLKLGVIIALVSFILNDFLLPLGSIGRLKIFNDIKEEIPHLILK PYSSKQYGDLIFVSGEKSETGYKNVTFFDNTRLKGYDRIFMAKELNIQKE NHQVYFILNNVLSIALTEDEKGFYDYFYADRMKYSIDQVTFSDGWVLTYV PPSQMSMRDVFKLVVRQSKLVEELNTKNYLEEDLLNMNFANIYLNYLYDK NNIFDENSIIENLNYVYNLSVNYAPYEDLIANRSYAFFYLEFYQKISLPL SVLFFIFLAFGMGMYSNKKYSIILELVISILICVFYWAMFMGGKVYTVQH APNPILVIILPNILLMVAGLILFLRLLKR >BRE_328 putative lipoprotein MIKKSKLLFLMLFVFAISLISCNSTPEDQQNDNSKISIKETGDIKRDIEE MKNGVIRERGNLFYSKEFNEAEKLEKEMNSKFSKGIIQEGNELAIKVLER YRNIVRDTIEKKEKINYLKENIEKYLNDAEVNEAYIWIPLEIDEVNNLYF EATRKYKIYDIESALGMYSKAFTKAQQTAKKAKEARALKETEERMYKQLK ALEAASNLPIYSNNKLIKPSPWNGRSLIQDKGERVNLLNLQDNTYLLGQI DAIVLPYEEKVEEVKNTEANKFKTLQLIEKARQLWEQGLKAKNLNNLRLA NELFLDSARYLKAYQSHSSKELYIIKIGNTLWGISKKLYNDPYLWPKIWF ANRQKIQNPDLILENWKIIIPSK >BRE_196 uncharacterized conserved protein MTIKILFLILINISILHKTINADERKQYNEQIITHITKINMLNKSLDKIE RIKNTYNYIKKYFIENQIQYKEHSLQEIGFIGYSHKAIHTKIKGKEKTIY NIIIPIETQYKLKNNLAIAIAITLINNFKNKEIKNSINIYFIEDDSHKQI STINSRLLLNSNTFEKDINTIYLMLNEDKRNNLIEFKNQSNIINSKTNLS FLKNSIKTFENNKVNFSVSKITNKNINEIYNLYLKEKIPILIISNNREHS LLKYIKENNPYDIYKAIEETIKTENNIQNEDTLHYVIINTIFKKWIINEI TLIIAIYATYNFIILIMIIRFKKTSIILRKTKENYHKIIKLFSILFLSSY LSILFTNKMLFAYENIIDYDIINPVYLVNFFLTLFNFNLMFYFAYNYKIH LNLKELKYLAISTSIVEFIIVLYIKIEFILITILKNILILMIPNKIKILK KLIIIFIWVINLILITSIQTTLMISRPIELSYFIAISLFSAILANIVEHL KHKTTTIKQEFQKSEKIEFIILLLIIAIIIISYDIEKIATIKISQTISFP EHKNEINVKYLQDNKNTIQLSIKDLNLKLDKNQTQIKKETKIQEKLIDVS FQKIDAAERSIYTIKITTTKIAEQIHLYLENASELIVYQSNTPYKIVSNN IIFTANNIKSNITNITFTIKCKEDIKYNAFAYFDTNKNEVKIYDQKTKKE IKNINIDYSYTIKHSGILPKSSKQDLDPFFKLQNDKEIEKLQNLNLN >BRE_727 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase MHSKKIITPNKITFLRIILSFVILFILCFEYLWNSYLILSLIWFLIIFNE ITDIIDGYIARKYGLISNVGKILDPYADVLQHFTYFVFFFYKGITPYYFF VIFVYRELSVGVIRNLIIQFNIIQQARISGKIKSLFYAIAVFASLLLYTF DKLKIVTFVDCFISSILNLTFSFSSIVAIIYVISTFITIISLIDYVMIFL DLGKYEK >BRE_208 hypothetical protein MKKCLLLLKNLIVLLILLLNSSLAYSQRLIKLGQEEIKNKNYSQAIKILS EAIQKHPKEQDGYYFLAIAYRENNQLTEAEGALLDGIAIGGNIDYKLYFE LGNIMFKRGKGYYNLAIRYYSSSIKNMPNYDKALLNRANSYVEQGKINFK EKDYKNAWDSYTMAIHDYSQFITLKYESSKKNAILHMIDLLRNKKADLEK LDKTLQNRSEEHIAKGKPKEQKNTQKYENKQEFGTEKQSSNSQQHQNSQN LNQSNNQQHKKEITPTQKPQQHQNSQNLNQSNNQQHKKEITPTQKPQQHQ NSQNLNQSNNQQHKKEITPTQKPQQHQNSQNLNQHNNQQHKKEITPTQKP QQHQNSQNLNQSNNQQHKKEITPTQKTQQHQNSQNLNQSNNQQHKKEITP TQKPQQHQNSQNLNQSNNQQHKKEITPTQKPQQHQNSQNLNQHNNQQHKK EITPTQKPQQHQNSQNLNQSNNQQHKKEITPTQKPQQHQNSQNLNQHNNQ QHKKEITPTQKPQQHQNSQNLNQHNNQQHKKEITPTQKPQQHQNSQNLNQ SNNQQHKKEITPTQKPQQHQNSQNLNQSNNQQHKKEITPTQKPQQHQNSQ NLNQNNNQQHKKEITPTQKPQQHQNSQNLNQNNNQQHKKEITPTQKLQQH QNSQNLNQNNNQQHKKEITPTQKPQQHQNSQNLNQHNNQQHKKEITPTQK PQQHQNSQNLNQNNNQQHKKEHQNKKTMLKEKFADNVKTNSLIELDKINW QEELNIDE >BRE_513 uncharacterized conserved protein MPITSGYSIDKKKKNSRRKTSSFNQVDIFLILFAIFLTAICLLLIIKSSL LNNIFNNEQINNNFELLKAKPKEIEVKIDNTKSETIKMLNNEKFLIKPPE IKKIKEELQEQEHKHLQNQKEVKLHFIKVTSEGHFLKQGVKRNIHYDKNI LEKTLKALFNGPNEYELKNNFLSLIPINTQILNLSVNEGIAHINLSKEFY ENSFGIEGIINQVKQIISTCLEIQGIKGITLNIENNPIILEDLNLNFSGV LDNTKLAKY >BRE_29 uncharacterized conserved protein MSGHSKWSTIKRKKGTLDAKRNKIFTKLIREISIAARMGGGDIDSNPRLR LAVNKARVANMPKDNIEKAIKKGIGDNMGSEYFKLTYEAYALYGVALIIK CLTDNKNRTASEVRSVLSKSGGSLGAPGSVSYMFHKKGLISYNLDKYHED EIIELALEAGAEDIYSEGSQVEVITSADNFESVSSILRTKFEEDIAEVAL VPESKVALDKEQMDKVLAIIEKLEDCDDVQEVYHNLEIVDDIC >BRE_1049 p23-like cell envelope protein MKKIIILLALFIIILSMASCFLDDQIDYSKVQLDQALSNIINKYNHNKLK DLQKEKVEEEEQTTFEVIEGQKEQCMCIGCWFWCSCPKPKCYITWMKIKA KEIVDQDKKVIAALKDKLRYSYSVSPIKYNNDYSKYVMPLILFESMDENI EVTSFNLTDHKNLDFNNKRVLGGLIQGIPKVEKSSEEGYQNVYPYGILNA TAPTGGEELISAFKSLYKNGKWDFMKAEIKVKDKTKNQESTHNILLDGKL FNEFIKTVINNHQGTTTANTKFQVPINN >BRE_472 uncharacterized conserved protein MKSLILCLICISLFGYAQSKNGLDDPSKLKEKDNSKKKSEFTFRADFSHG ILSPLYRRIILKGNPEVISSDFKLRADEIEIYGEGSSYIEARGNVYYEDY TNKMNVKSQFLFVNRKLDNFYLQKGVELEDLENKLVVKAERIEGSRKTSV YIMQYSVKIYKGDIFARAENGIYNKEEKEIVLEGVPVIYQDDNYYSASRI VLNTETKKYNLEGDVEGKFTQVEENVPQQEK >BRE_1002 hypothetical protein MQHAKSTIEQELKDTKKTLKSEQAKLLYAQSGILQDKIKEKETILNELFQ LTSQISSDNNPNNSITNSNRYEKFPASYGHGLGIPLVSFSILMEVDRHFF TQYFNDQAIAATFKYNKDRIYPILLGVTRIYDAYQKLKQKDYYTKQDENY KKMKEYSDVTSNFLYNINSMIPSLNYQNMLDDIYRNIHKVKINATIEELS NIKDQFKKYIQKLLETANKIHRRVNSVRFQQFNVLPETEEYYKVFKSIND DDLQQEIKTTNDYFSECMAYVRSIIKRVIPQES >BRE_110 basic membrane protein MGNFLCFLLFCVLGITSFAQNTPVVIINLHSNEIITKTEFDSKVNTLKKT QGRDLSNIEKKQVLQVLIADVLFGQEALKQGIKVADDEVMQTIRSQFGLA SLTDEQIKQMIESQGTNWNELLASMKRSLAAQKLVLKIAQPKFSEIKAPS EKEVIEYYEANKTKFVNPDIARISHVFFSAKDKKRSEVLEQAKDIAKQIK SSKITFEEAVRKYSNDEGSKVKNGDLGFLARGDQSAQNVLGADFIKEVFV LKKGNVSNPISSKEGFHIVKVTEMYSQKFLGLQDKISPNVNMTVKDAIKN NMINVHQQQIVAKIQQEIYDKLNKSASIQILDSSLK >BRE_7003 uncharacterized conserved protein MKNLNFFLYNNSNLKKNQVRLIKLISVLKYLNKNRLGYNQQDILNLINFF LKKEGYAVIKMKTLQKDLGFMKKHHIIKAFIIRLGEYRGSKIKYIPKKNA YRILGQVLDATEELLEKTFNIIYKLSKEEKEKNKNELKNSTKNSSVYNTI YNNINNIKKKMKIKQQKQQSNKKT >BRE_88 magnesium chelatase family protein MFYSAVQSFKRNFKVTLNNRQLKENYMQIYSHSSIGYEGELIEVEVDIKK EIPGIDIVGLAGSEIKESRERIKAAIKNSEFTFPKDRILINLAPAGIKKI GTAIDLSIATSIISTKENKNNNLKVLMLGELQLDEQIRTIKGVLPAISLA KEKGIKCIIIPFDNLEEALLISNLNIWGVKTLKETLEIIENLNNNIFPAK PTINFKIEENEEEFEYDFKNIKGQHRIKRALEIAVAGGHNIMIFGLPGSG KTLSIKCVQSILPPLTNKEIIETNRIWSIAGKLIDTKIIRKRPFRQPHQT ASKEGIIGGGANALPGEVSLAHNGILFLDEALEFQKSILQSLHEPIEDKT ISIVRASSKSFKYPANFQLMIATNPCPCGNLGKNDIECFCSQQEVSNYWK KFEAAMLDRIDIRVPVKPVNNAKLFQEDNESSQEIKKRIIKARNIQNQRY ENIKNVHENSDLKPEHIAIFCNLDKILTEEMIYILNKLNISSRATHSILK LARTIADLKDESHISRESLLKAIEHRKHGEKLLEE >BRE_141 uncharacterized conserved protein MYRVEIISNFSLEFDFHECITSIEEELGEVIYYSKVYNVKGKGTKGERQG NEVWPEENFIFIVYTDKLIIVEKLKNITEILDKKYPTEGIKFFVIGN >BRE_81 lipoprotein releasing system, permease protein, putative MKLNRLLFKRLILDEQNSLSLTIVIILSIVLGQIIIIITISIMNGFQNDF FTSISTLESGNLKIENKLNEQEFNSIKKMKEIIQINKIYETQGIGIENYY YPSILNIIAFDTKDVINDKNFLLLTGLTASQIQLNEDEIIIGDVLSYNLD LYAGDTIGLILNDEITNLHTLKNEVKQFKIKAIFKSNYSKINQSTVFMNI NYFYTKQLIKDIDINYQVKTKNLYPSKKLINAIKNINQKIKIKPWHEYNK EFYKALKIERNTMLIILTNIFLVIAVNTYYLQKRIIINKSKSISIILFLG LRAQKIRKVFLIHSVVICVLGSIIGIISGIIISLNINEILNTIDILINSL INAVNYILKLNLENIEIKIVKNTITPKIFLSDLMLILFFACLFTICSSLK VTKKIKYTDKINGATS >BRE_173 uncharacterized conserved protein MDMQYSSESSASTKTKIKALKFFSRKMLLELNFGGYRSIFKGLGLEFHEF RPYEETDDARLIDWNVSSKTDNIFSKVFREDKGINLHLLVDNSLSMSLGS ITSKKEIQDLLVSIFAHMAFFNNDKIGMTFFSSKTDKFISSRKGYSHLGL ILNETINRQLKRGSNLTYVFKNTAEYYKKRSLIIIISDFKASDYFKSLTV LSKRHNIIAIRLTDFFDENLPQYGVLTYEDIETREDFLVSGFSKKILNSY KNYWTLDKIKWRKECIKRNINFIEIDTRDDVFKKLKVLLKKENGI >BRE_57 preprotein translocase SecG subunit MILELVRFLVFIFFVIISFMIILLVLFQDEQGDGIGGVFGGGSSSIFGAR SSSVAIKITAFFITLFFVFVIALSFINTKRVDSDLLRNVKVDEKSSTFWN DDENKNNEDDALNKENQEDR >BRE_1070 putative lipoprotein MQKWLILFIISYLLISCNNPQKNTKIATSNNDYHLKQTAISTTKPKTTNK DQIANNIYDQNSQFNKLILNTTQKKTKYTFKNIVKKFDNQNIANKNIHKT TAKQIADSQSLTPDFISNSTAQLNPEENEALNFLTETLKDNNIAKNSKTY MDKEINDFIIYLKPQQIKKMIANIQQALKEIENIESNIKKVYDYKKNRTK >BRE_91 uncharacterized conserved protein MRKFNIFMNMLRFFLFFFIFSFILSLNSLGVKELPYWILIEKGRQLIYSK EGFIKSNLTDAINFLQEALLRKGIYPEANYYLSIVYSMIGNVVLQKLHLQ KTLEDKDYLLDKSFEKNILFSLAKIAEIKNNYVDMIDYLNEILSKFSRGD DYYNYHYIVQKYGDTSDNKSDMSFYLNSYLKQVRGTSGIDFTFNLYRFNN YGLIDTHKLLSKVYLKIGAHKLAITHGLVAAVGILTRMYHYINYYEPLYE FKNLRSFVKKINEYNDVKSSFESTDFWEIMYNISYATYIYDENKHKLRAV DTWKLIVDLAPKFSPYVLKSKTHIKNFLVNKNIH >BRE_127 uncharacterized conserved protein MLAFFLHLILTNIIISFLVSFFVVFFGILRFKFLLIYFISFLGSVLFLFF IPLFYSDYYDRQINILFYLFPIIGSVVLVSLLRFSERSKNDL >BRE_629 ackA, acetate kinase MKNIIILIINTGSSSLKFTLYEYQYQSEQILASGIIEKIKTTQAIIKIKF KNKLLELTNLNIKSHKKALKHLIKTLTNKKTKIINYLDQIQGIGHRIVHG GAQFKNSVIINQNVLNELKKISHLAPLHNPIAIKVIEQMFILFPNAKQVA CFDTSWHQTMNQKAFLYATPYSWYKDYHIRKYGFHGLSYAYITKRTAIIL NKNIEDLNLIILHLGNGASINAVQKGRSYDTSMGLTPLEGLVMGTRSGDI DPTIIPLMSKILKKTTKQIENILNKESGMLGISCKSNDLRDIWIESNNNE YNSKLAVEIMTYRIKKYIGSYLAALDFNIDAIIFTAGIGTSDYEIRKLSL QGFEKIGIKIDFQKNNLAIDKNTEYDISSNQSNIKILVIPTNEELTILED TYDLIKNN >BRE_142 acrB, acriflavine resistance protein MRLIMLVKKVVNKPITMLILFSLLIILSIYTFSRLNINLLPNVEDANLYV STLYAGSSAKEVEEKVARILESNLSLVKNIKTISSISSKGHSEITLNFYH GTNLDLALNEVKDTLEFSKGLLPKEAGLPRISRDRLDGIPVISFFMYSDR SVVELKRYAKELLKPRLERLAGVGLVNIAGGGDKHIVVEVSQNRLEAYGL TLSDIVPFISSQNVEFSVGEILDNDLQYQVQISGNFNSIKDLEDVVIAYK SYSLQDDSLVQIKLRDVASIKTIFKEEKYVYYSDKPSVSISIQKQNDANF VNVSNAVNAEFEKIKLILPKDISLDVFKDNAEHIKNALSSVSHSAYSGAV LALCIIFFFLRSFRATIIIGITIPLAIIITFCLMYFANISLNIMSLSGLA LSVGMVVDCSIVVIENIYRYRQKGAKLISAAILGTQEMMIPIMAATLTSI CVFAPMLIFKAELGMIGDFLRDFAFTIVISLTVSLFVAVFLVPVLSSYYI KLYTSFQKPIRNTLVKKVDGFLHNVYAFGERFYVVLLNYVLNHKLIFLFI VICSFIVSLVLFPFLNVSFMPNERPSVITFSFSFPNRTSLDISKSYSDKV LEILKSEIRAYKSIVSDIDSGGFYFRVLLSSTEEIDDWREIQYRVDNRVK SLYPILNSYALSDRNSLGGSPIAIKIRSLNFEYAKEYGELLINLLKKRFP SLINPRLNIQEEPQIDIDIDREKAYSYGINIETISREVGANIDGISAGKY VENGVSYDILLKLDRNNIVGLKDLNNIFVINKFGVKIPLSLIANLRKTKG VSSLLREDQSLVITLTAGIAPNESLASVTEDVVDFVTNKVPQRDGILVKF EGEYDSFINSMQQFKVIILMAVLLVFGVMAAQFESLLKPFIILFTIPLTL IGVILIYFISGEKISVLSAIGMLMLVGVVVNTGIVLVDYINLLIKRGFKL REAIVEAGRSRFRPILMSSLTSIIGLFPMAFSNSNNSELIKPIAFTFIGG MIASTFLALLFIPMLFEAFSKFSIKNFILIKFFFFVFKRDRKKKQDGLLN KKENKDVISKIGTDRNVKFNDFFINEDEN >BRE_6011 acyP, acylphosphatase MMHKYQYFISGKVQGIGFRFFTEQIAKKIGIKGFVKNLDDGRVEIIAFFI NNKQIDSFENALKKGNGYSKIHKIEKKILDTKYPFDFKNFCSYY >BRE_415 adk, adenylate kinase MKLVFLGPPGSGKGTIAKILSNELNYYHISTGDLFRTNIENDTPLGKEIK QIVENGQLVPDSITIKVVEDKINTIDNRDNFILDGFPRNINQAIELDRLL ENIKIINFLINEKLLVKRLSGRRICQSCCKIFNIYTLPTKEKEICDFCQG ILYQRKDDTKESLKIRLQEYNLQTKPLINFYSNSNRLNNIDASKNINEVQ KNLMEIISKIEKKLV >BRE_220 alaS, alanyl-tRNA synthetase MKLDELRAKYIDFFKSKGHCEIVGKSLIPDNDSTVLFNTAGMQPLVPYLL GEIHPSGDMLVDVQKCLRTGDIDEVGDLSHLTFFEMLGNWSLGAYFKELS VEYSFEFLTSPHYLNISKDKLYVSVFEGDKDIPRDVKTADIWEKLGISKD RIFYLSREHNFWGPVGNVGPCGPDTEIFVDTGIDKCSNTCDITCSCGKYF EIWNNVFMQYNKDNDGNYEELKRKCVDTGMGIERTITFLQGKSSVYDTDA FRPIIKQIEKISGKVYGDNLEDDRAIRIIADHIKASCFILADNFSVLPSN VGQGYVLRRLIRRSIRYAKKLGMESHCLADLVDSVEDIYKSFYKEITEKK DFIKNELNIEEEKFFKTLRYGEQEFVKLIHQLSSKLIPGDISFKLYDTYG FPYEITEELAIEYGFSMDREGFEEHFKKHQEVSKKGSDKVFKGGLADCSY ETTKLHTATHLLHKALQLVLGDHVRQKGSNITSQRLRFDFSHPCKMTDDE IKKVEDIVNLQIKNKLSVKKSIMSLEDALVKGAIALFGEKYEDIVSVYEI DGFSIEVCGGPHVNNTSELGTFKIQKEQASSSGIRRIRAILI >BRE_158 alr, alanine racemase MYKMTKHKEIIINFKNLEHNLITIKSHVHKKELVATLKADAYGHGLIQTF KFFKEKNINYFGLFSIYDALKLRKIDKKSNILLYINNINKNAIKNLVNFE ITPFVADSQYLSLIEEECKRQNKKIKVHLKVDVGMNRYGIKTENALNLAT KIQDSKLVEFEGICTHLPTTENTKITQTQSKKFDYLINELKNKNINPKFI HISNSGHITNYKISENFNMIRPGLILYGYHPNPNNQNNNLKLKPVLNLYS KVIFVKNIKKGDQISYSGLFKAKEDMQIGLIPVGYFDGIPQNTSKNFYCI IKDKKCFIRGKICMNISIIEIPQDLKINIGDKVEIVSERLSLDILSKESG RSTYELLCSIGKNEKKKYLY >BRE_785 apt, adenine phosphoribosyltransferase MIFLILMENLMIDKMGYYDRFIMKVPNFPKEGILFYDISNVLLQAEAYKS LLEDAHALYSSKEIDCIAAIESRGYLIGAPLALKMNLPLLLIRKGGKLPR QVLREEYELEYGLGSIEIHKDDIKQHTKILLVDDILATGGTIRAAVRLLE RASGVISDIFCFIELVSIRGRDILGEYNVNSLVRYP >BRE_852 arcA, arginine deiminase MQYLKPINVFSEIGRLKKVLLHRPGKELENLTPSIMKRLLFDDIPYLHVA IQEHDSFADTLRGNGVKVVYIEDLISETLSNDDSIKEQFISQFILEAGIR TENKTRALKDYFCNMSVNDMISNMIAGVTRDDLKNYKSDSLNSLVNSEYP LIIDPMPNILFTRDPFASIGHGVTINRMSTKTRHRETIFAEYIFKYHPIY KDNVPIWYNRDEDTTLEGGDELVLSRDVLAIGVSERTESESVEKVARKLF EQKISFNTILAFQIPQSRAYMHLDTVFTQIDHTTFTSFISDDMKFTIYAL TYDVSSGSIKVKSEKAKLEDILGFYFGCKVNIIKCAGGDLIHGAREQWND GANTLAISPGEVIVYSRNHMTNKLLEEFGIKVYQIPSSELSRGRGGPRCM SMPLIREDI >BRE_853 arcB, ornithine carbamoyltransferase, catabolic MYVYAFDKRRYLVREKMFMYNLQDSLRNKSFLRLLDFTQDDIQYLLDLSH KLKKVKQSGIEEQKLKGKNIVIIFEKDSTRTRCAFEVAVYDQGAHVTYLG PTGSQIGKKESIADTARVLGRMYDAIEFRGFSQEAVEDLAKYSNVPVYNG LTDIAHPTQILADFMTIEEHKGCLKNLKMVFCGDGRNNMANSLMEGCSMM GMDFRIFAPTELFPDPELVAKTKLIADKSGGSITISSSIEETVRDVDVVY TDVWVSMGETNWDERIKLLRPYQVNSELMQLAKKDAIFMHCLPAFHDLNT VVGREVFEKYGLKGIEVTHDVFEGDRSVVFDEAENRLHTIKAVMVGTLG >BRE_598 argS, arginyl-tRNA synthetase MIKTIKADLENKIQKTIKELALSSNIKLDKINIVMQKPPKSEMGDLSILI FEFSKILKLSIPVITQEIIKQIGNEYKTKSMGPYLNIKFNRKEYIQNTIK KVNKEKENYGANNSLQNKKTIIEFSSPNTNKPLHVGHLRNDIIGESLSRI LKASGSKVTKINLINDRGTHICKSMLAYKKFGNNITPEIAQKKGDHLIGD FYVKYNEYASQNSEIAENEIQQLLYQWEQGDEKTVQLWTKLNKWAIDGIK ETYNTTNITFDKIYLESEIFKIGREVVINGLKEGLCYKREDGAICINIPT ETNNIDNQNFKQKVLLRANGTSIYLTQDLGNIVARKNEFDFDEMIYVVGS EQIHHFKTLFYVADKLGITNENNLIHLSYGMVNLPEGKMKSREGNIIDAD NLIHDLSQSTMLELKKRYENEQNLQKLALNISLGAIHYYLLKTAIHKDIL FNKTESLSFTGNSGPYIQYVGARINSILDKYNNLNLPNKNTNFDLLINEN EWEIIKIISEFEEYIIKASKDRNPSIIANYSYLLAKNFSTYYQDTKIIDK DNLELTHARIDLAKAVLQTIKNCMHLLNIPYIQKM >BRE_103 asnS, asparaginyl-tRNA synthetase MHKSIKEILNNPITNNTITVKGWIRTKRSNGKISFLEINDGSNIKGIQAV IDENNPQFEKKEFKKLTTGASISLTGILILSPAKGQTYEIKTTNFYIIGE SDQKTYPLQKKRHSFEFLREIPHLRIRTNTFGAVARIKNQISYKIHEYFQ KNGFFYIHTPIITSNDGEGVGEIFRVSTLNLNNIENKKEIDFKDDFFGKQ AFLTVTGQLHGEAYAMALSKIYTFGPTFRAENSNTTRHASEFWMIEPEMA FFTLEDNINLAEDFLKYVLSETLNHCHEDMEFFDNFIEKGVIKKIEDVIN SKFEVITYTQAIKKLENAKKTFEIKPYWGMDLQTEHERYLTEEIIKKPTT VIDYPKEFKAFYMKMNQDNKTVKGMDILVPRIGEIIGGSEREDNLDKLNN RIKELNLETETLNWYLDLRRFGSTPHSGFGLGLERLLQYTTGMPNIRDVI PFPRTPKTLHF >BRE_448 aspS, aspartyl-tRNA synthetase MFKIIKCNQINNKLINKKIEINGWVKKIRNHGKVTFINIRDRYDEAQILV SDEKLLKITSQIKMEYCIKIQGKLNLRPLELVNREMKTGELEIIAENIDI ISKCNELPFMIENNNNASDNSKLEYRYLDLRREEQKQKIILRSKVIHIIR NHLTKQDFLELETPTFVKSTPEGARDFLVPSRIHKGHFYALPQSPQIYKQ LAMIAGLDKYFQIARCYRDEDSRGDRQPEFTQLDLEMSFIKKENIFKLIE NLIFTIFKNSLNITLPKKFKKITYKDAMNIYGSDKPDTRYELLIQDMSKA LKQSPFDVFKDTLQNKGTIKALIIKNQAHNFSRSKINSLEEHAKLYKART LYFTKIENNEFTGGIAKFINPIKKTLIETYSLKNNDIIFFIADLWETACK AIGQIRIKIATELNLINKNIFEFLWIYDFPLFEYDEDTQSYKAAHHMFSM PQAKYINTLESNPSKVLGEVYDIVLNGTELGSGSIRVHTKELQQRIFNIV GFNDKIAEERFDFFLKALEYGAPIHGGIAIGIDRLLMLMTNSNSIKDVIL FPKNSFAASPLDKSPSKISDEQLKELNLTIENK >BRE_96 atpA, V-type ATPase, subunit A MEAKGKVVGVIGNLVTIEMVGTVSMNEIVFIKTGGQSLKAEIIRIRDGEV DAQVFEMTRGIAVGDDVEFTDKLLTVELGPGLLSQVYDGLQNPLPELATK CGFFLERGLYLSALDRNKKWSFNATAKVGDFIVAGDFLGFVIEGTINHKI MVPFDRRDSYRIIEIVGDGDYTVDDRIAVIEDDAGGKHIITMSFHWPVKV PVTSYKKRLIPNETMVTQTRIIDTFFPVAKGGTFCIPGPFGAGKTVLQQV TSRNADVDIVIIAACGERAGEVVETLKEFPELTDPRTGKSLMERTCIICN TSSMPVAAREASVYTAITISEYYRQMGLDILLLADSTSRWAQAMREMSGR LEEIPGDEAFPAYLESVIASFYERAGVVVLNNGSVGSVTVGGSVSPAGGN FEEPVTQATLKVVGAFHGLTRERSDARKFPAINPLDSWSKYRGVVEYEAT EYARAFLVKGNEVNQMMRVVGEDGVSIDDFVVYLKSELLDSCYLQQNSFD SVDAAVSFERQNYMFNILYKILQSDFKFENKLEARSFINDLRQNILDMNL APFKQEKFNKLEINLKNLLRSKKLDF >BRE_95 atpB, V-type ATPase, subunit B MQMKRVYSKIESIIGNVITVIAKSVKYGELAIVKSKNGSSLAEVIKLERD KVSLQVYNGTIGISTSDEVKFLGHPMQVTFSENLLGRIFDGAGNPKDGGP RLEDNLIEIGGPSVNPAKRIVPRNMIRTGIPMIDVFNTLVESQKLPIFSV SGEPYNELLVRIALQAEVDLIILGGMGLKNDDYLTFKDSLESGGALSRTI FFVNTANDPVVESLIVPDISLAVAEKFALQGKKVLVLLTDMTNFADAMKE IAITMEQVPSNRGYPGDLYSQLASRYEKAIDFEGAGSITVLAVTTMPGDD VTHPVPDNTGYITEGQYYLRRGRIEPFGSLSRLKQMVNGKTRDDHRTIMD SMIKLYASSRESIEKKAMGFNMTEWDEKLLKYSNMFESKLMDLSLNIPLE EALDLGWTILSSCFEPNETGIKTELLEKYWPKNRD >BRE_94 atpD, V-type ATPase, subunit D MPKVKLTKNELKKQKDDLKMFSRYLPTLQLKKQQLHLEIRKVKALKEVKK LERDKLKRNMKFWISLFGERFPFQDWIQIKKVRKGFTNIAGITIPVFESV EYEDIKHDLLLTPYWVDVGIEAIKNIIQINAELEILDEQANLLELELNIT SQRVNLFEKVMIPNAKVNIKKINVYLGDQQTAAVVRGKMAKASLIKNR >BRE_98 atpE, V-type ATPase, subunit E MQFEVKDLINKIKKDGLDEAERLASEIILNAKQEAEAIILKAESEAKELK IKAEKEAYDYKRYSLEASRQAFRDLVIGTENSIKSLFKSALKDSVSSVYD SNFLRELIIRVLDVWGKDDKIDIMLNESDIDNLSSILKTSIRNKFGAEIE IKPFKGINKGFKVQQRDGSLYYDFTSEAIADILFEYLNPRFKEIIKLD >BRE_93 atpI, V-type ATPase, subunit I MLMIVKMKKVLLLTLLKYKRDSLEILRELGVVHINFCNKVSESLQKVIEE RSILNHALSLLGDDSEVQILSSSNENFLDIAKRIVDLGSEIKDLREMRQL LLRNRDIISCWGYFSVDLVNKLRGCNIHVQFFKSGMSEYKKLLLFSQVKV ALINNYKGTAYFVAINDSKQNIDVAEEYEFEFDLDSIETKLKMIDEVLEQ KLTQLSVLNKYRNILKDAIKEYEQIIEFEQVMADMNVECDEFVYITGFIP EDKQKYLQNATLNGKFVVQFAEPDDNDFIPTYVKRKGIAKLAKPIFDVLD TIPGYKERDVSCVFMLFFFVFFGMIIGDAAYGVIFLLIGIIINLISVLKN KPLTSAHALIFYLSTSAIIYGSMTGTWFGSGHFVLDLFPILKSLKVEYLT GNNGMQNVMFICFTIGVLQLSLAHVWNFVQKVKEKPHIHAIAQIGWLVLM PGLYYFVLNLILGSDNFPMHSMILNMIYFGVMLIFVFDKQDGSNFFVCML KSFGGLIEQFLATVSGFADIISYIRLFAVGLAGLAISDSFNSMSVSLLKS SNIGLIIGGVIVILFGHILNIMLSLLSVVVHGVRLNMLEFSNHLGQEWNG YSYRPFKKIKD >BRE_92 atpK, V-type ATPase, subunit K MDIGLVGVNSALTVSAIGSALGMGAAGSAAIGAWKRCYMQGKSAPFLLIV FVSAPLTQIIYGYILMNTLAEVMTQANPWLLFGAGFGGGLAMAISAFAQG RTAAGACDSFAETGKGFATNLLVLGLIESVALFVMVFLMIFKFV >BRE_265 bacA, undecaprenyl-diphosphatase MDNILRVIILGFVQGISEFLPISSSGHLLLLKKFMNIDLPIVFDIYLHFA TVLVVIIYYRRRILELVMVFIKFILRKSKMTELDSSNLNLILLILIITFF TALIGIFIEKFKVLFTFKLVLFNFIVTSILLFLIEFRIKIFNFKKNIFFS GLLIGIMQGIGAMPGISRSGITIFASILLGFSRTKSLEISFLSLIPIVFG SLFLKYNDLFKSDIIFNIFEINLGAIFAFIFGLFSISLFVKMLKNSKLYY FSIYLVSVVSLVYFLV >BRE_3013 bdr, bdr proitein MAHPQPIITQQMVLKELIKAGINRDIAADLSYRYYKNELTYKDLEYLENN FNSKIEKIESILKSEITSAKLEVNNKIDKVKVELDNKIDNKFNELDNQIN KVEDRLKSEITSTKIELNNKIDKVEDKLKSEIISTKIELNNKIDKIKIEL DNKIDNKFNEIKNTGKLHNWMFGTIITLNIGIFLTLFSIIYSLLNK >BRE_5001 bdr_1, BdrQ-like protein MNMDVAVTKEQLIDDNPINKSSIRSERVKKDYHNIPFDGHIISYYVLEEK FDLLQDRMMDNFHYLDDKINILKIDLNEKIDGVESRLSARMDKLDAKIEA VKSDVGQINSRLTFIESKLGFIEGKLGFIEGKLGFKGQLISSLTVIATLA VSYFVVQMFVTLGKYLGIS >BRE_2002 bdr_1, bdr proitein MEYMMQPVVTRQMVLNELVKVGINREIADDLSYRYYKNELTIKDLEYLKE NFDIKLKHLEEKIFDIKEELISRIDNKFNEVDNKIDNVRSELRSDIRDLD KKIDTVKHDLKSTIKELDNKMNTIENNFNIKIDTKFNELDTKIEINKMEL NSKLKLHNWMFGTIITITVGILLTLIFK >BRE_4005 bdr_1, bdr proitein MEYMQMEPVITRQMVLNELVKAGINREIADDLSYRYYKNELTTKDLQYLE SNFNLKLEMLERGLKAEIRELDTKIDTVENNLNIKIDIKFTELDNKIDIV ENNLNNKIDKVRDELKSDIKELDNKIDTVENNLSNKIDAKFAELDNKIDV KFNELDNKIDTVRKDMEVNKMELDTKIDIKFNELDTKIDKFASDVKGTLK LHAWMFGTIITINVGIFLALISMLYALFIK >BRE_5023 bdr_2, bdr proitein MYNNYIRRFFMEYMQMEPVITRQMVLNELVKAGINREIADDLSYRYYKNE LTTKDLQYLESNFNLKLEILERGLKADIKELDNKIDAGFTELDIKIDTVE NNLNNKIDRVRDELKLDIKELDIKIDTVENNLNNKIDRVRNELKLDIKEL DIKIDTVENNLNNKIDKVRDELKLDIKELDTRIDTVENNLNNKIDKVRDE LKLDIKELDTKIDIVRKDMEVNKMELDTKIDKFASDVKGTFKLHAWMFGT IITINVGIFLALISMLYALFIK >BRE_4027 bdr_2, bdr proitein MEYMQMEPVITRQMVLNELVKAGINREIADDLSYRYYKNELTIKDLQYLE SNFNLKLEILERGLKADIKELDNKIDIIENNLNNKIDTKFTELDNKIDKV RDELKSDITSVSHEVVLIRKDMEVNKMELNSKLKLHAWMFGTIITLTIGI LLTLIFK >BRE_2013 bdr_2, bdr proitein MYNNYIRRFFMEYMQMEPVITRQMVLNELVKAGIKRDIADDLSYRYYKNE LTTKDLQYLKENFDIKLKHLEEKIFDTKEELINRMDSKFTELDNKINTVE SNLKSEISLVRKDMELNKIELDTKIDKFASEVKGTFKLHAWMFGTIITLT IGILLTLIFK >BRE_2030 bdr_3, bdr proitein MYNNYIRRFFMEYIQMEPVITRQMVFNELVKAGINREIADDLSYRYYKNE LTIKDLQYLESNFNLKLEILERGLKAEIRELDTKIDTVENNLNIKIDIKF TELDNKIDTVENNLKSDIKDLDTKIDAKFTELDNKIDIVRKDIELNKMEL NSKLKLHAWMFGTIITINVGIFIALISMLYALFIK >BRE_5025 bdr_3, bdr proitein MYNNYIRRFFMEYMQMEPVITRQMVLNELVKVGINRDIADDLSYRYYKNE LTTKDLQYLESNFKFKLEILERGLKADIKELDNKIDIVENNLNNKIDKVR DELKSDISLVRKDMEVNKMELNSKLKLHAWMFGTIITINVGIFLALMSML YALFIK >BRE_2038 bdr_4, bdr proitein MAHPQPIITQQMVLKELIKAGINRDIAADLSYRYYKNELTYKDLEYLENN FNSKIEKIESILKSEITSAKLEVNNKIDKVKVELDNKIDNKFNELDNQIN KVEDRLKSEITSTKIELNNKIDKVEDKLKSEIISTKIELNNKIDKIKIEL DNKIDNKFNEIKNTGKLHNWMFGTIITLNIGIFLTLFSIIYSLLNK >BRE_380 bmpA-1, basic membrane protein A MINLLLVLCLLYFSCFTSEVDGEPVKVGVLVDGFFDDESFNKSALNGIKK VEKEFGLEVAIKESSPNSYLSDLNSLKADGSNFIWLIGYRFSDVALKIAL KNPEIKYVVVDFIYDSDLSIPKNLSAITFRVEEVAFLVGYIAASISKTGK IGFLGGMDDDFINIFRYGYEAGAIYANQNINIDNKYVGSFVNSESGEILA NEMYVDGIDIIYYAAGLSGIGVIEAAKKLGAGHYVIGVDQDQSYLLPEHI ITSSVKDIGRILSLVISNYLKTRAFEGGQLLNYGLKEGLLYFVKNPKKIS FNLEKELDDIYSKIINGKIIVPNNKDAYNRFLKIFFNQY >BRE_382 bmpA-2, basic membrane protein A; lipoprotein MNKFMVLICVILIFLGCSKKTSILGTSGKALISLIVDGTFDDKSFGEDAW RGAKVLEDEFEVEIVGRASTSSAYAGDLESLKDRGSDIIWGVGFRLQESI EHAALLNRDIIYGAVDVIYEDNTSIPDNLLGLSFKVEEASFLAGYLAAKI SKTGKIGFLGGMDGMVINAFRYGYQAGAKYANKDVGLTSQYLGSFVDLSL ARTIALKMYKDDVDIIFVSAGLAGLGAIEVSKELGDGHYIIGVDQDQSYL APDNVLTSVIKNVGNSIYEITKDYLNTKSFNGGKLLKLGLKDKAVSIVKN GFKITDELRSEIQIIENKIVNSDIIVPSNFDKYNNFLNIHIY >BRE_381 bmpC, basic membrane protein C; lipoprotein MSKNLSFILLFVLMFISCFFSKKKFAKSVDDQIVIGLVASGSFDDEGYFQ NFLDGVIDIKNEFGTKVIPKVITPYPSEEKMLMTASELLLEDVCELQNKG ANLVWFIGASFSDSVIRFAHENFNVLYGIIDPLHYENILIPQNFVAINFR SEEGSFLAGYLASKMSKSNRIGFVTGVNMDYVERFVIGFRAGAFYANPTT RVIVKRMLDEVDKVAGKLFAEHMYVEDGVDIIFPVMGPASLGMFKAAKEL GVGHYIIGVNKDQSYLAPGHVITSVIKDVGQAIHDYSANLIKNHKFAGGK VFDLGLEDNVIDIVKDPDIIDSGLIDVLIEIQTKIIKKELIVPSTEHEFD LFKARL >BRE_383 bmpD, basic membrane protein D MGGGLYMRWLTKVVLLFLLLSCSDSQDKVSFSNTVSVIVDGIFDDRGFNE NSSKAMTQIKEEFKVNIIQKESKASSYLSDIGGLEESGSDLIWGVGFKFS DVFLRKALENANVNYGIIEGSYLEDVKLPQNLVNINFRSEEGAFLVGYLA AKISNTGKIGFLGGIEGVVLNAFRYGYEAGAKYANKDIEVSFQYVGTFSD LSLGRSIASKMYSSGVDIIFAAAGLSGLGAIEVSKELGDGHYIIGVDQNQ SYLAPGNVLVSYVKCIDIVIFDLIKSYLKFDNWRGGNLEFGLKDGALDLI FNETINLDLIRNPDFLLEIKEKIINNEITVPKDEKSYNYFISDHLHKR >BRE_2026 bppC_2, BppC MKEYEILKAKIKELKKQNSILLKETRQYKKELLQTKSNTKSKSIPIRFYL NDKTIRLVKKSIDKLKQIDPISGWFVHILSITGCRGVEIQNIRLDDIVRE TNNNSDVFYNLRVNVAKKRSNICIREVVISKSEFESIEEIHKLNFKNKGQ DSRRTYLFQKSKHRFKDNRINISKISKQFKELLTKSRFKHPKSLHICRNI FIATLKSKGYNSFKIKELMKYASTSEIDNVYGLSKASKLKAYHDIKDGFK >BRE_1082 bsr, bsr protein MFENKYLTLKQKEVLRDIDNNFCSKIIFNGGISSGKTFLASYLLIKLLII NRDNYHKDTNNFIFGSSIGTLLANTLKQIEKICSLLNIEYLLKDSRQVTC TIAGLTLNIYGGKNIDSFTKIRGSNSALVYVNEATLMHKETLLEIMKRLR QKPGIIIFDTNPDHPAHYFKVDYIDNRDVYRTYNFSIYDNPLNSKDFIKT QEAIYKNLSAYKARVLLGEWTASIDSCFNEVILNCEYTFKSPIMYIDPAF SVGMDNTAICVFEKMGDKYYAYIYQDKKPISDESILHAISVFAEDFNINT LYIEDRDNTDRYEFLTKIMTSLRLNMNHYFKISAVKPLSNKFVRICTLIP LFNARSIEFLKITDKNVINDIYSYNGLSRCRDDALDALSACYLLLSLKYH DKIKHFSMSRYI >BRE_624 cdd, cytidine deaminase MNDNGQDAIIKAFQLAETARNNAYSPYSKFKVGACIKTKDNLFFQGSNIE NASFGATRCAEQAAIINMISSVGVQKIDFILVTTIPASVPCAICRQVMSE FFEEDTKILITDPNQFNMNKKVFKIYTLNDLLKFPFNKEELSKIFKANKT T >BRE_121 cdsA, phosphatidate cytidylyltransferase MLIVNLFFQMFYGQIILFFIMREIWNVLRIGRETLGDKGLFSIRSKKLTF VARLGTFLFFVPLVLLLIFLEFKSYLFINILIFMFSGIAAKEVNDLLKFK SASVSSTLSFFLGIFPPILTYVHFNILDLGINIVFYLVITLVFSNWIVNL VFIKENEIVNFLSQATSIIFILIYPGILMSFVVAITTLPKAPILLLILFS MVSGNDTFAYLFGYFFGKNSYKPTIISPNKTIMGFFGGILFSIIVVLIVV SLGLINLTYGEAMVFGVLIGFFTIIGDLFESGLKRSAGVKDSGKIIPGRG GALDSIDSYLLTGPIFYLYLS >BRE_572 cheA-1, chemotaxis histidine kinase MNSSDMIDKFKDSFKEESIENISDIEHALLNIEFESGKEVINSIFRNFHT IKGSAGMFGFNFTASLVHEIETILDPIKMGVEEFNQSTVDATLMAVDFVR ELIEGDEAIDEIVYKTREKSLIDAIKKELGIDIGVVKDIVLATNSKVQNS SINLDSQEAELNLSLNQNKYEDEALKVETKVYRVLFIPSRGILFHGHKPI NFLKKLLNLGNGQVKARVKNIPDLELISPDNVYVEWELKLETEESKSTIE DVFTFVDGQSKFVIEEVDASYEITDDSFLLNNVTQNVNEMFPEKEQNLLH SKELYNNKMSFKSGEHNVNDDTVKSKVNIASIKVDSKKLDHLVNLVGELV TIHSKLAKEAEISNNNVLNSISAEFSLLINELRDYTTGLRTVPIEILFVK FQRIVKDLSVQLGKSIHYYSQGGDTVLDKSIIERLNEPLVHLIRNSIDHG IEPDEERIKAGKKAHGIIKLSAQQSGDSVIVVIEDDGRGLDKHKIIKRAI EKNIISEAISSTLSDVDIYNLIFEPGFSTADVVTNISGRGVGMDVVKKQV ESLRGNVVIESEFGKYTRIKLIFPLTLAIIEGWFVRVYDQYFIVPLSSVE SCLEADKLDSRVYGLESGGNVMDYRGSMISFIRLREFFEISNEKSNSEHV VVVNTNSGKIGIVVDEVLGQHQTVIKTLGKVYSKVEGVSGATILGDGSLA LVIDVDNITKIIR >BRE_675 cheA-2, chemotaxis histidine kinase MIDADNKELLEIFFEEAQNLVDTLEENIISLEDDPHNMETIDEIFRAAHT IKGSSASVDMMELSSFTHVVEDVFDAIRDNRLKICNDLIDLLLNALDVIK SMLDTRLNGDVYLQDVSGLKSKLRGFLEYDYQTTSVSVLENKDNDEFLLS SSDINDMREAVGLGQKLLKVSVDFDKDNPMATIAGIQMFQALKDLAPILH TVPNYDQLISDQFLKRVDYYLIYLDIHKIEEKINLSDVASDYSINEFYID NELAKANLREQNSVDNTLSKDNTVSNKGGFQLSNDEIIDLRNYIGDSKLF EVKLYFNKNNPMSTISGFQMLQALKSLGEIYKSIPDSEDLLSDKFFDLIV YYLISKTSIESISKKVDLSDVVVSFDISEVDLKDIKGMDVSTEVDAYAPV KESKKSALNVNLIRIDSKRIDSILNLVSEAVISKSSYNQINSDMTSFIYG FNYFYDYQENFRNSFLSDLKMIFKDVGLDLENSIETRIVELLEHKLDRSL QDMMNLKDLLFKIHQDSRFASNRLSRIITDLHESVLRTRMLPVASIFSRF TRVIRDLSKKLGKVVELSTQGEDTEVDKSVIDDLVDPLMHCIRNSMDHGI ETMDERISKGKDKAGHIILRAKNEGNVISIEIEDDGKGIDPNVIRKKSIE KGLINENTVLSESEMLNLIFEPGFSTASQITDVSGRGVGLDVVKNNVKKL NGTIIIDSKINVGTIFKIKLPLTLVIVQGLLVKSGNEIYVIPLNSVLETH RINEDNIRLLENDHEVYNLREEVISVLRLDELFNIKNDHQDLYEKFLIVI SINDKKAGIVVDSILGEEDFVVKPIKDKYASSPGIVGATTLGNGKVVLII DVFRLFDLRDMKG >BRE_413 cheB-1, protein-glutamate methylesterase MRITIYVLIIDSSSVNRKAISDIINSSSKLKVIATAANAEFALKKLKQDP DVILLGLEKETIKDISLIQKKQNINNKIPVIILSSNKDLAINALLQGADD FIIKIDSKLDKIKDKIIDLLTIYGNKSIKNKIITNINCKPETYIPSQNEK DKKNNLNIINIREHNLKKTNTKYIVTSLNQKQIINDQDLKKLKNRKFEMV VIGISTGGPEALKIILSEISKNFPIPIVIVQHMPKGFTTEFANNLNKICN LTVKETKNNEILQKGCIYISSGGYHTKINKINDNYQIEVFDAENVNGHKP SIGVLFKSISENVKEKVIALIMTGMGNDGSREIGDIKKAGGVTIAQDEKS SVVFGMPKIAIEENNIDYIVSIGHVVKLLETILLDG >BRE_573 cheB-2, protein-glutamate methylesterase MKILVIDIQGLIRQVFVRAFSKDVDVEILNPGSNSLNLINVFLQKFPDVV IIDENTAKSHFGNSLNNVLNNILLPVVFIAENEVYPKFGFLDSKKDKIKL IINKLNFKLTVNLFRSDYLDLIKSEIKKLVDHKFVASFESKRIKSPDFFE KIESKESERDITNITKSYKVADVINVSPKNGPDVILKYQGVINKNKTGKV IFVGASTGGTEALRVFLKLFKKDSPPIVIVQHMPGGFTTSFAKSLNNEFE VDIKEAEDGDILRPGLVIIANGHYHLIVKYANGNYFTHLIDGPPVSRHKP SVNVLFRSAAMYAGENAIGVMLTGMGDDGASCMLEMKNNGAYNIAQDQLT SVVFGMPMEAIKIGAVDKVLPLNKISECILRRS >BRE_44 cheR-1, chemotaxis protein methyltransferase MNINNEFNIKINKEEFQRLTKIIYNNFGINLSEKKKLLIESRLSSTIKAK NLNNFTEYINYLENQKNQISLIELVDKISTNHTYFFREPNHFEFLANNIL PKMIKKITQTQEKEIRIWSAGCSSGEEAYTIAMILNEYINNNKIQCNAKI LATDISITVLKEAKEGIYPEDRVKTLPKHLKNKYLNKLQNDKFEVKDELK EMTVFKKLNLMNDVFPFNKKFDLIFCRNVMIYFDEKTRNKLADKFNQYLK DDSYLLIGHSETIRGNKNLEYVMPATYKKKSIQLKNNHND >BRE_412 cheR-2, chemotaxis protein methyltransferase MLNINDELLIKFCNFIYDNSGIRFDEKNKIVLKSRINDAIHELKNINTPQ QLYELIISDKFKKEYFLDLVTTNLTRFFRNEAHFKTFEKFIIPQLINIKT KENKNRIVIWSAGCSTGEEPYSLAFVLKYHIPENFEFIIIASDLSLKSLM IAKDGHYSSQQCEHIPAEYKKYIKPHMDGYKVVNDIKKHIRFDYHNLNFE SGFSNIDVIFCRNVLIYFDEKSQIKVLKKFYSSMAMKSYLFIGHSESLFG LNLPFKFLKTPWAIIYEKDDESVPNEKKLSFQNKYKL >BRE_319 cheW-1, purine-binding chemotaxis protein MFIKDKIMEKKSHLQVACFKIGKESYGVSIEHIREVIKVPLEGVYAIPNV PDYITGIYNLRGNVIPLINLNIRFNIPSVYATEEDKLLVGYLIVNIQNKL LGIFVDKVLKVISFDVSRIQEPPATLQTFDKKYISGVVKIEKEENFESEY LILIDIERIFDKSEFEKIPYKENNE >BRE_570 cheW-2, purine-binding chemotaxis protein MELEVDMQDTLNQYLLFSLDELYAIEIKYVVEVLEYTKISKIPRTPDYMA GIINNRGKIVPIIDIRKQFGMEERKVSDDEVKKKEINTSNIIILTLIYEG DELNLGILVDHVKEVLELSSSDIDDAPRIGAGFNSKFISGIGKCNDKFVV ILDVKNLFNIKELARFKNTTINDPDDE >BRE_676 cheW-3, purine-binding chemotaxis protein CheW MMEIKEIYLDEHNIGSHLKEKDSVNLDFKVVSFNIGDDSYLVDIMQVKEI RKSNNFTYVPNAKKYVVGLDNLRGEIISIIDLRIMFNLKVIKKDFEDVMV LRNNDLLIGVIVDKVNNVFSIDSSLIQNPHPILFQETLIHYMRGVVEYGS KLYIVLDVGKIFNYDNDIEEKEVLLEESKNTGDKIGTSEHEEQSISFDNN SLELSEASASNHVLSSKDNLDDLRVIKENLFKYSFNSSLVSDDFLKKIGV KLDIANINDLAYDNFLSEFYSKSSSQLWNEQYLKEFQEEIVQRHVNNMSD IGTILNVFEIGCGEGKETISFVNVLYESYKNPFKVTAIDNDFNKVIGTSN LVFLESEINLSEIYRKNSFEQASGVYKFKPEIMNSILFEYSDAILSEFPE NLGIVFLRDILCFLNDDGQVLILNAIAEKSVRGALLILGDNEELKNNDLF IKDKSVKYFNLYKRI >BRE_677 cheX, chemotaxis protein CheX MRIDYIEPFLDAASSVLRDMLLVDDIQMGSPGLKSINQKIKGVSVIVGLA GSVEGSIIIDMDIDTALFVASKLNFEEYVDFDDEETKEMVAATLTEVGNI IAGNFVTTLHSKGFVFDITPPAFIYGENMKISNKGSEALIVPFTLPDNKI IEVNIAIRERV >BRE_556 cheY-1, chemotaxis response regulator MLKLDEGVWKLEENKKALIVDDSIFMRKNLIKILKNLGFNEFLEAEDGIQ AIQEFKKQETLHLITLDITMMGMDGITALEKINALNKNLERKLNILMVTA LGKQELIAKALQLGAKGYITKPFREEQIAEQIKTLN >BRE_575 cheY-2, chemotaxis response regulator MQKRILVIDDNRAIRQSVAYILEQNGFAVAEAQDGLEGVSKFKEAVGQSD KDFDLVITDINMPNLDGIGVIKEIRELGSFVPILVLTTESEQSKVDEGRK AGATGWLVKPFNPNTLMQTISKIF >BRE_678 cheY3, chemotaxis response regulator MIQKTTIAMDASNKPRGINYDTGVPFNVLIVDDSVFTVKQLTQIFTSEGF NVIDTAADGEEAVVKYKNHYPNVDIVTLDITMPRMDGMTCLDNIIEFDKN AKVIMISALGKEQLVKECLIKGAKTFIVKPLDRAKVLQRVMSVFVK >BRE_845 clpC, ATP-dependent Clp protease, subunit C MNLVEISSREVARKNKNREVSSWHLLMSILLIHPKKSEIKNIETKTLKNI KQDTLYEIEKLEKVLIGTNEIVIPKISREIFTLIDQTKKEFKSKTLIGIK EIFYQILKTKKLLKKYKLNKLSFNFDEDNIITSIDKIRLIETYKEFEDET RQNDYFEINKYVKNLTTLAKEKKLDPLIGREKEIQSLISILERRNKNSTI LIGEPGIGKTAIVEGLAIKIANKEIKSQLQNKIILQIETSDLVSGTKYRG EFEERLNNIIKSIKNNKNIIIFIDEIHTLIGAGNSEGSIDAANILKPILS RSAIQIIGATTYDEYRKHISKDKAFTRRFQTISIKEPDEKETLNIINSII KNFENYHGVTYEKEAIENVISLSSQYLTNRKFPDKAIDLIDIAGAQKKQQ EINTKIVNAEDVKNTTDEFFGIKVKLSLTEEIAYLKEETINIKEKIIGQE SAIDEIIIEMVKTKLGINNNIQPLTSILLIGSSGSGKTILSKTISKIMIK DQNSILQLDMSDYREETSISKLIGTNPGYAGYTDGGILINRLKYNPRAFI IFENIEYAHNSVMSIIEQILENGELIDNTEDKISFKNSIIVLSTSIGSKI LLGKGILGFNKTDNNIDIKSTINNELKTKFKLSLIDKIQKKIILNVLTEK DLSIIYDNYCKELTQKFSLKNIQIEIDDSLKNHIIKKYYDKNSGARSILN AVKENIEEKIINQIFHNPNINLIKIYLEQNNIKIKQKEILCSKK >BRE_617 clpP-1, ATP-dependent Clp protease proteolytic component MIRECMHNLVPTVVEHTGNYERVFDIYSRLLRDRIIFLSGEINDLRGDTV IAQLLFLESEDSKKDIYLYINSPGGSITAGLAIYDTMQYIKPDVRTICIG QAASMAAFLLAGGAVGKRESLSYSRIMIHQPWGGIGGQASDISIQANEII RLKRLIIDIMSEKIGVSKEKLALDIERDYFMTPEGALNYGIIDSILVRN >BRE_764 clpP-2, ATP-dependent Clp protease proteolytic component MDFKDMNVQTEIQKSLEFALKSRSIVITGEIDKDTSKLFQEKILFLEASD STKPIFVYIDSEGGDIDAGFAIFNMIRFVRPKVFTIGVGLVASAGALIFL AADSKSRFSLPHARYLLHQPLSGFKGVATDIEIYTNELNKVKSELNDIIA KETGQELNKVEKDTDRDFWLDSESAVKYGLVFQIITTRLELEKFIS >BRE_618 clpX, ATP-dependent Clp protease, subunit X MARSKSQKIEGCSFCGRTRAEAEGKIISAKSVAICFECSKICHNLFKEES DKPASNKAPRGLPTPKQLKSHLDKYIIGQEDAKKVLSVAVYNHYKRIFKG SKRETGVELEKSNVLLVGPTGSGKTLLAKKLAAEMNVPFAIADATTLTEA GYVGEDVENILLKLIHAANGDVSFAERGIIYIDEIDKIAKKGENVSITRD VSGEGVQQSLLKIIEGTIANVPPRGGRKHPYEETIAINTHDILFICGGAF VGLENIIKKRINRSFIGFSSSSCKDTGGDNSLKYLEMEDLIKFGLIPEFV GRLPVHSYLDKLEKKDLMKILVEPENSIVRQYYHMFKMDNVDLLFEKDAL DAIAEEAMLKNTGARGLRSILEELLKDVMFEIPSSKQIKKVIVTKDSVLN TNVEPLILTGRHVNKPWAKELYEINSKSN >BRE_131 cmk, cytidylate kinase MIIAIDGPSASGKSSVSKALSMKLGFKFISSGYLYRIITLIAQRFTLNEY DLLNESKLVDLISQNDIKYNDNSFLLNGVDVISHILTEKIDFQVSLYSSY VNIRKIVNKKLREIVKIQDDDYIIEGRDITTVVFPEAKIKIYLDASVEVR TLRRYNQRDDDMALIELEQALEKRDEIDQNKEYGKLKLGKGVFYIDTSYK SLDDVCDIIIKTFNLKKK >BRE_552 coaE, dephospho-CoA kinase MGRHSSIIGITGRISTGKDTVSKIISNEYDFYEINADKIGHIILEEKKNT IIKTFGNKILNNINEIDRIKLRNIVFYDKEKLQILEKITHPIIHQKIEQI ILTNKSNKIIINAALLFKLDLAKFCKHIFIIKANDEIIKNRLKLNRNIDD KLIINILKWQKDIFFNKNIINSKIINIINNKSYEYLKRKIRAKMREVT >BRE_846 cpsG, phosphomannomutase MKNNKLQKKLKQYIQFEKNNFFKDEAIKLLKENNETEIYNRFHKELEFGT AGMRGIIGAGSCYINTYNIAKASQGIANYILTITQNPKIAISYDSRHFSK EFAYEAAEIFASNGIKIYIYKNLRATPQLSYTVRKLNCDLGIMITASHNT KEYNGYKVYWKGGAQIIDPHDAKIISEIQKVSNIKHTFIKREGINKRIII ELKNEIDIKYIQKINDEFPNFNQKSKTTNLRIAYTPLHGTGGTIIKKLFK GSKVELLTEQTQINPDPEFPTVKYPNPEEHTTMSRVIELAKKTNCDIAFA TDPDADRLGIAFKESRKWKILNGNQIACILMHYLLSRENNPKNTFIIASF VTTPMLDKIAQKYNTTLYRTYTGFKWIGNLIDKIQKKEPNKKFIFGCEES HGYLIGTGTRDKDAFSAIKGFCDLMLTLKKNQITINQYLQTMYKEFGYYE DFTINKIFKETNGDFLREKLMLQFRNNITKKFAGLFIIKKLDYKTLKEID MHGNVYTIKGYTHTTNAIKFLLENKIEITIRPSGTEAKIKFYISIYSRYE QKNSIFDIMNKIKMEIEKY >BRE_564 crr, PTS system, glucose-specific IIA component MGFLGFFKKVATLDLIAPVSGKVVSIDKVPDEAFAEKIVGDGIAIMPTGN ELVAPCDGNIGKIFKTNHAFSLETKEGIEIFVHFGINTLNLNGKGFTRVA EEGMSVKQGDVIIRLDLEYLKAHAESIVTPVVIANSDEVSSIEYVFGKLD DDSEYVVSSTTTLTEDIETKILQASPVEAGKDIVLRVKK >BRE_182 csrA, carbon storage regulator MLVLSRKANESIKIDSNIEISILEIKKDSVKIAIKAPENIKILRSEIYDI IKEENKKSILQDKNNIHKIKKLFDYFSK >BRE_795 ctc, 50S ribosomal protein L25, general stress protein MYSSRILKYEGRSKFGSSCARILRAKSEIPAVVYGKESDVLHIKINSNEF DKKFAKFTDNTVLLLNDGMVEKCVFIKDVSENLTKKFIYHIDFYEVDRTR EIERDISIKFIGASVGVKEGGTLSVLRNTVKVKALPLNLPEFVEVDLTPV KKGDQITLKDIVLSDNVKLSETDENLAVLFVK >BRE_360 ctp, carboxyl-terminal protease MCRNFSMKKKFLVFLYVVLALVISSSVIVESIFAQANSSKSNLSASSYGQ MMIEAFNFIKKNYVEPIDDEAVFEGALQGMFKALNDPYSQYLTKKDLVEI SKTTEGNYVGIGVVIAKKEISKKSNNTASDVPYIMIINAFEEGPAYRAGV RSGDYIKAIDGNSTDSMTIEQVSEFLKGKAGTKVKISILRNKNLELEYDL VREKIDIETIKYSVINNDVGYIRILSFNPSTNIYFKKAFEKLKLQNIKSL ILDLRLNLGGYLTDAIEIANDILVEGLIVSTKARDFKIPLEYVTREYRAD SSHIVPLDMPIVALIDKYSASASEVLVGALRDNQRVYVIGEKSYGKGVIQ RIVPFHTGGFKITHSKYYTPSGQSIHNVGIKPDLEIKERELSEVEFGVYT RMLNEEAIEKFLNSKINKKSLSEKEVDIFVNKFLETSYVKAGKDISNIDK KALGRYLFLQFYQDIHHNQPIYNLYYDEVLKTAYEYLVKKGTQN >BRE_842 cutC, copper homeostasis protein cutC MLVELGADRIELCENMFCGGTTPFYGTIKILKQILVDIPIVVMIRPRGGN FVYSTLEFQVMQEDIEICKSLGVEEVVFDILRDNGEIDIEKTKYLLNFSY PLKVTFHKAIDETHDIKDSVANLLDIGVHRILTSGGGLKAEDSLMILKDL ILMSRNKVEIVVAGKVNKSNIDSIDAILDAKAYHGRLIVGDLSLF >BRE_603 cysS, cysteinyl-tRNA synthetase MMVFMLLKLYNTKTKCLSEVKNLSETKIYACGPTVYNYAHIGNLRTYIFE DLLIKSLKLFKYNVNYAMNITDIGHLTGDFDDGEDKVVKAAKERGLTVYD ISRFFTKAFFDDCKKLNILYPDKVLVASEYILDMIEVVKVLEKNGFTYFV NGNVYFDISRFKNYGQMAGINLNDINENSVSRVELDFSKRNKSDFVLWFT NSKFQNQEMKWDSPWGFGYPSWHLECATMNLNYFNSTLNIHLGGIDHIRV HHVNEIAIMECYLGKNWCDMFIHGEFLIMENEKMSKSNNDFITIKNLEDE GFSPLDFRYFCLTAHYRTQLKFTFHSLKACKVARENLLSKLTSCYSSLSQ FDISLLSQDDENIEFILEHKYYDSFLERIAFDLNIPKVLALLWDIVRDNN LSSLSKLKLAFKFDEVLSLGLREEILREIDMSRIVIDDVMNSLIEERRLA KLKKDFKRADEIREYCRSKGFILIDTEEGTKVKRG >BRE_609 dacA, serine-type D-Ala-D-Ala carboxypeptidase MNVSSFFYLPFNSITNFYAIIYNIYCMKIIFIIMSMFLLFNAYKLFSITL LQIEKVVLDAKSVVLLDCDTKCVLYSKNPNLVFPPASLTKLVTIYTALVE AKKQNIDLNAIVPISSSASYYNLPLDSSLMFLEEGHKVTFEELLKGLVVS SGNDAAIAIAEFIVGKDLNNFVNLMNDNVFKLKLINTSFVDTSGYSKNNK ITALEMALFAKTYIDEFEFMLKIHSLKDFIYPKPENLGSTSSSKMLNLKQ DNKNILILNYPYADGLKTGYIKTSGLNLVATAKKDDIRLIAVILGVSKGV DNIGEKKRSLIAQKLFEYGFDHYSKFFCIGKNK >BRE_238 dck, deoxyguanosine/deoxyadenosine kinase(I) subunit 2 MDAGLVIVIEGLIGVSKTTLGHILSLDLEIPFYRELNNEFTLSMLNEFYK DKFRWAFPMQISFLNERFKLIKSVFKSKGKGILDISIYSDCVFASFLNDN GYISDNEYKIYLDLLDNMLEHSKKPELMIYLDCSIAEAENRIKKRNRSCE TDISKDYLEKLNKKYLTWYDSYNLSPKLMFNYDKINVFDDREKSNLITFI KDKLVI >BRE_197 ddlA, D-alanine--D-alanine ligase MKKNLMLIFGGVSFEHEISLRSAYGIYSSLLKLDKYNVFSIFVDKVTGIW YLLDSVPSSAELIKRHTTSIVNFIPGCGIFVNNKSLEIDVIFPIIHGRTG EDGAIQGFVKMMDIPCVGAGILGSAISINKYFCKVLLKSFNIPVVSFIGF KKDDYILNKEGIKEDINNKLNYPVIVKPSVLGSSIGINVAYNVSQIEKYI EEAFEYDLTVVVEKFIKAREIECAVIGNDQIKIFTPGEIVVQDFIFYDYD AKYSTVPGDSIVFNIPAHLDMKHLLDIKEYAFLTYKYLELRGMARIDFLI SKDTNLLYVNEVNTIPGFTDISMFAKMCEHDGLSYESLVDKLITLAFESY KKRKDKIDFTRLES >BRE_250 dedA, DedA protein MYIILEFIDLNIAYAPIVFFVLLILAGLNIPISEDAIVIMGGILASRKNE YTILIFLGIFWGAYIGDIISFYIGRFLANKFLKQKTKTNNLLDKINYYYK HYGSLTLLFGRFIPFGFRNAIFISAGMGNMHSSNFFIIDLFAAMISITTY FTLSFKIGESFNTIFPKIRFILLIIFIIIIIIILILLRYILKKKKPKKVD KLFE >BRE_68 def, polypeptide deformylase MEIVFYPDDLLRVQTKDVENIDDELRSIIFEMIGLMDKSKGVGLAAPQVG LDLSIFVVRKNMMSKPLVFINPVITSKSVELSVYKEGCLSIPGVYYDLSR PKSIVIEAYDENGKFFKIEDLDILARIIQHEMDHLKGVLFIDYYEDKLRN KLLKSYLKERRLVKF >BRE_823 dfp, pantothenate metabolism flavoprotein MTLAKNTLFINKNPFKNIKYNYIIFYKINMKKHKNILIGVCGGIAAYKAA YIISNLIKMGYNVKVIMTENATKFITPLTLETLSKSKVITNLWNTNHEEV EHINLARWADLILIIPATYNFISKIAAGIADDILSIVLSASKAPTYFAIA MNNIMYQNPILQENIKKLQKYNYKFIEPDKGFLACSLNAIGRLKNENDIL SIISNSPMTKLPLKNKKILITASRTEEELDPIRYFSNKSTGQMGFNIGIE AQNLGANVTIITGPSNEETPYGINVIRIKTAAEMYKETIDIYKEFDIIIG TAAVADFRPDKIYKTKIEKNNIEELNIKLVKNLDIIEHIGKNKTKNQIVI GFCAQKDEILIKKAREKLETKNLDYIIANDLKYFGSNVNKIYIINKDKVK KFPEMSKKETAIEILKILYQ >BRE_308 divIB, cell division protein MGIYRKILIIYIYVIISFILLEIIFIIFISPYFLIRYISFNDDIHISKED ILSISGIKPNTYYYNADISIYEKNIMKDLRVKNVKIKLKFPNMISINIER RVPVATAYENINGSFVYYFIASDGVILEKSKDLIYDLPIISGLNLTGIEV GDFLEDGMLTIIKNLNYVKINQNTLYNLISEINFLKLNFYDYKIILYIKN IYNKILIRMDMDLISVMHKVFMISNLLKKGFDIVDLRSGDIILLGEN >BRE_437 dnaA, chromosomal replication initiator protein MQEGKNIWSLILAAIRKELSEEEFYIWFENLYFIDAIGENIKIATPNSFH KNQVEKRFSKRIKEILIEKGHSTINVEFIHSQNELKDHNTESKDIPLKAI THQQDLQTKNKDIKTHAKNIINNTKQYSIKEEIHIKYRNPFLKKKYTFEN FIIGTNNKLAYNASLSIAKNPGKKYNPCLIYGGVGLGKTHLLQSIGNKTE ELHKEFKILYVTAENFLNEFVESIKTNETKRFKKKYRHLDMLLLDDIHDL QKKEGIQEELFHTFNALYEDNKQMVFTCDRQPSELVNFTDRLKSRFTRGL NVDISKPNFELRVAIIEKKAEEDGIKVPKNILNLVAKKVTTNIRDLEAAV TKLKAHIDLEDIEIDTNIVDKIIKEIIAYENDHTNTPNKINIENIKKVIL RELKLTNKDIEGNSKKPEITKARHIYAYLLRNFTELSTIEIGKIIGGKTH STVLYSINKIDKDRNKNLEINNLIIELMNKINKN >BRE_113 dnaB, replicative DNA helicase MAFTSISTTSTLLFNEGAEKAVISSIFYNPGKVEEALLYLKPDDFYNQDH EMIFKAMISLYEKRENIDPITVFEEVSTITPKSQLVNNLKALTGLQDYLS FLSGYLPTDKTINIYAKIVKEHRIRRDIAKISRELNDLANDSTKKVEQFV EEAQRQVLSIELDCSNKNLNHAKVIAERVHAEIYERSVQKREVDFGIPSG FKKVDSLIGGFRESDFIIIGARPSVGKTAFALNIASSIALKGDKKRRVGF FSLEMTSDALIKRIIASQANIDGFKIQNSILSGHEIKAINDVVNDISNSE FYIEDTANISLLTLATQARKLKRFSGIDILFVDYISLISLESKNVPRHEQ VASISKALKELARELKIPIVALSQLTRDTEGREPSLASLRESGALEQDAD IVILLHRDKDLKNNSDDDDGIVNAIDTKVIVAKHRNGPTGRVDILFLPHV VKFVNKEHEMDYYL >BRE_585 dnaE, DNA polymerase III, subunit alpha MNLKAKFVHLHVHSDFSLLDGAAKIVDIVSKAKEYNMSHIALTDHGNLFG AIKFYREAKKAGIKPIIGIEAYMSNTLKYIKKNDEFGKPYYHLILLAKNE QGYKNLLKLTSVSYLEGFYYRPRMDRDDLAKYSEGLICMSACIGGIIPQL ILSNRFDDAKNEILWFKNTFGDDFYLELQRHGIKQQDIVNEKLIAYSKEL DVQLSVSNDSHYVNKEDATAQDIIVCIGTGAKRSDSGRFKMETDEFYLKS PEEMCELFKDLPEALANTLKIAEKCNDFEIKFPGPIFPEYHIPEEFDTQG QYLEHLTLEGLKFRYANITDNIKERAFYELSTIINMGFEAYFLIVWDFIK FAHDNDIPVGPGRGSGAGSIVAYALRITDVDPLKYNLLFERFLNPERVSM PDFDIDFCFEGRDEVIKYVTKKYGEDKVAQIITFGTLKPKAVFKDVGRVL DIPFVQSNEITKLIPDGPKVSLREVLKDKVLKKYLNKGPVYNELMEAALV LEGMNRHASTHAAGIVIARTSLTDYVPLYKDYKQDTVSTQYTMDLLEDCG LVKMDFLGLKTLTLIKNAEKLIKITDPDFSIATISDSDAKTFKMLSEGRS TSVFQFESEGMQQILKDSKPDNIEDLIALNALYRPGPMQFIPQFVAAKTG AKRIKYPHPDLTEVLKPTYGVIVYQEQVMEVAKIIGGFSLGKADILRRAM GKKKEDEMNRMKVDFIKGALEKGYDETLASDIFELLKPFAGYGFNKSHAA AYSLIAYQTAYLKANYPASFMAANLTNEINNTEKLSYYIEETKSMGINVL RPDINQSFKDFRVVGSDISYGLNGIKNIGELMVDLILNERQENGEYKSFE DFIKRVDKKVINKKFLEASIKSGLFDSLGQNRRTLIENLDKLIAFVLENK NAKKQGQNSLFASQNILEETFNYNLFEEYSYLELLGFEKELLGFYVSGHP LDPYKSELEFFTNFNVVKDLASRRNTVVKFAGSLNFIRVVHLKKNNARMA FGIVENFEGSIEIVVFPESYDRYKHLLIEDDVIGVIGKLTFSRDKFSIIV EKILTIKEISINKINNLHIKFTNKGLNDSNLLTSLKNKIFDLEDDTGFSY VYLYLKNNGRDLKLKMDLILNFKPDEFKINELKDHKIVEDIWFD >BRE_717 dnaG, DNA primase MEYAKIIDLIKQRVDIVNIISEHVSLVKSGAFYKGLCPFHAERTPSFTIT PSQGLFYCFGCKKGGDVVKFLMDIEKLNYNDAVDSLCTKIGIEYDSATRS MGIKRKIHDKTLISEIYNLNAKLIKVFVFFLNNNQKILSYIFQERRISRE IVDLFNIGYLLCDVVGKSSFYDFLVSKGYSSSILSKSGLFASRREKFSIL SGRLIFPIKDFKGNVVGFGGRILGKNNGSKYINLSETRVFKKRELLYGFY EGLSMIKETRSIILTEGYIDVLAFFTAGIKIAVSTLGTSFSTQHLALIKR YADKILICFDDDMAGLVATFKAYQICLPFNIDVSVIRMKYGVDPADVLKN KGVSVLSNMVNDSCDAFEYLLEKYSLKYDLNKTTDLNSMVNLFINLIGLS STNTQRDLLLLKLESKLGVKLETLRKDYYSMREKKAIASYKKNACSYEVN TYERYLLVALLKDFNYFTIIRRNINDSDLYDIDVKKIFVCFENLFDNNKS FSLFNLKELLKNKYGSISEIFFENMLRVEFEVDDEMVKQILFAIKKRKVE NRILAFKEMIKNYVSIDAKAQIRELMFLNMQRENLRIYLNE >BRE_606 dnaJ, chaperone protein DnaJ MIVAVYNLFQIIFLLLPFILIFSPFILGIFFIFFILSIIYSILGGFRIST TTRDYFYSKSREFEFYKLSFLLMAKLISILGSMTGEQLNYISFIMNSLNL SERDKSELYNLFHFSVTQNRNADKILYTLKLGYFQRKDLFVWLVSVLKEI NNLARYKSLEGDKFILYVSSFLELDFESYDSYKNVDIKVVNPYEVLGLKY DASDDDIKRAYKKLVIQYHPDKFENEPVKQKEANEKFIRIQDAYERISKE RNLK >BRE_522 dnaJ-1, heat shock protein MKRDYYEILGLSKGASKDEIKKAYRKIAIKYHPDKNKDNKEAESIFKEAT EAYEVLSDDNKRAQYDRFGHTAFEGGASGFSGFSSGFSGFSDIFEDFGDI FDSFFTGKRGQDKNRYQERGQDLTYQIEISLEDAYLGYKNNINISRNILC ESCLGKKSEKGTSPSVCNMCNGNGRVMQGGGFFRVTTTCPKCYGNGKIIS NPCKSCKGAGGVKHKETLELKIPAGIDDAQQIKMRAKGSINPDSQQYGDL YIKILIKPHKIFKRNGKDLYATLPISFTQAALGKEIKIQTIANKKISIKI PKGTENDEQIIVKNEGMPILHTEKFGNLILIIKVKTPKNLNNNAIKLLET LSKEIKDIDEVTLNKI >BRE_661 dnaJ-2, heat shock protein MSKDYYNILGVSKNATTEEIKKAYKKLAIKYHPDKNKENKFAEEKFKEIN EAYEVLSSPQKKSNYDNFGNADFNNNFNTDSFTKGFKNSGFQHFDNFDLF SNIFGEFTKGTIQDKEVTIKISLYDAYMGGKKFILINNEKIEINIPKGTI DTTKLKFNGKGNTNPISGKRSNLIIKFEISSYKNFTLKDRNLETQINVYP WEIALGSEKIFETIEGKKIKIKIPKNTKNGEILNLKGLGMPALENAIKGD LKVKLIVDVPPIINDEVKIIYEKLKEIYNKKF >BRE_271 dnaK-1, heat shock protein 70 MMEKWIGIDLGTTNTVVSYFDVNSRVILNDRGERMTPSIVSFTDFGVIVG SAAKHQILVNPAKTFYNFKVNMGTDVVYQVGDNIYKAEDIASHLLLNIKI NAEKFLGTQVSNAVITVPAYFSEIQRRGVVRAADIAGLKCRAILNEPTAA ALSYAFEKQVEGLFLVYDLGGGTFDVTLLEKQNDTYTVLASKGENRLGGN DFNEVVEKHVLASFKEEYPDINLDDIVLIEQLREKIEDAKKNLSTMDEVN IVLPFTDGNHLNYKLTRDEFNLMIWDFIDRTISLTNECITDSGVDLKHIL KIVLSGGSTRIPLVKDRLNEVFPEIEILDSLNQDEVVATGAGIHAFSLAN NDTLIDFKDVTPYSLGIETCDDGFFTLIKRNTLLPVCERQIFTTTNDYQE EIEIHVLQGEYNKASLNCSISRFFFSNIQNALKGVPKIEILFRLDESGIL SIAARDLDINVSKSIKIRMTSASFDNNEKECLLISSGNIRAKEILEDKIE LL >BRE_523 dnaK-2, heat shock protein 70 MGKIIGIDLGTTNSCVAIMEHGKPVVIQNSEGGRTTPSIVAYTNKGERLV GQVAKNQMVTNPENTIYSIKRFMGRRFEEVASEIKMVPYKVEKGQNGDAR VNISNIKKQMSPPEISAATLTKMKETAEAYLGEKVTEAVITVPAYFNDAQ RQATKDAGKIAGLDVKRIVNEPTAAALAYGIEKKHEEIVAVYDLGGGTFD ISILELGDGVFEVKSTNGDTHLGGDNFDDEIIKYLITEFKKDSAIDLSND KMALQRLKEAAEKAKIELSGAQEASINLPFITADANGPKHLQYTLTRAKF EQMVDHLVQKTKEPCLKAIKDAGLKASDINEVILVGGSTRIPAIQKIVKE IFGQEPNKGVNPDEAVAIGAAIQGGILTGEAKDMVLLDVTPLSLGIETLG GVMTKLIERNTTIPTKKSQVFSTAADNQTSVDIKVLQGEREMASQNRVLG NFILDGIPAAPRGVPQIEVSFDIDANGIVHVSAKDMGTGKEQKIRIESSS GLSEEEIERMVKDAESHAEEDKKLKEGIEAKNIANSLIYQTEKSLKEYGE KITNQDKEAIENKIKELKDTLEGSDISLLKSKTEELQQASYKIAEMMYKD AQASSPAQNNAQNNAGSESKEADYEVVDEDKK >BRE_438 dnaN, DNA polymerase III, subunit beta MNEKFILCDTEQISDEIDKAKSIILNRNINDIWSAILLEIKSSNLTIKAT DRNIFFESTIPIVSTDNFNVLINASNLADAVKALNLYDELKMKFKEDENK LDIIGESDNNNENYINDHLSEPTFSTEEIENYNYDINDEVYNFAFELNQK DLKRIINKVAFSASHDESKNALNGIYFTKDSNSVLTLVSTNSYRMSIYKT DLIFEEDVNFIVPVKMFNLLKQMITGEGIIKFKVSDKKFYVEFNNYKIAC SLISGNYPDYESIIPNEYTNRALIDVFMFKDRLSRVNSYTDKRSKKVILN FSVNQLKLMAEDPITGRKGEFFMQGSNYDYAGTEEMLAINSVYITEAMGV FDTPKLEIKFSSGGLLKLNEEDKCDFIHLIMPLMFN >BRE_466 dnaX, DNA polymerase III, gamma and tau subunits MLFMGDGMISARGTAIKRRPRDFTSLEGQDFVVETLKHSIESNKIANAYI FSGPRGVGKTSSARAFSRCLNCQTGPTIMPCGTCFNCKSIDNDNSLDVIE IDGASNTSVQDVRQIKEEIMFPPANSRYRVYIIDEVHMLSNSAFNALLKT VEEPPNYIVFIFATTEVHKLPDTIKSRCQHFNFRLLPLDKIYEMLKCVCL EDDIKYEDEALKWIAYKSGGSVRDAYTLFDQIVSLSNSDIKFDQIRSKMG LTSDEFLEKLVLSILNDDLKELLSVLDTVFLTGISCEQFLLDAIEFFREI LFLKLDIKNIMFIGIKFESLKESLLNFDLQHVERSISVLLETYRDLQFSI NPKYEIEINFIKILRLKNYIPNHLLIKQIQDIETKALNEINCDIDKINCD VNLKSELSDVPLMEPDNATEEEIPLKVKIQEPDVHCDSEDDDIDKIFIET KDNFDKIDDNDRIKETFIYLVSKYVQTLVYSGEVLIDGGVLYYKIFSGFE YNQLQAYQNEIRTEFCKEFPRLNVIFQKQFKDNDDEFDNEVLRVKNIFGA SEVKE >BRE_214 efp, elongation factor EF-P MSTIKSGDIDKGSFLLFKGMPHIVLEREFSKMGRGGSIVRLKLKNLKNKS VIKETLKGSDTVEEIEVLEVNSQYLYKDNESLIFMDLETYDQFSVNLRDV VNLEDKVLFLQEAEVYSLIKWGNEVIDLKLPPKVAFEVVDAEIAVKGDTV TNAMKNVTLHTDLVVKAPLFINIGDKILVNSETKEYAERVKV >BRE_340 eno, enolase MGFHIYEIKARQIIDSRGNPTVEADVILEDGTLGRAAVPSGASTGTNEAV ELRDGDKSVYMGKGVLKAVENIINIISPELEGMSALNQVEIDRKMLELDG TPNKSKLGTNAILAVSMATARAAAEHLGLKVYQYLGTYKANILPTPMCNI INGGAHSDNSVDFQEFMIMPIGAKTFSDAIRMSAEVFHTLKSILSKKGYA TSVGDEGGFAPNLKSNEEACEVIMEAIKSAGYTPGTDIAIALDPATSELY DPKTKKYVFKWSTKEELTSQEMVEYWAKWVEKYPIISIEDGMAEEDWDGW KKLTDKIGNKIQLVGDDLFVTNTSFLKKGIEMKVANAILIKVNQIGTLTE TFEAVEMAKKAGYTAIVSHRSGETEDTTIADLVVALGTGQIKTGSLSRTD RIAKYNQLLRIEEELGSIAEYHGKDVFYSINK >BRE_666 era, GTP-binding protein MKSGFVSIIGRPSTGKSTLLNSICGHQISITSSTPQTTRNKIKGIFTDKR GQIIFIDTPGFHLSKKNFNIALMNNVYSAIIETELIIYVIDIQDQPGTEE NEILTIIQRSKINFIVAINKIDIHKTKEKEIMTFLEEKKIQKNKIIKISA EKQINIETMKDKIYENLNEGPLYYPKEYYTDQKINLRISEIIRGVTIKKL KEELPYSIYTEIEILEDRENKFFIKANIIVAGESQKGIIVGKGGKGIKSI GEESRKIISKILEKKCNLFLQVKLRKNWNKNAKLIKNLIN >BRE_534 exoA, exodeoxyribonuclease III MMNLISWNVNGIRAVSNKGFLNFIAEYSPDILCLQETKALKEQLPRELID IEGYYSYFSKSIIKGYSGVAIYSKIEPIKLENMNIEIFDREGRCIIAHYH DFILINAYFPNSQSLRKRLNYKLEFLMSFESIANSFVTSGKNLIVCGDFN IAHTEIDLSNPKTSRESAGFYVEETNWMDNFLNRGYVDTFRMFNKEPGNY TWWDYKTRARERNVGWRIDYFVINKAFQFKVKDALILNKVMGSDHCPVFL KLKQ >BRE_111 fadA, acetyl-CoA C-acetyltransferase MKKIAIIGGLRSPITRFGGTLKGMNIVDVSADIVKVLLERNSIDKVDEVI VGNVISSGLGQNIARQITLKASLGEAIPAFSVNKVCGSGLKSLELAFNSI SLGESEVVVAGGVEDLSNAPYLLPRNVRFDGLKFGDFKIEDSIYKDALVD TPSSTVMGITAENLAEMYEITREMQDQFAYNSHMKAKVARDSGYFNDEIY PLSIFDKKTKLKNVVSSDEEIRDNLSLEKLASLKPIFKENGTITAGNSSS LDDGACFLILASGDFVHKMNVKPLAYIGGFKSVGLNPLHMGFGAFLAIEG IIEKFSLNSNEIDFIETNEAFAAQSLSVLKALREKYGIKDDIVNVNGGAI ALGHPFSVSGSRILLTLARLMNMNNKSKGIASLCIGGGQGIAAFLYR >BRE_446 fba, fructose-bisphosphate aldolase MGVLNKIKPGVVYGKDLHTLYEICKSEGFAIPAINCVGTNSINAVLEAAK EINSPIMIQFSNSGSSFVAGKGLKVEKSQGTSILGAISGAMHVHLLAEHY GIPVVLHTDHCAKNLIPWVEGLLEYGEKYYKEHNRPLFSSHMLDLSEEPI KENIEMSKKFLERMSKIEMFLEIELGITGGEEDGVDNSERAHHELFSTPE DIYYGYSELIKISPNFQIAAAFGNVHGVYKPGNVQLTPKVLRDGQNYVIS KINSTNPKPVSYVFHGGSGSTLEEIHEALSYGIVKMNIDTDTQWAAWEGV LNYYKKNENRLQGQLGDGKDADVPNKKFYDPRVWLRESEISIKERVKIAC KNLNNINRN >BRE_591 femA, FemA protein MDTQKIEIENLNENYLQSKLWAVVKQNFSKQSAWKAIALNNNQFNKILVM QRRLFGNFYLSYVAHPEFSNKRIEDINIDKINNQIKKFSENIRQYLHKNT IFVRYDLMFYTSRSSKDKYIPLKIKFKNLKKSFDDIQPSNTTILNLNDSI DNIKAKMKKKTRYNINLSNKKNIKVIIDDDFKYFDEFYELYKETAQRDKF AIHSKDYIKHLIKAFKEDKHSTIKLIIALHNEKLISGIIVGIYKDKATYL YGASSNTNRHLMPNYAVQFETIQMLKKLSITEYDFLGIPPTADTKHPLFG LFQFKTGFGGTIIHRIGCYDFVYKKFLYNIYNIVEILRYIYYKVIKKRI >BRE_9 femD, phosphoglucomutase MLKNYILNMRNLKKSINEMILSPSGFRKIFAQSKKENSMDNEINEDDKIL VAIISLTISNYFQDKPKQYINVGLDSRATGNVISQIIIKTLILNNNKINF FGILPIPEILAYTKISKNSKGFIYISASHNPKGYNGIKTGLDDGGVLNSN EINKIIKQIKSNIQNENLIKNLIKKLQNFNNNTKYLKTYETIIASKDKLK AQSYNAYKSLMQQIIYSDEYNQENIDILKANIKKEQIGIIAEMNGGSRIN SIDKEILQSLGLKLEFYNTEIGIFKHGMTPEGKSLNMCKKILEQKFQKDN SFQLGYVPDCDGDRGNLITINKNGQANIISSQKIFALSVLSELSYLYHIG IKKNLAVVVNDATSLNIEKIASLFNAKVYRVEVGEANLTEMADILRNKGL IIKIFGEGSNGGNITHPSKVRDPLATVFSIIKLLKIKNLYKIWCTLSQNS YNEYYNLDDILKTINFYSNVEVSSKEAILKIRVQNQETLKTNYEKLLKTE FNKNNTIINQLQINNYEILNYEGITQTTTRTRDASGGLKVLLKNDKHEII GSLWMRGSKTEPIFRVLSEVKSEYHNLLYDILDFHKHLIKTANSII >BRE_700 ffh, signal recognition particle protein MFENLSAGFKDFIKYVSGKAVINEKNIETAIDTIKNTLIEADVNLRVVRR FVNSVVEEAKGIKVLRGVDPKSHFIKIVNDKLVNFLGDKHSELILNPINK LSCILMLGLQGSGKTTTCAKLAMRLKSENRKVLLVAADTFRAAAIEQLKV LGAQINISVFALENEDSPIKVVKKSIEYARVELFDTVIIDTRGRLEVEDL LLREIIDIKNIVVPTETILVADAMTGQVAVNIAKKFNESVGITGVIFTKF DSDARGGAILSLKTICGVPIKFVGVGEKPEDLDVFYPDRVSSRILGMGDV VTLVEKAQSIIDKEEALKLEEKVRKANFNFEDYLNQFKYMRNMGGVSTLM GMLPGVSSEMLNRNVNERELKREEAIILSMTQRERRNPVILNSSSRKKRI ALGSGTTIFEVNKLIKKFSQIVLMLKKMKNKSFQNKIASLFGGKGGMVD >BRE_674 flaA, flagellar filament outer layer protein MMDKMKKSVFILFFIIFLIPVFGQETSRKSSGDGSSDGEPGELVLDFAEL AKDPSSTELDLTDYIDRVYSGASSIMKPEDMVLNLGINNWSVLLTPSARM QAYVKNSIVVPAVVKSDSRRYAGETILGIRVLFPSYIQSSAMVLPPFKIP FYAGENGNQFVGRGLIDNVRIMKEVKVTVYSLGHDVDLEVLFEDMSGMEY VYPLGSLKFKGWADLVWSNPTYLPGISSRTADNSVPNYPLPSSKMRFKAF RVSKFHSSREQNLIFYIKDLRVIYDKLSISLDFDVDNESIFKIYETRGVE SLRKLKSQEALKKVLKVRESISMPDESFQDLFEKGKKSSNDKSGVRTEK >BRE_149 flaB, flagellar filament 41 kDa core protein MIINHNTSAINASRNNAINVANLSKTQEKLSSGHRINRASDDAAGMGVAG KINAQIRGLSQASRNTSKAINFIQTTEGNLDEVEKVLVRMKELAVQSGNG TYSDADRGSIQIEVEQLTDEINRIADQAQYNHMHMLSNRSSAEHVRTAEE LGMQPVKINTPASLSESQASWTLRVHVGANQDEAIAVNIYAANVANLFSG EGAQQVAPAQEGAQQEGAQAAPAPAAAPAQGGVNSPVNVTTAVDANMSLT KIEDAIRMITDQRANLGAFQNRLESVKASTEYAIENLKASYAQIKDATMT DEIVASTTNSILTQSAMAMIAQANQVPQYVLSLLR >BRE_555 flaJ, flagellar protein MLRKEDIYKKTQVNTSSSISILVMLYEKAIQDLEVAKEFYKNKDPNSTTK ADEKVYHAQDIIIELMSTLNFEDGGDISNNLFSIYSFLNKTLESVTLEKN IDNIQEVLKHLKNLHTAWKALLKKDNNIIIKKKLGINIVG >BRE_294 flbA, flagellar protein MNDLILKKKNFEKILTIRTYNRKFSENDLMNVNNKIVKIEEFLEGIIKGL CKLNSADLFLKGNYLDYISLKQKEEIKKLEEFKREYNKYYDIYLKKYAEE KKVDILIKTLNNTIIKGKIRSEILSLDEYVNYKICKKLGKNNE >BRE_293 flbB, flagellar protein MNNYLLFLFRFFLWLFLVIFFLGLSFFLTDLFGIYHTRDYLPKYIRTLFF KDDEQLLDYTHISLDEIRMIKEKEAIYIKSQQVEKLREELKKREDNLNKL EAELNQKQKDLDLKQKLIDDIVNKYRDEDANFAQAALYLINMPPEDAVKR IEELNDEIAISYMRKVEDIAKKEGRASIVPYWLSLMDSKKAAVLIRKMSV SALE >BRE_292 flbC, flagellar protein MSNLSKIIDVNLSKLNKNFNFINASLLSQDKKGGFADFISSEIQSMSKLR ISLLEFLKSNGLINKSSKNLSLNHSFVLEKFKDKDFMSDFKSLLKETGSL FDFESLKNLRENLSFDSEFVDRREMLSNVEKVLSELATLIGDLNFVFNAD CFNIGTDFECGDLGIIKKNTEKEKNLINIDVKNFKKNSGVKEFLNTNSRF RLVDNDNSVGKYALKETFDSSSEFMDNLSGSSVKNIKEFFLSQIDDNLMS EWNLKVNRNIVNKAKIVLKSNDTGEIRLILKPKKLGSIRINLNLDSNNNL LGKIIVDNHNVRTLFEQNMYSLNKMLSDNGFNSSLNLSLAGSDLGFSSGS NFKDDFEGHRHSLKESQVFRIEDYVEFFSDLEENVNLIV >BRE_289 flbD, flagellar protein MIYVTKLNGDSYYLNPSHIESIEANPDTTILLMNSKKLVVKESVADVVNK IKMYRREIALLDRITQENKGVEL >BRE_301 flgB, flagellar basal-body rod protein MDIFQRSVDLTHRYLDVLGLRQSVVADNIANVDTPNFKRSKVTFEAELER AILNEKTNNLSLIRGNNKHLDGFKELGYLDVKPQRMLDHLSTLNNNGNNV DIDSEMKSLVQNQMMYRLFTNIQAHHFKSVNIVIK >BRE_300 flgC, flagellar basal-body rod protein MYMGLFSSINTASTGLTAQRLRLDVIANNIANVETTRTADGGAYRRERII FAPRVVSPYWKGPFVPDYLDNGVGQGVRVSGIEKDKSPLKLQYDPTHPDA IKSGELKGYVEFPNVNVVEEMVDMISASRAYEANSSVINSSKSMFRSALS ILQN >BRE_291 flgD, flagellar hook assembly protein MNTISNIDNLVNIGQSKKIVNAGLKRDRDIKESNLGRDDFLKLLLTQLKY QDPTEPMKDKEFISQMAQFSALEQMTNMNKSFENLSSILGVNKDLNLLGK IVEFENVEGKIIKGKVTSVKAGVNPQIMIDGKYYVYSNVLSVGLEE >BRE_290 flgE, flagellar hook protein MMRSLYSGVSGLQNHQTRMDVVGNNISNVNTVGFKKGRVNFQDMISQSIS GASRPTDGRGGVNPKQIGLGMTVATVDTIHTQGSFQSTQKASDLGISGNG FFILRDGDNSFYTRAGAFDVDSNRHLVNPANGMRIQGWMAESVGGEQVFN TSSDIRDLIIPIRDKEGAKATEYITFACNLDKRLPIVQQGANEVDIARGT WVVNKTIYDSFGNTNVVELRVLKDATAPNTWNATVLVNGEENSNFTMGFD NEGALLSLNGQAGQPGDLLEFPITFGVIDANAGEGGEQTVNLRLGTVGSY ADSITQFADASTTKAIVQNGYGMGYMENYEIDQNGVITGVYSNGIRRTIG KIALASFVNPGGLAKAGDTNFTETSNSGQARIGETGFAGLGTIRSGVLEM ANVDLAEQFTDMIVTQRGFQANAKTITTSDQLLQELVRLKS >BRE_782 flgG, flagellar basal-body rod protein MMRALWTSASGMKAQQYNVDTIANNLSNVNTIGFKKIRAEFEDLIYQTQR RAGTPATEDTVTPLGNQVGHGTKVSATHRLFEQGNLQVTNLNTDVAIEGD GFYKVLLSDGTYGYTRDGSFKIDANGHLVTNQGYILLPEISFPEEYIKNS IAISQEGIISVKVNEGLEPIELGQIEIARFVNPAGLNAIGNNIFKETIGS GEEISGIPGSNGMGKLKQGMLEMSNVAIAEEMVTMIVAQRAYEINSKAIH TSDNMLGIANNLKKQ >BRE_780 flgI, flagellar P-ring protein MKKLIMLIILNLSSFAQENQVKNFSNQNNADKQINEHTKLKNISEIQPAN SQILTGIGIVAGLTDKGDSIKEKEILNQILNKIGINEIDLTKTGSKNIAL VNVAIKINGNMIKGATHNVYIASMLDAKDLTNGMLLKTEFKDKQGKLLAT ASGPIIINDKSKGTGYILNGATIHENQNYTTYNIILKNKDYSLINLISQN LTKNNIKNNIKSGNIIEIEVDDIRLISKIEKIEIKTMPKVLINEQNKIIM ASTNAEIGPLVLSIERKEEDLFSNKTNKNIKIEIQKMKLNEFISNNSTKL NNKELIQIIKRANKISKLYGELILEE >BRE_779 flgJ, flagellum-specific muramidase MINKINSQHIKTQNQIKILKEKVGEINQSKNDNKLYEAALEFEAIFINQM LKSMKNTLNKENNLINGGQTEEIFEDMIYSERAKQIAKSKNFRLADVIYN QIKITNNLRK >BRE_179 flgK, flagellar hook-associated protein MDSTFSGIEIGKKSLFAHKDAMNTVGHNLTNATKPGYSRQRIIMKTEMPI YAPQLNRANKAGQLGQGIMVQSIERIRDELLDIKIAEESHHLGYWNLKDR FISLLENVYNEPEEQSMRKRLNDFWASWQDLSKQPQGLAERNIILERGQA FVEVITSRFHSLERIYTMANDEIKITTEEINNYLRNISDLNKQIAKAIAM KGHPNDLMDERDLIIDKLSNLISISIENKRDPNEFLIHIEGKHLIQGTIA NELILEAANGPTKTKWNILWNNRETANINTGKLGALINIRDNEIKNEINE LDNIAINIAELVNEVHISGYGLDKQNGRIFFEQEYKLTDDRGRYDSNGDG QFDSVHIFKVNSTNEISPKEKLGFAGILRFQAINKNDFIEIPYNATDTVK DVIDKINNSDAQVTARINENKKFEIKAVKEEDKDSTIFRIKHIEDSGLFL TNYTGILNASGIEGAYNYQNINTTDQLTNTTRYSISPLKNPSAWIRISKV IAEDPSKIASGIQTPTNNTPIGDNKAALRIASFVNSQIMIEKNSTLNDYF VNTASNIAIKGQIAEITKNSQEQILKNLTDLRLSISGVNKDEELANMIEF QQSFIAASKFINISAELIDTIINKMGV >BRE_180 flgL, flagellar hook-associated protein 3 MINRVSHPLTYDNLKSSSTNKEVKITKLLESLYQGGKRITNLRNDPTGVT HSIRLDSNIFKLNTYSHNINNARGKLRYVEGYLQSLSNILTRAKEIAIKG ANGTYGTDDKKIIAKEINAILEDVLAIANAKGADGYSMFAGTKVDAEAFK ATRAKKINKLTQDRAETQIIKIDYNGNQSEQTTEICNGIYISTNYPGSEL FFSQNQYITSSKNVDNFVVQENTKIYIDNVEIVLTAGDTAADIIAKINES SAPVEASLDNILNSIIINTTTPHQMWITEEEGSTVLTDLGILNQNNDSKE PPYNIANNAEIRNRTIFDSLIDLRDNLEENREGLIGSRNLAEIDESLSKI LSTLADLGTKENRLEVSYARLSKEIMDMKDDMVQYTDLDVTKAITDLNMT SLAYQVSLGVSARIMQTTLLDFLK >BRE_278 flhA, flagellar biosynthesis protein MDLEKNSLLGYFGLNNKADLIVSVGLILIVAGFILPLPAFILDALIAINL MMSLLIILIVLYSKRPLDFSVFPTLLLVMTIFGLVLNISSTRLILIKGIN FDGQMIRTFGTFVVGSSGTQGLVVGFIIFLIIIAVQFIVITKGATRVAEV AARFALDALPGKQMAIDSAYSSGNLTEEEATRQKNDLQSEVNFYGAMDGA SKFVSGNVKVGFLITLINILGGLIVGVTLQGLNFNDAINNYVSLTVGDGL VSQLPALLISTATGLIVTRSISKNSFGGEIFEQFTSYAGIYWIVSGFLLF LAFLPGFPTLILILLSLLIGFFAYSLSNLSRDRELYEKQKAEEQILSYAD KEITPVVPLDPLALEIGYNLVPIVDDSKTSELLDRIVKIRREIALEFGIV VPKIRIVDNMRLEPNEYSFKLRGVEIGHGEIKLGKFLVINVGLDSGLEGD LTKDPSFGLPSIWVNDDVREIAEKLGYTVVDPPSIIATHMTELIKRHSYE ILTRQDVQNILDVFKKDYGAIVEEVLKDFSVGEIQRVLQGLLREQVSIRN LVTIFETIADFTNVTKDTFFLIEKCRQAIGRQIVNVYLDSNLELNVITIN PEFEQKIIDSRFEANNDLVSSLDPNLKSKFLYELFVLVNEVQSQGYYPII LSSESARPVIRVLTSRELSDVVVISVLEVPKNVKVNVLKTVEVEE >BRE_279 flhB, flagellar biosynthesis protein MNTRDEFLNKSWYIPLNFFASEDEGRTEVPTEQRKQKARREGQVLKSIEI NSSISLFILFAVFFFMLSYFAQELMDIFKWQASKLPEVMSISIYSLSFAY IRPLFRYVSIFFIVSFIVGFLVNIMQVGFVMTLKPIMPKWDRINPNFSKW MKNSFGSVDAFFNLFKSLLKIAIISFIYYIMLKSNIGKISKMPEYSLEGG ISVILSLAYRICFFSVMVLMGLSVLDYLFQRARYIENLKMTKEEIKQERK EMEGDPLLRSRMRERMREISNVNLRVAVPQADVVITNPEHFAVAIKWDSN TMLAPKVLAKGQDEIVFVIKQIARENNVSIVENKPLARDLYANVDINEEI PREYWEIVSKILVKVYSIAKKFN >BRE_277 flhF, flagellar-associated GTP-binding protein MKSNIMVQYFTERGPTYNEVIETVKRKYGKNARVMTYKTISHGGIFGLFS RDWIEVSGYVRYDIGQQQINVEEEKRKILQSIKKEETSSIEDVIKEVKSL KNELAHKKEEINHPTILKIEDILRSNDFSESYIRDINNFIKKEFSLSDLD DYDKVKDSVIIYIAKTIKCSGSLIDNLKKRIFILVGPTGVGKTTTIAKLA AIYGINSDDKNLNIKIITIDNYRIGAKKQIQTYGDIMGIPVKAIESFKDL KEEITQSKDFDLVLIDTIGKSPKDFMKLAEMKELLNACGRDAEFHLAVSS TTKTSDIKEIFHQFSPFSYKTVIFTKLDETTCVGNLISLIHEMRKEVSYV TDGQIVPHNISIAEPLTFIKKINGYRISDDVEFIRKLKSKSYY >BRE_783 flhO, flagellar hook-basal body complex protein MQREVIRIYMVRGIYTAASGMIAQRHRLEVIANNLANIDLTGYKKDLSVQ KAFPEMLIRRTNDDGLYKFPKGYLETAPVVGKLGTGVEENEIYTSFEQGS LKITGNPLDLALTEEGFFVVQTPEGERYTRNGSFTLGREGILITKDGYPV IGEKGYIHIKDNNFKITEQGQIFHNSTFESNPKRLVSESENSWENYELLD NLKIVNFEKARFLKKQGSSLWYSTEISGQAKNIPINSRPKIESGVLECSN VNAINEMVSMITVNRVYEANQKTIQTEDTLLGKLINEIGKF >BRE_150 fliD, flagellar hook-associated protein 2 MSSGFFVPGVDNKYNTKEIRESMLKPDKSKIDSSVQKLESLQQEKRAWQT INKKVSVLNSLAKQITSLDGPFNYMSGNSSNNDVLSVSARYGAKNENYKI GVNQIASSDVFLSANFKQKEINIPVGEYTFLVGKKEIKIRNNGDLESLVR DVNNRGKGFLSAKIVKSDSSGNSRLILQSLKEGENNRLIMKDEALNLAKK IGILSERTTNFSPNIREIVNSQQNSSNKIFLDKDDIVLEPLSEIAISIPD NIEIGKGSKIKFEIKYYDMDDKSILNEIVFNPGEATFEGAKVEGEDSIIN LESDYKPFLKEKKYIQMNMIKIHSGTGSLELPPINVASDFEKVEVEVGSL LGLKEINIENKLNNKAFVIRNIEIFDPKNRDGHLPINAKSFAENAKMKFD GVDVERDSNTINDLIPNVTLNLKQSSDDTVDVRVEPDYEGIRKLLLDFLI AYNEVLAGINIVSLNEDNVDTQKSDLLEEWSYLNEEEKEEAYKNLGILRS EFTLKNLKSRLESIMFNVYRTNDPNFSLINQMGVFTSSMSSSGGFSRYLK LDEKKFNEVLQSNISSVKEFFAFDFNDDRIYDDGLAKVLGDYLSLLIGAG GFIYNKIKSYDFRIPNQKNMVEDYKRKYEERERKVEGELNTLDFTVKRMK EQEEILKSLNLYRQNK >BRE_299 fliE, flagellar hook-basal body complex protein MKVDSFFTDSNVYLIRKNPLHFDKSFSDFSVKSEKQAGTFRELFLNLISN VNNSQLDMYKVSQQAILHPDSVDVHDVVISMAKANMNLSITKAVVEKSIK AYQDVINIR >BRE_298 fliF, flagellar M-ring protein MNNFITKFFASISKKIKKATMVQKVAFGVIALFIILSLVFLVSFSTRKQG IALFGISIKDQYLLDKIVQRLDRENAKYTITADGRIYLSDENMSKRIRAI LVREELIPMHMDPWSLFDIDRWTITDFERNINLRRSITRAVEQHIVALDD VDAVSINLVMPEKALFKESQESVRASVRITPKPGSDIATNRQKVEGLVKL IQYAVEGLEADNIVIVDNKGTILNDFSNLDGVDRIDLAEKERKLKLKYES MLRDEIDFALSKVLSSDRFMIARVNVTLDTSKQTTESKEYAPIELEPQNP KVSYNTRKVSDSTLISSQVHKREYEGQGYSPWGPPGQEGNTPPEYGDMSD IIGKSNEFKEIKNVALNEKKSLSEKEPARVSGISLGIFIDGIWDFVYDES GNFVMENGMRKREYKPISDETLKSITDVLQSSFEYKPERGDSITVRNIIF DRASEFRKIDEDYFAGEKFKFLIFVVSIIIALLILIFTVFFIISRELERR RRLREEEFARQAHLRRQQALMDGDNIGIDNVVGGFREEDELQSNAEILAR EKPEDVAKLIRTWIVKNV >BRE_221 fliG-1, flagellar motor switch protein MRGSMQDPRLSKYQDVKNLGVKTFQNIWNNKGIKSKELYDDLGDSEIQGS ILKSWVNLVKKRKKDSQSKLNASNKGVERPGFIRRESKVSKIAKYFLAIG LEKSAEIMAELDDADIIAITREITNIKYITPDDKKRIIKEFEELIRSEKK YLKVDDKFAYELLNKSLTKTQAKEIYKKVTGLDPFLPFDYLSGIENEQLW ALIRNENVQTLLVIYGYLTKEQKKYVFSMLEMDVKKKFIKTLAKPRQLNV DVIEVISNRLKDRLKIQGKLKTEKLDGSKILVDILSYMDFEDEKNLLSNI DMKVFNPVKDIEIKEKIFDINVILRITDNDMHNILREFKNHDIAMIIKDK SDEIRNKILFNISRRRKELVLEEESLLKRARKKDIKAMTMSFVNYIKELT LKGELIIYRKNEEFV >BRE_297 fliG-2, flagellar motor switch protein MEDQKEKEIFGVSTLTGKQKAAILLVSVGSDISSKIFKYLSQEEIESLTF EIARLDVVTSELKDSVLLEFKELMMAQEFIQKGGIDYARELLEKSLGTQK AVDIINNLGSALQSRPFEFVRRADPANILNFIQQEHPQTIALILSYLDPQ KASFILSSLPTEIQTNVARRIALMDRTSPEVVREVERVLEKKLASLSSED YTSAGGVDNVVEIINMADRKTEKFIIESLEEEDPELAEEIKKKMFVFEDI VLLDDRSIQRILREIDGQELAKALKSVDIPVQEKIFKNMSKRAAGMLKED MEFLGPTRRKDVEEAQQKIVSLIRKLEEQGEIVISRGGEEDVLI >BRE_296 fliH, flagellar assembly protein MYLPKVLYKSKEIVNAVKLEFVEIANPLFKSLEVKRKENEIFDVESRSVK LRNELETLMSQKAKLQEELEHEHELIKAEIDAECSKIFEKAREQANEIVS LANEKAESLQKEAEDKKGAIERESNLEIQRIIKEHEEKLKRELEIETEKG RNEGYDDGFQKGREDFDKILGKLNGIISSLIAKRKEILESSGEHIMNLVM QIAVKVVKKIIDSQKGVVIENVNEALKKIKSKTSIIIRVNLDDIDVVSHQ KHEFISKFDFIENLEIVEDVNIGKGGCIIETDFGEIDARISSQLDRIEER FKNFSSIF >BRE_295 fliI, flagellum-specific ATP synthase MMDNFFEGYSNILDDIHTISFIGRVKKIKGLLLESLGPKCGIGDLCLIEQ SCGKKIYAEVLGFNGSCVSLMAYEGFDGIKVGDKVYSLNKKPQINLSDEL LGRVIDSLGRPIDNKGPFFGNNYKELSFSSINPLDRGVFTEQIVTGVRVL DGFLPVARGQRVGIFSGAGVGKSTLLGMIAKNSKADVNVIAFIGERGREL NEFIKYELGNGCFNRSVLIVSTSDESPISRYKGAYTATLVAEHFRDCGMD VMLLFDSITRFANAKREISLSMGEPPATKGYPPSVFVEIPILLERSGLNA KGSITGFYTVLVEGDDFSEPISDNMKAVLDGHIILDRDLSDKGIYPSVNI LNSTSRSLHRIVNFEKQKLISKIRNLLSIYKSYEDLIKTGIYVKGSNKEV DLAIAKYPKIIDFLSQGMQEECDFENLDNEMREILA >BRE_286 fliL, flagellar protein MPEKDDDSMDVVGGSDSKKIGLLPDVIIRILQILAIGLFTVVIMIIVSYF VSKMVVSQSGAPNNFPIFSNEYLEKLPMLIWYESIDEIRGTTQDTPPKTF VIKLALGYAENNVNILSELGRQKVRLKDIIREYFSQRTGQEIKNESQIKA EIKARINSILRNGEIKEIALTQIDIFDM >BRE_285 fliM, flagellar motor switch protein MAGNPGALSQDDIDSLLESINSSDNLSSDDSLSNIISSPMGKKQKVKVYD FKRPDKFSKEQVRTVSSFHEAFARYTTTSLSALLRKMVHVHVASVDQLTY EEFIRSIPNPTTLAIINMDPLKGSAIFEVDPTIAFAIVDRLFGGDGDTIK DKSRDLTEIEQSVMESVIIRILANMREAWSQVVDLRPRFGHIEVNPQFAQ IVPPTEMVILVTLEVKIGKVEGLMNFCLPYITIEPIVSKLSTRYWHSLIG VGTTSENLDVLREKLEYTNMPLVAEIGEVKLKVREILSLEKGDVINLENS SIDQDLILKVGTKEKFKCRMGLVGNKISVQITRKVGEVEDFDLLKELTEE VE >BRE_284 fliN, flagellar motor switch protein MDVDDKNDFSEEKPEIKGVKLPDLIDSLPEGVDPSNFGLLMDVSMQVTVE LGRTERKIKDILAMSEGTIITLDKLAGEPVDILVNGKIVAKGEVVVIDEN FGVRITEIIKIKNE >BRE_282 fliP, flagellar biosynthesis protein MNKKLSFLLLFGVVNFAFAQTKSLQPTTGLNFPFVDFLNSFGGGIVFPLQ LLLILSIITLSPAFLVLMTSFLRIAIVLDFIRRALSLQQSPPNQVIMGLA LFLTLFTMWPTFNIIYKDAYLPLRDSKINFNEFYDRGIAPLRNFMYKQMS NSRHEEIRLFMSISDYAKPKNFSEVPTHVLIASFILHELKVAFKMGILIF LPFIIIDIIVAAVLMAMGMIMLPPVIISLPFKLILFVMVDGWTLITSGLI KSFM >BRE_281 fliQ, flagellar biosynthesis protein MTTGQIIYLIKISIENIIILSAPILITALIVGLLVSIFQAVTSIQDQTLS FIPKIIIILLVLVIFGPWILKKIMQFTFLVFNQIQNM >BRE_280 fliR, flagellar biosynthesis protein MNMDFLILKSFVVLPIFIRIFIFLRFSPFFSTIKMGYLNFFFSLILSIIV VDKVNVVYPLNNLTAFVLILLGEAILGLIQAFFVSIIFNVFHLLGFFFSN QMGLAYANIFDVFAEEDNLVISQIFTYLFLIVFLLNDFLFRFLVIGVYDS VLNVRVENMVNIKNYEFIKLVFYSFAILFEKSLIMSLSILGVLLLLYLIL GIISKTSPQINLLMISFAISLGLGLIVLYITFPSFVISVKRVIELSLESM RNALNLFSETLR >BRE_283 fliZ, flagellar biosynthesis protein MNRLILFFTFIVFFAENLFAQDNESDLNVTSKLENEVNLPIFDDNKVVLD NQDIQSISLFNVTDLFTLVLFFLFFVIFIFLFKKMILSYKKNKNNDMSSL IRELAFYEIDNKNSIRIVNVLGNVYVFLVSNSSSIVLKEITTSEELENLE FQLNKIKSRGNINSFKSIFNKILRNNKKDKSFINDHDEYAELENDIETSL KSKQDRLKKF >BRE_67 fmt, methionyl-tRNA formyltransferase MRIFFASSDGIALEVLKKISDQYDVVGVLTAPDKPSGRGLSLKVNDIKRE ALSRKITVLQPVVLDADVINLVKSLEPELMLVFSYGKIFKQEFLDIFPVG CINIHPSLLPKYRGPSPIQTVILNGDSVSGITVQKMTLEMDSGNILAQSQ FEIKSFNTSVDIFEYVSLNSFDLVIEALNKLLKGDIGIVQDKNNATYCSF LGKEHRTIDFKLSAFDIKNKINAYNPWPLARARLDNNEIIFYRADFISTN DYDDQVIGKIIAFDPSKGLLVKTGDGILVVLELQRIGKKVLDCVSFYHGN RDLIGKVFS >BRE_30 folD, methylenetetrahydrofolate dehydrogenase MLQTRLVEGRAYVSSVFDGKIFANRYYLLLKEFLIYHNLVSKISLKVILA NNSPASELYVSVKERVSKEIGINFNVIRLSENLHQDDILRLIEIENTNDY TDGIIVQLPLANKIDVNMILNSILSIKDVDGLSFVNLGKLVSGDKRGFIP CTALAILKILFDYKIEISGKTVVVIGRSLLVGRAISILLSCKPYNATVIV CHSKTVNLDFYVKQADVIISAVGKPKLIDASMIVGHPYVIDIGISRVDVN NSSVLVGDVDFEAVKDRVRFITPVIGGVGPVTVLMLMFNTIKAYLIRRKK FDLLEKLMKLVEV >BRE_123 frr, ribosome releasing factor MEEYKALLDEKMGRVVLSLESEYKSLRTGRVNSALFDKVFVDYYGEKTPL TRVANISVPEARLIVIQPWDRSLLSKIEQAILNSDLSMNPSSDGSVLRIK VPVLTIERRKEIVKQAKKIAEDHKIATRNIRHELNNKAKKQEKDSQITED DLRRILDDIQRDTNFYIKKIDGIFDLKAKEIMEV >BRE_406 fruA-1, PTS system, fructose-specific IIABC component MFLDFLKKELIFVSSTICSKDEALNFLVEEVSKKGYTNDKSVFMQGLLDR ENIGDTSWENGVAIPHFVGDVVSISFISLLYIKGNGIKWSDDNPPVNLIF LICMSKNQQGTGHIKSIAFIARLFENDDFKNFLKNGNNSDEIYSYIKNVE NNYLESDFSISRTENILAVCACPVGIAHTYIAAKKLEVEAKRQGYSIKVE TQGSIGIDNPLKKEDIEAADVIILAVDKDVDELRFDGKRVYKISTARAIN DVENVIKEAFSAPVLTFKGINTLKDNSNNSKSGFYKYLMSGVSPMVPIVA SGGILIAFGISLAGVGSGGPNFEQYPFYKTITDIGGVAFSMMLPVLSGFI AMSIADKPGLAPGLVGGVLARDVKAGFLGAILVGFMAGFIARWLARRQIP EWLRPIMPIFVIPLISTVIIGFFMIYGGVYIAQFMGLLENGLKELQSNSD AHGIIGKLLLGAVLGAMVSIDMGGPFNKVAFLFGVGMIPSVPQIMGMVAS AIPVAPMAMGLATLIMPQLFEEEERESGKISFLISFIGISEGAIPFAASD PARVLPSIVLGGAVSSIIAAFWGVADHAPHGGQ >BRE_636 fruA-2, PTS system, fructose-specific IIABC component MQDLFSKKLILLNYEAKSKDDIIEKMADMLNENGYLRNKENFIKDIKKRE EISGTGLEEYIAMPHAKGNFVEKHGIAILRVKDKGFDFGAADLKPSKLFF MIAVPENTTGNDHIKTISYLNNIFNNDILRQEIMNTNDKNRFLEIILNTP NSDTIMNKTNLENFILAVTACPTGIAHTYMAADSLKRAANELNVEIKIET NGSSGIENPINEKDIKKAKGIIIASGKAVNKTRFNGKPLIEVGVKDGIHK AKELIQDIINNKAKIYRSNTSQKTESSITNNTSNTEIYKHLMNGVSFMLP FVVSGGIIIAISFMFGIKAFDPTDPNYNKIADILMQIGDGNAFFLMIPIL AGYISFSIAERPGLAPGMITGLMMSKGNAGFLGGILAGFIAGYVTLTIKS ISQKIIPKNISSINPVLTYPFFSVLIAGFLTYILLTPIAYLNSSITNMLN SLSGTNMALLGALLGGMMAIDMGGPVNKAAYAFGIAMITAENYIPHASVM AGGMIPPIGIALATSIFKNKFSQEEHEAGKVCYVLGACFITEAIIPFAAS DPLKVIPACIIGSSIGGFLSALFQVKLMAPHGGIFILPIITNPLMWIVSI LIGSLITGVLIGFMKRDKK >BRE_637 fruK, 1-phosphofructokinase MIYTLTLNPAIDYKIVVEGFQQEHLNHVVESSFLAGGKGINVSNVLKNFQ MESIAFGFLGGFTGDYIKSYLNLMKIRHNFVNISDNTRINIKMMSYGKET EINGNSPVILEKDFGSLIVKLKELDVGILVMSGSIPSSLGFRAYNEIVEN LSSNLRVIVDTSGPALQEIIKIKPFLIKPNINELKELLGINVTSDKDLIN VGHKLVEKGVQNIIISMGGEGAIFINNQDVYIASVPKIDSLSTIGAGDSV VAGFVYAYHKGHSFGDSFKFAVTSGTATAFKGQLCNLDDVKAILSKINLE KISLD >BRE_307 ftsA, cell division protein MSRDLIVGLDVGTSKICTVVAEVNLNNQLEIVGIGTSISRGVRKGVLINI EAALDSISNSIEAAELISGCDIATLSVSMSGSSIEGTNSRGVVAINSKTR EIGDEDVERVIEAAKAIVIPMDREILHVIPQEFIVDGIPHIKNPIDMMGI RLEGEVHIITGSSSSSQNLVRCVNRAGFSVDEVVLGSLASSYATLSKEER EMGVLFIDMGKGTTDIILYVDGSPYYTGVIPIGANRVTLDIAQVWKVPED VAENIKITAGVAHISALETQMESVIIPNLGTRPPQEKSRKELAIIISSRL SEIFEMIKAEIVKRGLYNRINGGIVLTGGGVLFPGISNLTEEIFKYSSRI GFPMNINGVGEEYIDPKFSSALGLVLYKHEQQKFNKLKKGNNKSKRQGKI SSKLKGWFLKEWF >BRE_798 ftsH, cell division protein MNINNNNLNNNGKSNNKKKNKNWILGLVVVFLVLAIFMSYFMRGGENYKN VPYSTFQTYLDSGLIESVVIIDKSQIQFIVKNSNLGKSYFSTSIPYFDIN LLAELKAKRVEVSSGKSQSSLIGVLLQTLPWILFFVFFFFIFRQTQGGGG KVFSFGKSNAQKYEAGKNKVTFKDVAGQEEAKQELGEVVEFLKYPKKFEK IGARIPKGVLLVGSPGTGKTLLAKAVAGEAGVNFFHMSGSDFVEMFVGVG ASRVRDLFDNARKNAPCIIFIDELDAVGRSRGAGLGGGHDEREQTLNQLL VEMDGFGTYTNVIVMAATNRPDVLDSALLRPGRFDRQVAVTLPDIKEREA ILNIHAQKTKLAKEIDLRVIARATPGVSGADLANLINEGALIAARNNQSE ILMHDLEEARDKILMGVAKKSMTITDRQKLETAYHEAGHALLHYYLEHAD PLHKVTIIPRGRALGVAFSLPKEDRLSINKNQILDKIKICYGGYASEQIN LGFTTAGVQNDLMQATNLAKKMVTEWGMGEDVGPIFLVDDEAPIFLPKEF SKSKAYSENTADRVDREVKKILEGCLKEASDILIKHKDQLVKLAEALITR ETLTDNEVRELLGFELIESDYELSLKQSKQEETIDR >BRE_320 ftsJ, ribosomal RNA methyltransferase MYNVFDEYSQKAKNEGYLARSVYKLIEIDKKFSLFSSGNILDIGASPGSF SQYAYANLKNGVLVAVDLNDVNLNFTSNFYFIKGNIYLDEVYQKIKIFSP YSLIVSDAAPSTTGNRLVDTSNSFNLNIRIFELACESLMRGGNLLIKVFQ GGEEEQIFYKLKSCFRVVKKVRPKAVRKNSFEIYFLAKDFAKL >BRE_259 ftsK1, FtsK/SpoIIIE family protein MKNFYRYFQFLFFFMLAVILFSLLVALTPIGNIFIFFVFNLIGQMLLNTF SFLSFYLILYPLVNWYVYCNNMLSKKFIFNWNYTVILFFTLTFWLRINSN FESSNFVNWFLSNFGIIVGNLFVCLLFILELIVWVYLNYVFFKDASFILT TFHFITFKLKILFENMFSYLPFLSTLKIKKDIKVYKDCENNVSSDSILNK EDNIINDEEYQALWSFKEFLRNSNKSLDVDLDKTIFSKSEVMDDKLPKDE SLQEVQCDLNTENNCQYKILRSECEDSRLVVSGKIRASDIRHNGIINNIV RDEYENDTLFKVKSDENYSIDISVFAQREPENETEDVEYEREIQKQAMLL QETFREFNINAKLIDIIRGPVVTMYAVRPDKGIKLSKITSISDNIALRLA AVRVRIIAPIPGKEAVGIEIPNKRQKFILMSEIINSQEFQNDFKVPFALG KEISGNNVVFDLVTAPHLLIAGATGAGKSVCVNSLIASIIFSKSPDDVRL VLIDSKVVELKLFNNIPHLLTPVITNVNRALEALRWCLDEMERRYVLLDN FFVRDINSYNKKIVEEGLNEVPLPYLIIIIDEFADLILSARKDLENLISR LAAMARAVGMHLVLATQRPSVDVITGVIKANFPSRISFMVASSMDSRIIL GTSGAEKLLGKGDMLYVSPITPFPQRIQGGFLTEKEVYKLVEEVKKFGTP NYIDDEIFIDSVVESDTLVINSSDESMFEEALEIVRSTKKASASYLQRRL KIGYNRAARIIELMEEMGYIGPVNGSKPRDVFI >BRE_264 ftsK2, DNA segregation ATPase FtsK/SpoIIIE MKNFYRYFQFLFFFMLAVILFSLLVALTPIGNIFIFFVFNLIGQMLLNTF SFLSFYLILYPLVNWYVYCNNMLSKKFIFNWNYTVILFFTLTFWLRINSD FEGSNFVNWFLSNFGIIVGNLFVCLLFILELIVWVYLNYVFFKDASFILT TFHFITFKLKILFENMFSYLPFLSTLKIKKDIKVYKDCENNVSSDSILNK EDNIINDEEYQALWSFKEFLRNSNKSLDVDLDKTIFSKSEVMDDKLPKDE SLQEVQCDLNTENNCQYKILRSECEDSRLVVSGKIRASDIRHNGIINNIV RDEYENDTLFKVKSDENYSIDISVFAQREPENETEDVEYEREIQKQAMLL QETFREFNINAKLIDIIRGPVVTMYAVRPDKGIKLSKITSISDNIALRLA AVRVRIIAPIPGKEAVGIEIPNKRRKFILISEIINSQEFQNDFKVPFALG KEISGNNVVFDLVTAPHLLIAGATGAGKSVCVNSLIASIIFSKSPDDVRL VLIDPKVVELKLFNNIPHLLTPVITNVNRALEALRWCLDEMERRYVLLDN FFVRDINSYNKKIVEEGLNEVPLPYLVIIIDEFADLILSARKDLENLISR LAAMARAVGMHLVLATQRPSVDVITGVIKANFPSRISFMVASSMDSRIIL GTSGAEKLLGKGDMLYVSPITPFPQRIQGGFLTEKEVYKLVEEVKKFGTP NYIDDEIFIDSVVESDTLVINSSDEPMFEEALEIVRSTKKASASYLQRRL KIGYNRAARIIELMEEMGYIGPVNGSKPRDVFI >BRE_309 ftsW, cell division protein MGVMFVEKTSLRKCYFLVLFSLISYGLIVFYTSSFFLSLELTGDPNFLFL MRLKYLVLSLIVFFIFDKISLDFLKKIVFVILFITFALVLATFFSPSVSG AQRWIFFKGISIQPSEIFKVSFTIYLANYLSKFKLKANNYISYWLKPMLI FGIFWLLIILQNDYSTAIYFAILFFIVLFIAGMSLGYIFAILFTFIPIAM LFLLFEPYRVARIFAFLNPYDDPLGKGYQIISSLNALKSGGLLGKGLGMG EMKLGRLPEANSDFIFSVLGEELGFFGIFFAIVLFFLFFYFGYFVAIHAK TKFKFFLAFISSLAIFLQSIMNILIAIGLLPPTGINLPFFSSGGSSIVVT MALSGLISNVSRDIEGT >BRE_79 ftsY, signal recognition particle-docking protein MSIFNKIRNLFKNKEKTQIIERLEDLLLEADIKNDIVIEIVEHIQKIKAK DKQETVLQLKNLLKSYLNQQPLNLENKRLNILLILGVNGVGKTSSIIKLA NKFKNEGKNVLIAAADTFRAAAIEQLKIQSEKIGIKVISQNQGSDAAAVI FDSISSAKTKNYDILIIDTAGRLQNKENLIKELKKMDQVIKKQILDTNIN YKKILVIDSISGKNTNNQTEIFDKAIQIDGIIATKFDSSSRAGGIINISK LFQKPIYFFTFGEQVDNIKEFNTENYLNKLL >BRE_306 ftsZ, cell division protein MKDYNIIDSHSKRFDSATNPTVLKVIGAGGGGSNAVNRMIEYGVRDVEFI VANTDLQALQTSIAPIKIALGAKVTAGLGAGGRPEIGQAAAEEDIDVIKN HLAGADMVFITAGMGGGTGTGAAPVIAQVAKELGILTVGVVTKPFKFEGP KKMRLAEQGINNLRKSVDTLIIIPNQKLLTVVDKRTTIKDAFKRADDVLR MGVQGIAGLIIEHGEVNIDFADVKSIMQGQGDALMGIGYGKGENRAVDAA TSAISNPLLEEVRIEGSKGLLVNITGGEDFSLLELEEIMGIITASVDDEA TVIYGHAINSNLDDEIYVTVVATGFSAKKQKDLSGVVENNTLSSKEFDSL MSGSQDASGVTYGANDNFIAKSKNVNYFEDDIDIPTFLRNLNKKNGDN >BRE_653 fur, ferric uptake regulation protein MNNNTIEVHSTLEKVGITNDPILLKSLTTELGMKASHSRNRIILHIASNP REYFTAKEIYNKLIKEIPSLSKATVYNTLNILKERNILKDIKTTDQKETR FYLSLTSTIAHFKCNKCNQVYPIQLDDIKDILKDKLGEEWKTKSIEIIYS GSCNNCHQESQQEEYNTNDDNH >BRE_544 fus-1, translation elongation factor G MDYKKLRNIGISAHIDSGKTTLTERILFYCNKIYAIHEVKGKDGVGATMD SMELEKERGITIASAATHVEWKNHPINIIDTPGHVDFTIEVERSLRVLDG AILVLDSVAGVQSQSITVDRQLKRYNVPRLAFVNKCDKTGANPSNVKDQL KDKLGLNSVLMQIPIGLEDKHMGVVDLVVMKAYYFEGKDGTEIIEKEIPA ELLNEAEEKRKIMLDALSDFNDELMELHMEGKNVALETIYNAIRTGTLSL KLCPVFMGSAYKNKGVQLLLDAVNKFLPSPHDIQNIALDLNANEKEIKLK TDETLPTVALAFKLEDGQYGQLTYVRIYQGVLKKGQELINSRTSKKFKVG RLIRMHANNTEDIEFGNSGDIVALFGIECASGDTFCDPSINYSMTSMYIP EPVISLSIKPKDKKSADNMAKALGRFTKEDPTFKTYVDNESKETIIQGMG ELHLEVYIERMKREFKAEVETGMPQVAYRETITEKAEFNYTHKKQSGGAG QFGRVAGFMEPLDTEEQTYEFVNLIKGGVIPTEYIPSCDKGFQKAMEKGT LIGFPIVGVKITINDGQYHIVDSSDIAFQLAAIGAFREAYNKAKPTILEP IMKVTLEGPTEFQGNMFGLLNQRRGIILGSSEEGTFSKVEAEVPLSEMFG FSTVLRSSTQGKAEFSMEFLRYGKVPNATFNELCKKFNEQNNK >BRE_698 fus-2, translation elongation factor G MFEGFMEIRNIGIMAHIDAGKTTTTERIIYYTGKTHKIGDVDSGNTVTDW MTQEQDRGITISSAAITCYWKNYQINIIDTPGHVDFTAEVERSLRVLDGG IVVFSAVDGIQAQTETVWKQASKYGIPRLAYVNKMDRVGANFFKVIEDIE NKFGIVPVILQIPIGSESSFEGVIDIIRNKELHFEFRDGKPVVIEDVVRE EFVENVEIFREKLINSLSNFSEKITELFLEYSVVDDSVIIEEIRRCTIEG LVIPVLMGTSLKNIGIEPLIDAIVDYLPNPFEKKINAYSLKTNRNMLLDP REEKKLSALVFKVQYFSAIAAHLYFIRVYSGELDSSKKVFNVAKNKREKF TRIFRVFSNKNEQIDKVKAGDIGAVIGLKYSITGDTLVEEGNDIILESLV FPEPVVLISIEPERASDDARLKEVLEIIAKEDPTFSYREDKETGQLLISG MGELHLEIIIMRIRDDFKLNVYTGKPQVSYRESLSLTVNDVFKFVNMFSG KEINLKIGMILSPLSRGEGNKIEFECDIEPLFKAAISRGITSSFSSGIIG YPVIDTSVKIVSLNYDKVKVSESAIESISGFAFNEFFRRASPIKLEPIMM LEIRTPIEYTGDVVSTLNAVGGMIHSISNIDDYEIIRAEAAFAQLFGYTS IFRSSTKGRGVFTMEFLSFKEKVE >BRE_60 gap, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) MKLAINGFGRIGRNVFKIAFERGIEVVAVNDLTDPKTLAHLLKYDSTFGV YNKKVEARDGAIVVDGKEIKIIAERDPKKLPWGKLGIDVVIESTGVFTSA TSDRGGYLDHVEYAGAKKVILTVPAKDDIKTIVLGVNEHEITSDLKAVSN ASCTTNCLAPLAKVLHEAFGIEKGLMTTVHAYTNDQKILDFPHADLRRAR AAALSIIPTSTGAAKAVGLVLPELKGKLNGTSMRVPVPTGSIVDLTVQLK KKDVTKEEINSVLKKASESRELSGILGYTEDPIVSSDIKGNSHSSIVDGL ETMVLLDGFVKVLSWYDNEFGYSTRVVDLAQKLVK >BRE_345 gatA, glu-tRNA amidotransferase, subunit A MDLSGLNLIKIKELILTRKYKIYDIILYYKKVYEDNRDINGYVEFFDDAL EIAKEYDDLLSKGGGQDLPLLGIPIAVKDNIAIKNKDLTCASEILQGYIS PYDATVIKRLKDNGAIIIGRTNMDEFAMGSSCEFSYYGVTLNPSNKEYVV GGSSGGSAAVVARGQSPFSLGSDTGGSVRLPASFAGVIGFKPSYGGLSRY GLSSYSSSLDQIGFFANSIDDVALILKYTCGIDTMDSTSIDIIQEPYPLL NKPLKGTKLAVIKEFSKDLMEEDIYCEFSKFKSALLSKGVEIHEISIEAV NFVLSLYYSISPVEAASNLARYTCLHYGKRLNDTLSLNDFYYKHRSLFLQ EEVKRRVVLGNYLLSEGYDLEYYTKACKIIENVLIPKFDEIFNNYSYIIT PTSFLKPFKIGENFDDPLKMYYSDLCTVIANLIGFPALSIPFAKDDKGLP IGMQVIGRVKRDFELLSFSKNIIEELELDGI >BRE_344 gatB, Glu-tRNA(Gln) amidotransferase, subunit B MEYKLLIGLEVHVQLGLKTKAFCGCKNDFGGIPNSRVCPICLGLPGALPS VNKELVSSAILAGHATNSTIRNIVKFDRKHYAYPDLPKGYQISQNDAPIC ENGFIFIKTSLGVKRINIARIHMEEDSGKSLHLLSNDNQSYIDFNRAGAP LLEIVSQPDIRSGEEAVAYLNALREIFRYLDLSECSMENGSFRCDVNINL LINENDVNYKTPISEIKNLNSFKSVKLAIDYEESKQKEEWILYRKTLESV GKCTMGFDDKKGITVLQRSKETISDYRYIKDPDLPLIKLESDYIENIKSH RMVELPFDARIRLQEQYGLSDFDVVTLTSDKNLVKYFEEAALTSSEPKKV ANWILSEVLSVLNEREIGILDFNLPASYIGELVEFILNGKISGKISKEIF LEMVDRNVSSITIINEKKLEQISDKSFIESIVIEVLNENPKSIELYKKGK SHAVKFMMGQIMRKTSGKVNPVLSNEILMNKLQDV >BRE_346 gatC, Glu-tRNA(Gln) amidotransferase, subunit C MKNIHLENSLKLSLLKLSEDEKQQFVMKFEKIVCMLDKISEFKIKDGFHK AVCNFSDLRDDEILPSLTIESIKNFSNVFVDGYFLSPKVLE >BRE_776 gcp, sialoglycoprotease MKVLGIESSCDDCCAAIVENGNTILSNIKLSQKEHKKYYGIVPEIASRLH TEFIMYVCQQAIISAKINISEIDLIAVTSQPGLIGSLIVGVNFAKGLSIA LKKPLICIDHILGHLYAPLLNHTIEYPFLSLVLSGGHTILAKQNNFDDIE ILGRTLDDACGEAFDKIAKHYKMGFPGGPNIEKLAIDGNQYAFNFPITIF DKKENRYDFSYSGLKTACIHQLEKFKNNNAQITNNNIAASFQRAAFENLI IPIKRAIKDTNIKKLIISGGVASNLYLREKIKNLEIETYYPPIDLCTDNA AMIAGIGYLMYLKYGASSIETNANSRIENYKYTKGVKL >BRE_176 gidA, glucose inhibited division protein A MFRKIGMDFDAIVIGGGHAGIEASLALARLNFKTILITQNLDTVGKLSCN PAIGGLAKGNMVREIDALGGEMGCLVDFSMIQFRILNKSKGPAVQAPRAQ ADKLVYQIKAKETLEMQNNLELFQDTVSDFLLNPMKNKIEGVVTERGNKF TSRVVVLTTGTFLRGKIFIGEYKAYMGRISEPAAFGLEKILLELGFEMGR LKTGTPARVHRRSINFAKTEIQFGDSDIIPFSFSNTKIDKTQLSCYVTYT NKKTHEIISENMHLSPLYSGEIVGNGPRYCPSIEDKIVKFKDKDKHQIFI EPEGINTQEMYLNGLSSSLPEDVQKRLINSIDGLEDAVITRSGYAVEYDY INPIELYASLETKRVEGLFVAGQTNGSSGYEEAAAQGLMAGINAALKLQK KEPMILPRTSSYIGVLIDDLVTKGTKEPYRMFTSRAEHRLNLRHDTSDKR LIKWGYEVGLVSEEKYSRYFFKEKQIEEIKELLRHRRLKEKEASSFELKR HINKDFYHIVKDPYINLKDLVNIDPKLNASKVILEQVELDIKYEGYINRQ KDLIRKMNNLELIKLPLDFNYEIDGLSREAREKFVKIQPANLAQASRVSG VRNTDIQVLLIYFSNPKNKVVLNLDL >BRE_175 gidB, glucose inhibited division protein B MMTNFKFALKNLKVNFTSENIDKLRFYIEKVLLFSDRFNLVSNNVRNFDA MLLHALDSVSGLPIVKDKNLRQVLDVGSGAGFPGIVLALFDRCRKYVLLE RSNKKAIFLKMISLELGLENVEVLEHNVEEEQNKYEFITIRAFGDIRKYA NILGSILKSGGLIMAYKGKFDKVEFEMSYVKNLFDKVEIKSSEVISDKER YFLLLYDYKC >BRE_21 glpE, GlpE protein (GlpE) MIVSYLKLICLIVFLFFYIWFFIILKMKRTNIALLEKIKNGAKILDIRSP KEYTKSHYTRAINIPFKNLFAKKDKLGSLDTQIIIYGKSFSKSFEAEKLL KGLGFKNVFVAGTLKNMPKLPGSKEEING >BRE_239 glpF, glycerol uptake facilitator MVYTKTQEFISEFLGTFILLSIGTGSVAMTTLFPSNPTIAGEIINGGYTN IVFGWGLGVTFGVYTAAKISGAHLNPAISLGLATIGKFPKSKLCYYIPAQ ILGAFSGTLMTLIVFYPKWIEIDPKFEITQGIMSTFPAIPGFWPGFIDQI FGTFLLMFLVLVVGKFIKEDIQNPFFPFIIGAIVIAIGISFGGMNGYAIN PARDLGPRILLLIAGFKNHGFNDINVLIIPILGPIIGANIGAMVYKLTLK DKK >BRE_242 glpQ, glycerophosphoryl diester phosphodiesterase, periplasmic precursor (glycerophosphodiester phosphodiesterase); lipoprotein MKFKLIMFAISTVLIISCAKENAKINKKSALIIAHRGASGYLPEHTLEAK AYAHALGADYIEQDIVLTKDDIPIVMHDPELDTTTNVAKLFPGRARENGK YYSVDFTLAEIKSLSLSERFDPETQQPIYPNRFPATEYDFKIPTLEEEIK FIQGLNKSTGKNIGIYPEIKKPLWHKQQGKDISKIVIDILNKYGYKSKED KIYLQTFDFDEIKRIREELGYQGKLIMLVGENDWEEAPTDYEYIKSEEGM AEVAKYADGIGPWIPQIIINGQITGLISLAHKYNMQVYPYTFRIDALPSY VKDPNELLELLFIKAKVDGLFTDFVDISIKFMQ >BRE_241 glpT, glycerol-3-phosphate transporter MKKIFNFLKPAPHIQRVDKELEESLYKKLRLQIFLSIIIGYAGFYLTRKI FSFVMPELEKEGLNKSQLGIILSGVSIAYGFSKFIMGNVSDRSNPRYFLS LGLSLTAAISITFGLLPWSSIDTSIAIVLMFILMFANGWIQGMGWPACGR TIVHWWSKKERGIIVATWNVSHNIGAGIAGIISAQALFYFNEWQAVLYVP AFIVIIIAIFVLMTLKDTPQSVGLPPIEEYKNDYPDNHTEDAEKELNAKE IFIKHVLNNKLLWYIAIANAFVYFIRYGILDWAPTYLAQVRNFSIKNSGW AYSLYEFSAIPGTLLAGWMSDKVFNGRRSETGIIFMTATLIAIIIYWQLP ENTPTLTTVLLAIIGFLIYGPVMLIGLHALDLAPKKAAGTAVGFTGLFGY IGGSVTASAITGFVLQYFSWDVYFYLLMISCIFAITFIALTLKKEKNNKN K >BRE_735 gltP, glutamate transporter MNMTITYVILNVTIMFILIGFLYFLRKKHISFTKRILIALGLGIIFGTLI KYCYESNPTIIQETIQWTNIIGIGYIRLIKMMVIPLILVSIISAIIKLTN SQDIWKMSLSVIFILIFTAGIAAIIGICISIFFKLTAEGLQSGVDEIMQG QKLDRKLQVLHQTPMTQKLSELIPDNIFADMAGTRPNSTIGIVIFAALVG IVALRVAKKKPESIDFFKQIISTAQDLTLGIVTLILKSTPYAILAMITKI SATSDLISIMKLGKFALASYVAIGITLLMHMTIIACNRLNPITFIKKVWP VLTFAFISRSSAATIPVNVEVQTKKLGVSEGIANLSSALGTSIGQNGCAA LHPAMLAIMIAPTQGINPTDPSFLLQLIGIIIITSFGVAGAGGGATIASL IVLSSMNLPVSLVGLFISIEPLIDMGRTSVNVSDSMVAGVITAKNLNQLN KNIYNNQNTK >BRE_371 gltX, glutamyl-tRNA synthetase MIFQKRTFFIKRGCVLNIRVRYAPSPTGLQHIGGIRTALFNYFFAKSFNG KFLLRIEDTDQTRYYKEAEEDLYQSLAWLGIDFDEGPTCGGSYSPYIQSQ RTEIYRKYAKELIESGNAYYCYCSPDRLERIRKIQTINKMVPGYDRHCRH LNKDEIKDALSLGISPVIRFKIPFDGETSFNDILLGKITWANKDISPDPV ILKSDGFPTYHLANVVDDHLMEISHVLRAQEWISSGSLHVLLYNAFGWNP PIYCHLPMVMGSDGQKLSKRHGATALKQFIDDGYLPEAIINYVTLLGWSY DGKSEFFTKNELQKLFSIDKISKSPAVFDYNKLDFFNSHYIRTKEDHELA ELLLPFLQKAGYIKKDSNSCDKEKLLLLVPLIKPRIRKLGDAVGMLRFFY TNISTWNVNEFLGKKKTVRDIYLLLEKIKPVLEGFETRILSENEQIFYNF AKENNLKIGEVLIPIRIAVLGSKVSPPLFDSLQLLGKVKVFDRINKAQDF LKKYEL >BRE_605 glyA, serine hydroxymethyltransferase MIDNILFDLIEREAKRERENIELIASENFVSSDVRQAVGSVLTNKYAEGY PSKRYYGGCSVVDDIENLAISRAMELFGASYANVQPHSGSQANMAAIMSL IKPGDKILGMELSHGGHLTHGSKVSFSGMFFDAYSYGVSRDSEMIDYDDV RNIAKACRPNLIIAGASSYSREIDFKKFREIANEVSAYLLCDIAHTAGLV ATGFHNSPIDVAHLTTSTTHKTLRGPRGGLILAGKEFNTMINYNNKERTL DLAVNSCVFPGTQGGPLMHVIAGKAVAFKEALNKEFKDYISRVIENTKAM AEYFISEGLRIVSGGTDNHLFLVDLSGLGITGADAEKILESVNITLNKNA IPFDSKNPSVASGIRIGAPAITSRGLNRDDSIKVAHFIIRALKTKSTDEL RKIKQEVIGFISSFDMP >BRE_370 glyS, glycyl-tRNA synthetase MFDMAKIEDIISLAKRRGFVFQSSEVYGGLSGVWDYGPLGVEIKKNIQEE WWKSMVYFHENVVGLDSAILMRPEVWKASGHVDSFLELLVDCKNCKNRFR TDFIDLSKGCPNCGSIGTFTTPRSFNLMFKTNIGAVEDSSSEIYLRPETA QGIFVNFRNVLDTTRLKVPFGIAQVGKAFRNEIIAKNFIFRVCEFEQMEM QFFVHPSQMDDWYCYWREKRMNFFIETLGIKADNLRFQKHNDDELAHYAK AAVDIEYNFPFGFQEIEGIHNRGNYDLNQHAKFCGKSKLFEYHDLITGDK YIPYVIETSLGLTRSVLMTLCDAYACEELEGGDKRIVLHLHPKIAPYKVA ILPLVKKDGLPELARKVFMQFSDDFYMFYDENGTIGKRYRRQDEIGTPYC VTIDYDTIENRTITLRDRDTMTQTRISIDDLYSYVKTGILNYKGV >BRE_566 gnd, phosphogluconate dehydrogenase, decarboxylating (gnd) MDIGIYGLGVMGSNLALNIADNGFNVYVYNRDNEKTEVFLANNSHKKISG VSDIETFIRSLKKPRKIILMVSNSAVDEVIEQILPFVEKFDIIIDGGNSY YKDTIRREQELSSRDIYFVGLGISGGERGARFGASFMYGGNKKAYELIEP ILNKIAAKTNEGDVCSAYLGKDGVGHYVKMVHNGIEYADMQLIGEAYFFM KRAFNLDNLRIAEVFDKWSEGELSSYLIEITSKILKYKENNEYLIDKILD VANQKGTGKWVSIEALHLNVPANLIFESMFARFLSILKHERVIASDILKM DVDFVEFDLSDWILDLYYSLLVAKILAYSQGFMILKNASANYLWDLNLGK ISLIWREGCIIKSVFLDKIKLAYDKNPHLINLLFDDYFLDIIKNHHKSLR RIVSKASEIGIPLPAFYASLSFLDSYSTNYLPANLIQAQRDFFGAHSFER IDSNRGEFFHSSWE >BRE_682 gph, phosphoglycolate phosphatase MTFKGIYNMKIKACIFDMDGTLINSIMDIASSMNFALKKLGYREIKTEEF NTLVGKGYSKLIENTLKHLNIDLNDKHLNDNLYQEFVKTYNQNLYFHTKT YDGIPELLKKLNSLKIPIGILSNKNHEELLIITKDIFKDIKFFEVRGYSS KFEAKPDPENALDMIIELNLMPQEIAYIGDSDVDMLTAQNAGFLPIGVSW GFRTIQELKENGAKYILNNPFELLDILK >BRE_664 gpmA, phosphoglycerate mutase MYKLVLVRHGESKWNKENLFTGWTDVKLSEKGVSEACEGGRILKEEGYSF DIAFSSMLVRANDTLNIILCELGQSYIDVEKSWRLNERHYGALQGLNKAE TAEKYGEDKVLIWRRSYNVPPMPLDESDKRHPIHDSRYKNIPKSELPSTE CLKDTVARVIPYWTDKIAKAILEGKRVIVAAHGNSLRALVKYLDNMSEED ILKLNIPTGIPLVYELDKNLKPVKHYYLGDEDKIKAAMESVANQGKKIDR >BRE_367 gpsA, glycerol-3-phosphate dehydrogenase, NAD(P) MKISIVGAGAWGTAVAKVLADKFKDPVLIWSFEEDVRESINNSHENTKYL KGIKLPDNLIASSDLLDIVNQSDYIFVVTPSLYTLNVLNKLKSVLTTKKF KLAILTKGFITIDDKPCTIIEVAEGVLREYKDEITYIAGPSHAEEVGLGI ITGLVAASRNRANAFEFINLFSGTSISMFYSYDILGVQVASALKNIFAIA FGILDECKIKDPNLIGNNTESFLFSVSLNDMKNIAFKLGSCNEETFLFLA GSGDLDVTCRSIFGRNRRFGREIVGKNILEDFRDIDDLISNINKIGYLPE GLVAAREVALLFKFLGISSDFQNLAMIVYKILNKELKPEAVIDYIKNFKF >BRE_135 greA, transcription elongation factor EF MSNITIERLDNILQEDKWTRIVVNNYSLAKIKELDELIDNIISENLTEEA LDICGKHLKDIKKSIAGLYISGMLIYSRRPLNDMSLLTVVDLFSQNLKWS LVEHICHKMLLTSENKHALYTLAKIYAQNNENDKLPSIWMRIVEADVDNT VFVRQLATHYENVDLQKSIYFFRKAIYRFIDKKQMSGIREIWSKLIRYVS DDFDSFLLILQKVEKELGFKKVVVLYEDLYEHYAVSGNIDETIEILKGIL KLDNKNQKARENLVIFLREKYKDVNNIEEYLEKSDIENLDKNFVDVYSDF EKYLFFAKGNFVYHQTWFVGIVKDVNDQGILVDFVSKRGHFISFDMAISA LSPLEREDIRVLKAIKPKEELVEHLKRDIEWALKVIIKSYKSIDLKGIKR ELVPSLMTQSAWNLWSVKAKQILKDNPHFVMASGKADCYIYNERASNFNE KIYDKFKVEKDFYKRYEIFMHYYTSGGIVKDSHIEEEMLNYFLIYVNNFA KVDHYVISSYVILKSLKDFDDKIALKINIERDINLEVLLKEYSKSIVDLF DAILNADIKKELISLIKEELVDWVVYYKQLFPCYVNKKLIDSLYKEDIKE TEHLFNYVTKNYKMYKDAYIWILKHYTSYSLNLDYSDAELLVNLIKILTD SVIKINNKNNSVANKRIYKMVSNLLIKDKYLSIVLSNVMDEELAKRIYMT CFYIRDFPPKDLIHIKTAIRTVFGNIEFEDEKMQVSGDKVEIGFLTILSS LSKKQKELQYLKDVEIPENSKEIGKARELGDLKENAEYHSAKERQQFLTK RLNTLMSEIDVAKVIDIKELQSSVVGFGTKVTMINKDTEREESYLIFGPW ESNPDEGIISYKSPFGENLLDSREGDSLDFVINNTHFQYYVKKIEPAKIN >BRE_655 groEL, heat shock protein MAKDIYFNEDARKSLLSGIEKLSNAVKVTLGPKGRNVLIDKKFGSPIVTK DGVSVAREIDLENSFENMGAQLLKEVAIKTNDLAGDGTTTATVLAYAIAR EGLKNVSSGINPIGIKKGIDHAVALAAEKIRKSAKKITTKEEIAQVASIS ANNDTSIGEKIAEAMDRVGKDGVITVEESKTFDTTISYVEGMQFDRGYLS PYFSTNKENMSVSFDDTYILICEKKISTIKELLPVLEKVVNTNKPLLIIA EDIEGDALAALVLNSVRGALKVCAIKAPGFGDRRKAMLEDIAILTGGVLV SEELGLTLENVELEQLGQAKSVKVDKDNTTIINTGNREQIRERAELIKKQ IEETSSEYDKEKLQERLAKLVGGVAVINVGAVTEVELKEKKHRVEDALSA TRAAVEEGVVPGGGSTLIEVAMYLDTVDVSKLSYEEKQGFEIVKRSLEEP MRQIISNAGFESSIYIHQIKTDKKGLGFDAASFKWVNMIESGIIDPAKVT RSALQNAASIAGLLLTTECAITEIKEEKNSAGGNYPMDPGMGMM >BRE_747 groES, chaperonin groES MKMKNIKPLADRVLIKIKEAESKTTSGLYIPENAKEKTHIGTVMAIGSNK EEINVKVGDTVLYEKYAGAAVKIEDKEHLILKAKEIIAIIEE >BRE_524 grpE, chaperone protein GrpE MDEKEKCKDPEKIKENENETFQNEDNPNMEKKIIELENEISNLKDLYLRK QAEFENFRKRLEKDKENFIKFANENIMKDIITFLDNLERAIDSSKQSKDF DTLLSGISMIENEILSSFDKKYNLKKFGKLGDEFDPSQHEAISIEEKEQI INPQIVEVYQKGYCYNNRVLRTAKVKVAQSKN >BRE_206 gtaB, UTP--glucose-1-phosphate uridylyltransferase MKGIILAAGYGTRFLPITKTIPKEMLPILNKPSIDYIIEEFINSGIKEIL IITSRRKKVLDNYFDREVELEHTFIKECRKDFLEQIKLKDINICFIRQNT MMGTGHALLHAKPWIGNESVIVAYPDDLHIGSPPLTAQLIELYKKTGKNI LSIIENPKNINRYGVIELNQDNIHVKDIVEKPAIGHEPSNKASIGRFLYT NEFFKFLEEGFKFHQKGEYHHIYALKKLMIENKVLYKKIEGERLDIGDIE GYLETIIKIAKQDDKLLQIINNSLRN >BRE_1108 guaA, GMP synthase (glutamine-hydrolysing) (glutamine amidotransferase) MSNNAVVILDFGSQYSQLIARKIREMGVYTIIVTYSLSAKEIKDMNPVGL ILSGGPASVYLDEAPGVDIEIFDLGIPILGICYGMQLIIKVFEGVISKCD KQEFGHTELFIDDNKADLFLELPSKFEVMMSHGDNIEKIPEGFKQIAYTK ICVGAVFNLEKRIYGVQFHPEVSCCDIGNQIFMNFVFKICKAQTNWDLSN SIEDLVKGIRHEVGDSKVILGLSGGIDSLVCALLINKAIKDNLICVFVDT GFLRKNEANGILEFNKKYNLNIKHIDSSLLFLTNLRDVDDPEEKRKIIGK TFVEIFEKVALEEDDIKYLAQGTIYSDVIESDVKNNVCSSTNIKSHHNVG GLPDKINLNLLEPLRNLFKDEVIQLGVQLGLEEEVLYRHPFPGPGLAIRI IGEITKDKIDILQGADHIFIEELLINDLYYKVRQAFVVLLPVRTVGVMGD NRTYEYTAVIRCVNTLDFMTASWVELPYSFLRKVSSRIINEIRGINRVCY DISSKPPATIEWE >BRE_219 gufA, GufA protein MFKHLCDYLLTLHPIFLGFLGSVFTWFTTAFGAAAVFCFRRVNNKIMDAM LGFSAGIMIAASFFSLIKPAIEMAEELGYVTWIPAVCGFLCGAFFIYIVD VFVPDLEKLTFIDEDLTRHGKKDFLLFTAVTLHNFPEGLAVGVAFGALAS SPDLHTLVGAMILTLGIGIQNMPEGAAISLPLRRGHVPLWKCFNYGQMSG LVEIIGGFLGSYAVYTFTRILPFALSFSAGAMIYVSIEQLIPEAKRKDID NKIPTIFGVIGFSLMMFLDVSLG >BRE_435 gyrA, DNA gyrase, subunit A MIGALMAIENNKEQVLNIKIEDEVRTSYLNYAMSVIVSRALPDVRDGLKP VHRRILYSMHEMGLKSDKSFKKAGRIVGDVLGKYHPHGDQSIYEALVRLA QDFSLRYPIVSGQGNFGSIDGDPPAAMRYTEARMAKIAEELVIDIDKQTV NFKPNYDDSLLEPEVLPAAFPFLLVNGSSGIAVGMATNMAPHNLREVCDA IIYMLEHDDVSIYDLIAIIKGPDFPTYAEIIYNENLIKAYTTGKGSVVIR ARYHIEEKSEDNISIIITQIPYAVNKSSLLMKIALLIKEEKLEGVSDIRD ESDREGIRIVLEIKKGFDPHVVMNLLYEYTELRRNFSINNLALVNGIPKQ LNLRELISEFIEHRKNILRRRVEFDLKRAQEKAHILEGLNIALRNIDRVI EIIRFSRLVKDARECIMREFQLSEIQANSILDMKLQKLTSLEVAKIEEDF QVVLALIKDYEDILISPSRIVNMIREEIINLSLKFGDDRRTKIIYDEEVL KTSMSDLMQRENVIVILTKQGFIKRVLQDEYKLQGIGGKGLGSFDLQDSD QVNVALCVNTHDFLLMISNEGKLYVINAYGIKDSSRISRGQNIRELINLG EKEEILAIKNCSELSVDNYLLITTANGKIARIETEGFKTVKSRGVIIMKL DDKDFVTSAEIVSRDDKIICISKKGNAFAFSSNDIRLTHRGTQGVSGMKV REGDMLIKALAIKQGSHLLIMSENGYGKRLEVSKVTGLKRGSTGYTCYKK SDEKAGEVVDAITVSQDDEILLISKSSKVLRTLVDKISEQGKDARGMQVL SLDEDKLVAVSKFIK >BRE_436 gyrB, DNA gyrase, subunit B MCGRFMSYVASNIQVLKGLEAVRKRPGMYIGSVSINGLHHLVYEIVDNSI DEALAGFCDRIEVVINSDNSIMVNDNGRGIPTDIHEEEGISALELVLTKL HSGGKFNKGTYKVSGGLHGVGVSVVNALSSFLEVVVSREGKLFKQTYSRG IPTSEVEVVGVSFTTGTKVTFFADSEIFETLKYDFETLSRRLRELAFLND KIRISIEDRRLGEEKFLEFYFEGGIKAFVDYITNNNKNIQSSPYFIEGVC NDVIVSVGLKWTEGYSDNTLSFVNNINTKEGGTHVAGFKSGLLKAMSETF RDSKISKKDIPNLTLDDFKEGLTAVISIKVPEPQFEGQTKGKLGNSYIKK IVETIVYDGLLRIINENFVEIDIILNKAIRAARAREAARKARESERKKSA FESLALPGKLADCTSKNPAEREIYIVEGDSAGGSAKMGRDRFFQAILPLW GKMLNVEKTREDKVITNDKLIPIIASLGAGVGKAFYIEKLRYHKIIIMAD ADVDGSHIRTLLLTFFFRYMRELIDNKHVYIAMPPLYKIKHENKVHYFYD DFEKETFLGSIDVGKRNKVSLQRYKGLGEMNPTQLWETTMNPATRKMKLI EIDDAIQAEKIFVTLMGDDVEPRREFIEQNALDVVNLDV >BRE_202 hflC, Lambda CII stability-governing protein MKYILKFLLYFAKILAFTLIFGLILLAITQPIYILKENEISITTRLGKIE RTENTAGLKYKIPFIENVHIFPKYILRWDGEPQRIPTGGEEKQLIWIDTT ARWKIVDINKFYTAIKTMFRASIIINAAIEPAVRSVIAKYPLLEIIRSSN DPIQRLSDGILTPQDITNNTTYKITKGRKIIENEIIEVSNQNTKDIGIEI VDVLIRKIGYDPSLIDSVYNRMISERQQVAEEQRSIGIAEKTEILGSIEK EKLKLLSEARAEAAKIKAEGDSKAAQIYANAYGQNTEFYKLWQSLESYKI TLKDKRKIFSTDMDFFKYLHHTK >BRE_201 hflK, Lambda CII stability-governing protein MLNNILNFFNKTYEYTIILIVLVIILIITISNVFIVGPSDEAVILRLGKL NRILEPGIHIKIPLIEEKLIVPIKIIQEVKFGFNANNNMVINPDEDEEII ITGDLNIIKVEWLVQYKISDPYSFMFKVEDPEKTITDIAKASMNRLIGDN TIFEIINDNRVGVTEGVRDSMNEIIKTYNLGIDIIQVQIRNAMPPKGKVY EAFEDVNIAIQDKNKFINEGKKEFNQIIPKIRGEALKLIEEAKGYKENRI NSALAETAIFNAILDAYIKDPEITRERIYNETMKEILKNKDNIEIIDKNL KNFLPFKEVK >BRE_138 hisS, histidyl-tRNA synthetase MDVRTLKGFRDYLPKEALIRTHIIKQIYSVLVSYNFDLIDTPILEYSEFL LKKGGDEVEKQIYRFKDNGDRDVSMRFDLTVPFARFMATNKSKIKFPFRR SQIGKVFRGENTQKGRYREFMQFDFDILGEDTFRSDAEILSIVYCGLEEV FLNFIEGINIKFVIHFSHIGILNTYIEKLGLKDKSIFILRNIDKLDKIGI EAVRENLLLELSEEHVDLVLEFVNLDGTFSNKVKALRSILGDNNAVKRIE DIFVHLNALGIQDAFNFNLKIVRGLDYYTGLVFEAEMLGVNMGSICSGGR YDNLLSLFSGSLQKVSGVGGSFGIDRIQDIIEIDKFNYIKLFVVKASSRV LIVNIDDTLQDYYYKLADKFRRHDYSKINNIACEVYPKSKDGKNIKIQIE YALAKAIRFLIFVGQEEYQEGKLKVRDLTKKEELLLSFDEAIKFIKGNDK FLCTPF >BRE_17 hisT, pseudouridylate synthase I MKKILAEIAYDGSLYHGFQIQPTKPTIQGEIEKALEKINKTKVKIQSAGR TDKGVHAKRQIISFYIKININLKNLKTAINSLLKNDIRIIKLKYVSNEFQ PRFHAKKRKYTYYILNNENHYPWEEYQAYYVRKKLNINRLNTMAEMLIGL HDFTTFSCIRDQTNSKLKEIYLAKFKKKNKFIVFEIIGSSFLWKMVRSIV GTMIDIEIKNESVDTFIKILKSKNRKYARTTAPAKALFLDRVFYE >BRE_145 hlyA, alpha-hemolysin MIYIRILKKIFIMINLILILLIKIYQKTLSKIVGFYCIYQPSCSNYALNC LKKYNILTAFILITLRIIRCNTLFKGGCESLPTKNPILNSLKEFKTRLIK >BRE_422 hpt, hypoxanthine phosphoribosyltransferase MSDKISTLFTEKKIKSKIKELAQKIRSYYKDKNNVVFISLLKGFFMFFAD ITREIGLNVKIDFLQASSYGNKTLSSLNVLIKKDIEINIENCYVIIFDDI VDTGLTYKKIIAHLQTKKPKEIKIFTLFNKPSRRLTEIKIDYTDFEIQND FIVGYGIDFNEKHRTLRSVAKINQ >BRE_837 hrpA, ATP-dependent helicase MNDFELPIYKYKDDLIKKLSTNSVLIVESPTGSGKTTQIPRIIYEAGLAK LGKIGVTQPRRIATISIAEYIAKHIGVNLGEEVGYKIRFQEVISPKTKIK LMTDGVLLQELKKDTLLYEYDVIIIDEAHERSLNIDFILGLLKDILNKRN DFKVIISSATINTKIFSKYFNNAPILSIETITYPVQIIYNPPLLNTSKSM ILKIKEIIAGIIKEKKEGDILIFLSGEKEIKETIKEIHALNLKKDLIILP LYGRMAKEAQEQIFMPTPKNKRKIIVSTNIAETSITIENIKIVIDSGKVK TNKFQMKTHTYSLQEVPISKSSATQRAGRAGRLSKGTCYRLYKRDEYQLR DEYQKEEIYRTDLSEVILRMADIGIKNFTKFDFISKPSIKSIQTASDILK SLDAINEKNELTEIGKYMIIFPLVPIHSRALVEAMMHYQQAIYPTTIGLS FLSTSGIFLLPQNEEIEARQAHLKYKNPLGDLIGFINIFEDYRKAINKED FAKENYLDLQGLEEINNIQRQLENIVNSFDIPIVHKNEIDHEGYLKSIMR GMKDYICFKTSKNKYKTIKAQNVVIHPGSLINTDSVKYFVAGEIIETSKR YARAIGVLKKEWLNNIQFEENKNIPQKENKQSHHSHKNNILNKENKDSLK KEIKIGGKKFYIQNEYKNQLTFSLKEIKQLISKGLKNEEEKAIKNVLAKL TYENLIIFKNKKLIEIMRIVNGMEPNWTLLKTYENTSVNINEIDKIKNIL ECTMNFIQHSNKKSVLFLSLRSDYADNFWLKPQKSFIVAIEESMDSIKSL IDNQENITKLTSIKKTINKVYKKLNFFF >BRE_302 hslU, heat shock protein MMNKIEDQSIVPREIVAELDKYIIGQSEAKKLVSIALVNRYIRSKLPKEI RDDVMPKNIIMVGSTGVGKTEIARRLSKFIKAPFIKVEATKYTEVGYVGR DVESMIRDLMSIAVNMVREEMYDSVKEEASKRAEDRIIDKLLKNSENSEN DNITDEEKRVRDKLRDKFRKQLRKGELDENLIDVYVSGKMPVSTIEIFSG GNLEEIDMSIGGLINNIFDRKKRRELKIKKAREIIISEELEKLVDYENIV DIAKSRVENMGIVFIDEIDKIVTKNRTGNDVSREGVQRDILPIVEGSKVN TRYGIVDTSHILFIAAGAFNLSKPSDLIPELQGRFPIKVELTSLSIDDFK NILKCTKNSLIKQYIAMFKVYNLTLTFTEEAIDRIAELTFNMNFEGENLG ARRLHGVMEKILADLFFEAPGSKLKKIEINLDYVDEKIKINEQKDLNYYI I >BRE_303 hslV, heat shock protein MNFKGTTVIAIRRAGKTVVAADGQVTFGYTVLKSNAVKIRKLVNGKILAG FAGSTSDAITLFEKFEEKVKSREDGIIDIKRAAVDLAKDWRADKILHKLE AMMLVADSDNILLISGTGDVVEPEEDVISIGSGGNYAYSAALAYMENKKL SAADIAFKALKIAARVCIYTNSNIVLEEIG >BRE_565 htpG, heat shock protein 90 MKKQFDTEVNDLLYLIIHSLYSHKEIFLRELISNASDAIDKLKFLNITDE KFKDIKLDPRIDINFDEKSITIKDNGIGMNREDLISHLGTIAKSGTKEFM NNLKKDEKKASSLIGQFGVGFYSAFIVANKVEVITKKALDNIAYIWSSDG KTGYEINETNKDENGTEIILHLNKEGTEYANKWKIQEIIKKYSNHISYPI FIKYREPIMKDGKQEGFEEKEDKLNDTTAIWTKNKNEISNEEYNEFYKNL AFDYENPLIHIHTKAEGSIEYTNLFYVPSKASYDLYYPNTKPGVKLFINR IFISDSADSLLPNYLRFIKGIIDCQDLPLNVSREILQQNKTLAKIKASSV KKILSELEKLSENDPTKFNEFSKEFGRCLKEGVYSDFDNRNKLISLIRFK SSNVNGFVSLKEYKDRMPAEQKSIYYITGGKENILKINPIVNAYKDRGYE TLIMDDEIDEAILNFITEYEGIKLKAINKNETSDELKDQNFKKIEEEFQD ILSKIKEILKDHVKDVSLSATLVQEPSAIIIDSTDPTYQMQKIMLSMGQE VKETKPILELNPNNKIIQNLKNLDDTTLEKISIILLEEAIITSGLPSKNP NQFINIINEILEKNI >BRE_106 htrA, periplasmic serine protease DO MEVYKMNKNFISVFFASFLALAVGFFVGIGYLKSEKNTIVFAQEKGDAVH SLQDSFREVSKKILPSTVEIYATGTIKTRDPMQFFFFDIPGLNLEKKAQW GGSGVIIGKDSKKTNLFYVLTNSHILENASEFEVGTYNNKSYKAQLVGKD DKKDIALVSFEADDVVDIGVAELGDSDRLEVGDWVIAVGSPYHFSFSVTA GIISGLHRSFNPNLKARNLFIQTDAAINRGNSGGPLVNTKGEVIGINSWI SSPSGGNIGLGFAIPINNAKSVFDALMSGQKSESSWMGVAFHRLRSKDVE FLKSLGYEDESVSLAIVAGVYDGSPALKAGFRAGDVISKIDGVAMNLFFD VKQYINDFYAKEKIKVEVLRGQETKTFEVELGVMPTNIDKEKGNTLDLKL MPGFTVYPLTKEVRVQLGLRNWINGVVVDSIDSTLGNNPQIATGDIIMIV NSKNVKTLRDFYDAIKHGKNNYSILRNGQTLKVSI >BRE_844 ileS, isoleucyl-tRNA synthetase MFKKVENKVHFPQLEEKILQFWNHNKIFEKSMKQREGCEEFTFYDGPPFA TGLPHFGHFVPNTIKDIIPRYQTMKGKNVKRYFGWDTHGLPVEYEVEKSL KLSGRYEIEQYGIDKFNEECRNIVLRYTKEWKKIITRLGRWVDFENNYKT MDLTFMESVWWVFKTLYNKGLIYESYYVLPYSPKLATPLSNFEVNLGEYK EIHDPSLTIKFKIKDKNEYLLAWTTTPWTLPTNLGIAVGKDIDYSKVVDQ EKNEIYIIGTKRLNHYYQDENKYVIIEQFKGEHLKGIEYEPLFDYFVNQR NKGAFKIHTAEYVTTDDGTGIVHIAPFGEEDYQILKKNTQTDMITPIDAE CKFTSEVKDFEGLFVKDADNKIIEKLKSMNLLFKRENYLHRYPFCYRTNS PLIYRPISSWFVNIEKIKEKLIRSNEQINWIPEHLKKGRFGKWLENARDW AISRNRFWGNPIPIWKCSKTGNKICIGSREELEKLSGQKIIDLHKDKIDK ITWPSKYGGTYVRTSEVLDCWFESGSMPYASKHYPFKDKDKFQNIFPADF IAEGLDQTRGWFYTLTILGTALFEKTAFKNVIVNGLVLSSDGKKMSKSLK NYTDPIQIINTFGADALRLYLIMSPVIKADDLKYSDDGVKDVLKNIIIPI WNAYSFFITYAIIDKFTPNNYVNLYKTNILDKWIISEIESLKQILNEEID KYNLTKSIEVLLTFIDKLNNWYIRRSRRRFWKSENDNDKIDAYETLYYTL KNLMLMLAPFIPFLTEEIYQNLKTKNEKESIHLNNYPQSIKELINIELEE KMNFTRKVITIARALRASHNIKIRKPIKTIYIITKNHKEQNTLREMTEII LEEINAKEIKIKSNEEELVTYKAKANFKELGSKLGTNMKSVALAITKLSN EDILEIINGNKHTITINNNTYDITLKDIILERHERKNLKVINEDSITIGL DTLITEELYLEGLSRELIRKVQNLRKESNFNVTDRIILYTNNDEILTKII NNFENYIKTETLAITIEINNKKALTTLELDEEISVNIGIEKCLN >BRE_167 infA, translation initiation factor IF-1 MNTKEEAIETEGIVKESLPNTMFRVELKNGHLVLAHLSGKMRKHFIKIVP GDKVKVELSPYDLTKGRIVYREK >BRE_812 infB, translation initiation factor IF-2 MNLKRSNSLSENIDDDHSEDEKKIKVVKLRKKVVKVVAHTDKNLNSSRDD SLKSSNSWNKQSSGKGYSYDNKDRGGRSSSFHTDNRGNSGTVQQGNKGYV HRNSTYNRDSNSRDNRGYSYSRGGGIKSSSFRTTDNKDNSGVVQQGNRRY SNRSSTYNRDNREHSYSRGGGIKSSSFRTTDNKDNSGVVQQGNRVYSNRN YTHNSRDNSNSSNNSSQSFRRVIRTKVVSSATISPPSDSDNKGLLNRKLG EKKKQQQESQKVYKRKKEEIESKTIEQKVFEQLQKKKKENLANSIPKSID IMGSITVAELARKMNLKSSDLIAKLMTLGVMATINEKIDSDTATILVEEY GSRVNVVSIYDETVIEAEEGDGSKEVTKPPVITIMGHVDHGKTRLLSVLQ NIDINQTEFGGITQHIGAYTINYNEHEITFLDTPGHEAFTMMRSRGAQVT DIVVLVVSAVDGVMPQTVEAINHAKDANVPIIVAVNKIDLPDSNLDKVKH QLSEYDLIPEDWGGNTIFVAISALKNIGITELLDMIILQAEVMSLKANPT KRAVGRVLDAKIDMGRGVVCSVIIEDGTLSIGDSFVGGVYHGKVRALINE RGVSVKSIGPAKAISVLGFSSIPQAGDPFQVTKTEKEAKLISSKRQDLKK YEDAKNVKKVTVSNLYDSIKDGELRELKIILKADVQGSVEALKHSLEKLT NNEIRVKVIHSSVGAITETDISFAAASEAVIIGFHVRPTAKAQFLADQEK VEIKKYNIIYDAINDIKSVLEGMLEPDIEQQFIGFAEVRAVINIPKVGVV AGCYVSQGCIKRDAVTNIMRDGYQIHSGKIFSLRRFKEDVKEVGAQYECG IMIDNYSNIKEGDVIEAFEVKKVKRRFES >BRE_188 infC, translation initiation factor IF-3 MINRNSGKDRDRSRSGDKELRINHRIKAREVRVIFNDGTQSVLPIEDAIK CARDVELDLVEISPNALPPVCKIIDYGKYKFHQEKRQKEQRKNQKIIKLK EVRMQPKIDTHDLDFKYKNILGFLKEGNKVKVTIRFRGRELAHTHLGYGI LESILERVGDSNYVLESPAKMEGKTMFLIIAPKSRK >BRE_321 ispB, octaprenyl-diphosphate synthase MQNKSFLDKIEKNINNIFSKDYFLNLFTDKNLKLTLNIQESTINAIQAPV IEIINRGGKKIRPMLMILLAHALGYNNSDTENLYKLSMLLELPHSGSLII DDIEDGALKRRGKPSIHLIYGLDNSINTANLIYFLPAKLIQTSNLKTSQK LIIYENFFTTLSNLHLGQGIDITLHNGTYIPSIEEYISLVEHKTSSLFGM AGFLAGILTNNENKAKNLYNTFLNIGTYFQMIDDIKNIKDGVKGKDFGDD LIEGKKSLPIIYFLREKNFDNKIIHELAKIKNQPIDKVKEKILQFSNMIN SSNAIQNSSILATSYLNKFIEELNSYKLINKYKDMIIKLVTKIKEDNQ >BRE_444 jag, spoIIIJ-associated protein MSYEFYGKTEQEAIKKAMRDLDLREGEFDVEILDKEKVGFLFKKEMIRIK VSPHAKEEEVKSDIQFDEDIYNQVLDFVKEIINKMGYSVNLKVESREGNY VKIVIETDSPNILIGREGRNLDALQLLANIYISRLIGDTGNFNRVILDIE DYRERFKSRFINLAINSLHKVKRSRRSILLPTMNPFERRIIHTTLNRYSD IKTESEGDGNLKRVRISYVRNSKYNNNFRTYHKKDANSKK >BRE_707 kdtB, pantetheine-phosphate adenylyltransferase MRAALFPGSFDPITWGHIDLVKRASLIFDKVIVLVANNSNKSYLLSDIER YELTFEVIMSLGWTKIFVDKYDGVILDYALKNNIGFIVRGVRAFHDFEFE FERYVVNNKLNSSIDTVFLPSSDKYLFVRSDLVKELIKNKNFNLSNFIPE LVQKKLKSKFIDKLS >BRE_594 ksgA, dimethyladenosine transferase MNINYNSINSIKNVLKNKNIAPRKIWGQNYLINENIRAKIIDALDIKKNE KIWEIGPGLGAMTATLLNKANFLTAFEIDPKYSEILNEKFGQLKNFKLIE GDFLKTYKQEKKSINKIVSNLPYNIASKVISTLIEDEILIHMVFTVQKEL ADRMIAREGNKNYSSFTILVQSHFNVIKIMDIDKKNFYPIPKVKSTTIKL IPCKENIKNFQIFNKLIRTVFTSRRKKLKNTIINFIKNENILKKDFLKNF LDKRPEEISVKEFITIANKLTTYH >BRE_608 lctP, L-lactate permease MVNRKRSSHSIMNLYNFIKAVIPIIIIIIGLGIIKKPAYYVIPICLIVTI AIVLFDKNLGISNTSLAILEGTIMGIWPIIIVIVAAIFTYKMAESQNDMQ IIKAMLSNVSSDRRIIILLVAWGFGNFLEGVAGYGTAVAIPVSILIAMGF EPFFACLLCLIMDTSSTAYGSVGIPIISLAQATELDVKMLSYDISLQLII PTLLIPFILVILVGGGIKSLKGGMFILTLLSGASIAISQVYVSKILGPEL PAIIGSIPVMAIIIIYAKFFDKENKTCNKIKVSKMQGFLACMPYILIVSL IIIVSPLFHSINKYLSNFKTILEIYPGAKPLQFKWLTSPGLLIIFATIIS YSIRGVPILDQLKTFLLTIKKLALSSFVIICIVSISRLMTHSGMIKDLAD GISTLTGTLYPLFSPLIGALGTFLTGSDTVSNVLFGPLQTQIATNIDINP YWLSAANTTGATGGKMISPQNITIATTTAGLIGQEGKLLSKTIIYAIGYI LISGILVYFLL >BRE_89 ldh, L-lactate dehydrogenase MEMVMLKRNKVVLVGAGGVGSSFAYALTIDNSLVHELVIIDVAQDKAKGE VMDLNHGQMFLKKNIKIEFGSYDDCSDADIVVITAGLNQKPGETRLDLVG KNTKIFKEIVTSIVSSGFDGIFVIASNPVDIMTYVTMKYSNFPTCKVIGT GTTLDTSRLRYFLAERLNVNTQNIHSYIMGEHGDSSFATWDETKIAMKSL SEYIVDGTILESELDEIHNNVVNAAYEVIKLKGSTYYAIGLGIKRIVNAI IGDQNLILPISSYINGQYGDSIKDIYIGAPAVVCKDGVKEVLDFKISERE LKKFQISANQLKSYLDKIKF >BRE_90 lepA, GTP-binding membrane protein MDIERERGITIKSQAVTIDYKCSDGNIYELNFVDTPGHVDFSYEVSRAIS SCEGALLLVDASQGIEAQTVSNFYMAFEHNLEIIPVINKIDLPSANIDFV KEQIENDLGLDANVAVLISAKNGIGIDELLEAICKYVPFPKGSRESPLKA LIFDSHYDSYRGVVVHFRIFEGQIRPGYKIKFMHADREYFVEEIGIFKII LEKKDVLEAGDVGYFIAGIKNISDVKIGDTVTLVDNPAVAPLEGFKEVKP VVFSSVYPVDANQYDDLLKAMDRLKLNDASLTFEKDASAALGHGFKCGFL GLLHLEVIQERIEREFDLSVILTSPSVRYKIIPKKGNPYFIESPEQFPGN ENIEVTLEPYIRANIIVPAEFLGNIMSVCLLKRGVQENLIYLDAKRVEVI YKMPLAEILFDFYDKIKSVSRGYASFDYTLLGYEETDLVKLDILVNGDRV DALSQLVFRDGARAKALNICKKLKDEIARQQFKIAIQGAIGSNIIARETI SPVRKDVTAKCYGGDITRKRKLLEKQKEGKKRLKMIGNIEIPQSAFLAVL KSDDN >BRE_34 lepB-1, signal peptidase I MPGYLTFEQRLLRKQRRKIFFKIILLFLLSNYFVTKFVLQIFTFQGDEMF SLITKNNTLVFVSKHIRTFFIPLTLNDIVIYEDPNLRYNFIFKFLRDLFF LNNIFNIGSYKIAKIVATWGDLVYVKGFDVLVYRQVNNSYYLNGNLMIGY KLNDFFGFDEVIKCYSLKKNEFFLLNENLEILNDSRVFGPVGQADILSFL LLKIMGYKVVK >BRE_35 lepB-2, signal peptidase I MFLEKLDNFANFLVRIVERYLTYRKQKKYFYKLRAKKRGFMLNFLLELLG ASIFVLGINQYFLQAYRIPSGSMENTLQIGDLLFVDKFSYGPELLPGLCK IVGIKEPDESEIVIFENVEYKSKGLFFDILHRLLYMLTFSFVDLDKDEDG NPSVRFLVKRALFADGKLVRFRNGLVFVKREGEEEFIEEDIYKSSLGYNF TVKKNVEEVDYKVYDNLAMFIALNQLNVNLENVSDFSFFNLREIDRFEIE RLEYRYLVAFMPYVDYYMEKAIMRDYGIYVPYGYVLPVGDNRDNSYDGRF FGVIDKKKILGRAFFMYFPFSRIGLI >BRE_270 lepB-3, signal peptidase I MLQIHKQVLIPVTLAFILLITMIKMSLSFHLVKGSSMLPTILDQNWIINH KLAYGIRIKNKETYVVLWSKPKKNETVLIKDPITKKISVKKIFAIPGEKF IKLQPNIISIHNLNFNINKEHLQKLKSIYIPKDYYLVVGDNKKVSLDSRE YGFININDIIGKIIYQL >BRE_252 leuS, leucyl-tRNA synthetase MSKYDFKKIEKKWQNYWDKHKTYKVNEDPNVPKEKRIYILDMFPYPSANG LHVGHPEGYTATDILTRYKLLNGFNVLHPMGFDSFGLPAENYAIQTGKHP KKITEKNIEKFKEQIKALGFAYDWDREIKTHDVNYYKWTQWIFLQLYKKG LAYTKEIPVWYCPDLGTVLANEEVIQTPDGPRSERGFHKVERKPLRQWLL KITKYAERLIRDLEEVDWPDSVKEMQKNWIGKSTGVEIEFLIKESKEKIK VFTTRPDTIFGVTYLVLAPEHPMVDKITKDELKPIISKYKDKEILKSDLE RTSLEKDKTGIFTGAYAINPITKEEIPIWIGSYILGTYGTGAVMSVPAHD ERDFEFAKKYNLPIKQVVSQTGTNEVLIKPFTENGISINTPTEFNNLKTI EVKTKVIKWLIENKMGQEKVNYKLRDWIFSRQRYWGEPIPILFDDNLNEI PLNDDELPLTLPDIENYKPSGTGESPLSKIKDWVNVKRNGKIYKRETNTM PQWAGSCWYYIRYLDPHNEKEFANKEKINYWMPVDLYIGGAEHSVLHLLY ARFWHKVLYDLGYVNIKEPFRKLINQGMITSFAYQDENGILIPNDEVEKK DNKFFSKKNNKELKQIIAKMSKSLKNIINPDDIIKEYGADSMRIYEMFMG PLTDSKPWNTQGLIGIFRFLNKIWLIKNKELTNETPPKEIISELHKTIKK VTEDIETLNFNTAISTLMIFINELLKHEKNYLKIFRPISIILSPFAPHLG EELWEFMGEQSSIFKNAKWPKYDLNSIIDDTREIVLQVNGKTKDKIMIKK DTDEKTLKKIAFNNQKIIQNINNKQIIKIITVKDKLVNIVAK >BRE_363 lgt, prolipoprotein diacylglyceryl transferase MPNYINYPSWLHPEIIKGIPITWYSLSYIIIIIISYKFIWYQIRTDKLDI DKNDYEQLMFSIVMGAIIGGRLASTLIYDKSGIYYTHPWMIFLPFDQNWN FTGFRGMAIHGGFFGVIIAPLIMINTKLKNTNVKKYFKKITDYGAIAFSL GYILGRLANFANAELYGRPMKGGVIFPNAEPFKISQNGVKEFAESVGLEI LPHDLFINLPRIPSQLIEGLFEGPVIFLLLWFIFRKIKKYDGFIFGVYII LYGTFRFLIEYLREPDKEIGFIITYRKPESMLDFSFLNISMGQIFSSILI LAGIIWLIWTKKQAQKN >BRE_579 lgtD, glycosyl transferase MYKYKVSVIICFFNAESTLETMLKNAVNQTLRDKEIILVNDGSYDQSLKI AQKFAEKYDFIKVINQKNMGISVARNNGFEKSEGEYIVYWDSDDFIENTM LEVLYNRAKADNSDIVCSQFYIYFLARKIKRKSVLPFPNYPITGEEAFKN LLLTVFSSFYKKNFVVGTVWDKLIRRDLIVSNNVKFNDVILEDIVFMLHA FLKAKKVSFVNNYFYTNFQRMGSASSSISVISKVNMSLKVVENLLKEEGL FEKYFEYYKKFYLQLYYYISFKQVYVINWHIKDKLVYKAHKAKLIFVLNE VKNSKEFQNYYGSLKNSRFSELQTLPKMMLKIWNLSSVLYVNFSIFMYKA FLKN >BRE_557 lig, DNA ligase MGKDIKDEILSLRDAIKKWDREYYVDSSPTVGDVTYDKALLRLQYLENRY PEYKTLDSPTLKFGSDLLNDFKEIEHSYPILSLDKAYDVKELLLWVEKMS LEGSNLGFDMGISAEPKIDGCSIVLYYKDGILEKALTRGDGRFGNNVIEN VRTIKNVPLCIGERVELVLRGEIYITKKDFLKINHTLDDSYINARNLTSG ILRRINSREVVNFPLDIFVYDILYSSLKLNTNHDAFDKLKHFGFKLNPFC KFFCGKNLGENIINYVKEIEEQRERFEYEIDGVVLKVNDFRLRDVLGYTS HHPKWSIAYKFESLRAVSKVIDIVVQVGRSGKITPVANIEKVLIAGAFIT SASLHNQDYIDSIGLNVKDVVAISRRGDVIPAVELVVEKLSVGNFKIPNY CPSCKKSLIKEGAHLFCVNIHCPLKIMGHIKYFCSKKCMNIVGLSEKTIE FLFNMNFISSEIDLYTFDFDRLIGLKGFNFKRVNKLKRSIEESKNRPFKK LLLAMGIKDLGINTILLLINNNLNSFDAISLLCQDNKNALVKLLDIKGIG ERIAFNIIRAFNDKIILDKFNFFKKLGFKMQEDSMNCVIDSSFLFGKKFC ITGSFDEYSRHVLIDKITKKGAIFHSAVSRYLDFLLVGKSPGLKLKKANN LGIKILSLFDIKNLVNLDD >BRE_209 lmp1, surface-located membrane protein 1 MNKRKNLPILIILIILLITSFGGLGYYIYKERLNKNNQEIMLNEVKNSIM DRNYKKAHSITKILKDKYPQNTDIAMIENTLSELANDSPFESKNLQRDTA NQILDKIQGKEQSIPLDNENSEIAFNNKYIKDTTKIENYADRQDNTGIAN ENILEFNQNTIPQNLNDNTNTIKEQQKSNIENKNDTDDKKNLFNLQKLKA SLNKELDQTNTDQTNTKPKKIIKTDHKNKDKATTDNLIQDNTKQTTAKKE NFTISKPKTKIENIKDTPKNQIIDKIEIPYNYSTKKILYEILDNINTGNS LLAKERINELVKKGLNEQFSKINDLIDKQKNQEAAQLLIKLIKQDVKPNQ TSKRQAPLEKELLKQKLPIEEIPPIKEQPIDTQIQTEKDPNIEPNQSMQN SQKLQTLKTLASKNEKQKNFKKAETIYEEIANTTNNEEDHYKLGIIKFKL KKYEESLQAFDKAISLNPQHKKAYTNKGTSLIALNKPQQAIKEFEKAIAI DQNYDNAYYKKGIAEEQDNDKQNAFISFKKAYEITKNPHYALKAGIIANH LGDFKNSEKYLKQSNTSLNAKNDIMFYNLSMANFKNNHLNESLININKAL NINPTQTEYLYLKASIYLTKENYNEAVPLYNTVISKNPDNITAHINLAKA YEKLKNIPKAISILEKISNKNHAIALNNLGILYKNQKNYQKAIEVFQKAE AQSNIDAKYNLATTFFAIKDNKKAMEKLKEYIKINPNNPEALHALGIIEY TEYGNDKILKEVIKKFPNYTQNKTITEIIGK >BRE_254 lon-1, ATP-dependent protease LA MKSREIEYFMEEIKDTVSKEKKRSKNSGGILPHFDKPVRVPLIAVPSHPV FPSMFIPIVIVSDIDMKAVDYVIKGNGIISLFVLRDKFLEKSGNNKDGKL TINYQKDIYSVGVTAKIVKKINLPDGGYNIFVSTIDRVKFVKVVLNEDFP IIEVDYLKQIPIKKYDVNLKAIYSSILLKTKEIFSHRKMPEFQLNMVNIE DKGRLCDVVAGMIASSKESHQEVLETLSVKDRLKKVLELLYEELNLIEIQ NKIAKGIQEKLEKQQKEFFLKEQLKAIKTELGVGDEKNSEFLKMKSKIDA LALKGEALDAVGRELEKFSFLERHSSEYIVVRNYLELITNLPWEDTKVDF DKFNLQSAEKILDKTHYGMREVKDRIIEYISVLKLRKSQKGAIMLLVGPP GVGKTSIGAAIAEVLNTKFFRFSVGGIRDESEIKGHRRTYVGALPGKIIQ GLRITKTNSPVFLIDEIDKVSSSHYGDPFSVLLEVLDPEQNVNFRDHYLD LPFDISNVFFILTANSLETIPTPLLNRMEVIQLSGYVDDEKIEIARKYLI PKVLKENGVDKDSLKFQSSSLVQIAREYARDNGLRNFEKYLKQIVRKIAR KLVEDKSVKAYQISKENLEEYIGIPVFRKEKFLDKAMSPGMVMGLAWTNY GGSTLIIETVKTESKSPGIKLTGRLGDVMKESANIAFTYVNSISNELKVH KSFFEKYMIHLHIPEGATPKDGPSAGITIASAFISLALNKTVRPNLAMTG ELSLTGNVMAIGGLKAKIIAAKRNGVEHIIIPKANKVDLDDIPINIKNGI NFHLVDSMKEVIKLLF >BRE_619 lon-2, ATP-dependent protease LA MLISLGQKNFMKSILNLINAKKDDLPIILVKDNVFFPNVSLWVSLDDNAS INAIYQSMLEDRLILFFCVKDLESISANAKINVDNLYSIGTYSKIIQVIK VTETLVKILVDFHDRVVLKSILKKNDYFRARVDFISDKCEINGELFTYAK FLKETYNTYKSYLPPATSKDDENINFFDSPAKFVDVIASNVNLEYRVKVE LLQELNVKVRIEKLIMNLNIETELLMLKKDIKSKVKSKLDKGQREYFLTE QVKEIQKRLGKDETDYFERLNVKDIPKDIKSRIEREISRLARTNANSLDV NIIRNYIELLLELPWNENTVMKNSLKEIEIILKNSHYGMNEAKEKIMNFL AVYHINSKVQAPILCLVGPPGTGKTSVALSIAKSLSREFAKISLGGLRDE TEIRGHRRSYVGALPGVFINAIKVAGKSNPVILLDEIDKINSTYKGNPEA ALLEVLDSEQNTRFVDHYLEIPYDLSNVLFVATANSINEISRPLLDRMEI IKIEGYSCVEKLEIAKNFLIPNIIKESCLGKVYIRIEDDVILHIIRNYTM ESGVRNLKRVLTNLFRTVLRELLYSYSKEDIIEGNFYFPSSLIHGNNLLF THDPDIRGIYKIINMHNFHCYVNCESRFNLMRIDSSGFVYGLAWTNYGGA VLPVEAIKFDKKGDIILTGSLGAVMKESAQLAYSVVKTYSSKLNLDINEI PEIHLHFPEGAIPKDGPSAGITIATAIASVLSDKKVPLDVAMTGEVTLKG SVLSVGGIKEKVLAAYRNGINKIILPRDNEKDYVKLPEDIKDNIDVKYVS YLREVFDYLNII >BRE_476 lsp, signal peptidase II MNINRNRLVSNLIFISILVFFDQWSKYLVVTYVRLGTEYLSFFGDLFKII HVRNTGVLFSLGSNIDSSLKNLFFLIIPIIILVFVFSFSLKENNKVSRFA LILILSGGIGNIIDRLFRPLGVVDFLDVKFFGIFGLQRWPTFNFADSYVV VGMIVFIIYDLFTKDKSTNL >BRE_665 lysS, lysyl-tRNA synthetase MIKLSLNRGNIMKTAHWADFYAKKIITEKGEKEQYTVSSGITPSGTVHIG NFREVISVDLVARALQDQGKQVRFIYSWDNYDVFRKVPKNMPDQELLTTY LRQAITRVPDTKTNKSSYARANEIEFEQHLPTVGIEPEFIDQSLKYMSSD YANQIKFALDHKDEIATILNKYRITQLADDWYPISIFCTKCNRDTTTIKN YNHCYSIEYYCECGNKESLDLRKTWACKLPWRIDWPMRWKYENVDFEPAG KDHHSSGGSFDTAKEIVKIFGGTPPITFQYDFISIKGHGGKISSSSGDVV SLKDVLEIYTPEVTRFLFASTKPNTEFAISFDLDVIKIYEDYDKFERVYY GIDEIQEKKKETFKRIYELSQPKAPDKEIPYQIGFRHLSVICQIFEGDKD KIFTLLNNIKEHQKTKLINKIECAINWIKKFAPEDFKFSLRSTFDNIEVL QDNNKQAVIQLLKFLKENFNNITEKDIQDEIYNIARKNNIEPPLFFKQLY NILITKDKGPKLAGFIKTIGIEKFEEIVKHYI >BRE_126 maf, maf protein MIYKENFEIALVSSSLARIEFLNALKLNFVSLSVDIDENLIMRSGEMEIT KKISLIKLTNAIEKYGKDKCLITVDTLVKNDSIYIGKIQDEKEAFVKIME YSCKLVEVETSLCIFIPVKEKIVKACEVSFIKFRELTPDIVYHYISLGYW KDKSGGISLKNGVADILIEYINGNYSNIVGLPIGLFYDILIKENIISAI >BRE_425 mag, 3-methyladenine DNA glycosylase MNLVFVLFRIVLMNREFFMQDAVIVAQSLLGHLLVRKINEIEIISRIVET EAYMGVIDKACHAYGGKITNRTSAMYNVGGYAYIYMIYGMHYMLNVVASD KHAPHAVLIRGIEPIFPKIDRIFTNGPGKLTKFLNIDLKFNKIDLLNDSK LFLRKSLSLNFEIVCAKRINVHYAGEEYANKLWRFYIKGNKFVSKY >BRE_6010 malX, PTS system, maltose and glucose-specific IIABC component MSILSKSIFTTLQKVGKAFMLPIALLPIAGLLLGIGSALTNKTMIQTYGI EALFGEKTIMHATLSLIKYTGEVIFANLPLMFAIAIPIGLAKAEKGTAAL AGVIGFLVMHQTINGVLSIQGITPATTNVEALLAIGTTEAEAISKSQEYT NVLGIFSLQMSVMGGMIAGFIAAMLHNKLHNIHLPTFLAFFGGSRFIPII TTLVMFIVGIILTCIWPFIQGMMTSLGNIIEKSGYFGSFAYGAIKRSLIP FGLHHIFYMPFWQTSLGGTMEINGELISGAQNIFFKQLADPNTTHFEVTK GTRFFSGEFIVMIFGLPGAALAMYHTAKTENKKDAASLLISAGFTSMLTG ITEPLEFAFLFAAPALYYLIYVPLFGLAHLLAHIFNIGVGLTFSGGLIDM FLFGILQGNSKTTWIMIPTIGIFYFIGFYYIFKLAIIKFNLKTPGREDIE EDIIKTNPHKTKISEIARKVLEGLGGKGNITYLDACASRLRINVNQIELV KSDIYFKSIGASGMLKKGNDIQIVFGGVSDNIRMEINKIQIIK >BRE_405 manA, mannose-6-phosphate isomerase MSVDNIFLMKNEIKEYDWGGYGFIPSLLGQKENGLPKAEMWLGAHKTFSS KILVDGQYVSLFNFLEIHKELLGFGSELSFLFKILSVHKPLSLQIHPSKD IALKGFAFENNKKIVIDDSKRIYKDENPKVELVYALSDFYALKGFLPLDG INHIYRSLGLDFNFMTHESFVKTLFDLHEFEIENIIYKVLGNLNFIDEFR AFWFNEIYKMYGIDIGLLVFLGMYIFKLKTGEVFYTESREVHAYLKGECI ELMTNSDNVIRAGFTTKHIDKDEMLKVGKFEEGVFSLLKSENIDGCDVFK LPGTNLSLFHKCIGGESYFERVGVMILLVIKGKVQLNNRISLKMGDSVFI GNCDCNKELLICGNGEIFIALSL >BRE_107 map, methionine aminopeptidase MKLRLKSREEIEKIKASGRLLAQTFLEIEKNIAPGINTKTLDFIASDFIT KNGGKSAFKGYNGFKGTICASINEEVIHGIPGSRMLKNGDVISIDCGVVL DGFYSDMAKTFKVGKVSSQVSRLLEITEAALYKGIDEMKVGNRILDISKA IENYIKPFKFGIVREYTGHGVGFSLHEEPSIPNYYDPFFKNIEIREGMVL AIEPMVNLGSHKVSLKSDGWTVFASDLSFSAHFEHTVAVIDGLPLILSKV >BRE_584 mcp-1, methyl-accepting chemotaxis protein MYKFPFFCKKKSSTSDVKDNSFNDVDNIDDISTCENESSLKEIVRSFYHT KSSISNVLVNIEFLYKNLFSGFVNVEKVCISLISKVNDGRIKVNAIFEDI EKNNKEKLQKVTDIIMDVQKSLETINSFLGATNMISLNAKLEAARAKEYG KGFSVVADEIKRLSDQAKGVMNMISVKEIEQVSTDLISENIKKLQLGIDN LFLNMIEELTSLEESFKYCIGQQGEFSTLINELENIEASVSYLSRNCDSL SVSKAFVYSNDDFLKELEFIISEHMSWISVVKAIVDNQKSMAIQSDPMKH GFGLFYQGFAPKELEIREVWENIYSDYLNIHKLVVEIIKIFSQGNFNNAD LKNARDFFMRAENLSNEIISRLESVKNMVVECENQNINVFC >BRE_600 mcp-2, methyl-accepting chemotaxis protein MKRNHFSSTLFYKFNIVIVIYTIIIAMTIFILLERGYRKIITTELQNFTK FVNNIMIKSFSRDTRNMLIAIDNFAKHHNQNINKQQNEHFKNIITSEQLS SFPSYIKILEYTDKNGKILYSNNERRLHTYINLQEMQKDNNIGNHHTLIL NQDLTIINNKYYIPMIYKLPQKEQHDFYDTNDANIKLEQSERMDHNGYVV LYVDILEHIKQLRNNIFMLLERSLLEKDNHHKSSHYFNIYAMNNQGEIFG EKNEDTLKPIKLSINDLFENNTNITNPLLNAMTKRKSNYNISNNNNIISI TRLTSSSWYLAIQMNHNNIFSNELNNIKLMSASIIILFIIVFILIMIIII KKLIISKIEKLNNIIPKVKEGDLTIKINSKGKDSISATINHFGYFIENLK NVINSLQGRVKLLKDNGDLLFNEINKAYDTITNSNRYIEKTQGEIEKQVE FISNTTNTIENLSKNIASLDNSIETQASSVEESSSAIEEMIGSIQSVTEI TQKAAKSTEELKAFSDDGRKKQEEIIMQIKDIYKNSTRLQEANALISSIA SQTNLLSMNAAIEASHAGEAGKGFAIVAEEIKDLAEQVTSQSESVAASIN EIMDSINQTVKTSELTNKAFNQIFNSINLVVQVIEEINHTMQEQSIGSQE ILKALNTMREITYEVKIGSNEMFRGNKEIINTVSGLGEINITVSNSMKGL KEEIKKLIEAIESIKTFGTTNSDHITKINTDTNQFKTK >BRE_601 mcp-3, methyl-accepting chemotaxis protein MKLYFYGLNFGEFFMREDLVSVKLKNMRFFLYLMLFIFICFGFLFLGQAY LNYRHEYLNRIEADFKLFSSNVAFKIKNKYDGAVSVLKNLIKDNNVLNVL HKVSNNFVSNVDLRFIDLNTSIALFLSSKGFNDISKIFQHIPLEANSLEG VFYIPVGKNVLISNKNFSFLDINNIIEDPIYFVPVKESSVYYSSYKRVRN KLYSLVSMPLINDNHTVLGVICFFVCFDSLFVDIANQLNSYFKLSNKNYE FFMIDRDFQPLLLNLNDLNVNNFSENYANSVLSSVIEGVRSDPNIVKKIL KHNTSSYFLSTSQIAGQVVQGVIFNMNHVPLKFQSNAIFFLGFVFVACLI IFCLCIKFVLPFFSDFKMLIEQKKEREDILKLDSTSEFKYKSFIFSYINT EFDNLFSKTTNIVNNIKFYVQELRGRLNEINIPEESIERVHNSLTTYDGI GDAFSKFEKAVMNILKDFESTSNPINEHNKNILDIAAKFEENTNAFYSID KNLEVFNKVVVSNSASIDTVKSKVSELNSVFDSVNKNFSDLLSQTNNLQS ANKLLVLISAQTNMLAMNAAIEAAKAGDAGKSFAVVAEEIRKLAINSGKY STTIKDELKKVNNIISVISAEIDSIYKDFIDIQDNINNNSMQHERINVTL AKHVREIGEFKEQYLAHDIKIKDTKNMCKEIFNSYFVISGKFHNLNSDLS EFEVSKMSLDALETLREHILLINEFKEKIARMRNVVENMNKEFWDV >BRE_686 mcp-4, methyl-accepting chemotaxis protein MLKVKYKFVGYLFLCLLLVILFFSLIFKFILGNYLERYYKQLTRAQVRRA AFSVQSLLDTFYIIIDGASSNLALETMDEYSVVKNGGRMFSEMEIDRFRK NSKIVLDTVKFDKKYRSRLYNILWDLKLDTFYEDFAFLDFEGNIIVTTRY ENNSDFAQSESHTEYFKRAVEGYNKDKLDFVGWYTSLNEGIAGEVAVRSY YKDKKASAIVVPVHSAEDKVFLGYLVGYLLDDCIREQLDRSRFGFYNRGN LAYFDSQNYLVNSLIEYDEGFKVSDSFISLLKSTLAHPPRKSEVATETSV YEIQRAFLPEMGLYNYYAILPISSELGTNSGVLLARIPYEDIYGVVNSLA FKFIACSILGLIILIIILSVKIESIIVFRLNVFINLVKRMLKGNLDKTCI IADDGYYDELSLLGVQIIKMKNAIADAITSVLKNIDYVNKVSIEVANSSQ GLSSSALQQASTLEEMSANIEQISDGVKMSADSSQETERIALVTNQNAHV GGEAVEESVVAMQSIVEKVSVIEEIARKTNLLALNAAIEAARAGEEGKGF AVVASEIRKLADLSKESALEISELVEENSRLATEAGMIFRDMLPDIEKTT DLVKKISEGSYKQNEQIMQFRVALDQVGEVVQASASSSEELSSMADRMLE KAKELREVISFFKTDDSGKFEVDDLMNENFAPINVKTSSVIGNKANGVRD DLSMNYKSINKRVDPKKAIDVIDKDLDFDDDFSDF >BRE_687 mcp-5, methyl-accepting chemotaxis protein MKLKLRVRILLIVSMLISIFISVLFIGFGMLINSSLVAQQLDLMQNLIGN VKNSLTSYLYSMEERVKVNSMYLDSVERFESIARSKPKRIEAILDQIEIL GKTGRGSNLMITDKLGKIIFTTAVKDNSDYGVSVADKEYFIKLQTASYMY NSSVLLADSGSIEEVLMKDISQMKNESGQIPYLLIGVPLRDDVTNDIFGY FMIFYAFDYLYNSFKDIRFGTLNSGRAMVFDETGSFLIHHKWSPGNNFVK SNTYYERVFKNCYEDLIQKNKEISFGRYVDPLNDEYIGFAQRIKCKLSGV SFIVYLRANRGDFYYMSKLTTFILSIGFVITLIVLGFVTIYLVGRLSSAL NGILSYSEKLASGDFTITSHSLRWDTEEIHELYDDLGLLRENFSSIAKII NENLDYLYENAIQIANASQNLSSGAVEQASTLEEMTANIEQISQGVTENT YNASTTESIAVNTNEKTKEGYQSVTKVIQAMEIITDKISIIDEITRQTNL LALNASIEAARVGDKGKGFEVVAAEVRKLADQSKESAREIIDIANKSLTI ASKAGNNFKQIVPGMEETAGLVKNITRESSNQSNQIVQFKNAIEQVSQLI QTTASSSENLSAMSERMLESVKHLKDSVDYFKIDQ >BRE_592 metG, methionyl-tRNA synthetase MQKKNLITAALPYVNNIPHLGNLVQVLSADAFARYSRMMGIETLYVCGTD EYGTATETKALIEKTTPEELCNKYHAIHKSIYEWFNIKFDIFGRTTNKYH KETVQDLFLKLDKNGYITEKENEQFFCQQDQMFLADRYVTGECPNCGNNT KGDQCENCSNLLVTNELLNPRCIICKNIPIIKKTKHLYIDLPKIKNELEH WIQQIDQNTNWNINAIKITNAFLRDGLKERTITRDLKWGIPVPKKEYENK VFYVWFDAPIGYISITKEIIKDWESWWKNNEDTNLIQFIGKDNILFHTIM FPSIELGSQENWTMLNKLASSEYLNYENLKFSKSAGTGIFGNDVITTEIP SDVWRFYIYYNRPEKADFQFMWDDFMERINSELIGNFSNLINRVLTFYKK FFGDKIDKIELNENFWQIVNIKYERTINFFKQIELKAALKEILDISRIGN KIFQDKEPWKTKNSTPQTTKELLLNLIYLIRDLSILISPFMPHTSDRIRS FFGKSYEISNKFLGTNLGLTTIQSTEVLFTKLEKQLIDSLKLKYSGRTNM QDEKNKNSINLFSEQICLKTVKIKTIDRNPDAEKLFILKLDDGTPEGKQI VSSIADHYTEEELIGKHIIIVDNLKPAKFRGIRSEGMLIATKDENKNFKI IIVEDFKDNPIPGERVILESDTGKELKSPTKISIDKFLQAQIVAENGELK INGINLILEHSKEKVLSKEIPNGKIY >BRE_375 metK, S-adenosylmethionine synthetase MNNNNLTATSESVSEGHPDKIADQISDAILDEILKKDKMAKVACETLVSQ NLIVIAGEINSKAKKDIDIKETAKQTIKNIGYTNIEYGLDYKSATIIDAI GSQSIDITNAVEKKDTKDIGAGDQGIIFGYACNETKNFLPIAYELSNLIL KEASKLRKSGEIKWLRPDAKSQVTIEYDSYKNPIKVSNIVLSHQHDPDIP YSYLKQTIIEKIIKPVLNSRSMFDNNIEYYINPSGNFVIGGPTGDTGLTG RKIIADSYGGFARHGGGAYSGKDATKVDRSAAYMARYISKNMVAAGISRE FEMQIAYAIGIPKPISIKITTGINDNEYEKKILNFIINNFDLTPNGIIKK LKLREPIYSQTCTYGHFGKNELEWEKLDFVDTIKKEFQI >BRE_630 mfd, transcription-repair coupling factor MNIEKELTTKLKNNQNLQKMQKFIEQNIHFTLTGYEKFFKAFLIHKIKKY SNNKVILIVKNENISDEIKNDLTQITDQIYELNYFSPLIYKGIGSKSKVF CDRVKFLINFYENNPGIYIVSLKSLLSKIPTKKDLFNNIYKIQTDKIINI ENFEKKLIKMGYEKTMRVTLPGEFTINNKIIDIHSFNHKEPTRISLNNDK IKQINYFNPLNQLKQKNAIYEFNIIPKKEIIWNKENIDKLKNYIKESEYK QFFKQIETKYNARTEEVFYPLLGETLLSQEINENTITINFEIPNLKEEIK QIYKEYDRLYTQAIESDLKIVSPKEIFINPNDLKLKTNIYFIKTPINQQT EKPTKEIIEFKIESERRFFSNIILAKQEIQNWIDNGFQVIITAESNSQKE KLKYIFQDIPKIKVEVIKISSSLIINEEKIAIITEADIFNKKQKTNKTFE SSKTKPIDSFIEIEKNSHIVHINHGIGIFRQIKRIKTSLIEKDYIEIEYA DNEKLFIPIEQTHLIQKYIGNETQNIKLDRISSKTWEKKKVYATKKIDKI ADQLVSLYAERENITGFQYPQDDEWQLLFESEFPYDETPDQLTAISEIKQ DMMSSKVMDRLLCGDVGFGKTEVAMRAAFKAVMGKKQVAILSPTTILTEQ HFNTFKKRFKNFPIQIAMISRFITKSKEKEILRNLETGNIDIIIGTHKIL SKKITYKDLGLIIIDEEQRFGVKEKEKLKEIKVSVDSLVLSATPIPRSLH MSLIKLRDISVLKTPPQNRIKIETYVEEFSEILIKHAIENELSRDGQVFF VHHNIQELDSIKAMIEKVVPYARIATIHAKLTGEQIENIMQDFINKSYQV LLATTIIENGIDIENANTIIINNANRFGLAQLYQLRGRVGRSSKKAFAYF LYKENSNLNEGAIERLRAISEFSELGAGFQIAMKDMEIRGVGNLLGREQH GEIESIGLDYYLTMLNKAIEKRMGKNSKKNEINIEINYNGFIPNSYINNE QHKISIYKKISAIQSEEENNKIRSEIYDRFGPIPNELNSLLILSELKLLA QKLNITSLKERNGLLEIEYLDINSIPAEKIMKIIKDNPNILKLNQEYQNS VFLNLGNIKETDKINWIYKNLYLLL >BRE_683 mglA, ribose/galactose ABC transporter, ATP-binding protein MMQNILVLDKVTKRYGDFVANDNVCINFKKGEIHAILGENGAGKTTLMKI IYGIHRPDGGQIFLRGRELKLKDSSESIRSGIGMVFQHFMLIPKFTAVQN IILGYEDSKFGFVNYDRVRKKIIQLSEKHGLKIDIDKPVEDLSIGMRQKI EILKVLYRNADIIIFDEPTAVLTPNEINEFMNVLKILAIEGYTVILITHK IKEIKSVAQRCTVMSLGRVVRTFDVATTSEVIFTKLMIGKNTFLDMSRKQ SINYTNVLEIKNLKVKDERGVLRVKNISFDLREGEIFGIAGVEGSGQEEL IDAIIGVRSIFSGDIIKKVDDKFESIKGLTVKQIIDKKIGHIPSDRQKHG LILDFNILQNIAIKSFDDVKYLKMKGNDIESGKIKFKFLNTLKKQFVNFN FSVLKKISEQLVITFDIRPRDILRKVKNLSGGNQQKVIIAREINLKPEIL LAVQPTRGLDIGAIENIYEKIIEQRNAGMTVLLVSLELDELIRVCDRIAV MCDGKIIGVLEDNFDANIISKMMMGTG >BRE_325 mglA-1, methylgalactoside ABC transporter, ATP-binding protein MVEFKNIVKYFPDIERPILNSVNLRIEESKILTVIGRNGEGKSTLSKIIA GLVRFDSGEVFVNNIKQKNWNVDVAKNNGIYIVSQIPKLDMNLKVWEYLS IYWFDSKFFMPMNRSATYRYYKWLKQFYNIIFDLETRIQDLNIKEIYFLL IMSSLKKNAKIIIFDESVAYFSQKEAKEFIKLLQDLRKIGITSLFITHRE ISDAIKFSDEFIILQEGKCFRTTNKEIILNKLEIPSGKFIAVNSKRGEQN EEFIKFSLFFEDFWKYDINFSLKKRGILGIVAEEAAIKTWEKLFLGKIPF VGCIKMNGHRYENVDFNELKAGFLPLGIGNLFPDNITILDSFLSKIMSFE NEIFIKKSTINKLKKFFKNDMEYCDSKILKTFYSKSVAFSGGTLKKLALF REKYITKSFLICFSPLSNLDYRAYIETSNFIRNFSNEKPVLLITPNLDEL LFLSDDILAIKTGEVVLRLKREYVDKSTLKEMLFV >BRE_378 mgtE, Mg2 transport protein MIDVVFLKTLLKEKKYSDIKEELLKYDAFDISEALKKLNGSDLILIYRFL PKKVAVEAFSNFDQVTKNKLANSFTNKEIREMVDELNLDDVIDLLEEVPA NVVQRFLASSTEENREIINKFLSYSDDSAGSIVTIEYIELKEYFHVREAL DYIRKVAKTKEDIYTYYITDEEKRLKGVVKIEDLMLSSDDVVISTIMKNS GFYIVKVGDGKEDVALLFQNHDISSVPVVDNEGRMIGVIIIDDILEVIQN LNTEDFQIMAAVTPLGKSYLDTSIFDMTKNRIIWLLVLMISSTLTATIIT NYQNLVLSLVILTSFIPLLMDTSGNAGSQASALIIRELALGTLKVKDFFR VLFKEICVSILVGLILASVNFLRIVFFVIPAHDEKFKIAFVVSACLMIGL MVAKILGGLLPIMAKLVKIDPALMAGPLITTIADVVTLIAYFNIAKLVLS NYF >BRE_831 miaA, 2-methylthio-N6-isopentyladenosine tRNA modification enzyme MKTNKIVFIFGPTAVGKSDILFHFPKGVAEVISVDSIQVYKEFDIASCKP SIELRSHIRHHLVDFLEPIYEYNLGIFYKESCKIIESLREQKKIPIFVGG SAFYFKHLKYGLPSAPPVSDKVRLYINNLFIRMGKDYLLEELRRVDFKRY ESINQNDIYRIKRSLEVYFQTGIPISQFLQRENMFENIVAIGLRRPMDEM KSRIISRVKNMIDCGLLDEIKSLLGKGYDEKTPAFKGIGYREFLLWRSRP CYLLNDIINLIVKNSFLYVKRQMTFFNKLPNVLWFHPDDDLKNILDLIFV >BRE_2005 mlpA, lipoprotein MLYILFKINFKRGLFMKNAFIFLYISCILFNSCWHNPNAINNYPKDIQMR EESVKKQITKDQSLFLDLVRDSLGTKKADVYGKILALDISKIKPVLDNMQ SNLKKCGGNYNDNLVKLKKKFKESLKDITTNDIDTSDNDISSNTSSDNSN GNNIFSDNIFEGLCDALKN >BRE_288 motA, flagellar motor rotation protein A MNLASIIGWGVGFGAILISMAFTPTGLGVFWDLSSVFITIVGSFSALVAS SEITIVKRIPTYLGFFFKRSSFSKIPIIKTLVELSEKARKEGLLSLDDEL DQIDDIFFKSGMRLVVDGTDPEIIRTMLFLELEQMQERHKVGADLFGTWA KLAPAFGMIGTLIGLIALLGNLEDRSALGSSMAVALVTTLYGTIMSNLML TPIQLKLESIDLEEASVRAMIVEGILSIQAGDNPRILEQKLVTFLTPKDR NQLGSGVLGGE >BRE_287 motB, flagellar motor rotation protein B MIFKTKKKRSKCEDGGAPEYMVTYGDMVTLLLVFFVTMFSLNDVIMKENV LKIMSASFTGSGFFKGGKTLDIDKLSYLSNSFMSLPSTAKNKQASQASKN KSIIEFVEKIQSNKVIVRRHERGVVVSLLADAFFDSASAEVKLDDNRDVI QKIASFIGFLDNQGYNFKIEGHTDNVDVNINGIWKSNWELSSARAVNMLE QILNYTDHSKIESIESKFEVSGFAGSRPVATDDTPEGRAYNRRIDILITS DASLSFAKGIKQ >BRE_174 moxR, methanol dehydrogenase regulator MKNSFQIDSEVENALSLINKFRREVASRILGQREMVDAILMGILTEGHVL LEGVPGLAKTLTIQTVSDVLDLEFKRVQFTPDLLPSDLTGNMIYKSTTGT FKVRKGPIFSNIVLADEINRAPAKVQSALLEAMSERQVTLGDETHKLPDP FFVLATQNPIEQEGTYNLPEAQLDRFLLKVNVKYPSIQDEIKLLKIFSVD GGLENIKVAKIMNAYSLADLRRIIGKVKVDDKIMLYIVTLIAASRENDKK TYPFTKYIEFGASPRASLSLLKCARVNALYEGRLFVLPEDVKAVAYNVLR HRITPSYEAEVEEMNTDDIIKILLSAVALP >BRE_310 mraY, phospho-N-acetylmuramoyl-pentapeptide-transferase MFCFLGLRLLKYITFRTAYATIFAFLLALIFGPFIISRLKKLKLDQILRK DGPKHHLSEKMGIPTMGGVLIFFCVLVSLFFWIHFFNIYFLIVLFVMVSF ACLGFTDDLLKIKRKNSDGLNPKFKIYGQILFSFISVVMLYYFGGEHVSI LYFPFFKSLKLDLGILYIPFGMFVLISASNSFNLTDGLDGLAIGLSIVVI GALIIIAYLTSRVDFALYLNIPNVKGCEELVIFLGALLGGSFGFLWFNAY PAKIMMGDTGSLSIGAVLGMVALILKSEILFAILAGVFVVETLSVIIQVV VYKKTKKRVFKMAPLHHHFEELGWSEMQVVIRFWIIGLIFAILALSTIKI R >BRE_721 mreB-1, rod shape-determining protein MNFFKSFLIDIGIDLGTCNTLVYIKDYGVVMSEPSVVAIDVNKNNRVVAV GRNAKKMLWKTPENIKAVRPLRDGVIADIENTEKMIRYFIGQIFSRKKLF FKPRMVIGVPTCITEVERRAVKESAMNAGAREVKVIEESLAAAIGSDIPI FEPTGHMVCDIGGGTTEISVISLGGMVVSRAIRTGGDEFDESIIKYMRNA HNIIIGQQTAEKLKIKIGNVYPDTHNLKIETIDIKGTDAVTGLPRKQIID SMEVRESLQEPISTVVDEVKRTLGATPPELATDIVERGIILTGGGALLKG LSRLLSKETGVPVYVADNPLLSVAVGAGLFYDYANRIDISKNIYSFINE >BRE_725 mreB-2, rod shape-determining protein MAVFRKSYDSLTLFSLVMISFIGILLIYSSDYTSNGSLMKIEYIKQIIWV IGGFFVIFVVGRYDLKIIYGMVYPLYSLLVISLIFTAVFGITVNGAKSWI GIWKLGGQPSEFGKIIVILTLAKFYSSKNEYHNFFAFVFAFIIILPVILF VFLQPDFGTAIVYLNMFIFISFFAGVDIHYILYFTLTGFLSFIFVVLPVW YEYKADMGNTLYLIFSNNFYFKVAFLVLALIFLSSVIGFFISKYNLNIRL IYFYISFVSSILLIAAFCSKFLSKFMKPYQIKRFLVFLDPNIDLKGAGWN LNQVKIAIGSGGILGKGFLKGPYTHANYVPSQSTDFIFSILAEEFGFLGV SLVLILFFLIFFRILIIMDKSKDRYMSLILAGVLCLLFFHTAFNIGMSLG LLPITGIPLPFLSYGGSSTITFFLAMALYFNIESIVTMD >BRE_722 mreC, rod shape-determining protein MKFLVNFRDFIKVITVLIFATILMFYDTNGSRVKKRDDFFIFTLNSYIQR NMYEFFNFVSSIFKAINEYKDYGETIEAYKKRIQQLEIVIQNVQVLRQEN SRLKEQLEFYSEHSNVFISAEIIYLNYANISSLMAINKGYNDGVQKDMIA VAYQDGFSGLVGKVVKVYANTSRILPLTSYENFVSARIQNSKFIGLVEGK GYGEVLEMNYVNKLAENFLKVGDSVVTAGFSDYPGGIYIGKITHFDVLEY NSLLSIKIEPIIILDKLEYVFLIKGDERMKN >BRE_143 mtrC, membrane fusion protein MMKARRGAISDYISLNGDVDTKVKVKVFPDVAGKIKSFNIKLGSYVEKGQ VIAILDPSKPGSFYLQSPVRSPISGYVLFVNCKIGETVTPQTSVALIGKM DVMKIKTYVSEKYILDIKVGNNALIEFGSYSDKKFWAKISEISPILDFKS RSAEVYLEPLGSATNKMVVGMFVKLKIVTKNSKNVIKIPKHAFLEREGKL CVFRVNTDSTTVERVFPLVDFEVDNIVSIKDGINEDDLIVTEGVSWLSDG AFVNIVDTQNGLDVEDNI >BRE_479 murA, UDP-N-acetylglucosamine 1-carboxyvinyltransferase MYSYLVEGGFKIGGKITASGNKNAALPCMIAALLTDEEVILENVPNIRDV EVILKILEDIGVDVVRDGNILKIKALNIAKTEIDSSLTDLIRASILFVGP MLARCGRIDIAPPGGDVIGKRRLDTHFYGLGKLGAKLIENERIVLEVDNL IGAEMFLDEASVTATENIIMASVLAFGETVIMNAACEPHVQDLCNMLNLM GADISGIGSNLLKIRGVKKLRGAKFRIGADFMQIGSLISLAALTGGELEI NKADPGNFILIKHVYSKFGIDFEYDNENIYVKEKQYLKVRLDFGGHIPKI DDGPWPSFPTDLMSIMIVTATQVQGTVLIFEKMFESRMFFVDKLIKMGAQ IVLCDPHRVVVTGKTILKGNDVSSPDVRAGMSLLIAALCAEGKSRIHNIY QIERGYEDVVSKLSFLGARIKRVRDE >BRE_602 murB, UDP-N-acetylmuramate dehydrogenase MKKIIIQYKMNNMLENINNFLKKINIQPQTTNLANYTTYKIGGISKLFLI PKTIEDTKHIFKTAIQEKIKIFILGGGSNILINDEEEINFPIIYTKHLNK IEIHDNQITAECGTNFNDLCNFALKNELSGLEFIYGLPGTLGGAIWMNAR CFGSEISDILDKIIFIDENGNFICKKFNKNEFAYKISPFQNKNTAILKAT LNLKKGNKKHIEKIMKQNKQIRINKGHYLFPSSGSTFKNNKNFLKPTGQI IEECNLKGLQIGGAKVSHYHGNFIINNNNATSREVKTLIDKIKTQVQIKT GFLLEEEILYIGFNQKN >BRE_827 murC, UDP-N-acetylmuramate--alanine ligase MMLLYINFMSKKVIWINKMKIDLDNWSNIFLVGIKGSGLCSLACFLSDKG YFIEGVDVPLKFHTEDILKSKNITYYENIYEFSLKIYNRSYDALIYSSAY DKDNLPILLEAYELGIPVLSYPEVIGEISKKYYSIGVAGSHGKTTTAAFL GILFHSLGLQPNLILGSSVKNLEDKSSLVGESNVFIAETCEYKGHFLSFS PDIIVLTNIDYEHVDFFKNYEEVEDIFLQYVNNLKKNGILIINADEINLF NIKNKIIRKDIRVFSVGFNSLSDFKIEHFEIGDGFLKFDFLGSIDIRLKT PLIHNVLNFSIALLALKLFLEEHKKLVWNFDERIKIVARKYMGIKRRMEF IMEKDGVIYLDDYAHHPKEIESTLLGLKKFYDGRRIVLDFMPHTFTRTKV LFDEFVRVLSNVDVLILHNIYLSVREDFDPKRLSRDLFLSLRDLNQNVYF FEEVGDSVDFIKGLLKRNDLFVTMGAGDNFILHDFL >BRE_590 murD, UDP-N-acetylmuramoylalanine--D-glutamate ligase MCLNEIKGKNFLIMGLGLHGGGLAVAKFLLKHGGNLVITDLRNEIELSPS INYLKQFKNKIRYVLGYHNEDDFKRADVVIKNPGVSFDNQYLKLAKRIES EISLFLMFNRNPIIAITGTKGKSTLASLLYRVLVASYPNVKLGGNIGISP LNFLDELDGISPIILELSSWQLHDIKSLSPMISIITNVYCDHQNYYSNFD DYIEDKAKIFINQNSGILIVQDQAYYNYFSRFKHNLKIVLFSEIMPVDFK EDIFYFKDGKVYLNDGEIGVLNESKIVLLISKMITVFVANYLHLNLNISS EIVSIFDGIEHRLEFVKEFNGVKYYNDTASTIPDSTVFSIKSLKVHGESI HLITGGTDKELNFKIFDDILSFVKTWILLQGSATLKIIEFLKSRNVNYFI FSSLKECVCYAKEVAMTNDIVLFSPASASFELFHNEFDRGICFKNLVNSM T >BRE_198 murE, UDP-N-acetylmuramoylalanyl-D-glutamate--2, 6-diaminopimelate MNMNRKVLNDVLFRLNQNLIQKIIGSCEVEILGLAYDSRCVSFNFVFFAL PGLYFNGQKFIESAIQRGSNVIVHTNDIDFYDSNVTYIKVDPCNIKRFMS NFAHVFYDEPSKKLKIIGVTGTDGKSSVCFYIYTLLKSMGAKVGFISTVF LEDGSGALVKNPYRQSTPESTEIHLVLSKMVANNVEYAIIESTSHGLDDR TSRLLDIEYSVAVLTNISHEHLEFHGTMQNYLRAKLNLFYSANSHGGFGI INMDDNHFSVFMNSINRTYTYSLKNEKADFFISKINEQMGFTEFEFYHNK TKYAARVNLTGSFNVENVMAALIVVSQIMNVDISKLICKLINIESLYGRM QDINFGQDFSLIVDYAHTPGAFLKMFPIFKRLAKKRLISVFGSAGERDIL KRRLQGEIADEYSDVIILCDEDPRGEDSMQIIRDIAEGIVTKTLNRDLFF IPDRKCAIEKAINIACSDDLVVTLGKGHESSIIYKDKSIFWDEQAVIKDI ILSLGNRG >BRE_311 murF, UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate-D-alanyl-D-alanine ligase MMHIKIKDILDSLKDVKFIGDVSNVQKIVSFYSLDSREINVENSEVSLYF AYKGDRVDGFFFVKYLIDIGVKCFVCSKDRELLCIEYLKKDKDLIFLLTT NVVTCLQNLAAHFIKKTRFKRIAITGSNGKTTTKEMLYSILSERYKTCKT WGNLNSDIGLPLSILRTKGDEEYAVFEVGISYVGEMNIIAEILNPEIVIV TNVSYAHMQAFEDLKIVAYEKSKIITKDTKMLILNESCPQYVYLEEIAKS VNPNINIFYFEFHNLQIRSFSFINDKFSYDFTYKGCDYSILLPGKHNICN AISCINLALFLGLSENEIRNGLLHADFQKGRAELVRIKDYLVLNDSYNGN LSSFMALKEMILDLEIKDKKIIVLGSFKELGKFAYEVHKTAIEEVVLMNF DKIFLIGEEFQAVKRVDSLSSNSCLFYFNNFESFIDCFVNALESGCFIAI KGSRTNRLERVLDYL >BRE_774 murG, UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) MQQYINTKKRIFFTGGGTGGHIFPGIAIISKLKEYDTNIEFFWLGKKNSI EEKLIQEYEYIKFIAIPSGKFRRYFSLQNFTDFFKVIFGIIKSFLIIQKY KPQIIYATGGFVSSPPIIAASFLGVKSITHEMDLDPGLATKINSKFAHKI HISFQESTKYFKNKNVLYTGSPIRKEFLNPKSDIIKNLTQNTQKPIISII GGSLGAEILNKLVINIKNKIDVYFIHQCGKNLDPTREDNYLRKQFFNAEE MASIIKFSDIIISRAGAGAIKEFANAGACVILVPFIKGSRGDQVKNANLL ENQNACLKIDEDDLNEIKIINLIKEILNNKEKFNIIKQNIKKFHNQDSSS IISNLLLKEFEDINAKQSF >BRE_102 murI, glutamate racemase MNNLEDVIVIFDSGIGGLAYFEYISKKLFNRNYIYVADNKNFPYGDKSSN FILNEFLELISKLREIYNIVSIVVACNTASISVYNKLNFNFPIIYTLPSV SLVKELVFKRVILIATNTTINSEFVKKEQNNHIDLILKSAGELVKFVEYG DIFEKDALEYLKSLKFEVQSTKRDMVFLGCTHYLHIKDMIESVLEIPVYD NRKIVADELNKSLKNVENSDYCFKRYFYLTQDKNLHFYKNFCKKYNFYFK GIFN >BRE_210 mutL, DNA mismatch repair protein MNKIKFLDKTLVQKIAAGEAIDRPCSILRELLDNAIDSGADKIEVFIEEG GIRRILITDNGSGISKEDLKICYLPHTTSKINEEKDLERIQTLGFRGEAL SSIAICSNLMITSSITGENSYQIEIENGIEKYFKKQSAINGTMVDVTNLF HNFPARKRFLKKDSIETKMCLKVFEEKAVTHPGIDFKLSVNKELKKVYFK ESLADRVQSVYGEIIENNKFGKIEAEYDHVKMKIFFTPPNFSRKDRRNIK IFVNRRPIEEKSLSESIINGHSRILTYKNFPVCYLFLEIDTTHVDFNIHP QKKEVRFFNLPFLPKQISNNINEFFDREKQEILQDYHNVIIKRQLTNDAH LLHPENDLTNSNFKTYEITQDEDLILDKPKNNKVTNIIEDKVKFEGQISQ KYKPSFKQHIQKIFIKTSKMPNNFQKSTQTNEFKYMGQLFSEFLIVENAN EIYFIDQHALHEKIIYQTLINSEKTIQKLLVPIEFQVECEDTDKILTSEL EEYKKIDIIVKKIQNQTYRLESIPNICNKYENIIIQFFKTRKSKIIDSLE TELYATLACRQAIKCNDTISLEFSQFLINEFFNLKLKHCPHGRKIYHKIT KFELEKSVNRQ >BRE_808 mutS, DNA mismatch repair protein MSVIYMKKDITPMMRQYLDIKDKYKDSILFFRVGSFYEMFFDDAIEGSKL LGLTLTKRENVPMCGVPCHTSREYIKKLILLDRKVAICEQGLQTDPKGPL EREVVEVISPGVIIDEDFLQDDVNNYLVAISDYKDYCSFSYIDLSTSKLG IIFYKGNFLEKLRRDIEKYSPKEIIVSDDFYYEYLEKLVLDRFLVNKVPS WHLDKDIAIKSLKEHFNIVSLSVLGFTESEPYYISSFLIIDYIKNNLKNL LINIDTININNDSEYMFLDDVTQINLELVKNNNDLTVCYSLYSVLNDCKT PMGKRLLREYILNPLLDIGAINNRLFHVEFLSNNVNLSMQLRDILSDVWD IERIISRLQMKKYVKKDFLFIKETLLAFFSVKELLNEYSFKYWIFDVNDE TSIMEVYSLIDSSISNEQEELIKHGYNVKIDRLREIKNNASKYIDDYLNF ERDFNKINSLKIKRTNIKGLFFEVTKSYYGQVPSHFIESQNLNSAKRYKT NKLIELERDINDAEDNLLAFEQEIFDEIALRVVKYSVIIKKIAEFFAYID VIANFAYLARKNEYVRPILTNNKEIILECARHPVVEHYMRGIEAFTKNSV KINSEKYFCLITGPNMAGKSTYLRQTALIVLMSHIGSFVPASKAIIGITD KIFCRIGASDNISKGESTFLVEMNETANILRNATQNSLIIMDEVGRGTST NDGLAIAYSIVEYILKHIKARSLFATHFHELSAINHDSFVNLSMKIEQQG DELIFLREVEEKPSLNSYGIYVAQIAGIPLEVVKRANIILKSLTSREHFC VSNFATMTSVIDEKLPEKSLNYKSELNAYFELQNFISQININSITPFQAM NLLNEIILKIKT >BRE_691 mvaA, 3-hydroxy-3-methylglutaryl-CoA reductase MKLSDDFRNKSILDKKLEIKDLLKLNFDDFFYDSIDENFLSHMIENYIGY LSLPVGIVKNLKVNDKYYSVPIATEEPSVIAALNFAAKILKTANLSYSVG EVLGIAQVYISTDKDLSDILLGLHEKIDLWSKSLLKNMELRGGGFRRLST KFIEEIGIQKLNIYIDVCDVMGSNLLNSVAEKVAHNINLEFGYKCVLKIL SNDSNDFSVKANFKLNINNLLKNNEESLTLAHNISLISKIGFFEEERAIT NNKGIMNGITGLCVATLNDTRALEASIHKFASRSGRYLPLSKFYVFDENL VGEIELPLQVGVKGGSVGSHEASMLSFKIMGIDCKKEFMGILACVGLSSN FAALRALAFDGIQRGHMRLHVNKILYLLERDYNVSSDEREKILVNMNENG IYSIDFALKFLNDLRA >BRE_692 mvaD, mevalonate pyrophosphate decarboxylase MKVKCKVNPSLALIKYWGKRDRFLNTPATSSIAVSVDKFYSITELVLSSR DEIILNSKSVVLQDREKKFFNYARKILNKLDIGFKIVSENNFPTSAGLAS SSSGFASIAACILKYFDQFSYQKASELARIGSASASRAIYGGFTFLKEGA LNAFQCNNYNCFNELCIIFAIVDGQEKEISSRTAMELCKQERFYWDAWIK SSQNIFKEALYFFLIGDFNKFGLRVIKSYQCMFALMLSSSIIYFKDITIN LIKYVAELRREGFSVFETMDAGPQVKILCLKKDLNLILPKLTKNFKDVDF VVSGIGSGLEWIR >BRE_694 mvaK, mevalonate kinase MFIIKKSSKILFLGEHSAVYGFPVIGATIPFYMYLVYTFSTDWRYLGEPS LKIDEIISFINRNFSKVRPIEFLIFSQIPVGLGFGSSASLSLCFAEYIVS HDEYNAYDKIVLARKIENIFHGKSSGMDILLVELNGTFYLENKNGIFSYK KIEFCNFYFLVGAVKRECETSKIISDLNYKISVENNQFDIIERLGYIVED SYAAFNKRDIDLLANNINIANKYLSSLELSSNILDYIIARGREFKAIAGK LSGAGRGGAFILLFKDKNEAVFCLEKLDKDLKENNINLIFKLHLFRF >BRE_821 mviN, virulence factor MviN protein MSRDVISTVVVMIAIFFSRVMGFIKIKVFSYYFGANIEADIFNYVFNIPN NLRKIISEGAMTSAFMPEFTHEKQKSDRHAIVFFRRVITFNIIIISFIIC VMVFFSKQIMYLVSSYRDSNLDLASYIFNYLILYILLISLSSIFASVLNS YKVFFIPSFSPVMLSCSIILSIYFFYSQYGIYSAVIGVIVGGILQFLIQM INCICIGLIYRPILNFNDSSFLMFLKRWSHMILSALFAIITQQVSFALAS TLDIGSVSVLSNAIVYYQLPVGIFYVSIATVIFPKMSEYASLGDKERLNA IFNQGINMLIFLLVPMSFLMYVWAAPILNLLLTGGKFSVYDTQRTVGVLQ YFLLGLLFSSIFGLFQKYYFAIRNSKIPLYFNILFSIIDIIISVFGIKYY QTVNVLPIAQSVSFIICIIIFYFIGLRHDMNLELNKSIIVFIKSFISIIP LYLFYFFLKNLKWDIGFSFNNFYLLSVIGIVNIIILILCYYLLGVIRVFK FISRDIT >BRE_790 nadD, nicotinate-nucleotide adenylyltransferase MMRIAILGGTYNPVHIGHMFLAKEIEHFLNVDKILFIPTHKPVHKCVEDI SVTDRVTMLKLAVQYEDNMFVDECDVIHGGVTYTIDTIACIRNKYANDDI YLIIGDDLFETFDSWKNPEKIVESVNLVVVHRIYSKRLSSRFKHIYVDNR VFPISSSEIRNRIEQGLPVDYLLPFDVLRYIKNNNLYVKGM >BRE_151 nagA, N-acetylglucosamine-6-phosphate deacetylase MSNFCLFNAKSVLTGNDKIDNSAVLIRENKIFDIVTSDRLEKLELQDYEM IDIKGNYITPGLYDNHIHGFYGYGTDQCSTNSIIKMSEHLAEYGVVGFLP TLYPRPTEEMIETIKACTQAIGKEKGAKILGLHLEGPFFSPEKKGAHPTS YLQKPSIEIMKKFIEAAGGTFTDSFGRKRTNIATMTVAPELKGMRELAIF CMENNITLQAGHTNAKYENMIEGFQVGILHTTHFFNAMSKLDHRNPNAIG AALIHGDVSCEIIADGHHIHPKLVLMLRKLKDISKLVLVTDGLTPTLQPS GELIANGEKVYLKNNDLFYIIESDTIAGSALTMIQGIKNLVEFGYSLSDA IQASSYNPIRIINLEKKGLICHGYDANINVLDKDLNLKLTMIESKIIFNK L >BRE_152 nagB, glucosamine-6-phosphate isomerase MLLIQKYKEQQMRLIIRATYNEISRWAANHVARKIKEWEPTKEKPFILGL PTGSSPIGMYQNLIELNKLNKISFENVITFNMDEYIGLDKNHPESYYSFM WNNFFSHINIQKENINILNGNAINLINECKKYEKKIKSYGGITLFVGGIG PDGHIAFNEPGSSLKSRTRIKTLTQDTIIANSRFFENDINKVPKSSLTVG VGTIMDSKEVMIIVNGHNKSRALKHAIEKGVNHMWPISILQLHKNAIIVS DEAATYELKVGTVKYFNDIEKHNYNNEL >BRE_836 nagE, Sugar Specific PTS family, n-acetylglucosamine-specific enzyme IIABC MHNLMKNMQNLGKALQTPAAVLPIAGLLLGFGYLIISLTQPFEILGKIGK LMEQSGSAILGNLPILFAIGTGMGLSKNNKAAAALGGAVGYLILNAGLST FTIIINEKTEPVNMSVLGGIITGISSAMLSDKVVDYKIPQFLGFFSGQRL VPIANGIFSVIFAIVFGFLWAPIQITINQIGIWMIEAGNLGLFVFGFLNR LLIITGLHQLLNTLIYFVFGEYTTSEGNIVQGEITRYLNGDPTAGGFTSG MYPIMLFGLPGAALAMYLTAKKELRQEIGGILLSASLTSFLTGITEPIEY TFMLIAPMLYLIHAILTGISLIITNIFGIRIAFALSAGIIDYFLMFPKST NALLILPIGLTIGIIYFTIFFTLIKAFQIKTPGREDDINQQNFKHIQNIS QNDTFEVIIQALGGTNNIINIDSCFTRLRVDVKSPELVNQDLMHNLGATG TIITPGNQAQIIFGAKSEQIANYIKSKI >BRE_449 napA_1, Na+ /H+ antiporter MRKKLLYTILFNINPILSFGMVDYMKDTGHNIDAKISSFIMSLAIIVISA SLLGNLVNRFGIPKVIGQITAGILLSPTCLGKIKVPLLFPLGIINSGENY LINEDIFAISTIASIILLFMAGLETDLKLFLKFLPRGGLIGITEVIGTFT SFALISTILFDVQLINPTSLFIGIIATPSSAGIAASILSAKKKMSTSEGV TIISTSIIDDVLSMIMLTSVITISRSLSDLDITISIRSTIQNILIWFCLT FILILLSKPISQLLKSFNSVTLATVITLTFTFIISSIFQNLGMSFVIGAY IFGLAMSKTDIVYVIQDKLTLFERFFIPIFFTSIGMMADINVILSKEVLI IGTLLSLIAIATKVVYCFIPSYFLGFNKLGALRIAFGMVPRGEISLIIAN VALSSEFISQKIFGIIIIIVFLPTIIATPIINILFQINKNGLKKEMKIEQ NTQITIALKYDNLTKIFVWDLKNELRNEGFFTQQIKNDFSQYINARRNDI SLSIKREGSKITFECPKKHLIIIQDLLRETILNLEKITEEVKIVSVKAQK LNYSINYDKIRSNIALDKRIKKENIILNLKATNKIEVLRELLSIIKVDID KETILQDLMEREKLITTALKEGFAIPHLKTNLIKKMHIAIGISHDGIDFN AIDKNLSYIFILILYPAKEHVNYPRILSSIVGKVDSNKKAMLKAKTDKEI YNILIG >BRE_697 napA_2, neutrophil activating protein MENHLGHLEKENSDKIHLALQELLAGLHIFYANLRGIHWNIKDINFFVIH KGTEKLYDYVAEVIDIIAERSRGLGYDSEFRCSEFMKKSFIKEISLDVSS SLIPSIKSIICNLGDIIKNMSKTRCFIDCTSDYGTANILDDIIVSFEKYL WMHKSLLNGCACVCNNE >BRE_469 ndk, nucleoside-diphosphate kinase MHIHELNKLCLIISLHCIKNIGRLFMSTLIQKTLCIVKPDGVRRGLIGNV VSRFERVGLKIVAAKMVLVDRKMAEEHYLYDDIAARHGESVWKSLVNFLM SSPVFAFVIEGVESVEVVRKFCGSTEPKMSAPGTIRGDFSYHSFNYANAK NFAVYNVIHSSASLIDANREIPIWFTKDEIFTYKRDDEFEHYY >BRE_644 nhaC-2, Na+/H+ antiporter MNTDSHIKPNFFGLVPFLVFIVLYVGTGIVLEIQGVEMAFYQMPPIIAML LAVVTAFLLFKGSFIDKLNEFVEGCAQNDIIFISFIFMISGAFSAVCKEI GSVETVANIGLKYIPANLLVAGIFLICLFLSTATGSFLGTVVAITPIGFE IADKSGIPLPVVAGAVLGGGAFGDSMSLISDTTIIASRTQGVKIIDVFRN GVFFTFPASILSTVAFAILGSYMSGIGVEFELGDINYFKVIPYLFVMIFA FLGVDVFLVLFFGILIAGFIGIVNGDLTLLLMAQKINEGLLDLSEMLIIV IFTGGISYMTINHGGFEWILTKLKYLARCRRSAEFTITFLIIMVTGFLSN SGLAILVNGTVTKGISEANSVCPKRCAALLSISSCALIGALPYGMHMISV MNIAKGAISPLDIMPFLFYQVFLGIIIIFSIAFFKLKKISF >BRE_86 nifS, nifS protein MNINILENKNEKIKNLRKDFPILNKTINNKKIIYFDNAATSHKPQSVISS IVEYYTNYNANVHRSGHQFAIESSLKIEETRKIVKQFINAESPKNIIFNS GTTDGTNTIANSLLLSKFFKENDEIITTTLEHNSNVLPWINIAKFLNLKI KLAKFNEMGIIQSEQIQNLITDKTKIITMSGINNILGTMQNLEQIGKIAS DNKITLFIDAAQMAPHIKIDVKKINCDFLVFSGHKMLAPTGIGVLYISDK IINKLNSSKLGGNAIENIYIKNEKLDFQTINSPNKFEAGTPNIAGIIGLG QAIKYINNITMEFIQEHDQELIEYCISKLKEIDEVEFILNKNIKRKSIIS FTVKNIHSHDIETYLDTMGIATRSGKTCAYLAFFSENIKKDHLLRISFYL YNTKEEIDIFISSLKKTIKEFY >BRE_734 nox, NADH oxidase, water-forming MKIIIIGGTAAGTSAAAKAKRINKELNIVIYEKTNTTSFGACGLPYFIGK FFDEPNNMIARTPEQFKQNGISVFPKHEVTKVDIKNNILQVKNLQTQEIF NDTYDKLMIATGGTPIIPPINNIKLKNFYTLRNMNDGKEIRELLNKQEIK NIIIIGAGYIGIEMVEATKARKKNVRIIQLDKRILTESFDKEITNIMEEE LIKNNVLLHTNEFVTSLIGKDKVEGIITNKSKYKADLVILSTGIKPATEF LEGQLDTLKNGAIIVNEYGETSAKNIFAAGDCATIYNIISNQNDYIPLAT TANKLGKIIGENLAGKRVSFKGTLGSASIKVLSLEAARSGLTEEMALKLG IQYKTVFIKDKNHTNYYPNQEDLYIKLIYNQDTKEILGAQIIGKNGAALR MHALSLAIYSKLKINELGMMDFAYSPPFSKTWDALNIAGNAAK >BRE_1046 nrdE, ribonucleoside-diphosphate reductase, alpha subunit MSYLEHHMMLRILWKGLVMRHLELNNEMMVLRDGFYRLEKDLEALSVFLE EIKSKSLKFENPNKRMHYLIDNNLYEDFYQKYSEDQILEIYKAVEGEEFK FKSYMSASKFYKDYALKVKDTYFESYEDRIIAVSLFLADGCFDFALRLAL DMIKQRYQPATPTFLNAGKYVRGELVSCFLLEVGDSLNSITFNISSAMQL SKIGGGVALNLSNIRARGEEIRGICNVAKGVIPVMKLLEDGFNYADQMGQ RKGAGAVYLNIFHYDIEDFLDTKKINADEKSRVQTLSLGVIIPDKFFELA KQDKNYYALAPYSVYKETGLMMNDIDFDKDYDLLASNPRIIKKEISARDM LVRIAKLQFESGYPYIMYQTSCNLNHPLKEVGRVKMSNLCTEIFQIQTPS VIGNYGEGDVIGYDVSCILGSLNIVNVINSDFEFIVDLAMRALTSVVDKS CINNAPSVRKANDDYRAVGLGVMNLHGFLIKNKIPYESDEALDFVRTFFM LLNFYSLKSSMNIAKERNSVFKDFKQSEYYNGNYFNMYLNEDFSPRSEVV REIFSCLQIPSKSDWNNLKGDIQRYGLYHAYRLAVAPTQSISYIQNATTS LMPIVEPVEARVYGNSTTYYPMPYLSRENAIFFKSAYYMDMRKLIDLVSE AQRHVDQGISTLLYVTNETSTRELVKLYIYAKNKGLKSLYYTRNKNLSVD ECILCAI >BRE_1045 nrdF, ribonucleoside-diphosphate reductase, beta subunit MRKNREAINWNRLNNGYTKMFWDQNIRQFWVDEEIPISDDKLVWNTLSVD ERDVYEKVLGGLTLLDTEQGSVGMPRIALAIDNLDYKPILGFMGAMEHMH AKSYSSIFSSLSNIDRIDYIFDWVKTYRNYQEKLELILGKYNNIHDRMSL YQALCTSVFLETFLFYSGFFYPLYLAGQGKMVNSGEIINLILRDESVHGV FVGLLAQEEFDKMTMKEQELAYKEMLLILEKLYSLEREYTKELYSCVGLE SAVDVFVRYNADKALMNLGFDTKFNIKDTDVNPLVLNGLRTDTKTHDFFS TKGNGYIKPMRVEPLHDDDFM >BRE_1047 nrdI, ribonucleoprotein MVYASKTGNIGRFISKTGLGNIFRIVTGDEIVEEPYVLLTYTIAFGKVPS EVDKFLEHNFKLMIGVAGSGNKNWGDSFCNAVNLIKDKYGVPEILKFELS GTSHDVKNFMERISDETLRVK >BRE_753 nth, endonuclease III MVNIDLIVDETLFRYPYVKPFLTFKNNYELLIMVILSARTTDNMVNKIAP KLFDKYGDFKSLACVDLVDVERLIYKLGFYSNKSKNIINCARMILENFDG IIPDNIFDLISLPGVGRKTANVILGVVYKKPAIIVDTHFSRVVIRHGITF EKTPLKIELDLRNRIPADKQYRFSMAINRHGRDVCTSRSQNCKNCFLEKF APRLV >BRE_730 ntpJ, K transport protein MLKIEFSDRFFLFSYFILIMFIGSLLLLLPIAWNNVESLKYIDVLFTSVS AVSITGLVTVKMESFSTFGFIVIMLLIQFGGLGFITITTFYLLIPKRKLK LTDVRIIKQYSLSNIEYNPLKILKNILFVTFSIELIGGILILLFFKIRGI KISLLEALFTAVSAFCNAGFSMHSESIYAWRDVPEAIIVIAILIICGGLG FMVYRDVTNTMKYRKKLSLHAKIVFTLSFFLILFGAVVFFFSEIHKLRDG YSLGTLIFNAIFYSISTRTAGFNYLDNALISSRTQMLSLPFMFIGGAPGS TAGGIKITTFFLIILAVIKSQDGNGYIIGSYKVSIDSIRFALLFFVRAVF ILCFSFFVLLAAESGGKWRVIDLGYEVFSAFGTVGLSVGVTQDLSFLGKV IIIFTMFAGRIGLFSMAIFVSRNSRFEEFTRPRQDILVC >BRE_452 ntrA, RNA polymerase sigma-54 factor MLKQNLKLTHKLQLTQINTIKMLSLDKQELIQIISDELDNNEYIKVDSNK IFFESLKTYKFKKIFYKENENNKTQYEIALAKTSPKISLKEHLLLQLRIQ RLNEEEINIGEIIINNLNRKGLYIINPYDFFNKEEWPQVTKMIKLIQQFD PIGICVPNIIESLILQAKYHNLDTNIIKILQKADLLTNTKEKLKKELNIS TQDLNDAINTMKLKLNPNPTFEFKDKDDTNDYIEPDIIVINKGNKLKIKI KEVSIFKTEINKQEVKDLCKYKQAKWLIEALRYRDETLAKIGIAIYTLQK EFLKRGFKRLRPMNLDDISTRINLSKSTISRAIKNKYLKFDWGTIAIRKL FNSIGGTKTNEFSKLSIKIIIKGILEQNKNMVDSQISDILKSKGITISRR TVNKYRNELKCEGEIYGT >BRE_408 nucA, endonuclease precursor MKKKSKILIILYISILIGFLFLHQNPKIVNKIKEITSNYLEEIKNRFYRP QIPIKLQEEYLLPQGYLTTQVLHKKYYSLGYAEHARQSEWVAYQLKREMV ELALILVKEKKITRSKKFFEDPDIKGIAPKLSDYLHSGYDRGHIVSSADM SFSKEAMRETYFLSNISPQKSSFNSGIWSKLEQKVRKWAISKEKIYIISA GILTENQGFIGNNKILIPKNFYKIVLSLNNKSNNYEIVAFIIPNKKAKDT DLKNYVVNVNSIEEKTKIDFFAKLDAKIKKIIKMQKNISSWELK >BRE_811 nusA, N-utilization substance protein A MLRRLNCLKGVLDMIKGTGQMIANIASERGMSIDAIRKTVRESVIIAYKK YFGTSDNALIKFDDNTGDLIVYSKKRIVDEVKNNVMEILVDDAKTFEVVD NEYVYVEINPKIFDRLSIQVAKQRTKSDLQGIEDNELYLEFKHKLHKIVI GYVQQNRNGDLYVNLGSTDGVIPKKYQSPREVYSLNDKVRVLVYSVKKGR NGIEVILSRTHPKFIAELLALEIPEIEEGIIKIHKIVRDPGYRTKVAVYS EKEEVDSVGPCIGQKGVRIQSIIKELEGEKIDIIPYSKDIKEFIKDSLTP AKIDNVYIIDEDLHKALVVVSDDQLSLAIGKMGQNVRLANRLLDWAIDVK TNSQFAEMKASGEFKQDTFEMFDKIIQDNVQEDEFEEINKISELKVLDDD IVAKLIQRDLDDIDNFLNASEDKLFELGITYEKQEEINKILKEGMVIISN DDESVEDVKDEEDLLCPECGAVINENMTFCPGCKIGLSFEFEEE >BRE_109 nusB, N-utilization substance protein B MVMDLRHKARILAFQKIYSIDVNCKAKDNIFDIFSFEENGIDLDGDLKLF YSVLVNGTYDNLESIDKLISGISLNWRLDRMDKVDLAILRMSVYSLKFQD LDVPKRVIIDEAILIAKKYGNKNSDKFVNGILDALLKDMESSFENK >BRE_392 nusG, transcription antitermination factor MSRAWYVLQTFSQYEKKIEQEIKLLISEGVFGNNVLDVKAPIERVEEIRN GKKRIRERKIWPGYILIELDLSDQEWKSTVANIIKISGVVNFVGTTKEQK PLPISDEEVKSVFMLAGEIKADKSIFILYDFEEGERVRIKGGPFDSFEGV IGSIDYEKKKLKVAVQIFGRSTPVEVDFQHIEKI >BRE_789 obg, GTP-binding protein Obg MHLFKDSLNLIVSSGNGGAGCVSFLREKFKAKGGPDGGDGGRGGDVIFKV KSNLKTLSLYRNGQKLSASNGKSGMGLKKSGAAGSDLIIFVPPNTSIYDA DSNCMLFELKNFNDEVVVLKGGRGGLGNVNFKSSTKRTPRFAQPGESGLT LNLRLELSLIADVGLVGLPNAGKSSLISKITASRSKVANYPFTTKIPHFG VVRVSYNDLIIADLPGIIEGASKGIGLGFEFLRHISKTQILVFLIDVSSN DFMSAYDILINELRVYDIGLLKKKRIIVASKLDLEGATENFNQLKSILSE ERVLGISIYDNIGINELVSEFFSLAKI >BRE_334 oppA-2, oligopeptide ABC transporter, periplasmic oligopeptide-binding protein MSKNHLKLLIISAKIELKLIKVIKLNKEIKMQIKKITFIIFFLITILSCS KESNKENVSFKIAIGGEPKSIDPQLAEDKMGATIILQMFNGIVIGDPKTG GYKPGLAESWDISQDGTVYTFNLRKNLVWSDGVPITAEGIRKSYLRILNK ETASNYVALVKSTIKNGEDYFEGKISESELGIKAIDDLTLEISITSPKSY FLDMLVHQSFIPVPVHVIEKHGNKWTDPENMVVSGAYKLTERTPNEKISL TKNDYYFNAKNIEVQELIFYTINDASTAYRMYKNNEIDAVFAIIPSDLIK EIELRNDYYSSPINGLYYYSFNTHIKPLDNVKIREALTLAIDRQTLTSKI IKNGAIPTRNVSPKFNNYSYKKSLELFNPQKAKQLMSEAGYPDGKGFPTL KIKYNTNENHKKIAEFIQNQWLKILKINIELTNEEWASFLDNKQKGNYEI ARSGWIGDYADPSTFLTLFQKGLSNFSSYNYFNEEYENLMKQSNFEQDPI KRQDILREAESIIIEKDFPIAPIYIYAGNYLFKNDKWTGWEPNIAERFDF SQLKLIK >BRE_335 oppB-1, oligopeptide ABC transporter, permease protein MLRFSIQKLLETLPTLIIIIFLCFLIMRLAPGNPFDSEKPIDPQVKEKLM QKYHLDKPFYMQAYYYIKNILKGDFGPSIAKKDLSVNQYIKLGFPKSFTI GIISLIISLTLGIVLGSLAAINKNTHIDYIIRMAAIFGISVPTFITGPIL QYILSVKLKLFYTSGWISERGGLANLIMPILTMSLPWIAIFTRIIRGSML EILNSDFVRTAKAKGLSFNVIIRKHVLIGAILPIVSYIGPAFAGIISGSM VIEQIFRIAGMGIFTIEASLNRDYPLLMGSLLVYSAILLISILASDIIYK KLDPRI >BRE_755 oppB-2, oligopeptide ABC transporter, permease protein MAINVIISTFFCISILNAFSNNRPNIPFIKTNIFKDYLEYIGLIKSIESY KLIYDFDPNTPLSKDYFAKHISGSLYIVYKTQYQGIIWNTTYNTPLIKGK SPISVIFSKIKNTLTISIPGLILSYLIAIFFIIIWTFFVKNKILNNILEY IMLFLHSLPRNLIIMLVITILYYLNINQKNLIIGGFAWFFSFFIFNAVIF KQSLTKNLSEPYIISAKSRGIKNFSIITFHSLIPSLTSLITQLRSTLTTS FFGSSFIEITFGIDGIGALTINAMKNNDYIVYRDLLFVGVLIMLITNLIT DILTYNMNPYKDILE >BRE_336 oppC-1, oligopeptide transport system permease protein MIQEYRRTNQMSNIKQNTCVNIDTQTANKRAWLRFKENKLAYISIFVIGF YMAIAILQPILPIYKYYTQIVEHVDLPPSFRYAGELWYKKELDFIKRLAK KENREINEEEKEKLEEIKRKIETEIQIINGKETKIHKRIYLLGTDNLGRD LLSRIIQGSQISISIGFIGALISMLIGSIIGATAGFFGGIIDRIITKITE VLYSLPNLLVIITLMTIMERNIIGLFIAISIISWLTISRIVRGQVKTLSQ SEFIEAARTLGATNRRMIFKHLIPNSFGMIVIITTMNVPSFIILESFLSF LGLGISAPMTSWGELIKNGIPTFIEYPWKIFIPASIMTIFLLFMNFLGDG LRDAFDPKDNL >BRE_754 oppC-2, oligopeptide ABC transporter, permease protein MNKFKRSYILLLSIFILFLIIIPNLINENSKFAIYKKDPNKIYIKQTNKL PQTPTNTNPLGIDKMGRDILSRLILATRNSILLAFSYAAISAIIGIFIGI IIGNFKFKTCLIISKLIESLQTIPFFYVLTLILYYFSKQKNYNILEVSFI LAIVHGWIKFSFITRNNTLLIKNFDYIKASKMMGASQYRIIMYHIFPEIF SSISSIIPLQISKSLTTFEVVNFLQQQDKSYYPSLGELLRYIEMGKEYFW IWINPLIILLIINIILTSISLKLKKHTKFFISS >BRE_337 oppD, oligopeptide transport system ATP-binding protein MNENYMLEIKNLTIEFQLKHTTIYPVNNINLKMKRGEIRAIVGESGSGKS VTSMAILKLLPESTTIYKTGEIIFENQDLLKLKEKELQSIRGNKIAMIFQ DPMTSLNPYLKISTQIEETIMLHQKLNKKQAKQKAIEMLKTVGVINAEER IKHYPHQFSGGMRQRVMIAMALSCHPSLLIADEPTTALDVTIQEQILLLI KNLSRKFNTSTILITHDLGVVAEICDTVSVMYQGKFVEEGTVQEIFKNPK HPYTIGLLKSILTLDKNPNEKLYSIKDYPIETITNNNEGI >BRE_338 oppF, oligopeptide transport system ATP-binding protein MTNEKDIILKVENLVQTFTIGENFLFWKNKRKVNAVNGISFEVERNKTLG LVGESGCGKSTTLRTIMQLYTPTSGRIYFNGKDITKLSKKELLKTKKDMQ MVFQDPHTSLNPRMTIREIIAEPLVIYNENKIIPRTKQEIEQRVNELMDI TGLSKSMLSRYPHEFSGGQRQRIGIARALALNPKLLLLDEAVSALDVSIR AQILNLLKDLQKELSLSYLFISHDLAVVKYMSDKIAVMYQGIILEIAPRE ILFSNPKHPYTKTLIASILEIDPEKIKNKTIKLDEPSLTNIRNTYSPTEN EILEEVEKDHFVSKYLFDEMNSLLNKN >BRE_824 panF, pantothenate permease MTKACVLFFVFLVLYCLYGFLFRGKKEEKVFLRDYFLANRGLNFFVMALV VASTYVSASSFISGPSAVYRYGLSFIFLAVIQIPTSLISFVIVGEKLNLE SKKINAINIIDYIGYRYFSRSLVVISSVILIFFSLFLISAQLMGGAKLLE VFFQINYIDSLICFALFVFLYVCFGGFKMIAYMDLIQGILMIISSVLLFA KLIDLGDGIGDLFRMAQLGLREDLLLPSNLDLKIGYIISFWILIGVGMLG LPQFVNNFIAFKDVKTIRYSLPIVTFMIGFLIVIMHLIGFFSLVIFPNLA ANDKVILDIALKVLNPNVFIFFFVGLVSAIMSTIDSGLLLMSSTLVKVIL LLSRNIGDKIGVKRITIISNVCFMSIIVWLSLTPPDFLFFINIFAIGALE VSFFSIIVFGLYFNFVSKISAFISQFTGLLSYLLIIFCDKVSIYDVHPIV PSFFISICSFLIVNFICKKCSKI >BRE_711 papS, tRNA nucleotidyltransferase (CCA-adding enzyme) MIFKNKLKPYLNLRKNSISTIIYFYMNLGNNTKDIIKISQIFNNHNYEFF LVGGALRDLLLKKIPYDFDFTTNATPKEIMKLFPKNIQTGIKHGTISIIF NKKIFEITTYRIDIDYENKRSPKQIKFTKNLKEDLKRRDFTINAIAMHTL NFEIIDYYNGQQDLNKKIIKCIGNPNKRFEEDALRILRAARFASTLNFTI DKNTLISMKYKKNNILFLSKERINNEFIKLLEGENPTKGIKYLQKINFFK YFFNIEINKKLIKKITLLNKNKFYLKAIVIFTIKQDISNLKQNLKLLKFS NKDIKLILLYKTTINAIHKLNPKKLYHIRIFLSKTTRENYKETLDIYKAL KGKNNKFKFITNKIKNNKLLRDPLSLKELQINGNDVKKFQLRTHKNTGII LNHLLNEVLIEPKLNKKEILLQKIKDQYSQYF >BRE_39 parC, DNA topoisomerase IV MNIKTLLRDNFLQYSSYVIKDRAIASVIDGFKPVQRRIIHSLFEMNDGNF HKVANVVGNTMKYHPHGDTSIYEALVNMANKDLFIEKQGNFGNLLTGDPA SASRYIECRLTPLAFEVLYSKEITTYEPSYDGRNAEPLIFPAKIPVILIQ GSEGIAVGMAAKILPHNFNEILRAVKSELLGEAYKLYPDFPTGGIVDVNE YADGNGKVLVRAKIETTDDNKAILIKELPFGETTESLIASIERAIRKNYI KVSSINDFTTENVEIELTLPRGVYANEIIEKLYHYTNCQVSISVNLLLLS DRYPVIYTVTDIIKFHAEHLQKVLKMELELERSKILEKIFSKTLEQIFIE HKIYKILETISKESDVVDIVMSEIVKYGDRFSRKIVLDDIENLLKIPIRK ISMFDIDKNNKDIQILSKELKSVESNIKSIKNYAINFIDKLLAKYSKMYH RKTEISLIESKNAREIATKNMKIYVSLKAGFVGTSLIDGEFIGNASYYDK ILIFKKDSYILKNIEDKTFIEKNNVSVLVYDINNSKEQVFSIIYLNKVDN FYYVKRFRIDKFLTDKVYYFLNKDDEFIDFTFNAQFVAFSTSRDVVKMID INNFMIKSRISVGKRISNNIIKKVKFK >BRE_40 parE, DNA topoisomerase IV MKKNCYDESKIVTLSSLEHIRLRSGMYIGRLGDGSNIDDGIYILIKEIVD NSIDEFIMGYGKEIVIKREDNVITVRDYGRGIPLGKVVESVSVINTGAKY NDNVFQFSVGLNGVGTKAVNALSSKFLIRSIREGNFFEAVFSKGNLINTT EGKSDEQNGTYIEFLADTEIFGKYKYSEDFLQRRFFHYVCLNKGLEINYN DQIFRSDNGLLNFIRAEIKYEDLLYDFVYYSSKTLEFAFSHTNNYGETYF SFVNGQYTSDGGTHQTGFREGFARAINDFLKKTYSSTDIREGLVATLSIK IKDPIFESQTKNKLGNIETRGNIAKEVQRLILEILYKDKTLAKTIESKVI DNERLRKELSSVRKEAKERAKKISFKIPKLKDCKFHFNEKSVHSDATMIF LTEGDSATGSMVSCRDVYTQAIFSLRGKPQNMFEKNRSEIYKNEELYNMM VALGIEESIENLRYNKVVIATDADFDGFHIRNLLLTFFLTYFEDLVLNGH MHILETPLFRVRNKSATIYCYSEEDKQKALLKLKNPEVTRFKGLGEISPN EFKGFIDVANIKLTKVDLVNIKEIKEQLGFYMGPNTPERRNFIMENLI >BRE_139 pbp-1, penicillin-binding protein MMNKNFASSLRLNIILIIFLIITLLTIYQYFILMFSKNMQHFPQKINHIS RRGNIYDRNGKIIAFSSKSYSVGTDPRKIKNIVNTSETLGAILKIDPQTI KQKLLSKKGFQYIKRQITKEESELIKRIQSEGRLKDIILYPDYKRIYPFK ELTSNITGFVGIDNIGLTGIEFSLNSILNEDFTKQQYINDKLSTNNIYLT IDIDLQNNINQIAKKYFQENKPENMITIVMDAKNGEILSMLQFPQYDANY YSQYSKEIWNNFSTSLTYEPGSINKIFTVAILLDSGLLKPNEKFLDNGIY QKKFKSGETIIIKTLNPPYDYIDLSGILLYSSNVGIAHLTDKINNEYFYN KLIDFGFGERVGFPFPGETKGILNHHSKWSGRSKATIGFGQEIGVSAIQI LQAASVLSNKGIMLKPKIIKKIINEMQDTIQEFPKEEIKKVISEHTAQKV LKLMREVVNKGGIPKLKTKNLSISAKSGTSQVIDQNTGKYSNEDYTSSIL VIYPTEDPKYIIYVVYRYPKKIIYGTRIAAPMAKEIINLIEQKNNKEEYN KIKISSKISIPKPIIKHNIKETLPNLKGLSKRDLMKILKDYINIKINIKG NGFVYKQSHSPNTKLKDIKELEIILQ >BRE_724 pbp-2, penicillin-binding protein MKLVSGIRYKFGMFLLSFVFFSYLFTLFKMQIGKHLFYDREATVLLSRVE KVSASRGEILDSNFNVLANNLTVFVLKISLEQYYSMSVKDRDEMLNFLSD ILGIDREPILSKIEATRGYLKDVEIIELNPEMLFRIAEKRSYYPALLWTY SFKRNYLVDDSYSHPIGYVGRINQRELRAFYNVKGYDNNSTIGKLGVEQI YDSYIRGKEGLIKYRVDSRERKIDSGSIIEHMIPGHNIVLNINKDIQMLA KNTLGKRYGTVVVLKPSTGGVMALHNYPYYSMNDVYNKHSREDYSFLNRA IQSVYPPASIFKLVMATALLEEQVLDKNKKLHCQGYFRVGNRMFHCWNRV GHGYVDLEHAVAHSCNVYFYMVGLKYLGVERIVKYAKEYGFGEKTEIDLP NEVSGLLPSPEWKEKTFSQPWVGGDTVNFSIGQGFLNATPIQIVNMVAMI ANEGVIYKPRIVSKILNGNTNEVILENVPEVLRKTNIISKRTFRLLKKYM RNVVTYGTAKNSVLTKAVEVVGKTGTGQTGVIGVENSSFVGLAPYNEVSS KQIVIFSFVEGRSNAGMWPAKSVDLMMQGIFAKQSYEDILREYKPWYIR >BRE_738 pbp-3, penicillin-binding protein MKRVNFSKKANMLVYFTYFIISFSIIFLSIAIVETINIQKDKKFGNINPA IPSKLFDTNGKLITQFISDENRELLPLREMPNNLINTLLIREDLSFFFHR GFSLMGILRAAFNIILGRYFSGGSTLTQQLAKLLYTNQAKRSVLRKLNEI WWAIQLEKKLSKYEILEKYLNKVYFGNGNYGVVAASKFFFNKSVKDINTA EAVLMIIQLPNAKLYSPFYNPKFAKKIQRAVLNQVVSHGIITPELAESEF NEYWQNYDWTRMADIPAISDKEDHAPYFSEYVRQRITQYLPSEANIYKDG YSIYTTLDLEAQKHANEITQEMITKARKMYNSTKSSETLVINSEIVPIID TMADLFGIRNTRINGRQYTKLKTRKFYEDNIDLLASFAAILGIDKIDKAT RAYTINNKTNPNLLVKPEGALISLDTTTGAIKAMVGGSGYRKGSEFNRAT QAKIQPGSAFKVLYFSAAIELKKITAATMLSDSPVAFFNQEGEIYAPENY GGKWRGNVLTRKALALSLNIPALRILDKLGFDNAIKYSAKLLGIKDQNEI NKIFPKVYPLALGVTSTSPIQMARAFAILGNNGKEVEPYGIKYIEDRNGK VIANVESEILTSIKNKGANAQIVSPQTAYIMTDMMKSTIQYGTLSNQRYT NLKNFKSDIVGKSGTTQNWADGWTIGYSPYITTAIWVGFDKKGYSLGTAG TGTALAGPTWGKFMAEYHKNLPQKVFIRPKGIINVQVQSETGLLPEGVPN ETIINEIFITGSQPFEKSKYYENKSEFLNKMEFNIYGIDNINDNDELNFD TTEFEYLTNDFHQYNKTENEKIHENNTNIINNDKFNDNINMDIQNDDFEY DNQEENMQHNIQDANKTENETNNTITDDNNNVDDSMKTTDQPNNTEPKKN PLISDEKQDNEIEHKDVNGENIQLD >BRE_775 pdxK, pyridoxal kinase MKRVLAMHDISTIGKASLTICIPVISSFNIQVCPLVTSVLSATTNYKEFE IIDLTNKLKKFILSWKNQNENFDIFYSGFLGNNKQHKIIEQILKLFKFKK IIIDPVFADNNMLYPTFDYKIVSGFREIIKHADIITPNITELKMLAKTEK IRNKDEIIKATSNLEIKGTIIVTSIEKDNLIGTAAYNTKTKEYSEFFLEK LEQNFSGTGDLFTSLLIGYLETYEIEYALKQATKVTHSIIKHSTLNNNST KKDIQIEFFLKNSF >BRE_611 pepD, aminoacyl-histidine dipeptidase MENIVIHYFKQISQIPRCSKNLKGISNFVKQEAIKFGFSFKEDNVGNIVV KIKANECDNVLPVILQAHTDMVCEKNESVVHDFEKDPIKIIEDDGYFFAS GTTLGADNGIGVAMMLAIMSESSAFKHPALELLFTVDEEIGLIGAIGLDP NLCSGKMLINLDGEEEGYFLVGCAGSRLIHIDFKPRYRKSKKKTCVEILF TGLQGGHSGVDIHIDFANSLKLIFFALNSLREKISFEIGHISGGCKSNAI PRESKALILIEDEDYSLLERELEMFKCYVHEMHNLDVGFEIVLKRVNFCG DVLDDIDQCKLLDMGMAFFHGVQKVENYDEKLVRTSLNFASLLKVGNEYQ FVFTIRSLLDIEKEYICCHLKSISKLAGANFKMIYDYSSWQPSKHSKLLS HLKNIYKDMYLKEAKTVMVHAGLETGVISEKFGEIDAVTIGPWINYPHTP RERVDIASVVRVYDFLKKSLETL >BRE_248 pepF, oligoendopeptidase F MIERNEINENDKWDLSSLFKDNEEYKNTVKQIRSKLQNFKKYETLEFDLN TFKEAINYYYEIEEEIERTIYYTHIQLETDVSNQTSNELRAMNINLETEA SNITSFFIPKILKIETTKIKEWLQDKELKDKKIAIEKILREKQHILSENE EKILANYTSLYSSYSDIFSALTNADMEFGEINGQLLSNSTYTLFLQNENQ EIRKQAFLKFYQEYKKHENTLANLLIADINKNKFLAKTRNFQDTISMKLF QNNIDKTVYTNLIETVNENLSVLHEYYEFRKTILNQEYLNHYDVYVPLTK NIKFKHSFQEACDKILKSLEILGSEYIDVLRKGLLEERWVDKYENKGKRA GAFSAGSYNGKPYILMNYKDESIRDMFTLAHEAGHSMHSYFSIKNNPFPH YQYSIFEAEIASTVNEQILAEYLLENENDIEKIKYIKLNQIDDLLATFFR QTMFAEFEYTIHEMINKNEPVVKETIKSIYLNLLTKYFGKSLKFDQKSSL ECLRIPHFYSPFYVYQYATGITAALLIYKNIKNNKKDATKNYIDFLKTGG SKYPLDSLKVTGVDLNLKSTIQNTINIFKEHLDNVKKLF >BRE_432 pepQ, proline dipeptidase (PepQ) MMLIPKENIYSKIEVKKSIFLSYIFHVTTREEINKILKKYKLKFKTATYV VHGFRIGNLNSFTNGMSDDKEPKHTAGKPTLEAILNKNLTDTLIITVRYF GGTLLGKQGLNKAYSKSAYEVINKTNLIEKEENEILSLNLNYNQYNLLIR MQNKIEIKIIDASFLDKIHTKIQFNIKNKNNILKFLQGNSLL >BRE_634 pepX, vacuolar X-prolyl dipeptidyl aminopeptidase I MHDATLDISHFQNLLDKSLTPYHLINYIEQKLLYYLNAKELKLNEKWKLE TGYYYIKKEGTSLIAFNINTNKIHEPFLISSAHSDSPALKLKIESSKNEG NVFSQHIEIYGGPIISTWTDRDLSLAGIVYFMKEGIINSQLITIDNIGTI PNVAIHLNRKANEGFTYNTHENIVVITSFKKSIKEIILEKLQISQQDFLS CDLIFTASEPSKIIGSEGEFLASKNLDNKSGCHAIMNAFVHTNNKKNKVA VFFDNEEIGSLTSRGANSTLLTEILERIDYVLNLGQEEHMIKLQKSFNIS MDGAHGIHPGYICKHDPYYKTSLGKGVAIKSNANFKYATTANGWAKLKAL AIKNNIKIQEILMKADTNSGSTIGPIANSKTGIETIDIGTPMWGMHSLRE TIAISDHIEAIKLLRAFFENWN >BRE_4018 pf32, PF32 plasmid partition protein MARKKPEIITIASIKGGVGKSTTSIIFAILLAQKYKVLLIDMDTQASTTS YFYEKIEKRNMDLRSNNIYEVLIDKLNINSSILNVENNLDLIPSYLTLHS INAFGYKHAFSEFKLKNDLKYLDVQYDYIVIDTPPSLDFTLTSSLICCNY LIVPMTAEKWTVESFDLLKFFMDKIALELPIFFVITRFKKNNTHKKLLKM IHSKNNFLGAISEREDLNKRIAENNIFDFEKDYIKEYKNSLINFFAKIN >BRE_5011 pf32, PF32 plasmid partition protein MDRKKPEVITIASIKGGVGKSTSAIIFATLLSKKYKVLLVDIDTQASTTS YYHEKLIENDIDVVNINIYRVLNETLDINDSIVNIDNNLDFIPSYIHLHK FIREAIPLKELRLKECLFFLQNEYDYVVLDTNPSLDATLANALICSGYII VPMTAEKWAVESLELIEFYMKELRINLPIFILITRFKNNNTHKELLEYIQ SKRGFLGFIHEREDLNKRISKNDVFDLNKDYIKDYGSALESFLTKKLIVR >BRE_7002 pf32, PF32 plasmid partition protein MRDIIAISSIKGGVGKSITAIMLGYIFSSKKYRTLLIDIDSQASVTSYFL PYFENKIDIREYNIYEVLKSKKSFMSIVHKITDDLHFAPSHIKLSQFSGE NIIGQEYKLKTILTPYFEEYDYILIDTPPSVNKELINSLMIATKVVIPLP AELWAIESYEILKSKMQEIINAYQKQDFKNYYVIQTLYEENRKIKKEFFY SLQQLYKEYVPIKIHRSAAIQKMITYRLEPQKDERYYNEYLRVAEVIEGV YNM >BRE_6017 pf32, PF32 plasmid partition protein MDKRKPKIITVASIKGGVGKSTTALFFSNILSSKNYKVLLIDLDPQASST SFYINIIKGQNVDIKKINIYRVLKKGLDIENAVINVNTNIDFIASHLSLS QFNEENISLKESLLKIFLSYIKYRYDFIIMDTAPTLGSLLNNSLIITDYL IVPLPTDQWAIESLDLITNRLRDIFRNELPMFYLVTNLVERQNIDRELKN FIESEYKDNFLGSVPKRDNLRKTVFYRNNFNPNEDYYKAYEGILDTFLKK IYHN >BRE_3015 pf32, PF32 plasmid partition protein MDKKEPEIISIANIKGGVGKSVLTIIFSYILKDMGKKILAIDFDPQNSLT SYFFKYVKSLSKNNIYALLKERPNFNLDKYLTKIHEFIYLIPSHPNLHLF NKENTSYKELFLKHRLKNVLPDYNFDYVIIDTPPNLDSLLDNALNITDKL IIPIQVERFSVESLSILMKYIDKISMYVGKDIDISIVENQFMKNRNTFMN IENSIKDKYGKYIKGKIHFSNKIKVFANDLKEPNFKEAYYQECLESLRNI LGI >BRE_1085 pf32, PF32 plasmid partition protein MDRKETKVITVASIKGGVGKSTTSLIFATLLSQSFKVLIIDIDTQASTTS YYFKIIKERGVDLFNRNIYEVLISNLHIDNAVVNVNSNLDLIPSYLTLHK FNSESIPYKEFRLKEQLKLLEFEYDYIILDTNPSLDFTLTNALVCSSYII VPITAEKWAVESLDLFNFFIDKLSIKAPIYLINTKFKRNNTHKELLNILK ENDNFLGTISEREDLNRKIARNDVFDLNKDYIREYQNTLSVLMDKIKNFV V >BRE_2008 pf32_1, PF32 plasmid partition protein MDRKKPEIITIASIKGGVGKSTSALFFCNILSSKEQRVLLIDSDPQASVT SYFLLQLQDQNVDIEKYNLYEILKQRKYIENCIFSMNEFIDIIPSSLELS SFNSESIPLQDNLLEKRLLSIKLKYDYIIIDTNPSLGHLLNNALIIADYL VIPINSDLWAVESIDLITDAIKKVYREDLEPNFLVTGALERQSIDKEIIS ELEIRYREKLIGIIPKRDDIKKTIFYRKDFCLDNDYYQAYKKALNNLLKK >BRE_2020 pf32_2, PF32 plasmid partition protein MDRKKSKIITIASIKGGVGKSTTSLIFSTLLAQKFKVLLIDMDTQASSTS YFIKDIESQKFDVVQFNIYEVIKNNININESIVNIKKGLDLIPSYLTLYQ FNAENILFKEMRLKENLKLLNEKYDYIIIDTNPSLDFTLVNALVVSSYVI VPMTAEKWAVESLQLLEHFIVKAGFKIPIYLIVTRFKRNKTHKYLLNIIE AKDNFLGAIKEREDLNRKIASNTDFDINKDYIVEYQNIFNKFLERQV >BRE_2040 pf32_3, PF32 plasmid partition protein MDKKEPEIISIANIKGGVGKSVLTIIFSYILKDMGKKILAIDFDPQNSLT SYFFKYVKSLSKNNIYALLKERPNFNLDKYLTKIHEFIYLIPSHPNLHLF NKENTSYKELFLKHRLKNVLPDYNFDYVIIDTPPNLDSLLDNALNITDKL IIPIQVERFSVESLSILMKYIDKISMYVGKDIDISIVENQFMKNRNTFMN IENSIKDKYGKYIKGKIHFSNKIKVFANDLKEPNFKEAYYQECLESLRNI LGI >BRE_4019 pf49, PF49 plasmid partition protein MKNDKSVKIYKRDIDSKGNALLSESNNNEESVEAVHYSTLKKKLYINLRE GIYNKIECMKILKEIKDNEYYKLDGYKSFDAFIKNYNVAKTQAYNYLKIA AALEEGLLEEKFVLENGFRQILSLLRDKQGKTIKRSKQNPIKPLRFQLKR QESYDFYKKNAKFTSFLLDKLFQSKQDLIEEFLKEFESLRG >BRE_6018 pf49, PF49 plasmid partition protein MMSKNKKIEIVRRIDLELDGIKEFNKTREERYLELKEKLKVLIKEESYNK IETARIFKEINESKYYALDGYKSFASFIKSYKIAKTSIYRYIKLVAGIDS GKIDYDLILNRGVDYAIQVLENGHLLCKSSAKPLKSLRFRLDDEESFSFY RSNIKFASFLLQEVYKIEKDFFYKMQDRYNSLKT >BRE_7001 pf49, PF49 plasmid partition protein MKLDILNTIKSRVGSVTQVEDSSDKERAMLRYRQLKEEIRARTLEEAVNK VELSKALYEIKKNKLYKFDGYDNFYEFCLDYKFSRTMIYRYVKIGAYLER ESISEQDIMQSSLNKIINDIRVKRDSSYCKPVVVKFNLKDKEKQLVLIKN KQKLEKFLLKCLLDNWESFIV >BRE_1084 pf49, PF49 plasmid partition protein MEMGIEVNKRNLTQNISSEEQVSIHYNKLKERLKINFQKEIFCKIEAMKV LKEIKDNEYYKLDNYASFDDFAKDYRLARTQTYKYLKIATAIEEGIVEEK YVINNGINGTMFLLRNKEGVNIKRSKQNPLRPLRFQLKCPDAYAFYKKNA KLTSFLLERVFSDEKEFLAKIVTQFESSKRVKN >BRE_5012 pf49, PF49 plasmid partition protein MKNVVLSNRVLHDNKDVKLINLKQESLIRYNELKEKLKQNARKEIYYKVE NIRILKEIKDNEYYKLDGHKHFDSFIKDYRMAKTQVYAYLRLANAMEKGI LAEQYIIENGINESLAIIKNKKTIKIKKIRRGSINSLSFKLKNQASYDFY KNNVKFIAFMLDTIFLNDRNYLQKLFQKYSNLHLDKKVVNIADLLEKFQ >BRE_2009 pf49_1, PF49 plasmid partition protein MGIKNKNKMIIGRRVKVNEDNLFVKLPEDSRKEEYLRLKDRLKSLVVDDI YNKIETAKVLSLINEKKLYIFDGYKSFYGFLADFKIAKSQAYKYIKIVSG MAQGIIDYDFIINNGIENTIKKLGIKNIVKKSKHNLTKQLCFQFKSQDSY DFYKRDTKFMCFVLDELFINNKEYLENLHKKYEHKLQKGI >BRE_2019 pf49_2, PF-49 plasmid partition protein MNIQLNDRVLEKFDSKEQLRIYYNKLKENFVNSFKKEIVYKIECMKILKE IKDNGYYKMDGFKTFDAFTKNFKIARSQIYNYLKLAVAMEDGVVSEDYLL ENGINDTLLLIKTNGSETIKKSRQNPIKPLRFQLRSQGSYDFYKENSKFT SFVLDELFENRKEFLEELQNEFEKLKG >BRE_733 pfk, pyrophosphate--fructose 6-phosphate 1-phosphotransferase (pfk) MYRLKNQNLGFNIENLGECKYDNPLINFYANESHVHFTSEESKIRFNVYK NEESWNQYEDVFLEKAGPRRKIYFVPKHVKAAITTCGGLCPGFNDVIRSI VRTLWNVYGVYNIYGVKFGYKGLLSESNLSFVDLNPDVVNDINQLGGTIL GSSRGGIRPVEIVDTLERMGINMLFNIGGDGTQKGSILIAEEIERRNLKI AVIGIPKTVDNDFMFVQKSFGFETAVEQSVAAVAGAHFEANSAYNGIGLV KVMGRDSGFIAAYTALSSNDVNFCLIPELDFDIEGPNGLLAHLERRLLQK ESMDEIPHAVILIAEGAGQKYFDPGIRKKDDSGNLLHEDIGLYIKDKINE YFKSKDIPVNLKYIDPSYIIRSSPANASDSLYCARLGSNAVHAAMAGKTK LLISLWSTKFVHVPIKMAVIARNKVNVNGSFWRDVLASTGQPFSMKN >BRE_25 pfpB, pyrophosphate--fructose 6-phosphate 1-phosphotransferase,beta subunit MISILQKERYKYVPRLPKILTNDFQNISVVFGDKTDALGNKDELREVFEN TYGLPVVNFIQGSSNVDFTKILNVGIILSGGPAPGGHNVVAGIFDAIKKS NSNSKIFGFKGGPAGLLDDKKIEITQDLIDAYKNTGGFDIVSSGRTKIET YVQYEQVLSVVLKNNLNALIIIGGDDSNTNAALLAEFFKKKHHDIQVIGV PKTIDADLRNEHIQISFGFDSATKTYSEMVGNLCRDAMSAGKYWHFIKIM GRSASHVALECALKTHPNICIISEEVLAKNKTLSEIVEDIASVVIKRSLK GYNFGVIIIPEGVIEFIPEVKSLMIELCSIFDSNEEEFKGLDVKDIRKVF ISKLSEYMKKVYVSLPLFIQIELVNSVLEIDPHGNFHVSRVPTEKLFMEM VSVRLEELRNLGEYSGKFSPIDHFFGYEGRSVTPSNFDSDYCYSLGYNAA LLVLNGFTGYMSTIKNLNKNSTEWIAGGVPITMMMNMEERYGVLKPVIKK ALVDLNGAPFNEFVKHREQWAINNLYVFPGPIQYFGASELVDEITLTLKL ELET >BRE_374 pfs-1, 5'-methylthioadenosine nucleosidase/S-adenosylhomocysteine MILITSAMDEEAREIHQIIENKEEIKIDNYLGEKKIYKGEIEGHKIISLT TGIGKVNAAMWNSYIIAKYQITHIINSGTAGGLQESSNIKISDIIISSQT AFYDFNLTQFDYQIGQVPGFPQKFESDKTLLNKVISIIKDKFQNVNVHIG LILTGDQFIEDEKQIEKIKNDFKDALAVEMESAAIAQVAYTFNIPFIVTR SISDFPNNKNNHIDFNKFLQDASKNSAKMVRELIKSI >BRE_736 pgi, glucose-6-phosphate isomerase MIHYNDLNKLKSFQELKQMNPEKLKTVLNENRIQEYDIKIEGNHVHYNYA TKQINEAHLKLFQNLSDEANLIEKYKEIINGKHINLSENRKVLHHLTRGQ LGTTVTDNNENMREFFERELHKIFEFAQKIQNGTIKNTNGKVFKNVVQIG IGGSSLGPKALYTTIKNYAQQKNLYKMKAYFISNVDPDEAEEVLSEINLQ ETLFIVVSKSGTTLETSSNMQFLIKKLKDNGIEEYKKQIIIITSQGSMLA LEKGYLEYFFMHDSIGGRFSPTSAVGLALITLCFTEDITKEILKGAHESD KQALNKNIRENAPLLASIISIYESNILNYSSNCIIAYSKAMEDFYLHLQQ LEMESNGKSVNRFGEQIDYKTVRIIWGGIGTDVQHSFFQMLHQGTEIVPM DLIGFSQSQLKQDVSLDGTSSNDKLKANLIAQIIAFAIGKENINQNKSFK GERPSALIYSKELTPYTIGAILSHYENKVMFEGFLLNINSFDQEGVQLGK IIANKILKEDNSQNKIIKSYDRLF >BRE_59 pgk, phosphoglycerate kinase MSIRTIKDCDFSGKRALVRCDFNVPLREGNITDDTRIKAALPTIEYLKSQ GARVVLMSHLGRPKGEKNLRYSLMPIARRLSELLGQDVKMLSDCIGDEVV TAVSCMQNGDVVLLENVRFYKEEEENSDAFAMQLSKSGDIFVNDAFGTAH RAHASTSGVASYLPAVGGFLMEREDEFLGKILKNPESPFVSIIGGSKVSS KIAVLESLLPKSNVMVIGGGMAYTFLKVEGYSIGKSLLENEYIDVASSFL KKAKELSVEVILPIDHVVASEFQEYSMPEYVDSVNIPDSKIGMDIGEKTL KKIEGVLSSAKTVIWNGPLGVFEFDSFAKGTAKVAEYVANCPGITVVGGG DSVAAVNKFNLSGKITHVSTGGGASLEYLEGKVLPGIKVLEV >BRE_222 pgl, 6-phosphogluconolactonase MMEFLYSNKESDLKNKFFEFFLNNVSQSDFTSIGICGGRNIISFLNVFDE QNYSLKKSHFFLTDERCVDLNSSYSNFKLLSENFFSKMVEKNLVCGSNLH PFIYNEFDETSSIYNYNIEFNSRFTRLDLSILSVGEDGHIASIFPSKKLL FSEMEGYQYEYDSPKFPNKRISLTPKSLLSSKASVLFFIGDEKRGALENF LSSDISLRECPARIFKDHSHLLVFTNIERVYAGS >BRE_518 pheS, phenylalanyl-tRNA synthetase alpha chain MGNIFDIAKTLHPLEVRVILNYKEEDSVFALRLSKDLNYNEGQSNKVVEW LLSKGILKETFRKLNVFYRLTEKGVDAFNNGLIEERIVTLVSQKMVLVSN LASELKIDFRDVGKAFGNLSREGVLSLGSNKEIIIKNLECASYKMVKILV ERARDQDLLEDALSQDELLIISNYSKKKGASDVLFKIIEKLDLRFEFTKF GLEIKSYLEKNDLKGNEIVKLTPEMLKNKSYENKNFRAYNIHVSSNKTFI GRANPYSEYISKVKDKLVSLGFEEFDGPLVESEFFNNDALFMPQFHPARD IRDVYYIKEPNSLKSLPEPYFSNVKAVHENGYIAGSRGWKYNFSESISKR LVLRTQGTVLSAKQLINAKNPGKYFGIVRCFRYDQVDATHGADFYQTEGI VIGDVNIKTLLGLLEIFAKELAGATDFKYVPAYFPFTEPSIEVHVKHPIL GWFELGGSGIFRPEVTKPFGIDVPVIAWGIGIDRMALMHLGLSDLRELFT HSIGDVALRRGKSNA >BRE_519 pheT, phenylalanyl-tRNA synthetase beta chain MPKVEIYKSILLEKIGKNLTNYELESIIETAKAEICEIDIVNDKIKIEFN DTNRPDLWSSAGLARHIKTYLSGNVPSFDFFSMTDNLQKFYGEIFVSPEV FGIRPFIFGFLAKGMICDERMLESLIQLQEKLSHNYGQKRKRIAMGMYSS NLIHFPINYVTCSSDYKFVPLGMDIEMSIKEINERHPKGIEYSSIFENVD QYSLLLDYKNNVLSYPPIINSRDIGTLKVGDTNLFIEVTGTDLEATLLSL SIVACDLYDMGFKILPVKTVFPRETLFGKEIICPYYFQNSLKINVDSVNK LLGSNFTANDMCLDLKKLGISAYFEESDTFYIMPPVYRNDFLHEVDVIEE VMIGKGLDNFKSELPKDFTIGKLSPIEEFSRSVRNLMIGMGFQEMIYNYL GSKVDFIEKMNIKGSELLSVSNPMTESYEYIRGSIIPDLLKSESISSNFP YPHKIFEIGKVALKDLVSDEGTVTYDNLAFLMADKEFSFNEINSLVSSLF YYLNIGFKVKESSKNLYIDGRGADILVNDIVLGCFGEVSPYILNNFGIMV PCCVLEININGLLN >BRE_533 phnP, phnP protein MLGIFLGTGASSGVPMLNCNCRVCNSDFCKNKRLRSAFLLSLCGLNLLID MGPDIRTQLLRENILKLDLVLYTHEHYDHIMGLDDIKFYTRCVPLPIYAR ETTMHHIKNAFPHNFSSRMSISGKANILPRLAVDFEQIFFKGIKIIPIPL LHGDIISLGYRINNLAYLTDVKSIPEISYSYLEGLDVLVIDALRIKPHPG HLNFDDAILEVKKINPKIAYFTHIAHDIMHDEFDYLRRDNIYLAYDGLQI YI >BRE_45 phoU, phosphate transport system regulatory protein MNMIRRKLTKQLEIIKDYLWEMKECVLKMIENSLIALESRDKNLAKKIIN EDEKMIDDYQYDIEDLCGRIIATEHPVATELREILAIIKIISSLERIADH STKIVKVVLLLESNVGDFSSVDIYQKPLREMADTAKDMLANIFDAYFDGD FIKILKIVKYDNIIDKLFSKQKTLVIDAMKNNPENLDYLLNILFLNSFLE RVGDHVATIGELLYFVKVGEKVNLT >BRE_377 pkcI, protein kinase C1 inhibitor MEEILSDCIFCKIVKNEISCYKVYEDNLILAFLDINPLNIGHTLVIPKQH SNDILDVNNELDGQLLGVCKKVALSLKKLDFNICQGVNIYSAIGSEAGQV IFHTHFHVIPRFQGDNLGFKRNCSIELSGDEYLDLSKKISKNI >BRE_41 plsC, 1-acyl-sn-glycerol-3-phosphate acyltransferase MKILRSIITYISFFFFVLFFTVLFFVFLVFKIFGFENAFIKFIFVLIRFA IKTCLWLSGIKVVITKDDDCCLNKDGGVVIIANHIASMDPIFLIYVFIRP FVIVAKRSLLSIPLVNFILLSMGAIFVNRSSIRSSAVTQQKATKIIKEGG AIGIFPEGTRNRGGKTKDFKRGSVNLALRTNSPIVPVTLLNTHKVFIKNL ILNSGLSVYVHIHSLIDVSNLTDDEKEQLHVIVRDKIVKKLEKMKIQYNC >BRE_1105 pncA, pyrazinamidase/nicotinamidase (pncA) MKSTFFHLVLNNSALILVDIQNDFLQSGALPVPDGRDIIPLVNKLQNCFK HVIATKDWHPENHISFLSETNINGWPKHCVQNTWGAAFPKDLDVEKIKAI FLKGQDQNYDSYSGFYDDCNKKNPTGLLKYLKNNEICVVFIAGLALDFCV KETLIDAHNLGFKTYLIIDATKSISDFPELIIIELKKLGILTCFSKDILI NCDL >BRE_816 pnpA, polyribonucleotide nucleotidyltransferase MRKILKLKIGREDLILETGLLAKQANGAVLATYGGSTVLATVCCSDSIRE NLDFVPLSVEYNEKYYAAGKIPGGFIKREGKPKDKEVLVSRLIDRPMRPL FDKRFGREIQVVPTTLSTDQMNPPDIVGMNAAFTAVFLSDIPFNGPIAAV RIAYLNDEFIVNPSFDEIQDSVLDIVVAGSLDGITMVEGGANEVSEEILL DAIDKAYTYIKQICDLQKEFIYLIGEREKLPLAYEEKVFEFKDDLRSLIY FELKDACFVRGKLNRDKAIKLVKQKAYEHFSSLEQLNDENEILFYKACDD FEQEIVRKSILEDNLRTDGRTPTQIRDIIAEVDLLKRTHGSALFTRGETQ ALAVTTLGTSIDEQVMDDIDGDKRLNFMLHYNFPPFSVGETGRLMTGRRE IGHGHLAQRSLEAMLPKKDDFPYTIRVVSEVLESNGSSSMATVCSGSMSL MAAGVPVKEQVAGIAMGLISNDDKYVILSDILGEEDHLGDMDFKVAGTKN GITGFQMDIKISNVTKQLMRDALEQARIGRMHILSIMDSVISSSRGDISV NAPKIVQLQIDIDKISLVIGSTGKTVKAITDEFEVRVQIEQDGRITLFGT DNLKMQKAKAKIESIVREPKVGEIYDGIVKKINSFGAFIELTPTKEGFLS NRSRSRDDRYGSDIRHSRYSNRHSRYGRDNRSSFSMRFPRLEEGQIVKVR ISDIDKFGKIELELARD >BRE_553 polA, DNA polymerase I MKEIYLIDALNIIFRNYHVMKNNPLTNSKGENVSAFIGFFKTLFFIIKEK KPENLIVTFDSETQTFRQKQYPSYKATRDAPPDNLIPQIHWIKEGLIKAN IPMFELQGYEADDLIASFTKKAEQNNYLTYIISPDKDLLQLISNQTKIFK IENSSFLEMNNDYVIKKFGINKSQIKDYLSIVGDPSDNIPGIKGIGQKGA AKLLNEFHTLNGIYENLSLINNKYREILLREKENAFLSYKLISLVEDLEL PSLETFRLENLKEDIILLFEEYSATTLIKSYKSLLKKKNIINTMQKSIFD INKTKANKENTKDLQSTTLYANTLKTIQEENVKYKTILKKEELDLLIEQL KKASYIAIDTETTSINVYESNIIGISVSFKEFESYYIPIETKEKNSIGKD YIIQKFNELFNSQPKLIGQNYKFDYKVLKRHGFNVISAYFDTMIAAYVID PNTKVSLDFLAAKYLMHKNIKYEEIVPQHSTLKDIPLEIASNYAAEDADI TFRLFNILRKKLKEDNLESLMKNIEMPFSNVIIEIEENGIYLDSNYLTQY GHELEQELKTIENEVIQSIGIEFNLNSSKQLHTILFEKLNIIVSKNVKQD STDIKVLETIKDQHESIEKLINYRQLAKLKNTYTDNLIEFINEKTNKIHT NFMQTKTATGRISSTAPNLQNIPIKNERGRKIRAAFKPTKGNIFISADYS QIELVILAHLSEDESLIEAFTHKKDIHIQTASKLFKVDEANITPSMRRIA KSINFGIIYRMSAFRLSQELSIKRDEAQNFIDSYFNLYSKIKTFIQNQID FVKQNGYSETLLKRRRYIREINSQNYLERTGAERMAINSIIQGSASDIMK IAMIKVYNEFKNNNLKSKILLQVHDEMLIESPEEECEKAQIIIKEMMENA YPLKIPLKTNIETGKSWGDIHQ >BRE_648 potA, spermidine/putrescine ABC transporter, ATP-binding protein MDNYILEIKNLKHYYTDSNNKTLDSINLKIKKNEFITLLGPSGCGKTTLI KIIGGFLNQKEGEIYFLSKEISKITPNKREINTVFQNYALFPHMNVFDNI SFGLRIKKLNKNLIKEKVKTVLSLIGMQKYAYRNINKLSGGQKQRVAIAR AIIMEPKLLLLDEPLSALDLKMRQEMQRELKKIQRKLGITFIYVTHDQEE ALTMSDRIVVMNEGIILQIGTPEEIYNEPKTKFVASFIGESNIFEGTYEK EFVVKMFGKTFQCLDKGFKNNESVDLVIRPEDVKILPKGQGHLSGVITSA IFQGVHYEMTLEIQKSNWLVQSTKLTKVGEEVDISLGPDDIHVMCKE >BRE_647 potB, spermidine/putrescine ABC transporter, permease protein MNKIMLKLYSLFLLIFIIFPLVIIITLGFLNERNEFTFANFIRLLEPSYL RIFSRSINFALITTIFCILIGYPTAWFISMSKKSTQNNLIIMIILPMWIN TLLRSYAWIRILGKNGIINNLFIAMGFKPMDLLYNEKAVIIGMIYNFLPF MILPIYIGLSKIKYEYIEAARDLGARMWQILIYIKIPLTLSYLATGIIMV FIPSITVFIISDLLGGSKQILLGNLIEKQFLFVPDWNTGSAISFILMIVI VIFNLTIIKLMQKTEKI >BRE_646 potC, spermidine/putrescine ABC transporter, permease protein MLKILKNTFLFLTLSFIYAPIIILIIYSFNSGDNGFFFEGFSLKWYKEVF ASKQIKIVIYNTLLVAIISSLISIIIGILGAYSIYKIKNKKIKTILLSIN KIPIINPDIVTGISLMTFYSLIKIQLGFSTMLMSHIIFSTPYIIIIILPK LYSLSDNIIDAARDLGASETQIFTNIILPEILGSIATGGLIAFTLSVDDF LISFFTTGQGFNNLSILINSLTKRGIKPIINAISSILFFVILSLLFIINK YVGIKKLTVDTEI >BRE_645 potD, spermidine/putrescine ABC transporter, binding periplasmic protein MILKKVLILIIILIIVSCSSQKKQNVLNILNWAEYIDENLLAQFEKEHNV KINYDCFNNTEEMMAKFNNTKNYYDIIVPSEYLIGDLRDENKIELLDHSK LPNVKKNILDELKNLEYDPGNLYSVPIFWGVLGILYHKNKIDINDMNEFD ILFNEKYKKEIAMLDSPKENIGVALKKLGYSLNEHSIPIIKEAEKLLKNQ VSLVVGYFSDIAAKSLMLNGEASIQLTWGGEAIDAMLKDPNLDFYTPNST NLWFDVLAIPSDAPNKELAYKFINFLYENEASYANFEETKYNSPNKNVLK RLKSEATNKPEMKLYLDDRFVPKNFSKHEVFKRISKKVKEEQMRIYVEIS S >BRE_4017 ppap1, plasmid partitioning associated protein-1 MEDSLRRLKEKKLEIEKNQNKKDVFLKVERAKDRTIYHTKIFRDFYAFGI DKNDSNKFFLIFRDLFKDKTCKFHLFSIKDGDKFLGMYYGYRKPIKNVIS KYKENGIIKTYTFPKVFYVEFRFKKGSVFCYIKGIYYFFRKEKSNTKYCK ILFEIINRLEKQIYAFYGKQLPSGGIIKRWLEKNQK >BRE_1086 ppap1, plasmid partitioning associated protein-1 MVALLELLKQKKKEIDPKNQKKGKNIFSKVEEINNRKIYHTKIFNDFYAF GISKNEPTKFFISLRGIFNIEDISMFHLFSIRDDDNFLGIYYGIKKLDKA FLVKNFNKRETYTLRKCEYIEFRFKKGGVFCYLSGLHNLLKKGKIGSSYY QTLLSILLELERKLYAFYGKKLPEGGIVPRWIEKRQK >BRE_3016 ppap1, plasmid partitioning associated protein-1 MNCSLRRLKTKMIEIRLKDNKNDVFNEIEKIDKRTLYHTKIFNDFFAFGI SKKEENKFFISLRNLFNKGKRSRFHLFSIKENIDDKFLGMFYGFKRLRKP IYFKYKNNNTKDIETVPMYKIYYIEFRFKRGSIFCYIRAIHSLTKKEKFN KNYAQNLLKRIINLEYEVYEFYNETPIAGGIITKWIKRNQK >BRE_6016 ppap1, plasmid partitioning associated protein-1 MATCELKAKLLARRLELNKANNNFFKRIEDKNYKKMYHTKIFSMINNFEA KPNKGKFWLCFRNVFDPTKCESLHLFHMRQGDRFMGIYYGFAKLPKPFIV HYKENEVRKTSKIIKIYYIEFRFKKGSVFCYLRSLCTLLQSKNKEKNFYN SLLSRTLKLEKEVHRFYGKEYFEDKGILKWIKENQK >BRE_5010 ppap1, plasmid partitioning associated protein-1 MKETNKLLTEFERKNVICQLKNLESKPKKNFNDSFSKIEKEDARTIYHTK IFNDLFAFGVNRREEDKFFVALRGVFNSDKKSTFRLFSIEKEEDRFLGMF YGFKRLKTSFILRYKDDTKKSDVTTKIYKPYYIEFRFKKGSIFCYIKAIH SLIKKEKFTKKYVQTLLERIMKLEDEVYKFYNKRLPDGGIVTKWIEKNQR >BRE_2007 ppap1_1, plasmid partitioning associated protein-1 MQCPLERLRSKRIKIEPTNKNKKNDTFIKIEKINNRTMYHTKITKDFYVF GENKKQKNKFLICMRDIFKSERINAFNLFSIKGDDRFLGMYYGYKDLEKP IIINYKNDAVGTNQSIKMFKVCYVEFRFKHGSVFCYIKCMKNLLKKEKKN QKYCEILFSHLIDLEKKVYEFYDKTLPKGGIVVKWIEKNQK >BRE_2021 ppap1_2, plasmid partitioning associated protein-1 MDSVLERLREKKIEIKEKGDKSIFIKIEENNSRKVYHTKIVMDFYTFGVN KTQKNKFFIAFRNLLSMKKIYEFNLFSLKEDDKFLGIFYGYRKPMQKIVT RYEENGVMKSSTFSKIYYIEFRFKKGSVFCYIKGISRLIKKEKKETQYSQ FLLELIVNLEKKVYEFYGKKLLEGGIITKWIEKNQK >BRE_2041 ppap1_3, plasmid partitioning associated protein-1 MNCSLRRLKTKMIEIRLKDNKNDVFNEIEKIDKRTLYHTKIFNDFFAFGI SKKEENKFFISLRNLFNKGKRSRFHLFSIKENIDDKFLGMFYGFKRLRKP IYFKYKNNNTKDIETVPMYKIYYIEFRFKRGSIFCYIRAIHSLTKKEKFN KNYAQNLLKRIINLEYEVYEFYNETPIAGGIITKWIKRNQK >BRE_2022 ppap2, plasmid partioning associated protein 2 MAVIKEFNMGSTKRPINNKYQHKLIVLISTLNYINSHFKQYNQNKILYYF NNNLNNNGQKKATLKTLQSYLYKLEKEFHVTSNYYRHLGENCGTEIHYKL RFSKKVCHYKINRHFRNKKEDRFQQRANLYHQQTCTNNESLKKNGSVEKW ECINNNSNNNKKNKELEKIEKEKAQLEKYIKKCEFKDDKYLSVLNLETTK EIKIEKLIKLKKEENKRERERNKSNRLIGRQQELEKALAETKEVLKKEGY NEKQLETEIQKAYKKYKHKPHFIVESSKYGDLGQIIKRIKKTVECKKKGK KEDHKQIRNNIFSILLDQLKNKVEVKILAPILRNYLSNQIDLKYSQVFNN HYYYEILEMVEGKEHLRIEEYEKIVD >BRE_1087 ppap2, plasmid partioning associated protein 2 MEIKKIKGKTNRYQYNLIVLISTLNFMNLKLKQYTQTNILYFFNGNLTRN KQQKVKIKTLQNYLYELEKKYKITLNYCKHLGKQCGSEIYYKLKYPKKTC HTKINQYFRNIKKEKIDKFTKRIETYIQENGSPKWECINNINNNKKIEER ILKKYISKCHFKIDLPLVLLNSKIEKDLKIELIKEIKKYERAIEALSLDE INLLKGKLIEGTPNCVKGFLEGMGYLKNIESKIKRQEIKQKELKEILDLK RKELESQNYKEDVLNQEINKIYERYKNKPHFIIEQDKYRDLDLLIQKIKK NTEKCKSKTKERDDIKNNIFSILLEQLRHKFDIGILVPTLKKFINAQDEL KYSKVVDNTYYYELLDTIK >BRE_193 prfA, peptide chain release factor A MKMFLEKLNPIEKKIKILEEKLQDVNLIKNQKEYSKIIKEYNYLEKIKEK KDEYQHILNQINENQKILSEEDNLEMKDLIKQEIAHLYSKKDEIENTIKI LLLHQDENDDKNIIIEIRAGTGGEEAALFAHNLYEMYTKYSEKKKWKTEL INFNKTELGGFKEVSFEIKGKDVFKKLKHESGVHRVQRIPITESNGKLQT SAATVAVLPEVEDTDIEINDKDLRTDVYRSSGAGGQHVNTTDSAVRITHL PTGIVAQCQNERSQHKNKEQAMKILRARLYELENLKKQEQRSNDRKQQVG SGDRSERIRTYNFPQNRVTDHRANISLYKLEEIMQGELDSLLNTLALKFQ EQSLKNSQL >BRE_77 prfB, peptide chain release factor RF-2 MKMYGGSFDSDKIKIQLQKYEKQINNENFWNDNKRAQEILKNQNILKTKI EPWKNLICQLKDLRELCKIAESEDDKAILERDVNKLREQYKHILTLSYFK EDIDINSAFLTIHSGAGGTEACDWVNMLYRTYLRYSERRGYKIELIDLLE SEGGIKSVTIEIKGKYAYGFLKSEVGIHRLVRISPFDAAKKRHTSFASVF IDPVIDDKIEIIIKSEDIRVDTYRASGAGGQHVNKTSSAVRITHLKTGIV TQSQTDRSQHRNKELAMKVLKSKLYEHYKTLEQQKSKSKQQEKKDISWGN QIRSYIFQPYTLVKDHRTKFENPNIMSVMDGNIDNFIEEYLKWKNLN >BRE_19 priA, primosomal protein N MDDNLKQNFYYDIAFNIPINRLFLYKYKLTLKTGTRVITNFHGKETIGII IKRYYKEELKEDFTFSIKYILKVIDDHPIITEHNINLARWISKKTFSGFG ETLFCGLPKISTSNKKIKNNKSESPKSKVSIQLNEEQNKIYKDIIQSSIQ NTFYLFGVPGSGKTEIFIKLCENYLEQKKQIIFLIPEISLGYQIIQRLKS SLSTNNIYEYNSKVSNSNKIAIWNKVKNGESLIILGIKSALMLPFTNLGL IIMDEEHEHTYKSENTPRFHSRHIGFFLQNTFNAKFIMGSATPSLEAYLA MENNQIKKMILKNKFLTKTLKELKIIDMKKEPQIISSELLYSIQKSILEK RQALIFINKRGYSNTLECKICEHIICCPNCSVNLTYHQNENKLICHYCNH KTNIISTCPKCNSKDIMYKTYGIQFVEKELKKFLPNARIARIDSNINQKE ISQSINAFENEQLDILIGTQIIAKGFNFKQIKTLGIINADIGIDFPDFRS SEKIFAIISQVLGRAARFKSDNTIIIQTKNPNYYAIKYAYEGKYEEFYQE EIKIRKELNYPPFKKIIRIVVRSQKQEAAKHKCSEFFDISKEFLNDDIEY IGPSKAPMSKISKYYRYNILYLSKTFNPLEKLIRNTKERIKNTKDIYIEI DYYPLSLL >BRE_402 proS, prolyl-tRNA synthetase MWFMSDFIASREEEFSKWYLDIVQKAKLVDYSPVKGCMVIMPYGYAIWER IQSVIDDKFKESGHENAYFPLLIPYEFLEREKEHVKGFSPELAVVTTAGG EELREPLVLRPTSETIIWNMYSKWIKSYRDLPIKINQWANIIRWEKRTKP FLRTTEFLWQEGHTAHETSNEAQEEALFILNLYKKFVEDYLAIPVFYGKK TEREKFAGAVSTYTIEALMQDKKALQAGTSHYLGLNFAKAFDVKFQNKNG EMSYVFATSWGVSTRLIGALIMVHSDSKGLILPPKIAPIEILIVPILKKD DDVNKKILEYATTIFDILVKEKFRVEIDKDFKNSPGFRFAASEFKGIPIR IEIGSNDILMDCVTVARRDRDKNSKYQVSFKELLPKIKEELETMQCELFN KALEFRNSNTKEIIGFKENDYDLFKTYIKDNLGFVLSSWCGNEVCEENIK NDTKATIRCIPEDFQDKSLDNVTCIYCNTSAKHFVLFARAY >BRE_148 proV, glycine betaine/L-proline transport system ATP-binding protein MYKASVTVRNLYKTFSYNRNKKQIFKAINNYKNGKDRSDIYKEFSVFIAN ANINLDIYENEILVIMGMSGCGKSTFVRCLNGIHKIDSGSILVDNIEMND INQKDLSALRKDKFAMVFQNFGLFPHMNVLRNVTYGLEVKSVPKKVRIQR ALDILRLVGLEDSKYKYISELSGGMKQRVGIARALVVNPDILLMDEAFSA LDPLIRGEMQCELLRLVDKLKKTVVFITHDLIEAFKLGNRIAFMRDGEII QVGRPLEILREPKTEFITNFIKNLPVLNILKIKDIIKVDFDHYGYNDQFN VIIKKENDSFILHDISIGKKYSNVVSLNLDLGDEIKSVVKYLNKLDYLIV TKEQGDIIGYIDLGEIAALLAR >BRE_147 proW, glycine betaine/L-proline transport system permease protein MNRDFIVSSIDKAFDFLVDNFANSSGIGFAKIIDSFYENLKRLFTVINPV LFIVMICVFSFLFLKKRLALLIMLGFCFILYFDLWEVSMDTISLIFVSVF FSVLWGILIGILGGYCTKFYVFLKPLLDLMQAMPPFVYLIPAISFFDTGT SSAIFATIIFAMPPVIRYTRLGIIQVPSEVIEAAKSFGSSSARILFQIQL PLALQSIIEGINQSIMMAISMIVIAAMVGSSGLGRTVIYSVERLHFAEGL ISGLAVVIIAIILDRIMQAIFIKFSYLNTDNYGGKKENKFKRFLEMYNK >BRE_146 proX, glycine betaine/L-proline transport system substrate-binding protein; lipoprotein MKGIFIPVFVSFVLIFVACSKDDSSDNGNPKSLKSVKIAYVNWIGETIAT NIVRVVFERIGYNVEILPVTTSIMYQYLASGRVDGMVSSWVPTADKFYYE KFKDKFVDLGANYEGTLQGFVVPSYVTISSISELKGRGSEFKNKVIGIDA GAGTQLSVEETLNRYGLSKEYELISSSESVMLASLESAINKQEWILVPLW QPHWAFVKYDIKFLDDPLLSMGGPESIHSLVKLGLQESDPDAYYLFDNFY WGDDLLLPLIEKNYKEPGQEYKNAVEFVDSHKDYIKNWVPDKYKNLFD >BRE_549 prs, phosphoribosyl pyrophosphate synthetase MSLLMKKSIGIIACPGGRVFAEKIMAELNTIFLDAENKVIEQISQTSNCS KEDVLKFEGILSSFLEGLEFSNLRFDETMEIPVNFIKFANGEFKSEILKT IRNKDIFIVQDVSNIYPVTVNNNEEVVMTVNDHLMNLMTTVDACMQAKAN SVSVIVPSYPYSRQDKKHSREGLTASLFGRFLEELRVKHILTLDIHSKAI ENVFRKSYFENLNASYEIFDALAELIDIRDSNLVVVSPDTGAVNRNKFFA SNLKRPLALLYKERDYSKVTHNVTDSNISVTKLLGDVEGKNVFMSDDILA TGGTFIKAVKLLKSMGAKKIICAVSLPFFNGDAIRYFDKAYEEGYFYKII GTNAVYHDDKLLSKPWYYEANVAHLFAGAIFAIHNRVSLQRILDRSHDIQ NLISKS >BRE_217 pstA, phosphate ABC transporter, permease protein MKKIQMNKLFNQIAFCIIKFIAYFLITLLLFIISYIVYNSIFFTSKKESL FLDETTHFLPFKSNNNTVKIAFIINKSIKINEITTQDIYNIYNNKISHWG SISDQNLDIVPIASSQPNMSNEVILQTLIKNNKFNNRYIKLVESSEDMIE AINQTNGAIGYLTKDDLEKLDFKKYPKIKSLRIKSISILVGKKTLQKSEN EIIDIINLQQIKKLLIGKANWNDLISKDIKLNIIKYSDYDPNAIKMVEKN EGTIAIVPWHYFYKSDAPFLKLYDIKKNMPLNLNFILSTPRNSGKYGGIS YLILNTFYVILLTAIISILIGIGTGIMLAEYTSNKVFYKTVSMSVDILSS IPAIIFGLFGLIFFVPIFGMGILSGAITSSLMILPMIVKTTEESLKSIPK SYKYASFALGANKTETIIKILLPAANPGILTGIVLAIGRALGETAVLLFT MGTNLGLASTLNEPSRSLTVHLLLLFQEGYLDKGFATASILIIIILLINL ISKFLINKLYRI >BRE_218 pstB, phosphate transport system ATP-binding protein MNQDKAIIQTENLNLFYTDFKALSNINISILRNSITALIGPSGCGKSTFL RTLNRMNDLVEGVKIEGKVMYEGKSIYSNNFDVLELRRKIGMVFQTPNPF LMSVYDNISYGPKIHGIKDKKKLDEIVEKSLIKSALWNEVKDKLNRNALS LSGGQQQRLCIARTLAIEPNVILMDEPTSALDPISTGKIEELIINLKESY TIIIVTHNMQQAGRISDRTAFFLNGYIEEESKTDELFFNPKNIKTEEYIT GKFG >BRE_216 pstC, phosphate ABC transporter, permease protein MQLTLKTKRNIVRLAFKCFIVASATISTLIILLLILFIIKNGITPFLNNK INILNFLFNTDWNPTSKIQKSYGILSFIINSALTTFFSVAIALPIGLGFA IYLSEKTKGIYQKTLQTIIELLAGIPSVVYGFFGSTFISSLIKNTFIRED NLGYNLITSIIVLSIMILPTIISVSYTSLKTVPKSYKLASLALAATDWQT IYKVMIPSASKGILAGVILAIGRAIGETIAVLMVGGGSPLFIRNIFSPIR TLTVNIAIDMAYASGTHKEALFATALVLLSLVIITNSIKHLILSSSKRLK IK >BRE_215 pstS, phosphate ABC transporter, periplasmic phosphate-binding MTYLRLMILYIVVKGVNLMQVIKILFTILLAFLFSNCTKNKENVIAIGGS TSTTAIMDEMILKYQKINDQIKVTYDAQGSSVGIKGLFNGIYKMAISSRD ATEEEIAQVAKVTIIAYDALIFITSPDVKITNITEEDLVKILNGNISNWK QVGGPDAKINFINRDSSSGSYSSIKELVLEKILKNLEEAQFRKDSIIVKS NGEVIEKISLTPNSIGYISFGYARGAIEKGLHTLSINSIYPTKETIIKDK YDIKRKIIAITNNISEDQNTLDFINFILSPSGQDIIEEQGFIKVNTTENN >BRE_593 pta, phosphate acetyltransferase MLEGLVEYMGFFNFKDYVYARARKNVIDHGDKASIVFPESTDIRILKATI NILREGLAGFVVLIGVRDTILGKLRELMGFGDDILDMIKIINPSSFKDFN RYLDEYLSLFHDKKLDVSKAKEELLDDIVFSMMMVRLGDVKTCVCGALAS SAKVLKSVFKILPRFRETKFVSSFMIVDTRNVFAQSETCFGYEGILMFAD CAVIINPDSIQLAEIAMHSANSFRNIFDQEPKVALLSFSTKGSADSLEVR KVRDALDIVRSKCSDLLIDGELQVDAALVKSIAEKKCSDSLVAGIANILI FPNLESGNIGYKLVERLAFARAYGPFLQGLKNPVSDLSRGCSVNDIVLTS ALMICS >BRE_796 pth, peptidyl-tRNA hydrolase MNLLIVGLGNPGSNFLHTRHNVGFGLIDKLVMKNALSLRKAKNYEYADFN VDSRRIVLIKPLTYMNLSGNIFPCVFSKFYMKINNLLVVVDNVDLPLGKC RLRKVGGASTHNGLRSISESLGSTKYGRLYIGVGNNSAFGLKDFVLSKFN DSELVRVKNVFNFLSEEILGIDEFSFEHKIATINSSSF >BRE_651 ptsG, PTS system, glucose-specific IIBC component MGRFFQNAQKFGRSFMLPIAILPAAGLFLGIGGAFSNPATISTYTFLDVF FLQSVFNIMRTAGAIIFVNLPPIFAIGVAVGLAKSDKGTAGLAAFVGYLV LNSTIGILVEMFGKVEDFSNGAIGLILGIKTLETGVFGGIIVGIMTYCLH NKFNKVEFPRVLGFFSGSRFIPIIVSLSSIFLAVLMFIFWPFMQSGISMV GILVDATGYVGTLIYGIFLRMLGPFGLHHIFYLPFWTTGIGGSEIINGKL VEGTQNIFFAELSSHSTDKFFIGTSRFMSGRFITMMFGLPGAALALYRLA KPNQKEKVFGLLLSSALTSFLTGITEPLEFSFLFVAPVLYVVHAVFDGCA FMVAHILQITIGQTFSGGFIDFVLFGILQGNARTNWVLVPMVGVCWFWLY YFSFTFLISKFDYKTPGREDIVNSHDSFSLSKNEVVREGDVSVQVVMGLG GRDNIVELDCCATRLRVTVKDSIKVSKSILESTGAKGIIIKSSGVQVVYG PGVSVLKNEIEEYLDNEEN >BRE_450 ptsH-1, phosphocarrier protein HPr MQTTIEITNKEGLHARPSSMISELANKYSCCNIKLITEDGREADAKSTVE IMILGILYKEKITIVANGKDEIEIIDELKKLIQSNFKKEIQK >BRE_562 ptsH-2, phosphocarrier protein HPr MVKKEATIKAVNGLHVRPASTFVKKAKEYASDITIEADRKSVSGKSLFRL QTLELSYGKKLMVCAEGDDEERAVNELVELIESFKE >BRE_563 ptsI, phosphoenolpyruvate-protein phosphatase MWKVNMTLSGKRISKGIGIGEALFIKKDFDKLIDKSKITSSQVDGEIKKF NDAKLKAISVLRDLTRKVVSQLGADKEGIFEGQMLIIEDDELSESVINFI KNENCGAAYAVYLSFKELIASVEEYADVYLKERASDFKDIRNRLIANILD KVVDLAEVKRDVVLITEELTPSDTMQVDLSYVKGFITTVGGETSHAAILA RTMGLPALVMSPLDIDKIKEGEQLIIDGLSSIIISSPSSSELDKYSHKIL KYNEHEKELFELKNQDAVTKDGIKIFLKANIGTPTDIFYVNKYGLDGIGL FRTEFLYMESLKPPTEDEQFEAYKKVVENIEKKGVVTIRTLDIGGDKEIP YFNFPKEENPFLGYRALRMYMDYESLIQSQFNAIFRASHYGKIRIMVPML ARYEELEIINYFVDKAKENLKSRNLPFDENLEVGCMIEVPSAALLASELA DKLDFFSIGTNDLTQYTLAVDRGNQKISNLYDKYNPAVLKLIKNVFDAGH SAGIDVSVCGELGGDEAGALILIGLGFKSLSMVPSASLRIKYLLRKYTMS DLNELAIKVLNSKSESETLKFLDKYIGD >BRE_423 purA, adenylosuccinate synthase MAIYAVVGTQWGDEGKGKIIDFLSSKIDYVVRFNGGNNAGHTIVVNDKKF IFNLLPSGVLQGAKCILGPSVVIDPLILIQELEVLKNNNIKTEIFISDKA HIIMPYHIKFDELSEQKKGIHKIGTTKKGIGPCYADKINRIGIRTIDLLN TEIFANKLKTNLEEKNQIIEKIYNDKPLDYDDILNTYKKYIEILKSLITN TEKILHHAINSEKYILIEGAQGTMLDIEHGTFPFVTSSNTLITAAAGCGI PISKIKQKIGIIKAFSSRVGSGPFVTEISNSIGDIIREKGQEYGSTTKRP RRIGWLDLLTIKKAIALNELNHLALTKLDILNNIESLKICIAYEFQGKIY DYIPTSCETIEKVKPIYKVFKGFKEDISNIKNYDDLPIEAREYIEFIEKE VGIQISILSVGSEREKTIFRNQEWSNI >BRE_424 purB, adenylosuccinate lyase MEQYLNPLKSRYASKEMLYIFSPKFKYTTWRKLWYNLALVQQELGININN DQLNELSKQIENIDFKLVAKYEKKFQHEVMAHLYAYADLVGEDAKKILHL GVTSAYLMDNTDLIQIKEALLLIEKKLTEIIIILKQFSIKYKDLATLAYT HLQEAQLTTLGKRSSLWLQSLIFDFRELKFILSNMCFRGVKGTVGNQNSF KELFLSNFDKVKDLDINLAKKMGFEKVYKITGQTYDRKFDSSILNFLSNL AQSAHKITNDIRFMQHLREIEENFEKHQIGSSAMPYKRNPIYSERVASLA KFIISLQSSGGLIATTQWLERTLDDSACKRLNIPQAFLATDAILILLNQI FSNIKVNERIIEKHVQTEMPFILTEDILMKATKNGGDRQILHEKIRTYAM QVKENLYSGKNENNLIQLILNDKSFKLTSKDINEILNPNKNIGFASSQVE DFIKEIIDPIIKNQ >BRE_351 pyk, pyruvate kinase MIQKLTKIVATISDLRCDPEHIKELYEAGVNVIRLNTAHQSHADAIKVIN NVRQVSNKIALMIDTKGPEVRTANIEKPITVKIGDKVIISTTPINDSNAF QTNYNGFVNEVPNGAKILIDDGELEMIVIEKSADKLICQIKNDGQIKNKK SINTPGISLKLQSVTDKDKGFIELAAKQNIDFIAHSFVRHAQDIQDVKDI LNAAGNPDVKIISKVENQEGIDNIEEIAKASYGIMVARGDMGVEIPAEDV PLAQIKITKTCIKYGIPVITATQMLHTMIENPRPTRAEVSDVANAILNGT DAIMLSGETAYGKYPIEAVKMMTKIAREVEKYREQTLFQDEIFCSKKIIR NYIIKCAIDATKIMPIKAIIVDSLKGRTARIMATYRASVPLFITTNNERI ARELSLSYGVYSNLVENNFKRTNEFVATSLKMLKTQEIVKNSDIIVIISG NPNRDTNKGTEFMEINTVEEAIKGHNL >BRE_582 pyrG, CTP synthase MWAFVLRIEFIWRVLIMDNLKILVITGGVISGIGKGVTSASIARLFKDNL KITPIKCDGYLNTDPGTINPVEHGEVFVLDDGGEVDMDFGHYERFLNQNS KSTWNITMGKIYKSILENERRGKYLGRTVQLIPHVTNEIKETILNIAREE HSELLVIEIGGTVGDMENILFIETMRQIRYDIGIDNIAFVHLTYIPNPAG INEQKSKPTQQSVKTLNKAGIFPDLIIARSSQLLTRQIRDKIAMFCNVDA SCIVDNIDVATIYEIPISFYKQGLHKILGSKLKINVTPKVDGLEKLVNVI KKNLLSPQKVVNIAICGKYTELGDSYASIFESLTHVSANLDILVKTTVID GINFDEKMMEGVDGIVVPGGFGSRGYEGKIRAIKYARENNIPFLGICLGM QLAVIEFARNVCGIFDADTEEVLSEDNTMLNSINPVIHLLSEQKELENKG ATMRLGGYPVLLKKDTLAFKLYGNDMIIERFRHRYEVNNDYLDLFNKYGL VVSGFSEDFQIVKIIEIPKNKFFVACQFHPELITRLESPSKLFVGLVKAC L >BRE_26 queA, S-adenosylmethionine-tRNA ribosyltransferase-isomerase (queuine synthetase) MILVGSMETKEFYFDLPHHLIAQYPSERRGLAKLMVLDSICQKIYHTDSV NDILKYIGSNTFLVFNDSRVRKSRIYAKTDYDGNVEFLILNRLTGDTFTS LISKAKRQKVGKVYRFPQDLSAQIISKLDNEFTIKFNRYVDESYFEQYGF IPLPPYIKRDYDKEDEDRYQTIYSKYIGSSASATAGLHFSEELFSKFAQN NIEYDFITLHVGLGTFLPVRTKTIEKHKMHFESFSIRDSVACRLERAKSL GKKILAVGTTTLRALESAYDKQKGRFTRGEQKTNLFIYPGKNYKFKSVDM LFTNFHTPESTLLMLVSSFGGKDFVFDAYREAVTMNYRFFSYGDATLFLS HI >BRE_813 rbfA, ribosome-binding factor A MSLNNCLCLCMEKAIRKSKLESLLVQEIGNLIVTRSIKDPRVHEFLTVVR VEIANDLINTKVFVGSIKEGVSLDNAIKALNNAKGFIQRKLVKRIKVRNT PKLNFIRDDTISKAFYVNKIIENLNFSEE >BRE_684 rbsC-1, ribose/galactose ABC transporter, permease protein MINNSRFREVIITFISSPMFINFFSFFLGIVIVGLVVFVLGYSPLKMYFI IIEVIFLSPKHLGYIISYATPLIFTGLSIGIALKVGLFNIGVEGQFMLGS IAALIGGIFFEFFPLLHVIVVLFFASLVSGILGVLIGYLKIKFNINEVIT GIMFNWILFHINNLIIDLPVIKKGDSDLSKSIRESAFIDFFGSWKFSSEG LAYRGEHPFINDLLKAPLNFGIIIGIVVAILIWVLLNRTMLGFKISSIGC NILASYRVGIDIKKVLMFVMFLAGALSGLAGAIQVMGVNKGIFKLSYMEG TGFNGIAVALIGNNSPIGIIFSSILFSILIYGSSRVQSLMGLSSSIVSLM IGIVVIVISASHFLRKIFLEAIKGVKRTNISN >BRE_685 rbsC-2, ribose/galactose ABC transporter, permease protein MLNALIFLISETLVNSQTLILAGLGGLISEKSGVINVGIEGTMALGAFVG ATIAYCYGSPLFAIFAGGLSGLLLSLLHAIFTIFLKSDQVMTGMAINFLG PSIAMLFGTLIFGSSSTPPIDVKLPILFDGVLDKKSIIFQIFGKRYSLYI AIMCVIVFYMMFKYTKIGLRIKASGEAPEVLKSLGVNVVMIRFFCVLFSG LFAGVAGAVLSTVIASSYMQGIVGGQGFIAIVMVIFGNWQPFGILMGSFL FSFIRTLVVMTSQISFFSVVIPLKILIILPYIVVILSLVFFANNNYAPQA LGLPCRED >BRE_640 recB, exodeoxyribonuclease V, beta chain MKEIIDKIKNNDKILIEASAGTGKTYTLEHIITNLLTTTMYTPNEILVLT FTKKATEEMHTRILKSIEHIYQNAKTDNLLKNIYEQSNKIFISTINKFAL YSLNNFQIETENFSKYTVKENFTSEIDEIIYEFLRKENSLKKELKIKDDE FEIFKSKFTNTKDMIQALRQSYKRHKTEELGDWLEAQTTFKQILQNKERL LCNYNIIIDELEEMSTEEKRAFLNKHNQGIKISEIEYSHATDIIHITEIL TNNKFLCKIIEANLKKNVTLSPKELSIQTSLIQLSNETNTNKENKNTLKR FVILKVEYKILQYIEKELENIINTTNVIDQKHIMTNFKKHLESSEHKLLT SIKNRHKIILIDEAQDLDQTQIKIFELLNSCGIKIVFIADPKQIIYTFRN ADISFYNQGIKDKIKKDARITLLTNYRSNKKLVKPLNIMFERIYNKTHTD KIEQIEFVQLQTEPKNDNNKIFINDQEIKAINIIQAEENDNVFQKTALII KYLLINGKIYDNNQPRQIEKSDIKVLCRTSKEINFIDRELKKNNIKTHKT KEPFFKTKEFNEIFYLVKCLSKKQDFKTLNYVLTSKMINLPWELHLNLIQ NNKIKNIEEAISDIIYLLENQEITLMQAIDEIISKQDLWINLVKDLNNDE FTKFAQSKQNYKENLINENKFEELQNYESSLNFILKTYYKDKNIESLICI LEDLILGRDIENIEQYEEQTNNDNQSIEILTIHKSKGLGFNIVFLIGDTQ NNDTLIKKTDIFYKYYLNNKIKYDFLKLKENQQLAKNKILNEEKNIFYVG TTRSKFALFIINQGTIINKMLRSAEINTIDGINLNFNIPNLNNYNQYNQS DINNDQQKAITLIPPPPINKYLFRQEYIHSYTSLTSSYNTVNQNITDDET YDNDAIHNKNTLPKGKDIGNILHEIMKDINFNDAKDSLSNFKKNNSMLVQ QKIEYFNSKLNTPMIQELLIKMIYNMLNKKINFIDTKLCEIQELQKEMEF LIKINTKIYKQMSLFKQYNRLDFMLNNGYIKGIIDLIFKINNKIYILDYK TNYLGENLQDYRLSHLTKKMKQENYDLQYKIYTLGIKKILFKNKEEYEKH FGGVIYLFTRAFQEDIQTQDQTQNGIYSTIPNFQEIELEQIYLQLKH >BRE_641 recC, exodeoxyribonuclease V, gamma chain MYKIYKTNKISNIYNKVNELIRNDNLFKKETIILVKNNILSDEIKKYLAT INGISYNLNIKHNTIKTIYNISIENPNIKKFLENNTLLFYTETETLVLYY ILKDNQTQNTSQFQSTKNRYAFASKMINLFHKYYSKFLYLIDTWRSNNFL FEDKNKHYYESIQKEIFEQLFVNQINILDLQEKIKKEITNTKQDIETKRI IIIGESREIDRKILHSLQQIFNITIYELVLKDITQIHSNLINELIPIKIT KLQPTIQLTKEIDIQSFNEINFLSSLKNNIIKDTPLSNLDDSFKIIQAKT KKREVEILINNILHSTQNNNININDIVITYLAKDMDMYLPYIEELLSKYE LAFTILDSQDILKSKSIIALKQLMKLFISNRGTISNFNRKEIIEFLSNIK VMNKFNISTNELEYLIKFSDAMNINFGMNKTHKEKLSYDQNFLNSWEDGF NRFLMSLIFNDKYECNNCNENINFQDPESIIKLISIIRSLYEDIMYFKDQ KYTIHEWAEIIDIFIDKYIKLDDENRIDAYISTKIQYLKTFSKDANENLY KDYIIKIKEKKVDFSLFKAIFEDTITQKTHQLNNKSTGILVASCDKIEYL QKSEIHFLGTHELDSNIYFDNMDLLNEYYDYINLEQENISNLIKIIFAAT QKLYLYYSQSQYLNPDINNPKIINKIINHIKDTGLDIKIETHPNENYDPE YFKCNKANYLINYDTEAFNIAKSLQKGQSSNFKQKRLTLNKQITLDIEHI NKAITNPYKYFYEEILNVQIKDTSYINDIKEKQEEQIIDIDNFNYKLMSI ISIHEYIKNNTNEHILERINNIIENQIQRGIIPINIKKTKIKEEFIRKLL QIKNNIDINFQDFFKMQKADITLNKNIFIDFEDKTLEFKLNGKLKNIYKI DNQYFYIYLEKKDYGQDKIIKKINLYMLGLMIKTAITNIKSIKEIKINYE TSKLSIENQYTNEEINHLDIENLLKQIAYISSHPTPIYKDLIQKSLLKIE NINELPIALKTQIKYQQKSISINKNMEFILKDKDITWCPYYNRFRDTHDL NIEANLETLLQNFYAKFIKV >BRE_639 recD, exodeoxyribonuclease V, alpha chain MRNYLVLREFLQEEQKNYLNPELKIYEIIEILNINVEQYYKSHLLTKKIQ NDKYEELTIFLIFIFNYFSKGHLRANIDLLIQDIQNTINCASLELEEENQ HYQKSTHILQELTKFSKETKIKEMILYLEKNNIIKNYNQNEKITTPLILE NNIYIYTQKNFREEEELIKQIDKRLKNNKTEISDDRIQNIMDHLNITNLS KEQINSIKKALKSNFFILSGGPGTGKTTTINYILKAIDIHLDCKQNVALV APTGKASQKLKSSIKESFKNLETQHSTIQKLLKMSFINKDDKYDENNPLE FEIIIIDEASMIDANTFLRLLKALKTNTKIIITGDKNQLPSIAGGNVYSS LTKIKKINDDSVEILKKNFRSNNEINLLAKAIYKEDMDLIETQFNDSKNI ILKNLNKINIENELLKHTKKLYNNIPNFNLNSLNDKEIESIIHTLLSNTI LCSKNLGKFGTQKINEIIKLYLKKLYGNLIGQIILITQNDYKNDLFNGER GILFKENSKIYALFKRENEKYKKINFNLINKYELSFATTIHKSQGSEYQH IQIIIENHPFLTKELLYTAITRARESIEIISNKEIIKNVSLKKINRDSKI TEYINTLK >BRE_439 recF, DNA replication and repair protein RecF MVKKIEFFNFKNIENQVINFDFDNIYFCGENGSGKTNILDAIYCLAFASS FLVNTDKELITYGEREFYLKCFYQTKEKNGEINLSVRNDKKEIKVNNSIV RDRRDLILNIPAIIFSNHDIDFIIGTPMKRRWFFDQAMSFISLSYLDSLR KYRKILKQRNLILKQRDKDLLKIYNETFVDCALEITEMRKNFVEHFCRFF QYYCSLIFDVSCNLEIKYFPSVTCCSKDKFFEILCLREKDELYSETTLIG PHRDLYEILSEHRVFTDHASTGQIRVLALIYRLVQVIIFNDKFNMSPILL FDDVFLELDSIKRKKVFEILPKDSQCFFTFLDDCYDVNRESNFIVYRMNN GRFEL >BRE_587 recG, DNA recombinase MFLHEFQYGLQGINGLGSRGIDRLNNIRITNVKELIEYYPKKYEDRKNMA AFPDPLQVRICELMTIFTVIEHRDFGNTFKRNLKIIGRSENSELFEILLF NRSFLERIFKIGQKFYIYARFSYNDYTKMWSCSNFDSEIFSYNPVKFKKI MPVYSLSEGLSSKKISSYVKGALAYFVKFGQSDIPKFLINKYSLLSLHEA LNEIHFPSSLEMLRRAKKTLVYREIFLLQFFSRGKSYRVFLRAEKNLSND LLKQIISKLSFELTRDQKIAITEIINDLKNNKPMNRLLQGDVGSGKTLVA FLSSIPLIEAGYQVAFMVPTDLLARQHYNSLTNILKDFDISVVLLTGSLK KKDRDEVLEKIQSGICSLVIGTHAIFSQGTKFKNLAYVIIDEQHKFGVEQ REELRNKGEEVDVLLMSATPIPRSLALTLFGDLEVSLIKRGPEGRLPVTT YLAKHGNEEKVYEFLKNELGKGHQVYFVYPLISSSEKFNLKDATSMCLNL QNIFVEYSVAMIHSKLESYVKEEIMHNFYLKKIDILVATSVIEVGIDCPN ATCMVVEHAERFGLSTLHQIRGRVGRSNLKSFFFLLYKEPLTEAGKFRLK TIKENTDGFKIAEEDLKLRGPGNLFGLEQSGYFNLRISDFVEHKEIIGLM RAELDIFCSNRDFYDKSDVKLLDSLLVSYLSSVSKGS >BRE_256 recJ1, single-stranded-DNA-specific exonuclease MSKYYSKESKLEQEMKIWKKKKEIDIAEENIVNIKKKYNISLFEARLLLS REIKEEDFLFFLESSVNLMHNPFFLKNIDKFIYRINEAILEKENVLIFGD KDADGITATIIMYETLKDFGINVTYKIPSNGEFYGLTKEVIDKAFDDKIT LIITVDCGISNIEEINYARSKNIEVIITDHHLPNKEIDTENIIIDPHLKG DLYPFKEIAGCYVSFKACLALYLSTTNFYNKDLIFMFLEKFENNIKLHAI EINNYILKKHITLDNNNDLQININQIEEFSQNKHIIVFNKIEQAQLLNEF FKQKIDIEIIDINENFIKKYPKHANKTLKELMQITKYFKYRKINIYEKLY YMFYNIIFETNKNLLQNCLKRLKFVAIGTIADNMPIIDENRIAVKEGLKE IALRENISINYLLKEVNILTKPIITSTDIAFKIAPILNSTGRLEKADITI RFLLSQDTNKIENKFKEIKNINTLRKYKEDISWNTHNENTIFKNDKFIVC YDKNTPKGISSRMATRLSSYYKKVAVFLTKQSDIIKGSIRSNNKVNSKEL ISMIPKHLIINSGGHKAAAGFTLYENVLNEFIRELENALKKIEYKELQED SILIDAIIPQDLSKTELIKTIDLFEPYGHDFREFILMMENVCIQDIRTID KNGTSKHISMKIINNIDYYKAIYFNGTQTIQELGIKDGQNIDIIFTISED IYNQNDKILKIIDINKRKN >BRE_317 recN, ATPase involved in DNA repair MCHILIELFIKNLILIKKFYMRLNVGLFAFEDESDNIRGILLLSLFYYLF GYKIKDDVISNEGCRDVLVAKFQASDEFRRCLFFRGILVKDLKTIIFDFV NVILGHYYVNDKPISIFVLNSIFNMEFKICFQNWEYLFLKNILDCLNILN DYVNLNIKLETYKLEFKSYIRCLNSYYGFILKQKLYGDNIEKYEKTIKNE LKSYKSIYNSILNLRNVLNLDDNVCCLREIIKVICDAEYFLKVNICYFEF ENCFKNFYYELEDIGHDYSGVCLGKACDENELELVDKRLYFFPCLNKKYG PNFKNVIVLVDKYSEIINLLLNIATFKLANEQKLNVLFENLQKLSFSISN IIKTVALKFASGVIEIFHKFNMRDVRFFVSVFEGKMNLATVGDLKFFISN YIALKVQSIMYRVASVGEILKTILTIQSVQSIDDNHIIVNGIDYAIESKF NVTLGKYLKSLSQNMHIFIVTYLTNIANFLYFSKEKCIKREFVLKEVSLL FAYESVLGIVRMLYGNISNINFGYVVVF >BRE_468 recR, recombination protein RecR MIIQDLIELVSKLPGIGKKTAARMVYDILYTGKNFSRALGQILIRLHLEI QKCKNCYNFAEEELCDICTNLNRNKGIICVVEMPQDLEVIEATKEYDGFY FVLHGHLDPLRNIGPDELNLDKLENYIKLLKAEEVIIATEFSIEGDVTAN YISNLLKDLDINVTRIASGLPAGGSISNADKVTTLRALRLRLKM >BRE_6013 resT, telomere resolvase MFSMSLKVNIKKDLELFRKNLEEIYVKYLKQEISYSKLKMGLEMLAEKHK NILLRKNKFTNLSMILNLSKTRKIIKEYINLAVIEEIRQKNKLLFFWIPK EIKELSNIDIKDLCKIEELMIANNILGQKVYFESFLGLFKSPEWLNDYAH HYKISKINSYRREQISVKINLKTYIKIINILLTQKRDIRLKFYGVLMATG RRPVEIMKVSEFYVQDDEHILMKHIAKKKEHNLIHEIVFPTFADSRLVID SISKIRYMERTEKLSKEIISSNLAYSYNRLFRKIFENIFEPEESIYFCRR LYSRFSYLAFAPKNMELNLWITTVLGHEHDDIITAFHYNRYILENLDDNA DVDLLKLLNKRIHTYVRRKTTYSVVNMERLNTLLESCNIVDDNYIKTLRV IQEFMIEKGLAELEMLRGLNVKIRKLFKQKYGYNYNYAKLGEYLSLIFGY DT >BRE_229 rho, transcription termination factor MDRKCEEFDLEDEMKRLNSSKELKIEDNNKKKVVKVVTKKESVSSASRNS NIDKLRESNELSSDFDYDISDPDLESSIKTLEQSNIINFLGGKDSIVIDT LYDKPITEIRKVVEGLGTNHTIAVTMKKTELIFLLVKILTEHNINVLFTG VLDVLSDGYGFLRTASNSYLSGGNDVYVSPSQIRLFNLRTGDILYGQIRS PREGERFFAMIKIKSINDQDPTFAQNRIPFDNLTPLYPSSKLDLEYENCN ISTRLINLFAPIGKGQRALIVSPPKAGKTTLLQKIANAITTNYPDIVLMI LLIDERPEEVTDMIRGVKGEVIASNFDEQASRHVQVAEMVIEKAKRLVEN KKDVVILLDSITRLARAYNQTMPTSGKILSGGVDSNALHKPKRFFGSARN IEEGGSLTIIATALVDTGSKMDEVIFEEFKSTGNMELILDRSLADRRLFP AINIKKSGTRKEELLLSEEERSKILLIRKILSGVDDYEGVEALVEKMKKS KNNEIFLKTMSNGD >BRE_703 rimM, 16S rRNA processing protein RimM MFVKGIILSSYGINGYAKIKSISNGFSDFFCLKNSKLVLKKNFCCLVEVT VEDVSLRNNSLLLKFREFNAPEPIRNLIGFELWVSDELASKLEQDEYYFG KLIGYRVVNDGVELGIVVSFFECSKSVLLEIKVGDRLFFVPFLDVYLGDI NRELKTIELKVLELLQ >BRE_742 rlpA, rare lipoprotein A MLYIVICNMIQCVIMIGLFGLRAIDLRFVFLFLIVVTMQLNSATVGLASW YGEAFHGKTTANGEKFDMTALTAAHKELPFNSVVRVTNLLNNRTVVVRIN DRGPFRRDRIIDLSKSAAEKLDFIGIGVAPVKIEILKQVDVKNIENQKSE NNLDVKDASKSNSNSDVVDLKADKNVIVGKEHTEVAGQILNDTDKEPDFY IQVGSYKTKDYAQRAYKILEKAGLNVFVNSHGPFFTVFIPTYADDVQKNV ELIKSTGYKDILVRKTKIPGNNILMD >BRE_825 rluA, RNA pseudouridylate synthase family protein MFLGDVKSVGKYNVINVLNNDDGKRLDVVLIKFLKLPKSKVIKHIRNGDI RLNSLKVSFSQRVLKDDKIYLYKPLVQGLNLNGVVIKNKTDILRDVESRL VYEDKDLLVINKRKGVLVHGDGYSLDVLVNAYLLDENLASLSFKPSAVHR LDRNTSGLIVFAKNIYSARILSKAFSSGIVTKRYLALLDGEIRKSLTYKN FLYRDKIVKKTFVMDNLNSNINKFNAITIVKPLLVSKFATLAEVSIKTGF THQIRAQCAFNNHALIDDKKYNPKFKKNNYFLHSFLINFNHSFFLRNEFF VEPSSDFVKRINSIFGVYDFKEFI >BRE_710 rnc, ribonuclease III MGSSVVKLDVDRKQKLNEFLMGLHIDFNDIYLLNMSLSHSSYANEFDQKY ANNERLEFLGDSVLNLIITDYLYKFYPDKSEGELSKARSYIVSEDSLSSI ARELNLGNYILLGRGEENNDGRNKKGILADAIEAFVGALYLDGGFSKAST FVVELFEVHIRLMFNRGDFKDYKSLLQEYVQKKYKISPSYKLAKELGPDH NKIFCVELYVNDKFVSNGKGKSKKEAEMIAAEMALKNIVNIDL >BRE_49 rnhB, ribonuclease H MICGIDEVGRGCIFGPVLSAAVIFKTKPNFLNELDDSKKLTKTKREYLSS LILENAYYAFADISNEIIDKINIHNASLLAMQIAYQKLNIECNLVLVDGK FIPKIQAKQIRAIIKGDSMIDEIKAASIIAKVQRDKLMVEYDKIYPLYGL KKNKGYPTKEHKDAIKKHGILSLHRKSFRLI >BRE_442 rnpA, ribonuclease P protein component MKKRNINIKSRLEIQELFKKGQFVKIEGINIFYRFTSLAISRILITFPRV FKGAVKRNRVRRVFKECFREYFTLLKDGCADFIFVVYPQKANINYHEVKT ILKNMIVYVIKRKV >BRE_663 rpi, ribose 5-phosphate isomerase A MEKQKELISKYAIDKYVTSNMFIGIGTGTTVFYAIKHLSYKIKSGVLKNL TFYPTSSDTQCLLAKENIAYESKFTKLNKNIDITIDGADEVLLDKKALIK GGGAAHLMEKVVAYNSNQLLIIADETKIVTNLGEKTPIPIEIAPNALAFI KAKLEKMNFNPVLRTCKSKAGPLITDNNNYILDIKMNIENPKGTEKYFKL FPGILEIGIFNHQNTKIIYYQNGQIKET >BRE_390 rplA, 50S ribosomal protein L1 MAKSGKKYIQALSKVNKLKSYNIDDAISLLKEIKFVKFDETIDVSVNLNL KKNHTVRETLVLPHQFMKEKRILVFAKGEKAEEAREFGAAYVGDDDLINK IKDGFSDFDVVVATPDMMKDVGKLGPILGKRGLMPNPKTQTITNDLKGTI ASLKKGRTEFRANKNGVINFSVGKSSMDSKKIRENYDEFIKELLKRRPSD LKGTFVDSVYVSSTMGPSVKIDFV >BRE_487 rplB, 50S ribosomal protein L2 MGIKIYRPKTSSLRYKTTLSFDELSKGNDPLKSLTKGKVSRAGRDSSGRI SVRRRGGGHKRRYREIDFARRDKFGIPARVAAIEYDPNRSPNIALLVYRD GDKRYIIAPKGVKVGDILESGPNAPIKIGNALPLENIPVGKMVHNIELNI GKGGQLVRGAGGYAMIIASDGDYVTVKLPSGEMRMIFKKCIATLGEVGNE DYMNVSIGKAGKSRWLGRRPKVRGVAMNPIDHPHGGGEGKTSGGRHPVSP WGQPAKGYKTRKKNKYSDKFIVKRRNN >BRE_484 rplC, 50S ribosomal protein L3 MFGLIGKKVGMTQVFQSNGIVVPVTVIEFEPNYVIGKKTMERDGYDALIM GSVDLKGSKVSRPIKGQYKKLENIEPKRYVIEFKGLKGYDAGDEVGLDAF REIKYVDITGTTKGKGFQGAMKRHNFSGGPSSHGSKFHRHLGGTGQATTP ARTFKGTKMAGRMGGEQQTIQNLEIVFIDEEKRAILVKGAVPGVKGSFVI VKKAKKVGI >BRE_485 rplD, 50S ribosomal protein L4 MERKVFSKDGQELRTIDLDDGVFNIDVSYGSIYNAINNELANLRVGTAST KTRAEVRGSSKKPWKQKGTGRARVGTRRNPVWVGGGIALGPKPRDYSYKL PKKVKRLAFKSVLSLCASVDDRLKVVENFTIDSGKTKELALIIKNFIKHN GRTVILLGNDDQMIKRAGKNIRDLKILSFNRLRVVDLFYTKNLIALESAI NGLNELYVK >BRE_496 rplE, 50S ribosomal protein L5 MSYIPELKRRYRDNIVKELVSEFQYKSIMQAPKIEKIVVSMGVGDAVKNK KLLDSAVMELSQITGQKAVKTKAKKAISGFKIRQGQEIGAKVTLRGNMMY EFLYKLVNLALPRVKDFRGINGNAFDGNGNCSFGIAEQIIFSEIDYDKIE RISGLNVTIVTTALNDKEGKALLAKFGMPFSN >BRE_499 rplF, 50S ribosomal protein L6 MSRIGKLPIKIADSVKVDIKDNFITVEGKRGKLSQEINSSIRVKIEDNNI IVERAFNNKQTRAFHGLYRSLIFNMVKGVSDGFSKSLTINGIGYRVEQQG NSLFFNLGYSTQFEYVIPEGINIRLDGNTKIAVEGIDKCRVGQVAAEIRS LKVPEPYKGKGIKYDNEVIRRKVGKSGVKK >BRE_114 rplI, 50S ribosomal protein L9 MKVILREDFINLGKEGDIVDVKDGFARNYLLPKGFAVFSNKHNIDIFSQK KRAILKRQESRRKMAVELKEKLDKVNLEFIMQSNDSGKLFHSINSSNIAD ELLKLGFEIERRKIDMHHGALKAFGTYNVIIKLYEGISSVITVEIKREEK KNSLKKSKSVKKEV >BRE_389 rplJ, 50S ribosomal protein L10 MDKKINPKKVEMFNSLKEFLDGKDNIFFLDYRGLTVAELTKLRSRVEDEK GALKVVKNNIMKRVLKDKDIEGLDSYLLGPTAVVTAFDEANVIAKIFYEF VKTTTLKVKGGFVLGEVYDESKLSAYSKLPTKIESISLFMSVLKAPMSKL VRTLKALSDIKV >BRE_391 rplK, 50S ribosomal protein L11 MSKKKKEVAWVKLQVPAAQAAPGAKIGQTLGPHGVSGPQFVKEFNERTAK MEPGIVVPVIITVYSDKSFSFVVKTPPASVLIKKAVGIETGSKKSNTDKV GVISKEKIMEIAKIKMPDLNAKTEQAAFKIIAGSARSMGVEVEK >BRE_388 rplL, 50S ribosomal protein L7/L12 MALNKEDILTWLEEAKTSEVVELITAIEEKFGVTAAAVAVAAGPGPAAGG VEEQTEFDVMLVSFGDSKINVIKEVRAITGLGLGEAKALVESAPKAVKEG VSKSDAEEIKKKLEAVGAKVEIK >BRE_342 rplM, 50S ribosomal protein L13 MNKMTNNKTIWMKPRYVKKKWYVIDASDKVLGRIATEAIKILRGKHKPYY TPHQDLGDNVVIINASKVKLTGKKYFQKIYYRHSRYPGGLYSDTYRTLSE RKPTAPLEIAIKGMLPKGPLGRELFRNLKVFADANHKLSSQNLYKLEAN >BRE_494 rplN, 50S ribosomal protein L14 MVQMQTYLTVADNTGGKIAQCIKVLGGSKRRYAKVGDIIVIAVKQAIPNS PVKKGDVHKAVIIRTSKEIRRKNGTYVRFDDNACVILDANLNPRGKRVFG PVARELRDANFMKVVSLASEVI >BRE_503 rplO, 50S ribosomal protein L15 MIKLKRPLGANKSKKIVGRGQGSGLGKTSGRGQKGQKARNSSPRVGFEGG QTPLYRRLPRRGFSNHDYKIRYEIVGLGDIDRKFETGDLVNYDTLFQKGL VNKNKKNIKILANGELTKKVNFEISRISKSAEELATKIGCSIKLI >BRE_491 rplP, 50S ribosomal protein L16 MLSPRKVKYRKKQRGRLSGEAQKGNKISFGEYGLVSLEADFITARQIEAA RVAMTRRVKRGGKVWIRIFPDIPYTKKPAETRMGKGKGGVDHWNAPVKLG TVMFEISGVPRELAESAMMLASSKLPVKTTFVVRRDLR >BRE_509 rplQ, 50S ribosomal protein L17 MKTKVGFNRLDRKSSHRKALLKNMVISLFRHERITSTKAKLSEVRRFAEK LITRAKVDSVHNRREISKFIHDKYILNKLFTKISPIFKERKGGYTRVIKL GQRYGDAAEMAILELVDKTLGEK >BRE_500 rplR, 50S ribosomal protein L18 MKKVKEAEKKNIKRKKRIRDRIGFGVAERPRVTIFKSNKYFYAQVIDDIV GRTLASVSTIEKELSLNKNISDVKKLGEVLAKRLKDKNISKLIFDRNGYK YHGLIAGFATALREAGIDV >BRE_705 rplS, 50S ribosomal protein L19 MMDLIRKIEAKGKRAESFDFRVGDTIRVSYKIIEGTNERIQNFEGLVISI QNKGIGQTFLVRKISSGIGVEKIFPMHSPIIEKVQVLKRGKVRGAKLYYM RDRIGKAAMKVKERLDVKKLKY >BRE_186 rplT, 50S ribosomal protein L20 MARVKNGIVHVARRKRILKKTKGFWGTKKSNYKKAKDTLRKGMMYATRDR KTRKRDLRSLWIVRISAALTGMGINYSRFFEGLRKLNIKLNRKILSNLAI EDIESFKKIVYEIKN >BRE_786 rplU, 50S ribosomal protein L21 MIVMYALVEIKGKQYKAVKGEILRVDRIVANSGDQLEFNSVMLVKKDEDL KIGKPYVLGSCVKCTYLEDKKDKKVVSYRYRRRKESERKVGHRQSYSYVL VDDIIC >BRE_489 rplV, 50S ribosomal protein L22 MFVNKKYTAKGKNLPSSPKKVRPIANNIRGKPYNEAIAILCSMPNKGAKL LGKVVKSAASNAMYHNRNLSEDMIFVKTVMVDDGRKRRSIWPRARGRADR LINRSCHIFVEVYEKMYGGE >BRE_486 rplW, 50S ribosomal protein L23 MKVYDIIISPMLTEKTNIQRENMNVYAFKVKKQANKKEIGAAIKELFNVT PISCNLLNVKSKVKTVVSRKGYPIGRGKTSSWKKAYVYLKKEDKIDIF >BRE_495 rplX, 50S ribosomal protein L24 MKTKLRVGDKVKILCGKDRGKVGEIASIDRKKFKVTVKSCNMIKKVIKAR TPQEKGKIIDKEAPMDISNVMLFSNGVISRVGIKFENNEKKRYLKKSGEN V >BRE_788 rpmA, 50S ribosomal protein L27 MATSKSGGSSKNGRDSISKRLGVKRSGGQFVRAGEIIIRQRGTKFHKGKN SGLGRDHTIFALKDGIVEFKTSKGRKYINII >BRE_352 rpmB, 50S ribosomal protein L28 MGRECEITGKRTMFGNNVPRKGLAKKKGGAGQHIGVKTKRTFKVNLINKK FFIPELGKNVSIKISASTLRSISKVGLNVFLKKNNKKIDDFI >BRE_492 rpmC, 50S ribosomal protein L29 MLKNLKDLTLEDMKVKRLTLKKEYMDLRFKTVVGHVENPLKKRELRRDIA RLNTIIHEYAIGIRKV >BRE_502 rpmD, 50S ribosomal protein L30 MIKRKLRLQLKKIRFKAARSRFKNKAFIKRMEYNREVIAKSDIKVEVELR RSLIGKSDSKVKTLKALGLKRIGDKRIHILNKSLQGMLNSVISMVFISEV TDD >BRE_228 rpmE, 50S ribosomal protein L31 MKKDIHPVSNLVVFKDGANGAMFLTRSTLTSKEVIKYSDNKEYPLITVEI SSKSHPFYTGQQKFVDAAGRIDKFNKKYKKA >BRE_708 rpmF, 50S ribosomal protein L32 MAVPKFKPSKSRSRTRRSINMRKKIPQFQECSNCGNLAIRHRICAKCGYY RNSQYLELGL >BRE_395 rpmG, 50S ribosomal protein L33 MGKKKGKGAVGLIALVCEETGIRNYTTTKNRRNTQEKLELMKYCPSLRKH TLHKEGKIK >BRE_441 rpmH, 50S ribosomal protein L34 MKRTYQPSRVKRNRKFGFRARMKTKSGRLILARRRAKGRSKLTVSDEKKK Y >BRE_187 rpmI, 50S ribosomal protein L35 MPKMKTCKSARKRYAFTSKGKVKYKKQNLRHILTKKSAKRKRNLGKSGLV SNVEVKRIKTLLPYV >BRE_505 rpmJ, 50S ribosomal protein L36 MKVRVSVKPICEKCKVIKRKGVLRIICDNLKHKQRQK >BRE_508 rpoA, DNA-directed RNA polymerase MSLGKLLKDFTIPDRIEFVRGEDDGSYGKFVIYPFEKGFGVTIGNTLRRV LLSSIEGYAISAMRIQSNQEESLKIVSSEFDLIPGVMEDTLEVIANIKNV HLKLDEGVTNTTINLSVNGKDNNVLKAGHLEREGVEVFNKDLVIATLSSD ANLDFEFQVNYGRGYVSSEQNAKYLEEVNTIALDSIFSPIEKVTYSVEDT RVGQRSDYDKLVMEIWTTGVISAKDAIKKAASVVREFLLPLVNFEDKVIH SVDYAEFRDSDILSMNVEKLNLSVRSLNCLIKENVKTLGELISKSPVELS KARNFGKKSLEEIVEKLNAYGLFLGMSKVEALKVLSKHDKISH >BRE_387 rpoB, DNA-directed RNA polymerase beta chain MIKRVHLGQGKAEEILNLPNLIEIQLNSYEKFLQLERLKNNKPLLNEGLE SVFRDVFPMKSSNGEVALEYEKYYIEYDSISFTEKECKRKGQSYEAVLKI RLNLQFLTTGEIRQKDVYMGTIPLMTDRGTFIVNGAERVIVSQIHRSPGV VFYKEKDLYYARIIPYRGSWLEFEIDSKKDYLYVKIDRKKRILVTLFLRA LGLDTREKIIETFYKIRKIEVNDDTKREITGQYLATNITIKENMTYRAGD KITLQDIEDFLQNGVKEINLIDFDGYDSVPGKHFISSDVILNCFEKEDAY FALKDGFKELSRESVMLAVYSVLLPGEPISIDNAENDLRTIFFSEKRYDL GHVGRYKLSKKFGLDDLTTSVLTMTDIVNTISHLLRIYDGHDVLDDIDHL GNRRVRSVGELLTNIYKGAMSRVEKIAKDRMSNKEVFNLKPQELISVKPV VSAVKEFFATSQLSQFMDQVNPLAELTHKRRLNALGPGGLSRDRAGFEVR DVHYTHYGRMCPIETPEGPNIGLIVSLATYSKVNDYGFLETPYRKVIDGK VTDDIEYLSAIDEEKKCIAQANASVSSDGNYTDDLVSVRISGDYTTMMPK NIDYMDVSPRQLISVSSALIPFLEHNDANRALMGSNMQRQAVPLLFPQPP IVGTGMERIVAKDSGVVIKAKRPGRVVLATNKKIVIKPDNATSERDLDEY ELYKYERTNQDTSFNHSVLVKNGQIVNKDEIIADGPATRYGELALGNNLL VGFIPWNGFNYEDAILISERIVKEDLYTSIHIKEFSIEVRETKLGPEKVT ADIPNVSGKILSKLDENGIVRIGTYVKPGDILIGKVTPKSEGDITPEFKL LTSIFGEKAKDVKNNSLKVPHGTEGTVIDVQRITKDDVGNLPPGVDEILK VYIAKKRKLKEGDKMAGRHGNKGVVAKILPVEDMPYLADGTPLDICLNPL GVPSRMNIGQLMESQLGLAGKYLGEYYDVPVFESATNECIQEKLKKAGFN ETSKAVLYDGYTGEPFENEVMVGVIYMLKLHHLVDDKMHARSTGPYSLVS QQPLGGKAQFGGQRLGEMEVWALEAYGAAHTLQELLTVKSDDMSGRVKIY ENIVKGIPTNVSGIPESFNVLMQELRGLGFDLSIYDDNGNQIPLTEKEEE LINKT >BRE_386 rpoC, DNA-directed RNA polymerase beta' chain MKEIKDFEKIRIKIASPDQIRSWSYGEVKKSETINYRTLRPEKDGLFCER IFGTTKEWECYCGKFKSIRYKGIICDRCNVEVTHFKVRRERMGHIELSAP VAHIWYYKYIPSRIGLLLDITASNLNSILYYEKYIVIEPGDTDLKKMQLL NEDEYSEAKERYGMSFSASMGAEAIKTLLENLDLDELSSKLRLQMIDKDD KTDKKLLRRLEIIENFKISGNKPEWMIMDVLPVIPPEIRPMVQLDGGRFA TSDLNDLYRRVINRNNRLRKLLLLNAPEIIVRNEKRMLQESVDSLFDNSH KRKVVKGTSNRPLKSLSDALKGKQGRFRQNLLGKRVDYSGRSVIVVGPEL KLHQCGIPAKMALELFKPFVIRKLIESEAVFNIKRAKSLIEQEVDEVWQI LDNVIKEHPVLLNRAPTLHRLGIQAFEPVLVEGKAIKLHPLVCHAYNADF DGDQMAVHVPLTPAAQAESWALMLSTNNLLNPANGHPIVFPSQDIVLGLY YLTMERKNVMGEGRKFSNFNHVLLAINNKSLDYNAQIYVKVGEEYIKTTA GRVVFSEALPGKISFVNKTLSDYELQTLISEVYVIYGSSIVIEMLDIIKE LGFRYATKFGCTISMSDIIVPQEKKVYVEKANREIAKIQNDYTKGVITGE ERYNNVVSVWSKTNEELTNKMMEILKKDRDGFNVIYMMADSGARGSRNQI RQLAGMRGLMAKTSGDIIELPIISNFKEGLSVIEFFISTNGARKGLADTA LKTADAGYLTRRLVDIAQDVVVRIEDCGTINGIKVEALKNGEEIIEPLRE KAVGSYSIERIKSPITGEIILDVNEEITEDKIKLLETVGIDKLVIRSVLT CEAEHGVCQKCYGRDFSNNKPVSIGEAVGIIAAQSIGQPGTQLTMRTFHI GGVAQAGSEDDKIALKNAFILNGLEGFNVQVDGGLLFTRKGVLRIINVIY EESIKKIKKLKVSDSQKVIKGMSLFIDKSGVEVLSSHIGYIKIKDNKLMI VSEEQEISLKVGTRLEINVGDYVEAGRVIGTFDPFAEPIIAEVKGKIKFK DIILGTTLKEEINLETGNIEKRITDQVFESLDPRILIINDRGVEIASYVL PGDAYLQVEDGQDIDIGDIIAKLSKGSEKTQDITGGLPRVNDLFETRIPK NLTEMAKVSGVVQFKAIQKGKRLINVIDEYGVEHKHYIPAGKHLLVRDGD VVRAGDMLCDGRINPHDVLEILGGISLQEFLLAEIQDVYRKQGVSINDKH IGVIIKQMMKKVKIVSVGDTNFVYNQKVDKHAFYEQNKRVIEQGGEPAVA SPILIGITKASLNIDSFISAASFQETTKVLTDASIAGSIDDLRGLKENVV IGHLIPTGTGMNLYKRVKVRENSNSEV >BRE_718 rpoD, RNA polymerase sigma-70 factor MNSVDNKDLQAFKKKNSKLIKTILNYLGDKKEITFEDLSTFLSGDMLEPD NIDCIYGILENEGIGLINEKIGSDICDVDELDEASKLDSQCMMLDDAIQV DDELDDKLDDFDDEVLDKEDYNSGYIKSGLLKDSNSEDPIRLYLKEIGKE FLLTGNQEVELAKQMDSGESIIENILKNEGLVIENYYNLVNAIYSRVDKE EFFKKDREREKDNNFDYYNKKKRITSFYKSLLKPFQDRLVKYVERKHRLY ELGEDIFEESITNERLQIKELLKSIPLYQEELRLFSDDYIDSASKIKDLK RQQKSILDRLKIDKVRNLRILGRDLAIPEKRERIEKSLNIREDLIKEQIT EAQLAQKELERIEMYYEYPMDKIISMSEEILKGKQMMQHAKDQLIKANLR LVVSIAKKYANRGLHFFDLVQEGNIGLIKAVEKFEYKRGFKFSTYATWWI RQAITRSISDQARTIRVPVHMIEQINRLNRETRYLVQILGKDPTDEELSI RLGWDLKKVKTVKNVSREPVSLETPIGEEEDSVLSDFIEDKAIKNPAKHT SFVILQDQIRAVLGTLPEREQEVVKMRFGLEDGYSLTLEEVGLYFNVTRE RIRQIESKALRRLKNPKKTQKLKDYLEDLN >BRE_778 rpoS, RNA polymerase sigma factor MNIFSNEDLNIYLKSVREHRLITHEEEIELAKQIKLGSLKAKNQMINANL RLVLKIIKRYAGKGLKIEDLIQEGNLGLIRAAEKYDPSKNTKFSTYASFW IKQSLQRALNTKTRLVKVPYRKENLILQINKYLMEEEKSPKKEDIMERFN LTTAQYVKIIPYLEKEYSLDKKIEGSENSTLLNLYEDNSLNPESTLEQNS TLKHLNYILETKLNEKERYIIKKRYNLDNSDKKSTLKDISTELGISSETV RQIEKRVLKKLREELYQ >BRE_130 rpsA, 30S ribosomal protein S1 MRMENQEDLQENYLKVLEKVELGSSVSGIVINIMKDYVLVDIGYKSEGFI KIDEFETIPNVGDKLDAIVTKVGGELGLVLSVSKLDSLNLQDKIDEYIAN RKVLKGKILVELSSGYKVQINDNVTGFMPFYLSSQLRDEKLKRGSVVEFY VIQADKSDGLRLILDRRTLEREREFLKRKELVSSYSEGDIVDGIVEKITD YGAIIRIKNLVLGVLHKRNIAFNRVENVEDFIHVDDKLRLKIIKLSTNTG KMELSLKALKVNPWDSVESKYKVESIVKGKIVKILPFGAVVEIDSAISGF LHISNFSWVRSIKSPQELVKVGQIVEVKILEIDKENQKISLGIKQVNENP WNNLADRCGVGKVVQGVVKNITKTGAFVSIEEGIDAYISKFDISWVEEVN PEKYFELGSSISGKVIEFDAKRQNIKLGIKQLEENPWDDFSKSYKKGDVL EVEIMEKRSKGVQVRVYGKIMGFISKIQLGDTKESSLETFEKLNVGDKIK VIITNIDFKNKLVLLSYKAYKEQKSSEEISSYLFKEDDEESYKPFANLLK RDSDV >BRE_125 rpsB, 30S ribosomal protein S2 MAVITMKSLLEAGVHFGHQVKRLDPRMKRFIFSERNEIHILDLQKTLQGI KDSYELVQSVIKNGKKVLFVGTKKQASEIIEQEAKRSEMPYVNNRWLGGM LSNFNTIKKSVQKLKKLEKMEVDGTFEMISKKEVSQINREKLKLAKNLTG IKDMEELPGAIFIIDPKREQIVINEARKLGITIIAVVDTNCNPDVIDCPI PGNDDAIRSVALFTKIISDAILESDKEVGIQIVENLNEEDLMSEIEVKNE RKES >BRE_490 rpsC, 30S ribosomal protein S3 MGQKVHPYSLRIKINRDWKSKWYFDKKLYSEILHEDFLIRRETMKFLKGI KFDISDIEIIRNNLQRVTVVISTPRPGSVIGVKGANLEKIGQLLTRKVSK KINIKIKEIKKPEFDAQIVANGIAKQLENRASYRKLLKSSLLSSISKGIQ GIKIKVSGRLGGAEIARSFEVKEGRIPLHTLRANIDYGFAEAYTTYGVIG VKVWLFKGEILGKQINSDAGQVINRKPSKDKVERFDKGKIDDKGRKVVND DKFSREKLEIGSRSKNDFKNKNDSDI >BRE_620 rpsD, 30S ribosomal protein S4 MNRKSIAKGKLVRRFGVNIFEQPKYDKLLKKKTNPPGMHGRSRRTKVTEY GKQLIEKQKVKFTYGVSERQLTNVFKEARRQHGVTGDNLLALLERRIDNI VYRAGFAISRAHARQIVSHGIIILNGRRVTIPSITLRANDIIQVKEKDSF KKLVRSNIEKTSTLRKLPDWIEVNADALNVKIIRTPSRDEIPTLANEQMI VEYYSKRA >BRE_501 rpsE, 30S ribosomal protein S5 MESQVHKKQIEKLISLNRVTKVVKGGRRFSFSAFMVVGDGEGKVGWGFGK ANDASDAIKKSLTNARKNLKTVPIKKGTLPNMVIGNFKKAKVLIKPATQG TGIIAGGPVRAVMEALGVHDILSKSLGSNNSMNVVKATFKAFELVLDARK IAHIRGKTLRTLWS >BRE_117 rpsF, 30S ribosomal protein S6 MIKKYEGCFLFRSEELEYKSALEEVKKQLVAFGAVDFVENSIGERALEYP VRKQLRGRYEIIEFKMASDNLRELEAQLKLIKNLLRYMILVKINRKVSVK KVKRRNFREYRDNKDIKEKEQPSESNVDADLKVN >BRE_384 rpsG, 30S ribosomal protein S7 MSRKSKKIKKKVFKDSKYDSQVIAKFVNRMMYDGKKFISESIVYNSIDML AEKLEEVDKVAAFNKALDNVKPLVEVRSRRVGGATYQVPVEVREERREAL AMKWIISAARKASGKSMQEKLANELVNSYNSTGAAFKKREDTHRMAEANR AFTHYRW >BRE_498 rpsH, 30S ribosomal protein S8 MAVTHSVGDMLTKIRNASRVKHESVDLKMSKINRSILDILKEEGYIKNYN IFDKKGIPFIKAMLNYDGKRNPAINRIDAISTPGRKVYSSYKNMPRIKNG YGILIVSSSKGVITGKQAKDNKVGGELICSVW >BRE_341 rpsI, 30S ribosomal protein S9 MAKSDVKGVNLGMGTGRRKSSVARVYIREGKGDIKINHKNFDVYMQLEKL KTIALSPLALTHTLGKYDIYINVYGGGISGQAGAIRHGIARALFDLDEEY KMVLKSNEFLTRDSRKVERKKFGKKKARKSFQFSKR >BRE_483 rpsJ, 30S ribosomal protein S10 MITKDKIRVRLFSFDVKILDQSAESIVRAVQKSKTQIKGPIPLPTKIKKY TVLRSPHVNKKSREQFEMRTHKRLIDILEPTSALMDSLMKLELPAGVEVD IKQ >BRE_507 rpsK, 30S ribosomal protein S11 MSAKVSTNKRKVKRSIGEGNVYIQATFNNTIVTVSDIRGNTLAWASAGGM GFKGAKKSTPYAAQMTAEAALGKVKDFGINYVHVFVKGPGIGRESAIRAV GSSGIIVKSISDVTPIPHNGCRPKKTRRV >BRE_385 rpsL, 30S ribosomal protein S12 MPTINQLIRKPRKSQKEKTASPALQNCPQKRGICTRVMTVTPKKPNSALR KVARVRLSNGFEVTAYIPGIGHNLQEHSVVLIRGGRVKDLPGVRYHIIRG AKDTLGVNNRKQGRSKYGTKRPKA >BRE_506 rpsM, 30S ribosomal protein S13 MARIAGIDLPNNKQLQIALTSIYGIGRSRALEICKKTGILPEKRAKDLDN EEVNKLRKIIESDYVVEGKLRSELAMSIKRLMDIACYRGLRHRKGLPLRG QRTKTNARTRKGKRKTVANKKIAAK >BRE_497 rpsN, 30S ribosomal protein S14 MAKKSMIVKALRKPKYKTRQKNRCKLCGRPKGYMRDFSMCRICFRNHASA GLIPGVSKSSW >BRE_815 rpsO, 30S ribosomal protein S15 MTDEDFNYSKMVYCRLCYDGIGAVFMISKEQKQKIITEFGKNSNDTGSVE VQIALITDRIRYLTEHLKNNKKDHSSKRGLLKLVGQRRSLLRYYQKKNLE AYRTLISKLGLRK >BRE_701 rpsP, 30S ribosomal protein S16 MSVRIRLKRMGAKKRPYYRIVVMDSSSPRDGRAIEELGYYHPVERQNQVK INKNKFQEWVDKGAIPSDTVKRILNKSNFKVDN >BRE_493 rpsQ, 30S ribosomal protein S17 MARENKKELIGKVVSDKMSKTVVVEIVQRKMHPIYHKYLKVSRRVKAHDE REESKLGDKVKIVESRPISKEKRWRLVEILERSK >BRE_115 rpsR, 30S ribosomal protein S18 MYKDIDSHQRDSRTDGHQDGFKKNPNFRFFKKKTCKFCDMDRVPDYKEFD FLKKFITEQGKILPRRITGTSAKHQRRLALEIKKARYMALLPFVKK >BRE_488 rpsS, 30S ribosomal protein S19 MARSIKKGPFIEKSLYQKVLASSGKEKRVVIKTYSRASTIIPEMVSLTIS VYNGKSFIPVYITEDLVGHKLGEFSPTRIFRGHAKSDKKGRK >BRE_232 rpsT, 30S ribosomal protein S20 MIDYIIISWYIIYYHVCCIKEFNLGNNPSALKRARQNLKRNLRNVSVKSE LKTLEKHCIKLIKDGKKDEALEFFKFVSKKLDTAARKRIIHINKAARKKS NLSILLLQ >BRE_258 rpsU_1, 30S ribosomal protein S21 MVTVNVDKNEGLEKALKRFKRMIEKEAIIREWKRREYYEKPSTIRVKKEK AFKRKQAKKVRKLKQKIGK >BRE_263 rpsU_2, 30S ribosomal protein S21 MVTVNVDKNEGLEKALKRFKRMIEKEAIIREWKRREYYEKPSTIRVKKEK AFKRKQAKKVRKLKQKIGK >BRE_417 rrp-1, response regulatory protein MMKGIILDNFDEIAIEPQKLLLVDDTPTNLDLLLDILQNDYDIRVALNGF DALKQVEIDKPDLILLDVLLPDVSGYEVCRRLKNDPETRDISVIFISSRN STDAQLEGFNVGGVDYILKPFNGRIINARIKTHLELKRLRDYFKNLSRID GLTQIPNRRFFTDKFAKSWMQALEHQDNVIVGMLDIDYFKKYNDNYGHTN GDECLKLIAKSLNRIAIKYKIDVARYGGEEFILFSVNKSLEEMIKSVSFL IEDIRNLGIVHEYSDISHFVTVSIGLAEQVPQDSNFTNIIKLADDKLYEA KISGRNQFKY >BRE_770 rrp-2, response regulatory protein MSKLLVADDEKNIREGIATYLEEEGYFVFTASDGEEALETIQNEKIDAII SDLRMPQISGEELLKIVKDRNLNIPFIILTAHGTVDSAVDAMREGAYDFL TKPVDLERLLLIIKRALKKRNDKTQQNVLQKNVIIRKNLSYYEEIFGKSL IMQKILELVKKIAKSKASVLITGESGVGKEVIADAIFDLSNRNDKPFIKV NCAALSESILESELFGHEKGAFTGAIFQKKGRFELADKGTIFLDEIVEVS PEVQVKLLRVLQNKTFERVGGETTMQVDIRLLTATNKNIEEEIQKGKFRE DLFYRLNIININIPPLRERKDDIPNLTKILIKDVASENNKEEKSISNDAL KALYAYDWPGNIRELKNVLESALILSKGKQIVKDDLPPKIKNNTNQSFNI TLPIGISLKEAEKEIIKQTLLHSKNNKSKCAEILKIGRKTLHNKITEYKI H >BRE_28 ruvA, Holliday junction DNA helicase MINKIYGKIVDKKESSIIILAFPFEFEILVSSFCKMELRLLEDVEILTYF HFRDDDVKLFGFLNISEREVFENLIGVDGIGPKAALKILSGIKYDAFRLA IAKEDINLISKVKGIGNKIAGKIFLKLRGKLVKGDESSSYMLKFKELEQS IVNMGFDRKLVVVAFREIMLSDKFLILKEAEQEQFLFTETLKRLSV >BRE_27 ruvB, Holliday junction DNA helicase MDLGFLNSEKNFLYDNNEDDLRPEFLKDFSGQSHIKDNLDIFIKASRDRN EALDHVFLSGPPGLGKTTLASIIALEMNTTIKITSAPAFEKPKDIVGILM TLNDKSVLFIDEIHRLKPAIEEMLYIAMEDYKIDCIVGQGAVARTVRMSI PKFTLIGATTKPGKVASPLYARFGIVFRFDLYNEDELSKIIKRSAFILNV KLNDKAALLLAKSSRGTPRMANKLLRRMRDFAQVGGYDLITEDVVTAGLE MLKIDHEGLDEQDRNILKNLILKFRGGPVGIETLAIAVGETADSLEDFYE PYLILRGFIERTNRGRRATDFAYLHLNLNKNNQTIFDISR >BRE_840 sbcC, exonuclease SbcC MRINKLIFKNIASYKGEYEINFDVSVLRRSGIFLISGNTGAGKSTILDCI TLALYARVYRLDKNISDFISKGFDSAYVRLTFTVSEKRYESFIELHIKQK ETPRSMVLNCLSDGNFIENRDDVLVYIKSLCRLDFEQFCQTVILPQGNFQ EFLTSNPKSKAAIIDNIFNLKKYDNIEIFLKKELDLTKFNREKLIFLDTE EKNRVSINKKKINELKEILSLIDIEFLKKNLDNVYKLIVICEKIIKFNRN YLNIQCRIDNLKLDLSFKIESRKKLKHEHHLQSKIKSQLDQRLAFFHSND FLDLKNFVRRHIELLNDKNQFVYEFSRVKKDLEELKYLDLDNFNFDYVKE LYYENAIFCEIGFDEKAYNVLLVKERQLEIQRKKLLEKQRKKNVEIKSIA LKEVTFDFDKYVYYEALKLLKGFYEELILKYKNGLSLLLNSDNENNDFSQ VVNMNIKIDFYEKFLEHLIKNKELVERDIENLKFLEDAYRAYQGKEKLKI SNLNDLLELNSKLQVLQSELDILRLDILRNKENKIKWEGCVANFKKNNSE ILKRVGQSLFHKYIDYSDKNKMLVFESKFKKVSELKLILNDLNSKISLND VKIKDNLDKIKNLLSNINLNINFSDSTLLEEEFEKFLISQRNIENDRMKF NVCLDNINNEKLKLESQIEFIKQTILDFKIELKDELDNFTSNFLNFKVAM RGNTCDTDPIVFLDSLIPSKNSLEHFLKLKSNFMSQIEVFSKEISKYDAA FSSVQNLQLELNEQEINLRNINSKLININERNDKLEILKKIITVSPSLKY YVQSFLIDEILSIANKKYLSIILPDFGLEINTDSRDFNFLVRSKRDGNMT RNVKTLSGGERFLVSLSLSLAFSDMIRDSDLKIEAFFLDEGFGSLDEDTL KVVIPKISDLQRIDGRQIGIISHVSYLKEEIKTQIVVEKVSTVSKITIES F >BRE_839 sbcD, exonuclease SbcD MSIYKILHTSDWHIGKKIGHFSRIGEQQQFLNFLLKFIVNEKIDLLLIAG DVYDSKRPGIEEQKLINDFFYELSFTSCKWCVVIAGNHDKKDYFNIHKKI LSKFNFFLVTGDDIDNHLILLKDGNDVKFVIVCMPYVNERFLLDSDYQNI DLNNDVFLDNVEKAYETRITDILKLLSRDYFDVPKILMAHSFFSSGGMTD IIVNTPILSVNVFGNDFSYVALGHIHNFKRLKENIVYSGSPIQYSFDEDV KKYVNVLFFCDNKLVEQNRVLLPIFGKLYFLKGSFQEVINNLNRIKNEIS YLCYLKIEINDRVNSEFEEQIYNLIKSSFINIFDVYYNLEDSGEESFKNE RKLLGRDEVLNRDEKYFFQEKLKRDIVGGFKRRNKFKEEELIALFEEVLL KGRAGEYEDK >BRE_154 secA, preprotein translocase SecA subunit MIPNMLRAIFEATVGSKSKRDLKSYLPVLRNINKLESWALSLLDEDFSRE TEKFKNELQSGKTLEDILERAFALSREAARRRLKERPYDVQLIAGLALHQ GKIIEMKTGEGKTLSSVQAAYLNSLTGDGVIIVTVNDYLAERDSNWMKPV FDLLGVSVGVVLSNMDSSRRKIEYGKDITYVTNNELGFDYLRDNMCFDLS QKSLRNFNYCIIDEIDSILIDEARTPLIISGSTEGDTSAYLTVNSLVPFL KECSKDLKTGDYPLEIDDLDGDYTIDEKAKRISFTVNGLNNLERILVSKG IIQGSMYVDSNFNYVHYMTQALKAHLLFLKDREYIVGDFGVEIVDEFTGR VLKGRRYSDGLHQAIEAKEGVRVASENKTMATITFQNLFRMFNKISGMTG TADTEAKEFHKIYDLDVVVVPTNKLVARIDEDDIIYYTEDFKFRAITDEV FEAYKRGQPVLVGTVSIEKSEILSNMFKNRGIKHEVLNAKNHFREALIIA EAGAKYSVTIATNMAGRGTDIKLGGNLEHRVRKKFGTEISFDDLQKAMQS EREQYLKDYEEVKSLGGLYVIGSERHESRRIDNQLRGRGGRQGDPGRSRF YVSLEDDLMRLFAGDNLRALMGKLGMATGEPIAHSLLTKSLVNTQRRVED RNFEIRKHLLEYDDVITKHREFIYSQRNLILADNNIKERILLSLREYLDF LFDQVKGDVVTSSVLNEINSVFAYMMESVGSVEKMSIADLKDKLMEVARS NLDIKEELIGSELLNEFLKYEYLRNIDSKFQEHLANLDSLRESVYLRSYA NKNPITEYKEEGFAIFSELIKDIKIETLRRTLQVKIDVDSSNYKNKKPKD VHATHKEFSGIVSRERDDSVGVQIVRNTPKIGRNEPCYCGSKKKYKNCHG KN >BRE_658 secD, protein-export membrane protein MNKVSKLILILFVTSFAYFLIFPTLKWYFFTKEKDKQISSYSKEALRDYS KSQALSSLVKLKELYRKNPKGQIPDDLKYLIPVAKNNYKTYGREFPKSFN DIEALRGGFLTDSDIEELSLEIYRYYEEIKRNKNKIIQLGLDLSGGVSVT IFLDYLELEQRLGRALSVLEKEEAIGRTMQILKERVDTFGLTEPKITREA GGNRIFLDIPGEKDERRVDSLLGGKGNLIFYVVDLDATSVLNSKILEAGP LYSIHDIKNSMKLDDSKKIFPWYIKDAYGVDDEARVRYYVVDFGLDNSFD GSHIQDAGILSDPKTGKDVVTFTLDSEGSEKFFAFTQKNVGKTLAVVMEG KIKSVANINHAIAGGNVSIQGDSFDKKEAQELAFVFKTAAFPIEIKIDDL RIIGPTIGEKTIELGIKASLLALVLVFLFMFIYYKTSGFVSGFSLVIYNL FLILAILSAFNFTLTLTSIAGLVLTMGMAVDINIIIYERIKEEIRNGRKF ERAFEDGFKKAFWGIMDSNVTTFIAVLFLTLLGTGTIQGFAWSLSIGIVA SLFSSLVFSRFILELIISLNRNKCVSISWSSNYAKGV >BRE_393 secE, preprotein translocase SecE subunit MFKFFKESVLELKKITWPRYNEVIGSGKQVFWLVVFISVFLGVVDYIMYL VITYIF >BRE_659 secF, protein-export membrane protein MQKVFNFLKYGNKAIIASFCMIFLGFIYTFMYHGGYNWGVDFSSGLNINF VIDKAGIKDSDIKRVLSLFYKTFDVNEIIANDSKSHFDIIIKSEVTDYSL KKEIHSMLLDKLGIEFDANVEILDSYFIDSRFSSVLRTKSVLLVCLTFAL ILVYVTLRFRLSYAVSSIFATMHDILFVIAFLGLFRIEINSSIIVSILTI IGYSLNDTIIIFDRIRENSRNITDSSFLNILNISIHQTLSRTILTSITTF VAVFSIYIFTEGAIKDFSLIFMVGVVVGTFSSVFIASPILLSCYKKIK >BRE_504 secY, preprotein translocase SecY subunit MKGLFLNLLTIKDLRSKFLFTLFILFIFRVGSYLPIPGIDPVALRSYFKF QSDFSITNYFDFFSGGAFSNFSIFMLSIGPYISASIIIQLLVYSFPSLKK MQEGDNGRKKIKKYTKYLTIVAAMAQGYATSLYAKSIPGALNIPFYRYIF VAILTVTTGTFVLLWLGEQINQRGIGNGVSLIIFSGIVVRLQAALFNLFQ SMRDPSQNINPVFVILVLSIFILVVILIIYEYKAQRRISIHYARANSKNT VSSYLPIKLNPSGVLPVIFASVLITLPLQILSGFAGTSVLSRQILSYLRP NGLYYTLLNVCLIIGFTYFYSKIQLSPKDISNNILKNGGTIPGIKADEME TYLDKIMNRTLFSGSIFLSMIAIIPFLVQNIFRFPYDVSRIMGSSSLLIM VGVALDTLIQIDAYLKTQGLSRGPGKKYAFLQKI >BRE_225 serS, seryl-tRNA synthetase MLDLKFIRDNLELVRENIKNRGLKLELDLLISFDDERRKLITKIGELNAL RNENANAMKDNIGDSSRHYLIEKGKALKAEIMDLEERLGYLTSRLLVEHK RIPNISAPDVPVGVSEDENVVLKVSGNIPKFDFKPKDHLEIGIHLDLFDF EKAREVSGNKFYYLKNEAVFLELAMINFAFSKLKAKGFDLFITPDVAREF IVDGIGFNPRGAESNIYKIEDTDKYLVGTAEITLGGYYYNTILDLKSPLK MAGLSHCFRKEAGAAGQFSKGLYRVHQFSKVEMFCFCRSEDSDRIHNEFL ELEEEIFIELEIPYRVLNVCSSDLGAPAYKKYDIEAWMPGRGENGDYGEV TSTSNCTDYQSRRLKIRYKEDGQNKFVHMINGTAIASTRTLIAILENFQD AKGGVRIPKSLVKYTGFDYISPKN >BRE_578 smbA, uridylate kinase MIKIISLGGGIINPNHINTTYIKNLKNLIFQWIKKEHNRKVILITGGGKT AREYQDAYKQINPKFKNHELDEIGIMATKLNATLISKAMQPFCINDIVSN PTEDFQFKGQILVASGWKSGFSTDYITVKFAEKFNSNEIINLTNIDQIYD KDPKKYNDAKGFKNITWNKLQNIVGKDWEPGSHLPFDPIATELALKLGIK AYILNGTDLTNLQKVFDKNDDFLGTIVVK >BRE_37 smpB, SsrA-binding protein MSSILLENKKARFNYFIEDRLSCGIVLKGTEVKSIKLKKFTFNDSFANIK KDEIWLENLHIAKYKEGNIFNHEETRRRKLLITKKEIQKLKKFKEKEGYT LVPISIYLKNSLIKVELGICKGKKLFDKREILKQKSIKKDLSREIKQYK >BRE_153 sodA, superoxide dismutase MFKLPELGYSYDALEPYIDAKTMEIHHSKHHNAYTVNLNSVLEKTKVNCS YDIESILKNIQRFPIEFQKVVKNNAGGYANHNLYFRTLKPGNKDNILKNF EEHVNATFGSLDNLKVALKDLAVSIFGSGWAWLVLYANRELQVISRPNQD SPLIEDYKPILGIDVWEHAYYLKYQNRRAEYIDAFFKTLNWEEISRIYNE IIE >BRE_434 spo0J, stage 0 sporulation protein J MDESLKMVDINLLDIDKSQPRKSINLAELEELSISIKENGILQPIIVYPN NGRYNIIIGERRFRAAKLSGMSQIPVIEIEASTKDKDFMSLIENIQRENL TPVEEAYAYKNLMDKHALTQKALSEKIGKNRSHVANLVRILELEQEILNS LHKKEISLGHAKVLLSLKDNQDRYALYLLIIKKKLSVRDAENYVKNLYKT INDKSEISRDPFLNSIKEFLISRIQTKISIKGSKEKGKIEISYFTSSDLK RIISIFENIK >BRE_195 spoT, guanosine-3,5-bis(diphosphate) 3-pyrophosphohydrolase MIQVYEIAYLLKINDIDKLKNIFKKTVDNTYQDDIQKKLIFKSLEISEQL HYGQYRESKEPYVIHPIMVALFLIKFQLDFKTIIAGLLHDVLEDTSVQKE EIIKEFDQEVFSLIDGVTKIHDLHNKTRAIKEANTISKMFFAMTHDIRII IIKLADKLHNMATLSHLPKNRRERIARDCLATYVPIAERLGISSLKIYLE DLSLKYLYPKEYKEIKNFLSATKIEREKKLYKGKLIIEKELKKIGIDVTI TVRSKHFYSIFRKMKTRNNNISQIFDTLGIRIICKKQKECYEILEIVHKV WKPIPGRLKDYIAIPKENKYQSLHTTVRIPEDNQLIEIQIRTEEMDKIAK YGVAAHWLYKEKVELKADDISFINRIKKWQQESANKNQYSMHDIHKELLN TFIYVYTPEGEIVELPFGSNSIDFAYTIHTDIGDQALYAKINGKISSLTK PLKNEQIVEIFTSEEAKPDVIWLNSVRTKKARSKIRSWLNKNDNTIFVDN NIIAYLIGENKEQKRLFSLFKSLTKSKLKSITTASDCNPLTGEDIIGLIQ KDTIVVHKENCKEITYQKKNHLVEVEWEATPTRKVYHIIIFLKNLKDLFN YLDNLFTTFDVRLISEKIEDCGNEHGIINIIILSNHKNVSMIFNSLKENP NVLQIMQVEEDIKNYDN >BRE_55 spoU, spoU protein MVSDTLKRIEILAEFITRRRRERIDEVLNNRTNYLTLVLEDIFQSQNASA TMRTIEILGLSNIHIIETNNKYTLNPGVVLGASKWIGINKYKCVKVAFEH LKANGYKIVATSLDNEAISLEDFPIDTKMAVFFGTELTGLSHTILQNADL HLKIPMYGFTQSYNLSVAVAIVFYSLINRLRSSSIDYLLNEDEKLNLKLE YYRKIIKRYKVIEKLQFF >BRE_116 ssb, single-stranded DNA-binding protein MADINSLVLSGRLTRDSELTYTDSGMAILKFALANNRRIKKLDEWIDYAQ FFDCVIFAKRAESLSAFLKKGKQVVVSGSLKYESWQDKNTGDKKSKCSIL VDEIQMFGSSTAVAQGTNNVDFESYKKPDSFKTIDFDNGFNEDIPF >BRE_801 tdk, thymidine kinase MSYVWGEFVFMGFYLNLVNGDTRSKLDNIVSISHFNFKDNSNLMLIIGPM GSGKTEYAAKIYKDSLIIKNKSSEILASITRGLRNRANVFFIRNILDKKR FKNYPENVIPYRGGGSDEIDGVDFASDSFDVGQLIEKNPEYGTFIIDETC FYDERLVFIVNKIALDLNVLFILPTLLYNFRKEIFNNTARLLIEYADKIC SLGAYCEHINCMDESFLTYRYYFYEGKEIAAPYFDPLLIVGGDEIVESAI YPNYATRCFKHHYLVGREYFFTILKPFALLYIQGDRKFLEREIVDLKSNI VNSNFQKSLLIEVDEKYDITILENVLKLPFLAERALITLSFEYNILSKED FKEIVNRFSLSKDYIQKVIVSREYKGIF >BRE_820 tgt, tRNA-guanine transglycosylase MFNIIKNDKNSNARLGILELPHGNVATPCFMPVGTLGVMKALKHDVLEKL GCDLMLANTYHLYLRPGIDVIKKYGNLHNFTTWNKNFLTDSGGFQVFSLS NFRKIEDEGVDFKSHIDGSRHYFTPESVFSMQETFESDIIMALDICSPYG IDYDEASLYTNITTSWARRTLCAYKNRKEGYEGLLFLITQGNFFKDLRKR STELILELNSPGIAIGGISVGEPRDRYLEILEYNSSLIPKDKPKYVMGIG TPHYILDAIYNGIDIFDCVNPTRIARHGSLLTDNGILRINRAEFCFDTCS VERECSCTLCTRYSRGYLRHLFKSEEALGVMLASEHNIHYMFRLINKTKN AIMNDNFVKFRKLYLDKYDEGNLNE >BRE_177 thdF, thiophene and furan oxidation protein MSRLFQKEDDIVALATPFFSSALCVIRSSGVSAIEKFSTMFSDPSKLLEA SGHTIHYGYILDNETKEKLDEVVVCLYRAPKSFTGQDSIEVMAHGSLIGI RRIIDFFLKVGFRMAEPGEFTLRSFLAGKLDLTKAEAINELISAKTRQVH ALAVNKLSGSLFDKIDLIKKDILNFLSAISVYLDYETDDNEVVIPVDIIL KSKSELERLIDSYDTARKLENGVTLVLAGSVNVGKSSLFNLLLKEDRAIV SSYAGTTRDYIQASFEFDGILFNVFDTAGLRETSDFVEQLGIVRSNSLIK EASLIFYVVDLSGKLTDDDLKFIDAYKEDSRVLFVLNKVDLEQNNQTVEF FNSNDIVSLNTVKISTKTLFGINSLYDRIRSFIAVDYMKTSDYDIVISST RQAALLKRAYALIIELLSKIEQNISYDMLAFDVYEVVNVLGEITGEVTSD DVLNNMFKNFCLGK >BRE_628 thiJ, 4-methyl-5(b-hydroxyethyl)-thiazole monophosphate biosynthesis protein MRVAIILADGFEEIEAVVPMDILRRGNVDLKVVSLNDSKFVSSSRGFVFG ADEKISNCTADHFDLIILPGGMPGAINLFESKDLDSILRNMNLQGKLIAA ICASPVVVLAAKGLLGESKFTCYPGFENDITDGEFVNEDVVISNNFITSK GVGTSFKFVFALLKIVKGEGILEDVKNKVLL >BRE_726 thrZ, threonyl-tRNA synthetase MGEKLDKDSILYKKRHSIAHVMAEAVLELFPNTKIAIGPPIKDGFYYDFD FEKHISEDDLLLIEHKMREILKTGSPFIREVITREQALVLFKDEPYKIDL IQNFDVTDEITIYKSHKFTDLCRGPHVDNMNKLDPKAFKLTSIAGAYWRG NERNKMLSRIYGTLWNNEKDLKAYLKLQEEIKKRDHRKLGRELNLFSVHD EIGPGLIFFHPHGARIRALIENFWREEHFKNGYDILFTPHIGKSWLWETS GHLDFYKESMFEKIEMDRSDYYVKPMNCPFHIAIYNTDKHSYRDLPFRWA ELGTVYRYEKIGAIHGTMRVRGFTQDDAHIICTYEQVNFEVREVLRFAID MWNKFGFTNLKAYLSTKPEKAVGDDDDWQMAVKVLEKALIDFNIDFDIDE GGGAFYGPKIDLKIIDSLGRAWQMTTIQFDFNLPVRFKMTYTAEDGKEKR PFMIHRALLGSIERFFGILVEHYGGAFPVWLAPLQVVIIPVNSIVEEYAL EVLSRFQNEGIRIKFDNYYNMRMNAKIRQYQSKKVPYMFIIGEREVVEGK ISIRTRTNEQINGLELKEALEFVKLKISNKEIL >BRE_3005 thy1, thymidylate synthase-complementing protein MNFKIEKENLLNIEHKVLDKGFIKLVDFMGSDERIIQAARISYRGESIKR EDRELIDYLIRNEHTSPLEQVVFTFYIKAPIFVARQWMRHRTARINEVSS SYSLIREEFYVPLEENMNTQNVTDNQDNKKTECEFREEILNNLKENQKSS YKLYQNMINHNISKEISRIVLPLSLYTEWYWQIDLNNLFHFIKLRSALNA SKEVAEHSSKEMREYAKVLLEIIEKIVPIATKSFKNHILKGCKLSYEEIV AIADALDISKLKLDANALKRLQDKLNI >BRE_616 tig, trigger factor MILTSNVKLMPGSKVEAVIQISKEFVKAKYNEILKDYSSRLKVKGFRTGR VPFSIIEGKYSDNIRALAIENLIHKSLEEFFESAIYKPLSYAVPKILDEK LEINFDKDFEFTFVYESYPEFEISDISNFKVEIPEVVISDSDIEDELKLL QFENSIIVEDNGSVKVGSIVRVDFVELDDSLNEILATKRQDFVLTVGESD DYYGFGYDIIGMKKDEEKIVEKNYGSDYKFSELANTSKRLKIGVKDIKRR DIPELDDAFAKDVKDSLNTLEDLRDYVRENMLRVVQEKTNSLKLSKLLSG IAEKVNIDVPSSMFEAELKNVINEFSHQNKINITQLQNSSTGLEGVNDVF KENVLNKLKSKLVFQKMVDNDSSEVTELDLENELIKQAQNLKMAPQDVKK FYKERNLFGLLKDEIKRQKVKEKILQDLEEIKLEKVSFRDFVNYKTGE >BRE_512 tlyA, hemolysin MREYKNSLLNVLCRNYPSLTRDELRILIVTGRVYVNSHKEKNPKVLVLKN SKIELVESKSKQFVSRGGDKLFEALEIFKIVVKDKICVDVGASTGGFTDC LLQEGAKLIYAVDVGLNQLSYKLRIDPRVKVFEKTNIFNIKKFDIQPNLA VIDVSFRSVISICANLIDKLSDKLIIALVKPQFELKDLDLNIKDFNGIVE HKYLNEILNKVIKKFYDNYLQIKGILKLTTKGHKGNQEFMFLVSKNSGVN LMQSLAFLDDIDF >BRE_62 tlyC, hemolysin MMFKFFNFKNKKMKYVEGKDSEEKSRFETSLLNNFNSLKETIVKEIMVPR ISVIFIDYSVSKDDILKVVTSSNHSRFPVYKETIDDIIGIIHTKDILLHM WKKDFYDIDLKDIMRKVMFVPESKKIDSLLKEFQENHVHIAIVVDEYGGI SGLVTLEDILEEIVGDIQDEFDNEVDEIVPLDDGSYLCTARVLIEDLNEK LGLCLPDGDFDTLGGFVYDLFGRIPLKNEKIEYNNLIFTIKNMHQRNIKV IKISQKEGL >BRE_803 tmk, thymidylate kinase MTKILKNFYCIEGIDGSGKTSIIQKLQKICNNKMKYHFTKEPSTGIIGKL IRKQLTNFKNPLRKVSLAHLYVADRYEHLYNIQNGIITILNKNQTKVISD RYLFSSIAYQGELGYKLNKDFPLPEKLFFIKTDPNIAFKRIQKNRTQADI FEFEEAKFKEINSRYMEMFQIFNQLIDIVYIENSSEHDLEISARKIFDLI KF >BRE_838 topA, DNA topoisomerase I MQQKRLIIVESPTKATTIKKYLDSSFSVEACIGHIRDLPNSAKEIPEEYK KFEWANLSIDYQNDFKPLYIIPSNKKMIIEKLKKVIKDQDEIYLATDQDR EGETIAFHLKEVLQIKNYKRMVFHEITKSAIIDSLNNTREINMNLVNAGE TRRILDRLYGYTISPLLWKKIAYGLSAGRVQSVGLQLIIEKEKSRINFKK ANYYSITLECKHNKNNIQLKPTLEKIDNKNVAESKDFENDTGTLHEPNKT ILIDKILMNSITKELKQINNIEVISIETKEIKLTPPKPFITSSLQQEINR RLKIGTKQIMSYAQKLYESGYITYMRTDSYEIAKTAKEKIKNIIRQKYGE EYIEKNDRMYTKAKMAQDAHEAIRPSEMFTPPEQIQIESETAKEIYKIIW DRTIESCMKDAIKKMGKIKFKYKNFTFKANFTKLIFDGFLKNNKEFHEDN IIDFSLIKEGDKFTILNIKPEQHETKPPLRYTEASLVQKLEKEGIGRPST YATIISTLFEREYVFKQNNTLIPTIKGAAVINLLKKYFPILIELQFTSNM EENLDKIAIGKLDKIQYLNAFYNGKEGLKNTVSKIEPMISPEEFRMVYEY NNDKQFNYKINIGKFGPYLIFNGNNYAINLTTPLENLYKKDEIQKIITEK EIQPNILGVDPATGLNIIYKNSKYGGIIQLGEDIYEPQGFTKTGKPKKPK IIKAKKVSTKNIEYENITLELALQLLSLPKVIGKYPKTNEKIIATTGIFG DYIKTENDSIICPLKKDMKAYKITLEESIKLLDTKLAKNGIIVKIISLSK NKIGNKIYIYKQNDKFYAKIKRKKVNLPTNIDLNQIDATYVFGLM >BRE_58 tpi, triosephosphate isomerase (TIM) MRKVFLAGNWKMHYTSVEAADVAKQIVDGVYNINNNVVVMVTPTFTSLCK VCRVTKGTNVLLGAQNMSYENSGARTSEIAPSMLLEFGVDYVILGHSECR TYLGENDEIINKKVLTGLKHPFKYLILCVGETLEEREKGKTLDVVLNQVR NGLASVYESDLQRIILAYEPVWAIGTGKTATKEEAQEVHKAIRLEIQSLY SKSAADNIIIQYGGSVNVDNVEGLMGENDIDGALIGGSSLKADSFLKIIN KISK >BRE_326 tpn38b, exported protein MYFMRKRCFVFVSKSFFFRIFWIVISLICLFLFVYINFFKARGLKFSSNR KIALFIPGSITGSPSYKAMYDCLIEFQNSRSDIDIELFESGFNQHEWIEL LEKLLNSKNYDFLITTNNVMQGIIDKVSRNYPYTKFLLFDSLVKNTNPQV YSLSYNVAEEAYLLGYYVGLFLKDSNLANQNVALIAGQEYPVMNNYIFPY FKNGIKEVLDSEVFFRTLGNWHDSNRVKVLTESLILDSKVSVILPIVGAA IKGVLSAVRKHGVFVVLFDGEDYLDNKENIIGSGITNQRLFLEEVLSKAI KDEIQYGTYRVLGFKDKGVSFNLLNKFYLESIGLDLKEKLEEKMREMNDT EIKINLE >BRE_165 tpn50, outer membrane protein MHIKTITLLFLIKTITFSSEILEFKYTKGTKFRIETTDQQKIYLNGIFNS ETKTNIQVSSEIKDIKNNFANIKSYFRVLERNDESDVYLLKEELEGNFSI NKQGEYKINHNQKRPSVRGIPQFPKTPIRVNETWTYPAEEYIQASEIVKG IKDFITKFNVSYTYKGKEKIDGKYYDIIYSNYESKYNVKNILFSQKVNQK IYFDSKLGNIYKYHDTYEFQMKNGNNNIKMIGTSSGKIISIELPNDNTIE NEIKEYIKREQIDSIEIEKNKNGIKLSLDIEFYPDSFQIIRKEHNKLKHI ANLLEKFQDNNILIEGHTAKFGTEQEMQELSEKRAHTIGNYLLKMKVKNK NQIFFKGWGAKKPKYVSSSPLASKNRRVEITILNN >BRE_414 traB, pheromone shutdown protein METAKENTKDYFLHVSTLDIDHHKIYVLGTAHVSKKSSQDTANLIDILKP NFIAVELDEARYHAILQTDENEKWRNLDIYKVIKQGKAFLLIVQIILSNF QKKLAKEQGISPGEEMKTAILKAKEHNIPLILADRKVETTLKRAWNCVPI FEKTKIISSLFSFSDIKVTEDEIEKLKEQDALSNIMEELAKEIPTVKKVL IDERDEFIASKILEGSGTILAVVGAGHVKGIIENLKEIQDTKKIINIEEL NTIPKNNFSISKLISYLIAISIIILIASSFYFKDFEFAYKNLEIWIICNS VFAGIAAILLRANIITILTASIGAPIFSLMPFIGTGMVAGLVEAYINKPK IKDFESLQEDLHNIKGYFKNKVTKILLIVFFVNIGSAIGTIVGFKFLLNI FG >BRE_704 trmD, tRNA-(guanine-N1)-methyltransferase MKITILSLFPSIITPFFENSIMKKVVDKGIISYEVISIRDFSKDKHKRCD DVPYGGGAGMVLKVQPIVDALEYVNANSKTTIFVSPSGLKYTQKLAYDLS KKDELVIICGRYEGLDQRVIDLYVDLEISVGDYVLSSGEVAALVIIDSVY RLLDGVINPNSLCEESFSFECGLLEYPHYTRPYEFRNLKVPDVLLSGHHE EIKKWRLVKSVEKTKKNRFDLYLKYLEMRGEKNDGFDKKN >BRE_10 trsA, tryptophanyl-tRNA synthetase MMQKKVILTGDRPTGSLHLGHYVGSIVNRLKYQEEYETYIIIADLHTLTT QSDLKSISEISINVREIVLDYLSCGIDPERVNIYLQSAIPELLELNLILS MIVMVNRLQRIPSIKDMSINAGLSEIPYGLLGYPVLMSADILMAKADFVP VGRDNESHIELTRELARKFNFLYGENFFPIPEAIFTDFHTLVGIDGKTKM SKSLGNAIFLNDDERSLRKKVMSMFTDPKRIRADIPGEVDGNPVFIYHDL FNSDMDELCELKSRYKKGTIGDIEVKERLFNVLNQFLIPIRERREFFKAK KGYVDEIIFEGTNKARKVALETVRDAKNLMGISKTWNGIRRNIEKMAKYK >BRE_814 truB, tRNA pseudouridine 55 synthase MDGIILLNKLVGMTSYEALYPIKKYFSTSRIGHTGILDKFASGLLVVLVG KYTKLSDYITSLDKEYISEFEFGIETDTLDPNGKIVNTTDYVPNFNEVVL GVKSLIGEIFQVPPKFSSIHVKGQRAYKLALSGESFDLQARKINIYDIEI LDYNIDFCILKLKIKCSKGTYVRSIARDLGRALGSCAYVKSLKRTQIGDF KLGDAYCFDNLNDNSLLGIESLNFFEKIYVDDSMIRFIQNGIYINIAIND GEFKILKSQNEKILAVICGIGLNKYRYIIIF >BRE_64 trxA, thioredoxin MAISLTKQEFIDKVFDYKNNQEWNFKGTKPAIIDFYADWCGPCKMLAPIY DELSEEYGDKIDFYKVNTDKEQEVSMVLGVQSLPTIIFVPVGDKPRVSVG FIEKNSLKDAIKDLFKV >BRE_520 trxB, thioredoxin reductase MLNFEVLDIKKCNREIIRTEVDFVEDVIIVGSGPAGLTAGIYTVMSGYKT SILEGPEPGGQLTTTTEVYNYPGFKNGINGRELMLNMKEQAINLGATTYF ETVRSIKKRGDIFCLYTDNYIYKSKSIVIASGSIPKKLDTLKNLDLFWNR GISVCAICDGHLFKGKTVAVIGGGNTAISEAIYLSKLAEKVYVIVRKNYM KAIDMLQKSIKTLSNVNILYNCEAREVSGENIVSKIHIMDNKHNSAFELN VDGIFIAIGYKPNTEFVKGFLELDDDGYISTQDIVKTSVNGVFSCGDVSN KLYAQAITAAAEGFLASVEVRNFLG >BRE_124 tsf, translation elongation factor EF-TS MSISPQEVKKLRDATGAGFGDCKKALSVAGGDFELAKKKLKEMGIVSADK RSGRDAKEGRVFSYVNTERVGLLLIACETDFVAMNSDFVAFGNSLIKQLV ESGRDILDEHQELEIKNLAATIKENIYVSKVYISNIASNELVKNYLHGDH SKIGVFVKFKIDDALKMQDEKLNNFAMDLALHVAAFSPLYLSVNDICLNY IKEQEEIFMRQMESSGKPENVVKGIISGKLKKHLGEIALLEQGFVKDDKL TVKEKIEEVSKLILSKIEVVEFKYLSVG >BRE_482 tuf, translation elongation factor TU MAKEIFQRTKPHMNVGTIGHVDHGKTTLTAAISIYCSKVNKDAKALKYED IDNAPEEKARGITINARHIEYETANRHYAHVDCPGHADYIKNMITGAAQM DAAILLVAADSGAEPQTKEHLLLAQRMGIKKIIVFLNKLDLADPELVELV EVEVLELVEKYGFPSDTPIVKGSAFGAMSNPDDPEATKCIKELLETMDNY FDLPERDIDKPFLLAIEDVFSISGRGTVATGRIERGVIKVGQEVEIVGIR ETRKTTVTGVEMFQKILEQGEAGDNVGLLLRGVDKKDIERGQVIAALGTI TPHKKFKASIYCLTKEEGGRHKPFFSGYRPQFFFRTTDVTGMVSLEGKEM VMPGDNVDIVVELISSIAMDKNVEFAVREGGRTVASGRILEILE >BRE_369 tyrS, tyrosyl-tRNA synthetase MNLSLKVLDKRGFLKQCTNLEELSTLMDREKIVFYVGVDATSASLHIGHL IPFMVMLHLQRQGHIPIILIGGGTTKIGDPSGKDSMRKILLKEDIDENVK TISSQLLKIIDLSNGGYILNNAEWLDGINYIEFLREVGIYFSVNRMLSFE TYKRRLKDGLSFIEFNYQLLQSYDFYMLSRMKNCKLQIGGDDQWGNIVSG VDLVNRKSGNKVFGLTLPLITRSDGNKMGKSEKGAVYLDSELYSVYDFYQ YFRNIPDLDVKKFLYLFTFLEEEEIERIASVKGQLLNNAKEILAFEITKI VHGKDEALKASSAAKAAFKGGDGRADIPFFKLELTNLEESILLVDLMVLA KVVSSKSEARRLIDSGGVYIDKVRVGDQNYCLCKDNFINGEIELKIGKKK ILRIVL >BRE_20 udk, uridine kinase MVKIIGISGGSGSGKTTIVNKISEVISEFVLISQDNYYKSVGDYEYEFLD VNFDHPDAFDNNLFYKQLKKLKENQSINMPLYDFINHKRRDETIKIVPTP IIIVEGIMIFVEERVRNLIDLKIYIDTPNDIRFIRRLERDMSKRGRTLES VIEQYLRTTRAGYYRFIEPTKEYADLIIPEGGHNDKALYVLSSFLKTLVK DSSKFF >BRE_56 ung, uracil DNA glycosylase MEVKIEESWKEMLKSEFCKGYFKRLVSFIKNEYKTKKDKIFPPPRLIFNA FDTLPFKDIKVVILGQDPYHGKGQANGLAFSVNSDIKIPPSLQNIFKEIE RSLKIKTIPNGDLTRWAEQGTFLLNSILTVEEGRPSSHKDIGWKIFTNEV IKIISKNLNNVVFMLWGNFAKGKKKLIDTSKHLILETSHPSPYSAHNGFL GSNHFSKTLRYLQEHNKTTINFQ >BRE_122 uppS, undecaprenyl diphosphate synthase MSSNSLPSHVGIIMDGNRRWALKKGLSFFEGHKEGLKRAKEIVKHSCELG IKCLSLYVFSTENWNRTNSEIEHLMFLIADYLSSEFKFYAENNIKVVVSG DIKTLSQKVKKSIKDATNYTKNFDGLILNLAINYGGRNEIVRAIKKVLAK GLSVETLNEVEFAKFLDNQELGDLDLLIRTGGDMRVSNFLLWRLAYCEFI FSNVLWPDYFVFHYERDLECFKNRKRNFGR >BRE_848 uvrA, excinuclease ABC, subunit A MKENITVRGAREHNLKNIDVDIPRNSLVVISGKSGSGKSSLAFDTIFAEG QRRYMESVSSYARQFLGVMKKPNVEYIGGLSPAISIEQKTISNNPRSTVG TITEIYDYYRLLFAKVGKPYCPNDGNLIEEQSLDNIINVILSYSEGSKVI LFAPIVMGAKGIHNKELEKILNQGFARVRIDFQDYLVEDAVNLKLDKNKK HNIEIIIDKIKLSNDIRVRLAESIETALLVSNGYLRVEIEDDLKKIDRIF TEHNSCPLCGFSLPAIEPRLFSFNSPFGACSECSGLGIIFDFDFEKICPD MQLSFNEDAFITFKSSSPWALAIFKGLSKHYGFKLNTPISHIPEDVLQKI LYGDNVKIDFVYKSREMEAKEISGGFHYSKEFEGLIPLLKRRYLATESDS ARSFYESLMSRKICNFCKGKRLSCEALSVKLVEKDIQELNSLSVMDSYLF FENIELDEFDTKIAKEILKEIINRLKFLIDVGLSYLCLDRISGTLSGGEA QRIRLATQIGSALAGVLYVLDEPSIGLHQRDNEKLVKTLVNLKELGNTVI VVEHDEQTLRTADYIIDVGPGAGIYGGEIVAKGVLSDILNNENSLTGKYL SGQLKIEVPRVRRQIGKSKIVLLNANKNNLKNINVHIPLGVFTVITGVSG SGKSTLLNEVLYPALDSRLKANEIYSDGFEDIIGYEEIDKVIQINQKPIG RTPRSNPATYVGFFTEIREIFAKLPESRTRGFKAGRFSFNVKGGRCEKCQ GDGYLNIQMHFLPDVFVPCSLCKGKKFNEETLEIRYKGKNIYDILEMSVL EAKDFFESVPKISHYLSLLIQVGLEYIKLGQSSTTLSGGEAQRIKLAFEL GKKSMGKTFYIIDEPTTGLHFDDIRKLLEVLQLLVKNGNTVVLIEHNLDV IKQADYIIDLGPEGGVSGGNIVVSGTPEEVAKCKSSYTGMFLKNLL >BRE_847 uvrB, excinuclease ABC, subunit B MQFCLKSDYFPAGDQPKAIREIKESILRNNRYQTLKGVTGSGKTFTIANI IRDLERPSLIISHNKTLAAQLYREFKDFFPDNAVEYFVSYYDYYQPESYV PSKDLYIEKEATINEDIEIKRIRTVTSLSRRRDVIVVATVSSIYALGSPI FFKSAANVFFVGQKISIKEIADVFVKLQYERTFTNLEHDKFSIKGDVVEI WPSNEHGDFAYRIYLDFDKIMQINRISPLTKKKLGFANEFTLFAKSYFVI PYEKILNALPEIQVDLEMQYRYFQENNKLVEAERLKQRVKYDIEMLRETG SCQGIENYSAYFGGDEIDRPYCLFDFFPEDYLLFIDESHVTLPQFRGMYN GDYSRKLNLVNFGFRLPSALKNRPLKYYEFESLINQAVFVSATPGLEESK KSSVIVEQIIRPTGLVDPEIILRPSDGQIEDIYSEIQRRVVLNEKILITT LTKKMSEDLTDYLLTLGIKARYLHAEFNAIERVNIITSLRKSEIDVIVGI NLLREGLDIPEVSLVIILDADKVGFLRSASSLIQIIGRAARNSHGCVIMY YDQISCAMQEAIEKTRRRRNIQIEYNKANNIVPKTIVKKVQSILEKEFKN KTLDYNVEKIISDNNLSREDLIIKLKFELNEAVEDERFEDAIFLRDKIKE LINI >BRE_458 uvrC, excinuclease ABC, subunit C MRKHLNDLYKQIEKFPKTSGCYKMYSKDNKILYIGKAKNLRSRVKNYFSK RTSHKTKILMNNVTNIEIITTNSEYEALLLECNLIKKYKPTYNIKLKDDK GYPMIRITCEKYPRIFKTRKIINDGSEYFGPYVNVKNLDLVLDLINKTFK TKKCKKKSKNPCLYFHMGQCLGVCYREDLEDEYRKEIEQIKHILNGNISK LLNDIEIKMKEVIMKENFEAAIKLKETKKSLIEISQTQIITKIDKLSEDY LYIHKTNSLNTIVILKYKDGKLTEKDIHFDESIYEEDELIEKFITQYYTS PNMIVPDKIHIFKKIDTSNITKLINELKNIKTEIIYKETKDNIKIIEMAT SNAKLALITYNHEKNKAIENLKTILEMKKLPKTIEGFDIAHINGYKTVAS LVTFKMGKPFKDGYRVYKINSLSNGEIDDCKAIKEVISRRYSKLINEQLK LPDLILIDGGKGQLNSAYSILKGLRIEEKIAICALAKKEEIIFLPNKNQG IKLQKRNSALQVLQNVRDEAHRRANNFNNKLHNNIKLNYTKIKGIGEQKA KKILKVLGTYKDILLLNEDEIATKMKINITMANKIKKFAEEQNLNNKQNN HI >BRE_347 uvrD, DNA helicase MMSEIQKFLFSLNFDQKQIVFDDTTNPILVLAGPGSGKTRVITAKFAHLI NKGKVKPEEILALTFTNKAAREMNFRLNSLFNFDRSLHIQTFHSFGAWLL RLYFKEYDENYDSNFTIWDVNDVVKFVKQIGLASNIECAKYVTSSILKYK ENYSLHNNCGFDDKIYSEIEFYEQEKSKSNAFDFADLILKSVLMLQNCEN IRMRVQKRFKAIFVDEYQDTNYSQFLFLRELYYKDAYFMVVGDEDQSIYS FRGARVENILEFERTFDNVSKYYLVQNYRSSLSIVNVANNIISKNQNRYD KVIATENKIGKKIKIFIFQNPTEEAEYFANFLIENKLETAVLYRFNHQSL QFEKAFFKNNIAHKILGSIRFYEREEIKDVISLLRLFVNKKDKVSFLRII NKPARGLGKTTIDKIIATLNDTDVNLDLMLASRKVVKNLKGKARDSLDIF LSLYDELKENIQKGIYVNLSEFIKDVTMGFGIWNYYQKFDKDEKSKNIDE LISSGVEYSGSFEGLVIFLENSSLSPLVHGDFASSVLLSSIHGVKGLEFD RVIISGLEKGLLPSEIEELTADRLEEERRLFYVAITRAKFELFITINLQR FFKGILKNTAISVFFQEIHKDNYDIVFVPEYLKDNFKFFFTRSDNKNFNI GDYIIYNGENGIIVDKWYQDGGPFLKISLKNGKKAILSSSYIKKLSKM >BRE_745 valS, valyl-tRNA synthetase MSEELSSSYDPKVFEDKIYKRWLDNGVFSPDDKIELKFSMVAPPPNVTGI LHMGHALNFTLQDILVRYKRMKGFNTLWLFGTDHAGIATQTVFEKQLREL GKSKDDFSREEFIEGILELKNKHRKIIVNQVEKLGASYDHLRERFTLDDG LSRAVNKVFIDLYNKGLIYKGEYLVNLDPGSGSVVSDEEVEYKEILGKIY FVKYLLCDGGFIEVATTRPETMFGDVAIAVNPNDERYKSLIGREVIIPIA NRKIKIIADDYVDMEFGSGALKITPAHDPNDFEIAKRHNLAKINILNKNA KLNENVPIEYQGLSVNAGRSKIEKDLRDKEFLIDVKNHKHQVGHCHRSGE VIEPYLSNQWFVKMKPLADAALQALIDGKIRFYPRKWENTYKHWLSNIKD WCISRQLVWGHRIPAWYDVQTGEIVVSEFDPSLSKNYSGRSFVRDSDVLD TWFSSWLWPFSSLGWPDVTFDLKNYYPTTTLVTAYDIIFFWVARMVMAGL EFMGEVPFRDIYITPLLRDKKGQKMSKSLGNGIDPLKIIEQYGSDALRFT LSFLSVQGQDLNIDTKDFMFGAKFANKVFNASKFILSNLKGRLVLDSLEF DDIDKWLITRLNATVAVIDWSFENYKYNEATKAVYEFFWNDFCDWYIEIS KINLCSDDFDLQNITISKLIFFLKESLLIMHPFIPFITEEIYSKVMSLEY ILALKKYPEVTMQRDFGEACQQFNLFKDFIISIRTLRSEFNIVPNIKINV ALKFGNTFQSEKYFRRNEYIAKKLINFDYIFYNENYENMIGVPNVNFESF ADIKDLIDTDKELTKLSKQLEKYEKLKNVTLQKLGNQNFLSNAPDEIINF EKLKLEEFDSFIVRISNYISNLKKSSY >BRE_3018 vlp-a, vlp protein, alpha subfamily MLVMWMMGCNSGGVKGGEGAGGGGDGRGLSGAMMELGRSAERVFYAFIEL MSDTLGLKVTKDTTKQQVGDYFNSLGGKLGETSEELEKVVNKATSGVDKS DESKNAKNPVKIAVDSAKGVLALLKTHLESLKNIGDDNKVVEVANNQNGV AANSDALKIMCKALKGIVEIATKQGVKDPSASSVTLAQASIGVDAKDGAK VLAAGANAGAAVGDKAAIIVSVVRGEEILASIVKSGESDAAVGANATADT SAISFAKGGTADHVSHEASAKAAAVAGGIALRALVKEGKLASHNDNNDHK AVQSVGISAVSKLLVSVEDIMKRQ >BRE_2043 vlp-a, vlp protein, alpha subfamily MLVMWMMGCNSGGVKGGEGAGGGGDGRGLSGAMMELGRSAERVFYAFIEL MSDTLGLKVTKDTTKQQVGDYFNSLGGKLGETSEELEKVVNKATSGVDKS DESKNAKNPVKIAVDSAKGVLALLKTHLESLKNIGDDNKVVEVANNQNGV AANSDALKIMCKALKGIVEIATKQGVKDPSASSVTLAQASIGVDAKDGAK VLAAGANAGAAVGDKAAIIVSVVRGEEILASIVKSGESDAAVGANATADT SAISFAKGGTADHVSHEASAKAAAVAGGIALRALVKEGKLASHNDNNDHK AVQSVGISAVSKLLVSVEDIMKRQ >BRE_3 vlp-a, vlp protein, alpha subfamily MIKKGKSKMRGIRGIKDKEEMRGGIWKMRGVIKRSLVIMMVMGVMGCGQQ VGKEKGKSLNEVLIDVGRSAENVFYSFLELVSGTLGFTVTKDTKKSEVET YFINIGKKIASASEELEQVAVKATADIDKDSILNKTIRSAVDSAKKTLEV LRGHLDSLKDIGDSDKVGVAVSQNQGVAVAEPELKKAYNAFKGIVDTSVG LGVDRLKESNVTLAQASIGVANPENGAKVLAAGANAGAAVGDKAALIVSA VRGKEMLESIVKSAEDKAVKIEANATADTTPLEFAVGGTAANVANANAKA AAVAGGIALRSLVKGGKLAAHDNNDDKAVQSAGVSAVNKLLVSLEDIVKK TVKNVLENVKQEVDKARVPKAEV >BRE_6020 vlp-b, vlp protein, beta subfamily MKRGIKGEMINRVMIIMVLVMVMMGCNSGGGIKEGEGESSQSKFLKSIIG LRNEFLNVFTSFGDMVGGILGFNAVKSDDKRSKVGEHFKTIGDGLKSTKD KLDELSKQIVSTSNADIKGVEAVIQGTSEVIAKLITSITELAGITKEGNV DIGDAGTAGSAAAVAADKASVEAIIKGVKEIVETAEKSGVKIEKGNAGNS VANGNGPKAVVHNVQATAGDATKLAGEVAKADPWAMIDKIKNAKTKNNVA PAANDDAGQLATATGANDNGSASTNADLAASVALKAMTKGGKFTQPAANE DGAIKAAAASAVNKVLGILDMIIRKAVNLELDKVKEAVKGIRYSETSGSN ATEAGTIQTSTVK >BRE_3012 vlp-c, vlp protein, gamma subfamily MIMMVMMGCNSGVLEAEQGKNKFLQSLVNVSNEFLNVFTSFWEMVGSVLG LNVNSKKSDVGKYFRTVQETVQGIKDGLNKIVNEMKEEKNPNAEATESAV KTLVESKLDKIIGGAKEASEAIGDASDPIGNVSDQNAGAVGIEVDKLVKG LKSIVDIVLKEGKNDAGDDKKASDGSTSRTGGNAGDGEAGKLFASANAGT AENAKKSAADAAKAVGAVTCADILQSMIEDNGEVVKLASSNAAVAAVNAN KKDGVIAGGIALRAMAKDGKFAGSSDAASVDAKKTVKGAAVSALIKALDT LTVAIRKTVDLGLKNVKEAMKINANATSVLPDKDVSDAKNQ >BRE_2037 vlp-c, vlp protein, gamma subfamily MIMMVMMGCNSGVLEAEQGKNKFLQSLVNVSNEFLNVFTSFWEMVGSVLG LNVNSKKSDVGKYFRTVQETVQGIKDGLNKIVNEMKEEKNPNAEATESAV KTLVESKLDKIIGGAKEASEAIGDASDPIGNVSDQNAGAVGIEVDKLVKG LKSIVDIVLKEGKNDAGDDKKASDGSTSRTSGNAGDGEAGKLFASANAGT AENAKKSAADAAKAVGAVTCADILQSMIEDNGEVVKLASSNAAVAAVNAN KKDGVIAGGIALRAMAKDGKFAGSSDAASVDAKKTVKGAAVSALIKALDT LTVAIRKTVDLGLKNVKEAMKINANATSVLPDKDVSDAKNQ >BRE_4 vlp-d, vlp protein, delta subfamily MSLSLFQYSISTSFVGCNNGIAELEKKNEFLSSIANLGKGFLDVFVAFGD MVSGTLGIKAETKKSEIGKYFGDIENTMKTTKAKLNEILEKNGNYEKVKE EVLKFIDKLTKIEEGAKKAALGATGGVIGEVVKSNAAGNGPDAGSIKNLV EGIKGIVDLVITGGDGGADKTNPVDDDKKNIGKLFGAKTEDSKGAEDKHV AAASASVGAVTEADILKAIAAANADAKRDGKVNEAEDVAALALAKGTNID NDDQIKDSARKDAIIAAGIALRAMAKDGKFVVKDTADKKTEAVVAKGVAT QNNPDADDAGKASAILASVSGEEILASIVSSKESNAALVGECKCRYKCNF FCERGSSSSLSTYN >BRE_5018 vlp-d_1, vlp protein, delta subfamily MKREKKGEGKVRVVILMVMMIVMGCNSGGVKDPEKVFLSEMVNLGKGFLD VFVSFGDMITETLGIKVETKKSEIGAYFSKIENTMKVVKGKLSKILEEHG SYEKVKEKVEGFIGKISKSEEGAKEAASGASGEEAIGNATTAGHGATPAS KDAVVSLVKGIKAIVGVVLKDNEGSADANKTGDDKKDIGNLFVNDAGKGE AKEENIAKAAASIGVVSGADILKAIAKSKENPNIDTTNGIEKATDAAEIA VAKAVNDKKEIKEVTAKKDAVIAGGIALRGMAKDGKFAVKNEDKSANAVN GAVASAVNKVLSTLTIAIRNTVDLGLKEINKVLGEIKQGEGAVAKVNE >BRE_3011 vlp-d_1, vlp protein, delta subfamily MMMMVVMGCNSGGVKDPEKVFLSEMVNLGKGFLEVFVSFGDMITGTLGIK AETKKSEIGGYFSKIAETMKEVREKLEKILEENGKYEKVREKVGEFIGKI SKIEEGAKEASKGANGDIIGNAKKGEDAVAASKDSVVSLVKGIKAIVEIV LGEKEGNAGNNIITEDKKDIGKLFGKKDGDRAQEAEAAKVSTSIGAVSGA DILKAIAKSKENPVTDSANGIEKATDAAEIAVVPSVDDKKEIKEDTAKKD AIIAAGIALRGMAKEGKFAAKKDEDKSAHAVNGAVSSAVNKVLSTLVIAI RNTVDKGLKEINEVLGEIKQGEGVEAKVSK >BRE_2036 vlp-d_1, vlp protein, delta subfamily MMMMVVMGCNSGGVKDPEKVFLSEMVNLGKGFLEVFVSFGDMITGTLGIK AETKKSEIGGYFSKIAETMKEVREKLEKILEENGKYEKVREKVGEFIGKI SKIEEGAKEASKGANGDIIGNAKKGEDAVAASKDSVVSLVKGIKAIVEIV LGEKEGNAGNNIITEDKKDIGKLFGKKDGDRAQEAEAAKVSTSIGAVSGA DILKAIAKSKENPVTDSANGIEKATDAAEIAVVPSVDDKKEIKEDTAKKD AIIAAGIALRGMAKEGKFAAKKDEDKSAHAVNGAVSSAVNKVLSTLVIAI RNTVDKGLKEINEVLGEIKQGEGVEAKVSK >BRE_3020 vlp-d_2, vlp protein, delta subfamily MKEKKGKGNIEESISEYREKGREKRSKRGLKGIMVLVMVMMGCNSGGVSG GVKDPEKVFLSEMVNLGKGFLDVFVSFGDMITGTLGIKADTKKSDIGKYF TDIEKTMISVKEKLQTEVAKNGNYVKIKEVVDQFITGTLDKIAEGAKKAS SGAAGGAVLGSSVKNEDAAPGEVASVNALIEGIKTIVAVVLKNEGNADAN KTTDDDKKDIGKLFSKASDNGSEAEAAKANASIGAVSGVDILQAIAKSDV VSAAGKDIDQAKDVAEIATAKNDSGTKETKQKDAVISGGIALRSMAKGGK FATKNEDKAVPAINGVAASAVGKTLSALIIAIRNTVDSELKKINEVLATV KQEDKSSEATASVQ >BRE_5029 vlp-d_2, vlp protein, delta subfamily MKKMKEEGIKGIRGIRGIKGKEELGKKEGRRNNRIVLGMMMVMMGCNSGG VSGGVRDPEKVFLSEMVNLGKGFLDVFVSFGDMITGTLGIKADTKKSEIG GYFTKIAETMKGVREKLGKILEENGKYEKVKEKVEEFVGEIGKIEAGAQE AAKGATGEAIGNAASAGHGATPANRESVVSLVKGIKIIVDVVLKGKGNAE ATKTGDDKKDIGNLFADDNGKGDAKEENIAKASASIGAVIGADILQAIAK SKEDPKDYATDGIEKATDAAEIAIAKAVNAKKEIKEESAKKDAVIAAGIA LRGMAKDGKFAANQSAKDANAVNGAVASAVNKVLSTLTIAIRNTVDLGLK EINKVLGEIKEGEGFEVKTN >BRE_2045 vlp-d_2, vlp protein, delta subfamily MKEKKGKGNIEESISEYREKGREKRSKRGLKGIMVLVMVMMGCNSGGVSG GVKDPEKVFLSEMVNLGKGFLDVFVSFGDMITGTLGIKADTKKSDIGKYF TDIEKTMISVKEKLQTEVAKNGNYVKIKEVVDQFITGTLDKIAEGAKKAS SGAAGGAVLGSSVKNEDAAPGEVASVNALIEGIKTIVAVVLKNEGNADAN KTTDDDKKDIGKLFSKASDNGSEAEAAKANASIGAVSGVDILQAIAKSDV VSAAGKDIDQAKDVAEIATAKNDSGTKETKQKDAVISGGIALRSMAKGGK FATKNEDKAVPAINGVAASAVGKTLSALIIAIRNTVDSELKKINEVLATV KQEDKSSEATASVQ >BRE_3023 vlp-d_3, vlp protein, delta subfamily MKKMKEEGIKGIRGIRGIKGKEELGKKEGRRNNRIVLGMMMVMMGCNSGG VSGGVRDPEKVFLSEMVNLGKGFLDVFVSFGDMITGTLGIKADTKKSEIG GYFTKIAETMKGVREKLGKILEENGKYEKVKEKVEEFIGEIGKIEAGAQE AAKGATGEAIGNAASAGHGATPANRESVVSLVKGIKIIVDVVLKGKGNAE ATKTGDDKKDIGNLFADDNGKGDAKEENIAKASASIGAVIGADILQAIAK SKEDPKDYATDGIEKATDAAEIAIAKAVNAKKEIKEESAKKDAVIAAGIA LRGMAKDGKFAANQSAKDANAVNGAVASAVNKVLSTLTIAIRNTVDLGLK EINKVLGEIKEGEGFEVKTN >BRE_2048 vlp-d_3, vlp protein, delta subfamily MKKMKEEGIKGIRGIRGIKGKEELGKKEGRRNNRIVLGMMMVMMGCNSGG VSGGVRDPEKVFLSEMVNLGKGFLDVFVSFGDMITGTLGIKADTKKSEIG GYFTKIAETMKGVREKLGKILEENGKYEKVKEKVEEFIGEIGKIEAGAQE AAKGATGEAIGNAASAGHGATPANRESVVSLVKGIKIIVDVVLKGKGNAE ATKTGDDKKDIGNLFADDNGKGDAKEENIAKASASIGAVIGADILQAIAK SKEDPKDYATDGIEKATDAAEIAIAKAVNAKKEIKEESAKKDAVIAAGIA LRGMAKDGKFAANQSAKDANAVNGAVASAVNKVLSTLTIAIRNTVDLGLK EINKVLGEIKEGEGFEVKTN >BRE_4003 vlp_1, vlp protein MYVLYKSYFFASNPSKKSYKKAKKKKNKEAKRMKKGIKGEMINIVMIMCL MVVMGCNSGGVKGEEGKGTQGIGGLGEVISHLREGFLEVFVSFGNILKDT FGLTSNTTKKEVGERLGKIGEAVEIAKGKLEGIKGTEQFSLMKDKVDSVI TNAVNILKKLVEGTKKFKEATDGANGKIGNANGTEDAVQADIASVKSLVE GINMIYEAAKEVKVDSKGNADKTIADSKAIAKLFNDTASADATGLKAANV ALNSSSGADILAAIDSAKNGINAPAGQISAAKNAYDIAVAIKNSADAGAD VREKGSVITAGLALRAMAKNGKLATHANVPAEGLNAVLIGAVSKTVNEIV STIRRTVDKCLKDVNDCIKEGFSSVVKS >BRE_4033 vlp_2, vlp protein MYVLYKSYFFASNPSKKSYKKAKKKKNKEAKRMKKGIKGEMINIVMIMCL MVVMGCNSGGVKGEEGKGTQGIGGLGEVISHLREGFLEVFVSFGNILKDT FGLTSNTTKKEVGERLGKIGEAVEVAKGKLEGIKGTEQFSLMKDKVDSVI TNAVNILKKLVEGTKKFKEATDGANGKIGNANGTEDAVQADIASVKSLVE GINMIYEAAKEVKVDSKGNADKTIADSKAIAKLFNDTASADATGLKAANV ALNSSSGADILAVIDSAKNGINAPAGQISAAKNAYDIAVAIKNSADAGAD VREKGSVITAGLALRAMAKNGKLATHANVPAEGLNAVLIGAVSKTVNEIV STIRRTVDKCLKDVNDCIKEDFSSVVKS >BRE_4030 vsp, vsp protein MKREVKEGEIKGKRDKKVEGKRRVVILMMVMMIVMGYNSGEGIKEGEEGK ARKGDGSVIDLKVVSKKIGEAVVFVEDVKEVYTLVKSIDELAKAIKKRIQ AGGLQDDNDNLNGTLLAGAYQIMSDAESKLATLEGKAEKFVGMKDKVTSA KQKSTAFLNKLKSENATLGVASAAVSSANAKEAIDRNNGSKTKGAQELVD LNIEIDGLLATAKSFVSDVIKELTTSAKDVVVNP >BRE_2010 vsp_1, vsp protein MGCNSGGGIKEGEEEKARKGDGSVIDLKVVGEKIKSAVEFAGKVKEVHTL VKSVDELAKAIGKKVEGAGNLSDDGGQNGSLISAAYSIISSVSTKLDALE QQAEVSTELKAKITIVKTASKKFTDTVKGASADLGKKDASDENAKKALLK SDAVGDKGAKDLVALNTAIDELLKNAEVAVASAIKELTISSNN >BRE_5027 vsp_1, vsp protein MVVVMVMGCNSGGVSGGEEGQAKKGDGSVIDLKVVGEKIKSAVEFVEKVK EVHTLVKSVDELAKAIGKKVGAAGLGDIADHNGSLIAGAYSVIEAVDAKL ATLAGKVGLSSDLSTKVNDAKVKSTAFLNKLKSSTAEFDKEGASDADSKK ALLKDNADKTKGRDELDKLNTSIDILMASSKKELDDSIKNLIEEPVRPDT VGN >BRE_3019 vsp_1, vsp protein MGRIVKGIIMGMMVVVMGCNSGGVSGEGTGGDGKVRKGDGSVIDLKVVGE KIKSAVEFAGKVKEVHVLVKSVDELAKAIGKKIKDSDQELDALDGKNGSL MAGVFQIILTVKGGLTKLETDSSSVTEKIKTKITDAKTKSVNFLKKLQEK NTDLGKEDVSNADAEKAIDYVKQKDGDKGAKELGELNKAVDELLVSSNKI VSDAIAELVVKPIT >BRE_2044 vsp_2, vsp protein MGRIVKGIIMGMMVVVMGCNSGGVSGEGTGGDGKVRKGDGSVIDLKVVGE KIKSAVEFAGKVKEVHVLVKSVDELAKAIGKKIKDSDQELDALDGKNGSL MAGVFQIILTVKGGLTKLETDSSSVTEKIKTKITDAKTKSVNFLKKLQEK NTDLGKEDVSNADAEKAIDYVKQKDGDKGAKELGELNKAVDELLVSSNKI VSDAIAELVVKPIT >BRE_5030 vsp_2, vsp protein MGCNSGGVGEGSQAKATKADGSVIDLKVVSKKIKDAVEFAEKVKEVHVLV KSVDELAKAIGKKIDANGSLAAEAGQNGSLIAGVHSVISAVNTKLKGLET TDNISDELKGKIVAVETEGKAFLDKLKSGNAELGKKDASDDDTKKAIDRI GKKDGDKGVAELIKLNTAIDALLKLSTDAVEASIGELTVKPAV >BRE_3021 vsp_2, vsp protein MGEVSGGEEGQAKKGDGSVIDLKVVGEKIKSAVEFVEKVKEVHTLVKSVD ELAKAIGKKVGAAGLGDIADHNGSLIAGAYSVIEAVDAKLATLAGKVGLS SDLSTKVNDAKVKSTAFLNKLKSSTAEFDKEGASDADSKKALLKDNADKT KGRDELDKLNTSIDILMASSKKELDDSIKNLIEEPVRPDTVGN >BRE_2046 vsp_3, vsp protein MVVVMVMGCNSGGVSGGEEGQAKKGDGSVIDLKVVGEKIKSAVEFVEKVK EVHTLVKSVDELAKAIGKKVGAAGLGDIADHNGSLIAGAYSVIEAVDAKL ATLAGKVGLSSDLSTKVNDAKVKSTAFLNKLKSSTAEFDKEGASDADSKK ALLKDNADKTKGRDELDKLNTSIDILMASSKKELDDSIKNLIEEPVRPDT VGN >BRE_3024 vsp_3, vsp protein MGCNSGGVGEGSQAKATKADGSVIDLKVVSKKIKDAVEFAEKVKEVHVLV KSVDELAKAIGKKIDANGSLAAEAGQNGSLIAGVHSVISAVNTKLKGLET TDNISDELKGKIVAVETEGKAFLDKLKSGNAELGKKDASDDDTKKAIDRI GKKDGDKGVAELIKLNTAIDALLKLSTDAVEASIGELTVKPAV >BRE_2049 vsp_4, vsp protein MGCNSGGVGEGSQAKATKADGSVIDLKVVSKKIKDAVEFAEKVKEVHVLV KSVDELAKAIGKKIDANGSLAAEAGQNGSLIAGVHSVISAVNTKLKGLET TDNISDELKGKIVAVETEGKAFLDKLKSGNAELGKKDASDDDTKKAIDRI GKKDGDKGVAELIKLNTAIDALLKLSTDAVEASIGELTVKPAV >BRE_550 xylB, xylulokinase MNVLSIDVGTSTLKSALINSHYGILGCLDINYFDYFNVNFENFDYKIWIF ALKKIMSHFMYRKIDCISISGISPCLIALDSNLIPLEVLHWNSSKVVKNY KGKSTFLPFVLSTFERGIYDKVRYFVSCFEYLIYLLTGNLVTSYPSLSYI PFIWNNIELKEYNLDTSKFPPFLRMGEIVGQVTKRASIEFGINSGINVIN AGIDYLSVLIGSGAFFSGIVSNRMGTSEGFNFVSDTYLLDFSLIYPYFLD NLFIIGRIVPSGYLLQLLKDRLFQKEKSFGEFLEKISAIYTPSNIYFYLN KKELFCDYILIDPQIKNNLNEGIVGKLDDPLQIGIAILESSYFSFYNRML NLKSCKRDILDIFVSGTNSDNLFLNKLKANIIGKDLKIFEFKHSEIAGNA ILAFCCLKEFDNLEDAFKKLVKIKRIVSFNANMHDIYLEKYHNYVSNFNL FVNS >BRE_699 xylR-1, xylose operon regulatory protein MQGENMVSIRGGNRKKILLSLKNMQYSRTDLARRLSLTNAAVTILTNHMI KENILVEVGSKESDIKKHGRKEILLDINKDFAYSMGVIISSNYFQIGIAN LKCEVLISETYSFEPLVSAYEILERIKDHMIEIIWKHNFSRDKFIGLGFS ITGIIKDKESGIVNDSHGAWIEKDVPVKAILEEYFSLTVYLESYVKNLSL AEFMGKNVDNIMFFDYTDTAELSIWSDGNVYSGFNNKSGMVSHMVIDYGG EKNCPTCGNKGCVNMLISNFALQRLISKEFMNGEIPELYDKYESRLKKVT IYDIFALHDKYDFIHKIMEDTVKYLAIVIINIQRVLDFNYLVLYGQSFKL KSFFDLLKEEIKRLNKESIILKLSSLDTEVSVVGPASSVIFNKFYLTGGD ID >BRE_521 yacO, rRNA methylase MYITHANSIIESIKNNKGLELYISKTSPKAISIEQLARQHNIKIIKINDL TKILGNNNHRGFALKLQNLKDYNTINKNKNLEEYLKEFQHKNNILILILD SIEDPQNFGAILRTAEQFNIDLVITNQRKSVKDNATVLRTSSGASQYVNK LTVPNINNVIRYLKKQGFWIYASDIKGQAINNTKITDNKIALIMGNEGKG IHNLLKNNSDFLIKIPTKGKIDSLNVSVSTGILIFEIKRQLNLL >BRE_657 yajC, preprotein translocase YajC subunit MFLLQDFSHSSSFFRSLLVFVPVIAIFWFLVISPQRKEEKKKKEMLKSLK KGDKVLTIGGIFGVVKRVDDSEVLLELSETSEAKFVKSSIEKVIFDEIKD KKLKNEK >BRE_276 ylxH-1, ATP-binding protein MMEDQAQSLRDIMRLNNKSSFVVDDKIQNNKTRFISVTSGKGGVGKSNIA VGLALKYAHLGKKVLVFDADIGMANINILLGVIPKYNIYHMIVQGRCIQD VITKTEYNIDLLAGASGTTELLDLSETEMNQFIKELLKVYEYDIVIIDTS AGISRQVISFLFSSDDVVIVTTPEPTSITDAYGIIKVLSHKMENLKNLRL VVNRVANVSEGKIVAKKVVDISNQFLNLNVDYLGYVYEDQNIKNSVFKQR PFILLNPNSKASYCLDSIVAALEEITLDNKKRRGVIGFISKFFGME >BRE_362 ylxH-2, ATP-binding protein MIIIPIASGKGGVGKSLFSTNIAICLANEGKKVLLVDLDLGGSNLHSMLN IIPKKSIGTFLKTQIPFQDIILESGIKNLNFIAGDSDIPELANIAIFQKK KIIKNLKNQNYDYLIIDLGAGTAFNTIDFFLMSNRGVIVTIPTVTATMNA YLFLKNAIFRLISKIFTKETKAYKIVSNIRKDSTDLQKIYIPNLLLKIEE HDPENYAKFMQIFAQFSPFIIFNMLNKPEDIIKTEKILKSAKNYLNINLQ SIGSIYKDELVDQALNHKIPITIYKPTSLISKSIKKIAKRLIELEDVIND VELLNEDDLNASYYFVIKEAQDEYLEKYAYLESLLMNKTIDNNAIIDIIK SQQKEIATLRKQNIMFKKKLFTKLKKD >BRE_732 ylxH-3, MinD-related ATP-binding protein MTKIIPVASGKGGVGKTSFVANIGYKLARLGKTVILVDLDLGGSNLHTCL GVKNTGVGIGSFINKQEKDFSSLILKTPYKKLYLVPGDALYTGTANIPFS IKKRIIDSIQRELVADFVFIDLGSGTSYNTVDFYLSSYSGIIITVPETPS ILNAYSFLKNALYRLLYLGFPPKSPEREYISNFFKNKIEGTNVKFKDLVL GIEVISLSSSLKVKKMMNSFYPRVVLNRIESSEEIAMCENLINVVKNNIN IPVEFIGFIPFAKSFRASVNSRIPFVDFDRNSKLNKYFEFIARNLIKSPV EGSPYIYDDIYDMIKDQSQFIRK >BRE_365 yscI, aminopeptidase I MTKQNPWLSLNEEKKNNILEFAHKYKKFLNTVKTEREATNYAIQKAKEKG FISACQKKELQAGDKIFYTSRNKNIALVFIGREPIENGMHFIVSHTDSPR LDAKPSPISQENEFTMMKTNYYGGIKKYQWLSTPLSIRGIIFLHNGKQVE ISIGDNNDDPVFVIPDILPHLDRKVQRDKKADDIIEGENLRIIIGSLPIE SREKEKVKFATLTLLKEKYNISEEDFVSAEIEIVPAGEAKDVGIDRALIG AYGQDDRVCAYTSLEAILNLEETPNKTAICFLVDKEEIGSTGSTGLQSRY LEYFVSDIIFKLKQKEYNNLIVHKALWNSKSISADVCGAINPLFKVHDEQ NAPKLGYGIPIMKYTGHGGKIMASDADAELVFYIRNLLDKNNIAWQVATL GKVEEGGGGTVAKFLAHYGIRTIDMGPGVISMHSPFEITSKFDIYTAYMA YKAFFKG >BRE_643 zwf, glucose-6-phosphate 1-dehydrogenase MSGKNVSNFDVVIFGVTGNLARKKLIPSLFNLYKDGYISNFRIIGFARKN FTDEEIKNYIKDALWQEEFTALVDNFLQFVIYLSGDFRDKNAYLKLLSLL SNREKIYYLATSPEFYESIIENLKLYLCDDTSYLSKIILEKPFGSDLDTA RFLNSLLYSVFKEEQIYRIDHYLGKETVQNIFTFRFGNSIFENIWNNRYV DFVQITVAEEVGIDGRAEYYDSVGALRDMVQNHILQLLSLIAMEPPIGFN ADFIHDEKVKVLKSLRKFNQDTMKDNIIKGQYVCSKVQGVSRKGYRKEAN FLCNSDTETYLAMKLFIDNWRWSGVPFYIRTGKALVRKFSEIYIQFKKPN FTIFNTGLSNLANALVFRIQPRDGIEIKFNTKKPGYNYEIQEANMEFSYH ASFNKFFGESYERLLFDAFLGDRTLYARNDEIDSSWEFVSDILDKWGNIE NMDYFYGSEGPIEANLILEKDHFWRKM
|
Beutenbergstraße 11 D-07745 Jena • Germany |
Phone: +49 3641 65-6000 Fax: +49 3641 65-6351 |
E-mail: info@leibniz-fli.de www.leibniz-fli.de |
Data Privacy Imprint |
|